CN117320708A - 治疗癌症的方法 - Google Patents

治疗癌症的方法 Download PDF

Info

Publication number
CN117320708A
CN117320708A CN202180094288.1A CN202180094288A CN117320708A CN 117320708 A CN117320708 A CN 117320708A CN 202180094288 A CN202180094288 A CN 202180094288A CN 117320708 A CN117320708 A CN 117320708A
Authority
CN
China
Prior art keywords
subject
atm
sting
activity
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202180094288.1A
Other languages
English (en)
Inventor
G·格利克
A·W·小奥皮帕里
H·M·塞德尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Afumdeyou Co ltd
Original Assignee
Afumdeyou Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Afumdeyou Co ltd filed Critical Afumdeyou Co ltd
Publication of CN117320708A publication Critical patent/CN117320708A/zh
Pending legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/4035Isoindoles, e.g. phthalimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

本文提供了治疗对象(例如患有癌症的对象)的方法,其包括给予对象治疗有效量的STING拮抗剂或cGAS抑制剂或其药学上可接受的盐、溶剂化物或共晶体,所述对象被鉴定为从对象获得的肿瘤样品中具有与参考水平相比降低的ATM水平和/或活性。

Description

治疗癌症的方法
相关申请的交叉引用
本申请要求2020年12月22日提交的系列号为63/129,229的美国临时申请的优先权权益,其通过引用整体纳入本文。
技术领域
本发明部分涉及治疗对象(例如,患有癌症的对象)的方法,包括给予STING拮抗剂或cGAS抑制剂。
背景技术
cGAS/STING(干扰素基因的环状GMP-AMP合酶/刺激因子)途径是炎症信号转导途径的一个组分。当DNA存在于细胞胞浆中时,cGAS与其结合并产生2'-5'环状GMP-AMP(cGAMP)。通过cGAMP活化,STING可诱导干扰素(IFN)调节因子(IRF)的磷酸化和核转位。作为转录因子,IRF调节基因表达,包括调节免疫系统活性的I型干扰素。
细胞胞浆中DNA的存在有时可能是感染的结果。在某些情况下,细胞胞浆中DNA的存在可能是细胞核或细胞线粒体中DNA损伤的结果。在某些情况下,胞浆DNA被酶降解或修饰,以防止cGAS/STING途径活化。
发明内容
本发明基于以下发现:具有降低的ATM水平和/或活性的癌细胞对采用STING拮抗剂或cGAS抑制剂的治疗更敏感,例如,与没有ATM水平和/或活性降低的细胞相比。
本文提供了治疗有需要的对象的方法,包括:(a)鉴定对象,其在自所述对象获得的肿瘤样品中具有癌细胞的,其具有与参考水平相比降低的ATM水平和/或活性;和(b)给予经鉴定的对象治疗,所述治疗包括治疗有效量的STING拮抗剂或cGAS抑制剂或其药学上可接受的盐、溶剂化物,或共晶体。
本文还提供了治疗有需要的对象的方法,该方法包括给予对象包括治疗有效量的STING拮抗剂或cGAS抑制剂或其药学上可接受的盐、溶剂化物或共晶体的治疗,对象被鉴定为在从对象获得的肿瘤样品中具有癌细胞,其具有与参考水平相比降低的ATM水平和/或活性。
本文还提供了为有需要的对象选择治疗的方法,所述方法包括:(a)鉴定对象,其在自对象获得的肿瘤样品中具有癌细胞,其具有与参考水平相比降低的ATM水平和/或活性;和(b)为经鉴定的对象选择治疗,包括治疗有效量的STING拮抗剂或cGAS抑制剂或其药学上可接受的盐、溶剂化物,或共晶体。
本文还提供了为有需要的对象选择治疗的方法,包括为经鉴定的对象选择包括治疗有效量的STING拮抗剂或cGAS抑制剂或其药学上可接受的盐、溶剂化物或共晶体的治疗,对象被鉴定为在从对象获得的肿瘤样品中具有癌细胞,其具有与参考水平相比降低的ATM水平和/或活性。
本文还提供了选择治疗对象的方法,所述方法包括:(a)鉴定对象,其在自对象获得的肿瘤样品中具有癌细胞,其具有与参考水平相比降低的ATM水平和/或活性;和(b)为经鉴定的对象选择用治疗有效量的STING拮抗剂或cGAS抑制剂或其药学上可接受的盐、溶剂化物,或共晶体治疗。
本文还提供了选择参与临床试验的对象的方法,所述方法包括:(a)鉴定对象,其在自对象获得的肿瘤样品中具有癌细胞,其具有与参考水平相比降低的ATM水平和/或活性;和(b)选择经鉴定的对象参与临床试验,临床试验包括给予包括治疗有效量的STING拮抗剂或cGAS抑制剂或其药学上可接受的盐、溶剂化物,或共晶体的治疗。
本文还提供了选择参加临床试验的对象的方法,该方法包括选择鉴定为在从对象获得的肿瘤样品中具有癌细胞,其具有与参考水平相比降低的ATM水平和/或活性的对象参加临床试验,临床试验包括给予包括治疗有效量的STING拮抗剂或cGAS抑制剂或其药学上可接受的盐、溶剂化物或共晶体的治疗。
本文还提供了一种预测对象对STING拮抗剂或cGAS抑制剂的反应性的方法,该方法包括:(a)确定对象在自对象获得的肿瘤样品中具有癌细胞,其具有与参考水平相比降低的ATM水平和/或活性;和(b)将步骤(a)中确定自对象获得的肿瘤样品中具有与参考水平相比降低的ATM表达和/或活性的对象鉴定为对STING拮抗剂或cGAS抑制剂治疗有反应的可能性增加。
本文还提供了预测对象对STING拮抗剂或cGAS抑制剂反应性的方法,该方法包括鉴定被确定在自所述对象获得的肿瘤样品中具有癌细胞,其具有与参考水平相比降低的ATM水平和/或活性的对象,所述对象被鉴定为对STING拮抗剂或cGAS抑制剂治疗有反应的可能性增加。
在本文任何所述方法中的一些实施方式中,对象被鉴定为具有癌细胞,与参考水平相比,所述癌细胞同时具有(i)ATM水平和/或活性降低和(ii)cGAS/STING信号转导途径活性增加;和任选地,其中对象被鉴定为从对象获得的血清或肿瘤样品中与参考水平相比cGAMP水平升高。
在本文任何所述方法中的一些实施方式中,ATM水平和/或活性降低是对象中ATM基因的一个或两个等位基因同时缺失的结果。在本文任何所述方法中的一些实施方式中,ATM水平和/或活性降低是对象中ATM基因的一个或两个等位基因同时突变的结果。
在本文任何所述方法中的一些实施方式中,该方法进一步包括向对象给予所选择的治疗。在本文所述的任何方法中的一些实施方式中,该方法还包括向经鉴定为对使用STING拮抗剂或cGAS抑制剂的治疗反应的可能性增加的对象给予治疗有效量的STING拮抗剂或cGAS抑制剂。
在本文所述的任何方法中的一些实施方式中,对象已被诊断或鉴定为患有癌症,例如选自下组的癌症:肾透明细胞癌、肾乳头状细胞癌、嫌色肾细胞癌、葡萄膜黑色素瘤、舌鳞状细胞癌、乳腺癌、骨肉瘤和皮肤癌。在本文所述的任何方法中的一些实施方式中,对象已被诊断或鉴定为患有癌症,例如选自下组的癌症:肾透明细胞癌、葡萄膜黑色素瘤、舌鳞状细胞癌、乳腺癌和皮肤癌。
在本文所述的任何方法中的一些实施方式中,STING拮抗剂是具有式I-XXIV或式M1-M6的任一化合物,或其药学上可接受的盐、溶剂化物或共晶体。在本文所述的任何方法的一些实施方式中,STING拮抗剂或cGAS抑制剂选自表C1-C2中的化合物,或其药学上可接受的盐、溶剂化物或共晶体。
如本文所用,术语“STING拮抗剂”是降低(i)STING活性(例如,本文所述的任何示例性STING活性)(例如,与不存在该剂时的STING活性水平相比)和(ii)STING在哺乳动物细胞中的表达水平(例如,使用本文所述的任何示例性检测方法)(例如,与未与该试剂接触的哺乳动物细胞中STING的表达水平相比)中一者或两者的试剂。本文描述了STING拮抗剂的非限制性例子。
如本文所用,术语“STING”旨在包括但不限于核酸,多核苷酸,寡核苷酸,正义和反义多核苷酸链,互补序列,肽,多肽,蛋白质,同源和/或直系STING分子,同种型,前体,突变体,变体,衍生物,剪接变体,等位基因,不同种类及其活性片段。
如本文所用,术语“ATM”旨在包括但不限于核酸,多核苷酸,寡核苷酸,正义和反义多核苷酸链,互补序列,肽,多肽,蛋白质,同源和/或直系STING分子,同种型,前体,突变体,变体,衍生物,剪接变体,等位基因,不同种类及其活性片段。
如本文所用,术语“cGAS抑制剂”是降低(i)cGAS活性(例如,本文所述的任何示例性cGAS活性)(例如,与不存在该剂时的cGAS活性水平相比)和(ii)cGAS在哺乳动物细胞中的表达水平(例如,使用本文所述的任何示例性检测方法)(例如,与未与该试剂接触的哺乳动物细胞中cGAS的表达水平相比)中一者或两者的试剂。本文描述了cGAS抑制剂的非限制性例子。
如本文所用,术语“cGAS”旨在包括但不限于核酸,多核苷酸,寡核苷酸,正义和反义多核苷酸链,互补序列,肽,多肽,蛋白质,同源和/或直系cGAS分子,同种型,前体,突变体,变体,衍生物,剪接变体,等位基因,不同种类及其活性片段。
如本文所用,就制剂、组合物或成分而言,术语“可接受的”是指对所治疗的对象的总体健康没有持续的有害影响。
“API”是指活性药物成分。
如本文所用,术语“有效量”或“治疗有效量”是指足以在某种程度上缓解所治疗疾病或病症的一种或多种症状的STING拮抗剂或cGAS抑制剂的量。结果包括减少和/或减轻疾病的体征、症状、或疾病原因,或生物系统的任何其它所需改变。例如,用于治疗用途的“有效量”是包含本文公开的STING拮抗剂或cGAS抑制剂的组合物以提供临床上显著减轻疾病症状所需的量。在任何情况下,都可以使用任何适当的技术(例如剂量递增研究)来确定合适的“有效”量。
术语“赋形剂”或“药学上可接受的赋形剂”是指药学上可接受的材料、组合物或载剂,例如液体或固体填充剂、稀释剂、运载体、溶剂或包封材料。在一个实施方式中,每种组分在与药物制剂的其他成分相容的意义上是“药学上可接受的”,并且适合与人和动物的组织或器官接触而没有过度的毒性、刺激性、过敏反应、免疫原性或其他问题或并发症,与合理的获益/风险比相称。例如,参见《雷明顿药物科学与实践》(Remington:The Science andPractice of Pharmacy),第21版;LWW出版公司(Lippincott Williams&Wilkins):宾夕法尼亚州费城,2005;《药物赋形剂手册》(Handbook of Pharmaceutical Excipients),第6版;Rowe等编,药学出版社和美国药学会(The Pharmaceutical Press and the AmericanPharmaceutical Association):2009;《药物添加剂手册》(Handbook of PharmaceuticalAdditives),第3版;Ash和Ash编著,高尔出版公司(Gower Publishing Company):2007;《药物预制剂和制剂》(Pharmaceutical Preformulation and Formulation),第2版,Gibson编,CRC出版有限公司(CRC Press LLC):佛罗里达州博卡拉顿,2009)。
术语“药学上可接受的盐”可指药学上可接受的无毒酸(包括无机酸和有机酸)制备的药学可接受的加成盐。在一些情况下,药学上可接受的盐是通过使本文所述的化合物与酸,例如盐酸、氢溴酸、硫酸、硝酸、磷酸、甲磺酸、乙磺酸、对甲苯磺酸、水杨酸等反应获得的。术语“药学上可接受的盐”可指通过使具有酸性基团的化合物与碱反应,或通过先前确定的其它方法形成的药学上可接收的加成盐,例如铵盐,碱金属盐,例如钠或钾盐,碱土金属盐,例如钙盐或镁盐,有机碱的盐,例如二环己胺,N-甲基-D-葡萄糖胺,三(羟甲基)甲胺,以及与氨基酸形成的盐,例如精氨酸,赖氨酸等。对药理学上可接受的盐没有具体限制,只要其可以用于药物即可。本文所述化合物与碱形成的盐的例子包括如下:与无机碱形成的盐,例如钠、钾、镁、钙和铝;与有机碱(例如甲胺、乙胺和乙醇胺)形成的盐;与赖氨酸和鸟氨酸等碱性氨基酸形成的盐;以及铵盐。所述盐可以是酸加成盐,其具体例子为以下酸加成盐:无机酸,如盐酸、氢溴酸、氢碘酸、硫酸、硝酸和磷酸:有机酸,如甲酸、乙酸、丙酸、草酸、丙二酸、琥珀酸、富马酸、马来酸、乳酸、苹果酸、酒石酸、柠檬酸、甲磺酸和乙磺酸;酸性氨基酸,如天冬氨酸和谷氨酸。
术语“药物组合物”是指STING拮抗剂或cGAS抑制剂与其它化学组分(本文统称为“赋形剂”)的混合物,所述化学组分例如为运载体、稳定剂、稀释剂、分散剂、助悬剂和/或增稠剂。药物组合物有助于向生物体施用STING拮抗剂或cGAS抑制剂。本领域存在多种施用化合物的技术,包括但不限于:直肠、口服、静脉内、气溶胶、胃肠外、眼、肺部和局部给药。
术语“对象”可以指动物,包括但不限于灵长类动物(例如人)、猴、牛、猪、绵羊、山羊、马、狗、猫、兔、大鼠或小鼠。术语“对象”和“患者”在本文中可互换使用,例如指哺乳动物对象,例如人对象。在本文描述的任何方法的一些实施方式中,对象为1岁或以上、2岁或以上、4岁或以上、5岁或以上、10岁或以上、12岁或以上、13岁或以上、15岁或以上、16岁或以上、18岁或以上、20岁或以上、25岁或以上,30岁或以上、35岁或以上、40岁或以上、45岁或以上、50岁或以上、55岁或以上、60岁或以上、65岁或以上、70岁或以上、75岁或以上、80岁或以上、85岁或以上、90岁或以上、95岁或以上、100岁或以上,或者105岁或以上。
在本文所述的任何方法的一些实施方式中,对象先前已被诊断或鉴定为患有与STING活性相关的疾病(例如癌症,例如本文所述的任何示例性癌症类型)。在本文描述的任何方法的一些实施方式中,对象被怀疑患有癌症(例如,本文描述的任何示例性癌症)。在本文所述的任何方法的一些实施方式中,对象呈现癌症(例如,本文描述的任何示例性癌症)的一种或多种(例如,两种、三种、四种或五种)症状。
在本文所述任何方法的一些实施方式中,所述对象是临床试验的参与者。在本文所述任何方法的一些实施方式中,所述对象之前曾经接受过药物组合物给药,并且确定不同的药物组合物不具有治疗效果。
术语“给药”或“给予”是指向无脊椎动物或脊椎动物(包括鱼类、鸟类和哺乳动物(例如人类))提供一定剂量的药物组合物或化合物的方法。在一些方面,例如,经口、静脉内、皮下、鼻内、经皮、腹膜内、肌肉内、肺内、淋巴内、局部、眼内、阴道、直肠、鞘内或囊内进行给药。给药方法可取决于各种因素,例如疾病的部位、疾病的严重程度和药物组合物的成分。
在治疗疾病或病症的上下文中,术语“治疗”、“处理”和“疗法”旨在包括减轻或消除疾病、病症或病状或与疾病,病症或病状有关的一种或多种症状;或减慢疾病、病症或病状或其一种或多种症状的进展、扩散或恶化。
本文中使用的短语“提高的水平”或“升高的水平”可以是相对于参考水平(例如,本文中描述的任何示例性参考水平)的,或1.1倍到100倍,或更高(例如高达200倍)的增加。在某些方面,“提高的水平”或“升高的水平”可以是例如与参考水平(例如本文所述的任何示例性参考水平)相比至少1%(例如,至少2%、至少4%、至少6%、至少8%、至少10%、至少12%、至少14%、至少16%、至少18%、至少20%、至少22%、至少25%、至少30%、至少35%、至少40%、至少45%、至少50%、至少55%、至少60%、至少65%、至少70%、至少75%、至少80%、至少85%、至少90%、至少95%、至少99%、至少100%、至少110%、至少120%、至少130%、至少140%、至少150%、至少160%、至少170%、至少180%、至少190%、至少200%、至少220%、至少250%、至少280%、至少300%、至少320%、至少350%、至少380%、至少400%、至少420%、至少450%,至少480%、至少500%、至少600%、至少700%、至少800%、至少900%或至少1000%)的增加。
本文中使用的短语“降低的水平”可以是例如与参考水平(例如,本文所述的任何示例性参考水平)相比至少1%(例如,至少2%、至少4%、至少6%、至少8%、至少10%、至少12%、至少14%、至少16%、至少18%、至少20%、至少22%、至少25%、至少30%、至少35%、至少40%、至少45%、至少50%、至少55%、至少60%、至少65%、至少70%、至少75%、至少80%、至少85%、至少90%、至少95%或至少99%)的降低。
短语“ATM水平降低”指哺乳动物细胞中ATM蛋白和/或ATM mRNA水平降低。例如,ATM水平的降低可能是由于ATM基因缺失(在一个或两个等位基因处)、导致与野生型ATM基因相比ATM基因的转录降低的ATM基因调控区中的突变、导致与野生型ATM基因相比ATMmRNA翻译减少的ATM基因突变、和/或导致与野生型ATM基因相比在哺乳动物细胞中的稳定性和/或半衰期降低的ATM蛋白产生的ATM基因突变。
在本文描述的任何方法的一些实施方式中,可以包括确定由ATM编码的mRNA或蛋白质的表达水平。在一些实施方式中,可通过检测功能丧失性ATM突变、ATM基因缺失、由ATM基因编码的蛋白质中的一个或多个氨基酸缺失、由ATM基因编码的蛋白质中的一个或多个氨基酸插入和/或由ATM基因编码的蛋白质中的一个或多个氨基酸取代来确定ATM的水平和/或活性降低。
短语“蛋白质活性”(或特定蛋白质的“活性”)指蛋白质的一种或多种活性(例如,酶活性、定位活性、结合活性(例如,结合另一种蛋白质或结合非蛋白质(例如,核酸))。哺乳动物细胞中蛋白质活性的降低可能是例如与野生型蛋白质相比,蛋白质中的氨基酸缺失、氨基酸插入、或蛋白质中的氨基酸取代的结果。在一些情况下,哺乳动物细胞中蛋白质活性增加可能是例如与野生型蛋白质相比,蛋白质中的基因扩增或活化性氨基酸取代的结果。
短语“ATM活性”是指ATM在哺乳动物细胞中的直接活性(例如,DNA损伤诱导型蛋白质激酶活性);或哺乳动物细胞中ATM活性的下游信号转导活性。例如,哺乳动物细胞中ATM活性的降低可能是改变其活性、定位或功能的例如ATM基因缺失(例如,在一个或两个等位基因处),ATM基因中的一个或多个核苷酸取代、缺失和/或插入,ATM蛋白质中一个或多个氨基酸缺失、取代、插入、截短或其他修饰,或对ATM蛋白质的一个或多个翻译后修饰的结果。
术语“STING途径活性增加”指哺乳动物细胞中STING直接活性的增加(例如,STING从内质网转位到核周区域,或TBK1(TANK结合激酶1)活化;或哺乳动物细胞中上游活性的增加或突变(例如,本文所述的任何示例性突变或单核苷酸多态性),其导致哺乳动物细胞中STING途径活性的增加(例如,BRCA1、BRCA2、SAMHD1、DNASE2、BLM、PARP1、RPA1和RAD51中的一个或多个的水平或活性降低)(例如与本文所述的任何示例性参考水平相比)或MUS81、IFI16、cGAS、DDX41、EXO1、DNA2、RBBP8和MRE11中的一个或多个的水平或活性增加(例如,与本文所述的任何示例性参考水平相比))。
BRCA1、BRCA2、SAMHD1、DNASE2、BLM、PARP1、RPA1和RAD51(例如,在癌细胞中)中的一种或多种的水平或活性降低可由任何机制引起。
在一些实施方式中,BRCA1的水平或活性降低可能是BRCA1基因中移码突变(例如E111Gfs*3移码插入)的结果。在一些实施方式中,BRCA1的水平或活性降低可能是BRCA1基因缺失(例如BRCA1的一个等位基因缺失或BRCA1的两个等位基因同时缺失)的结果。在一些实施方式中,BRCA1的水平或活性降低可能是由BRCA1基因编码的蛋白质中的一个或多个氨基酸缺失的结果。在一些实施方式中,BRCA1的水平或活性降低可能是由BRCA1基因编码的蛋白质中的一个或多个失活性氨基酸取代的结果。
在一些实施方式中,BRCA2基因的水平或活性降低可能是BRCA2基因中的移码突变(例如,N1784Kfs*3移码插入)的结果。在一些实施方式中,BRCA2的水平或活性降低可能是BRCA2基因缺失(例如BRCA2的一个等位基因缺失或BRCA2的两个等位基因同时缺失)的结果。在一些实施方式中,BRCA2的水平或活性降低可能是由BRCA2基因编码的蛋白质中的一个或多个氨基酸缺失的结果。在一些实施方式中,BRCA2的水平或活性降低可能是由BRCA2基因编码的蛋白质中的一个或多个失活性氨基酸取代的结果。
在一些实施方式中,SAMHD1的水平或活性降低可能是由SAMHD1基因编码的蛋白质中的一个或多个失活性氨基酸取代(例如,V133I氨基酸取代)的结果。在一些实施方式中,SAMHD1的水平或活性降低可能是SAMHD1基因缺失(例如SAMHD1的一个等位基因缺失或SAMHD1的两个等位基因同时缺失)的结果。在一些实施方式中,SAMHD1的水平或活性降低可能是由SAMHD1基因编码的蛋白质中的一个或多个氨基酸缺失的结果。
在一些实施方式中,DNASE2的水平或活性降低可能是由DNASE2基因编码的蛋白质中的一个或多个失活性突变(例如,R314W氨基酸取代)导致的。在一些实施方式中,DNASE2的水平或活性降低可能是DNASE2基因缺失(例如DNASE2的一个等位基因缺失或DNASE2的两个等位基因同时缺失)的结果。在一些实施方式中,DNASE2的水平或活性降低可能是由DNASE2基因编码的蛋白质中的一个或多个氨基酸缺失的结果。
在一些实施方式中,BLM的水平或活性降低可能是BLM基因中移码突变(例如N515Mfs*16移码缺失)的结果。在一些实施方式中,BLM的水平或活性降低可能是BLM基因缺失(例如BLM的一个等位基因缺失或BLM的两个等位基因同时缺失)的结果。在一些实施方式中,BLM的水平或活性降低可能是由BLM基因编码的蛋白质中的一个或多个氨基酸缺失的结果。在一些实施方式中,BLM的水平或活性降低可能是由BLM基因编码的蛋白质中的一个或多个失活性氨基酸取代的结果。
在一些实施方式中,PARP1的水平或活性降低可能是PARP1基因中移码突变(例如S507Afs*17移码缺失)的结果。在一些实施方式中,PARP1的水平或活性降低可能是PARP1基因缺失(例如PARP1的一个等位基因缺失或PARP1的两个等位基因同时缺失)的结果。在一些实施方式中,PARP1的水平或活性降低可能是由PARP1基因编码的蛋白质中的一个或多个氨基酸缺失的结果。在一些实施方式中,PARP1的水平或活性降低可能是由PARP1基因编码的蛋白质中的一个或多个失活性氨基酸取代的结果。
在一些实施方式中,RPA1的水平或活性降低可能是导致异常RPA mRNA剪接(例如,X12剪接突变)的突变的结果。在一些实施方式中,RPA1的水平或活性降低可能是RPA1基因缺失(例如RPA1的一个等位基因缺失或RPA1的两个等位基因同时缺失)的结果。在一些实施方式中,RPA1的水平或活性降低可能是由RPA1基因编码的蛋白质中的一个或多个氨基酸缺失的结果。在一些实施方式中,RPA1的水平或活性降低可能是由RPA1基因编码的蛋白质中的一个或多个失活性氨基酸取代的结果。
在一些实施方式中,RAD51的水平或活性降低可能是由RAD51基因编码的蛋白质中的一个或多个失活性突变(例如,R254*突变)导致的。在一些实施方式中,RAD51的水平或活性降低可能是RAD51基因缺失(例如RAD51的一个等位基因缺失或RAD51的两个等位基因同时缺失)的结果。在一些实施方式中,RAD51的水平或活性降低可能是由RAD51基因编码的蛋白质中的一个或多个氨基酸缺失的结果。
MUS81、IFI16、cGAS、DDX41、EXO1、DNA2、RBBP8或MRE11(例如,在癌细胞中)中的一种或多种的水平或活性增加可由任何机制引起。
在一些实施方式中,MUS81的水平或活性的增加可以是MUS81基因扩增的结果。在一些实施方式中,MUS81的水平或活性增加可能是由MUS81基因编码的蛋白质中的一个或多个活化性氨基酸取代的结果。
在一些实施方式中,IFI16的水平或活性的增加可以是IFI16基因扩增的结果。在一些实施方式中,IFI16的水平或活性增加可能是由IFI16基因编码的蛋白质中的一个或多个活化性氨基酸取代的结果。
在一些实施方式中,cGAS的水平或活性的增加可以是cGAS基因扩增的结果。在一些实施方式中,cGAS的水平或活性增加可能是由cGAS基因编码的蛋白质中的一个或多个活化性氨基酸取代的结果。
在一些实施方式中,DDX41的水平或活性的增加可以是DDX41基因扩增的结果。在一些实施方式中,DDX41的水平或活性增加可能是由DDX4基因编码的蛋白质中的一个或多个活化性氨基酸取代的结果。
在一些实施方式中,EXO1的水平或活性的增加可以是EXO1基因扩增的结果。在一些实施方式中,EXO1的水平或活性增加可能是由EXO1基因编码的蛋白质中的一个或多个活化性氨基酸取代的结果。
在一些实施方式中,DNA2的水平或活性的增加可以是DNA2基因扩增的结果。在一些实施方式中,DNA2的水平或活性增加可能是由DNA2基因编码的蛋白质中的一个或多个活化性氨基酸取代的结果。
在一些实施方式中,RBBP8(也称为CtIP)的水平或活性的增加可以是RBBP8基因扩增的结果。在一些实施方式中,RBBP8的水平或活性增加可能是由RBBP8基因编码的蛋白质中的一个或多个活化性氨基酸取代的结果。
在一些实施方式中,MRE11的水平或活性的增加可以是MRE11基因扩增的结果。在一些实施方式中,MRE11的水平或活性增加可能是由MRE11基因编码的蛋白质中的一个或多个活化性氨基酸取代的结果。
STING、TREX1、BRCA1、BRCA2、SAMHD1、DNASE2、BLM、PARP1、RPA1、RAD51、MUS81、IFI16、cGAS、DDX41、EXO1、DNA2、RBBP8(CtIP)和MRE11的人蛋白和人cDNA序列的非限制性例子如下所示(SEQ ID NO:1-89)。可以理解的是,这些序列的其他自然变体也可以存在,并且可以理解的是,一个基因的名称可以用来指代该基因或其蛋白质产物。
本文所述任何方法的一些实施方式包括确定由STING、TREX1、BRCA1、BRCA2、SAMHD1、DNASE2、BLM、PARP1、RPA1、RAD51、MUS81、IFI16、cGAS、DDX41、EXO1、DNA2、RBBP8(CtIP)和MRE11中的一个或多个编码的mRNA或蛋白质的表达水平。在本文所述的任何方法的一些例子中,增加的STING或cGAS信号转导活性可包括例如:检测哺乳动物细胞中由BRCA1、BRCA2、SAMHD1、DNASE2、BLM、PARP1、RPA1和RAD51中的一个或多个编码的mRNA或蛋白质的水平降低,和/或检测由STING、MUS81、IFI16、cGAS、DDX41、EXO1、DNA2、RBBP8(CtIP)和MRE11中的一个或多个编码的mRNA或蛋白质的水平提高(例如,与本文所述的任何示例性参考水平相比)。
在本文所述的任何方法的一些实施方式中,可通过检测功能获得性突变(例如,由MUS81、IFI16、cGAS、DDX41、EXO1、DNA2、RBBP8(CtIP)和MRE1中的一个或多个编码的蛋白质中的基因扩增或一个或多个活化性氨基酸取代);BRCA1、BRCA2、SAMHD1、DNASE2、BLM、PARP1、RPA1和RAD51中的一个或多个的基因缺失;由BRCA1、BRCA2、SAMHD1、DNASE2、BLM、PARP1、RPA1和RAD51中的一个或多个编码的蛋白质中的一个或多个氨基酸缺失;由BRCA1、BRCA2、SAMHD1、DNASE2、BLM、PARP1、RPA1或RAD51中的一种或多种编码的蛋白质中的一种或多种失活性氨基酸突变;或BRCA1、BRCA2、SAMHD1、DNASE2、BLM、PARP1、RPA1和RAD51中的一个或多个的移码突变来确定cGAS/STING信号转导活性的升高。
本文描述了检测这些示例性cGAS/STING信号转导途径活性中每一种的水平的方法。本领域已知cGAS/STING信号转导途径活性的其他例子,以及用于检测其水平的方法。
如本文所用,“功能获得性突变(gain-of-function mutation)”指基因中的一个或多个核苷酸取代、缺失和/或插入,其导致产生由该基因编码的蛋白质,与由相应野生型基因编码的蛋白质形式相比,在哺乳动物细胞中具有一种或多种升高的活性。在一些实施方式中,功能获得性突变可以是由MUS81、IFI16、cGAS、DDX41、EXO1、DNA2、RBBP8(CtIP)、STING和MRE1中的一种或多种编码的蛋白质中的基因扩增或一个或多个活化性氨基酸取代。
如本文所用,“功能丧失性突变”指基因中的一个或多个核苷酸取代、缺失和/或插入,导致:所编码蛋白质的表达水平与相应野生型基因的表达水平相比下降,和/或编码蛋白质的基因表达与相应野生型基因编码的蛋白形式相比,在哺乳动物细胞中具有一种或多种下降的活性。在一些实施方式中,功能丧失性突变可以是基因缺失、由基因编码的蛋白质中的一个或多个氨基酸缺失,或由基因编码的蛋白质中的一个或多个失活性氨基酸取代。
术语“氢”和“H”在本文中可互换使用。
术语“卤素”是指氟(F),氯(Cl),溴(Br)或碘(I)。
术语“烷基”是指可以是直链或支链的烃链,其包含所示数目的碳原子。例如,C1-10表示该基团中可以具有1至10个(含)碳原子。非限制性示例包括甲基、乙基、异-丙基、叔-丁基、正-己基。
术语“卤代烷基”是指其中一个或多个氢原子被独立选择的卤素取代的烷基。
术语“烷氧基”是指-O-烷基(例如,-OCH3)。
本文使用的术语“碳环”包括具有3至10个碳,例如3至8个碳,例如3至7个碳的芳族或非芳族环状烃基,其可任选地被取代。碳环的例子包括五元、六元和七元碳环。
术语“杂环”是指芳族或非芳族的5-8元单环,8-12元双环或11-14元三环体系,如果是单环则具有1-3个杂原子,如果是双环则具有1-6个杂原子,或者如果是三环则具有1-9个杂原子,所述杂原子选自O、N或S(例如碳原子和分别为单环,双环或三环的1-3、1-6或1-9个N、O或S的杂原子),其中每个环的0、1、2或3个原子可以被取代基取代。杂环的例子包括五元、六元和七元杂环。
本文使用的术语“环烷基”包括具有3至10个碳,例如3至8个碳,例如3至7个碳的芳族或非芳族环状烃自由基,其中环烷基可任选地被取代。环烷基的例子包括五元、六元和七元环。例子包括环丙基、环丁基、环戊基、环戊烯基、环己基、环己烯基、环庚基和环辛基。
术语“杂环烷基”是指芳族或非芳族的5-8元单环、8-12元双环或11-14元三环体系游离基,如果是单环则具有1-3个杂原子,如果是双环则具有1-6个杂原子,或者如果是三环则具有1-9个杂原子,所述杂原子选自O、N或S(例如碳原子和分别为单环,双环或三环的1-3、1-6或1-9个N、O或S的杂原子),其中每个环的0、1、2或3个原子可以被取代基取代。杂环烷基的例子包括五元、六元和七元杂环。例子包括哌嗪基、吡咯烷基、二噁烷基、吗啉基、四氢呋喃基等。
术语“羟基”是指OH基团。
术语“氨基”是指NH2基团。
术语“氧代”指O。举例来说,用氧代取代CH2基团得到C=O基团。
除非另外定义,否则,本文中所使用的所有技术和科学术语都具有本文所属领域普通技术人员通常所理解的含义。所有专利、申请、公开申请和其它出版物通过引用全文纳入。如果本文中的一个术语有多种定义,除非另有说明,否则以本节中的定义为准。
从下文的详述、附图和所附权利要求中能够很容易地了解本发明的其它特征和优点。
具体实施方式
本发明基于以下发现:具有降低的ATM水平和/或活性的癌细胞对采用STING拮抗剂或cGAS抑制剂的治疗更敏感。鉴于这些发现,本文提供了用包括STING拮抗剂或cGAS抑制剂的疗法治疗需要治疗的对象的方法,为需要治疗的对象选择治疗的方法,其中治疗包括STING拮抗剂或cGAS抑制剂,选择对象进行STING拮抗剂或cGAS抑制剂治疗的方法,选择对象参与STING拮抗剂或cGAS抑制剂临床试验的方法,以及预测对象对STING拮抗剂或cGAS抑制剂(例如,具有式I-XXIV或式M1-M6的任一化合物或表C1-C2中任一所示化合物)的反应性的方法。
这些方法的非限制性方面如下所述,并且可以没有限制地以任何组合使用。本领域已知这些方法的其它方面。
ATM
共济失调-毛细血管扩张突变激酶(ATM)是一种DNA损伤诱导型蛋白激酶,通过DNA双链断裂募集并活化。ATM磷酸化参与DNA损伤反应的底物(例如p53、CHK2、BRCA1、NBS1和H2AX),启动DNA损伤检查点的活化,导致细胞周期阻滞、DNA修复或凋亡。
ATM基因表达ATM蛋白,该蛋白主要位于细胞核中,有助于控制细胞生长和分裂的速率。ATM蛋白在包括神经系统和免疫系统在内的几个身体系统的正常发育和活动中也发挥着重要作用。此外,ATM蛋白帮助细胞识别受损或断裂的DNA链。DNA可能会被有毒化学物质等物质或辐射破坏,当染色体在细胞分裂过程中交换遗传物质时,DNA链也会自然断裂。ATM蛋白通过活化修复断裂链的酶来协调DNA修复,而高效修复受损的DNA链有助于保持细胞遗传信息的稳定性。
ATM是DNA修复机制的核心组分,ATM基因的功能障碍导致STING的非经典活化。已经表明,ATM在DNA损伤诱导的STING复合物的组装中起着重要作用,其中ATM识别双链断裂的分子机制和随后p53的磷酸化提供了DNA损伤和STING复合物形成之间的分子联系(参见,例如,Dunphy等人,Molecular Cell71:745-760,2018)。此外,细胞中ATM活性的丧失导致胞质DNA的积累,并导致cGAS-STING途径的活化和细胞因子的产生。
ATM水平或活性降低可由任何机制引起。一些突变与ATM失活有关。例如,MRN亚基NBS1和/或亚基Mre11的突变可导致ATM活化减少。在一些实施方式中,杂合ATM突变(例如种系ATM错义突变7271T>G或IVD10-6T>G)可导致ATM活性水平降低(例如Bernstein等人,Br.J.Cancer 89(8):1513-1516,2003)。在一些实施方式中,ATM蛋白中的氨基酸取代(例如,G138R、V245A或R2912K)可导致ATM蛋白的一种或多种活性降低(参见,例如,Squatrito等人,Cancer Cell18(6),2010)。导致ATM水平和/或活性降低的ATM基因突变的其他例子包括8307G>A、8140C>T、1339C>T、1240C>T,9170G>C和8711A>G(参见,例如,Gilad等人,HumanMolecular Genetics 5(4):433,1996)。
在一些实施方式中,ATM的水平和/或活性降低可以是ATM基因中的缺失突变(例如8578del3缺失)的结果。在一些实施方式中,ATM的水平和/或活性降低可以是ATM基因中的插入突变(例如5319ins9插入)的结果。在一些实施方式中,ATM水平和/或活性降低可能是ATM基因缺失(例如,ATM的一个等位基因缺失或ATM的两个等位基因同时缺失)的结果。在一些实施方式中,ATM水平和/或活性的降低可能是ATM基因编码的蛋白质中的一个或多个氨基酸缺失的结果。在一些实施方式中,ATM水平和/或活性的降低可能是ATM基因编码的蛋白质中的一个或多个失活性氨基酸取代的结果。在一些实施方式中,ATM水平和/或活性的降低可能是ATM基因编码的蛋白质中的一个或多个氨基酸插入的结果。
在一些实施方式中,ATM水平的降低可能是ATM基因调控区突变的结果(例如,导致ATM基因转录降低和/或ATM基因编码的mRNA的翻译降低)。
在一些实施方式中,突变(例如,本文所述的任何示例性突变类型)存在于癌细胞中的ATM基因的两个等位基因中。在一些实施方式中,突变(例如,本文所述的任何示例性突变类型)存在于癌细胞中的ATM基因的一个等位基因中。在一些实施方式中,ATM基因中的突变导致ATM蛋白的截短且非功能性形式的产生。
示例性野生型人ATM蛋白的序列是SEQ ID NO:90。示例性野生型人ATM cDNA的序列是SEQ ID NO:91。
治疗方法
本文提供了治疗有需要的对象(例如,本文所述的任何示例性对象)的方法,包括:(a)鉴定具有ATM水平和/或活性降低的细胞(例如癌症细胞)的对象(例如,减少1%至约99%,1%至约95%,1%至约90%,1%至约80%,1%至约70%,1%至约60%,1%至约50%,1%至约40%,1%至约30%,1%至约20%,1%至约10%,约5%至约99%,约5%至约90%,约5%至约80%,约5%至约70%,约5%至约60%,约5%至约55%,约5%至约50%,约5%至约40%,约5%至约30%,约5%至约20%,约5%至约10%,约10%至约99%,约10%至约90%,约10%至约80%,约10%至约70%,约10%至约60%,约10%至约50%,约10%至约40%,约10%至约30%,约10%至约20%,约20%至约99%,约20%至约90%,约20%至约80%,约20%至约70%,约20%至约60%,约20%至约50%,约20%至约40%,约20%至约30%,约30%至约99%,约30%至约90%,约30%至约80%,约30%至约70%,约30%至约60%,约30%至约50%,约30%至约40%,约40%至约99%,约40%至约90%,约40%至约80%,约40%至约70%,约40%至约60%,约40%至约50%,约50%至约99%,约50%至约90%,约50%至约80%,约50%至约70%,约50%至约60%,约60%至约99%,约60%至约90%,约60%至约80%,约60%至约70%,约70%至约99%,约70%至约90%,约70%至约80%,约80%至约99%,约80%至约90%,或约90%至约99%)或本文所述的该范围的任何子范围)(例如与参考水平相比);和(b)向所鉴定的对象给予包含治疗有效量的STING拮抗剂或cGAS抑制剂(例如,本文所述的任何示例性STING拮抗剂或cGAS抑制剂)或其药学上可接受的盐、溶剂合物或共结晶的治疗。
本文还提供了治疗有需要的对象(例如,本文所述的任何示例性对象)的方法,包括:给予经鉴定的对象治疗,所述对象被鉴定为在肿瘤样品中具有细胞(例如癌细胞),其具有(例如与参考水平相比)降低的ATM水平和/或活性(例如降低约1%至约99%,或本文所述的该范围内任何子范围),所述治疗包括治疗有效量的STING拮抗剂或cGAS抑制剂(例如本文所述的任何示例性STING拮抗剂或cGAS抑制剂)或其药学上可接受的盐、溶剂化物,或共晶体。
在一些实施方式中,对象被鉴定为具有ATM水平降低的癌细胞。在一些实施方式中,ATM水平是癌细胞中ATM蛋白的水平。在一些实施方式中,将对象鉴定为具有ATM水平降低的癌细胞包括检测癌细胞中降低的ATM蛋白水平。在一些实施方式中,ATM水平是癌细胞中ATM mRNA的水平。在一些实施方式中,将对象鉴定为具有ATM水平降低的癌细胞包括检测癌细胞中降低的ATM mRNA水平。
在一些实施方式中,ATM水平和/或活性降低是癌细胞中ATM基因缺失的结果。在一些实施方式中,ATM基因缺失是ATM基因的一个等位基因的缺失。在一些实施方式中,ATM基因缺失是ATM基因的两个等位基因同时缺失。在一些实施方式中,将对象鉴定为具有ATM水平和/或活性降低的癌细胞包括检测癌细胞中的ATM基因缺失。
在一些实施方式中,ATM水平和/或活性降低是癌细胞中ATM基因编码的蛋白质的一个或多个氨基酸缺失、插入或翻译后修饰的结果。在一些实施方式中,将对象鉴定为具有ATM水平和/或活性降低的癌细胞包括检测癌细胞中由ATM基因编码的蛋白质中的一个或多个氨基酸缺失、插入或翻译后修饰。在一些实施方式中,ATM水平和/或活性降低是癌细胞中ATM基因编码的蛋白质中的一个或多个失活性氨基酸取代的结果。在一些实施方式中,将对象鉴定为具有ATM表达和/或活性降低的癌细胞包括检测癌细胞中由ATM基因编码的蛋白质中的一个或多个失活性氨基酸取代。
在一些实施方式中,对象进一步被鉴定为获自对象的血清或肿瘤样品中(例如,与参考水平相比)具有升高的cGAMP水平(例如,增加1%至1000%,或本文所述的该范围的任何子范围)。在一些实施方式中,对象进一步被鉴定为(例如,与参考水平相比)具有cGAS/STING信号转导途径活性增加(例如,增加1%至1000%,或本文所述的该范围的任何子范围)的癌细胞。
在一些实施方式中,对象已被诊断或鉴定为患有癌症。在一些实施方式中,癌症选自下组:肾透明细胞癌、肾乳头状细胞癌、嫌色肾细胞癌、葡萄膜黑色素瘤、舌鳞状细胞癌、乳腺癌、骨肉瘤和皮肤癌。在一些实施方式中,癌症选自下组:肾透明细胞癌、葡萄膜黑色素瘤、舌鳞状细胞癌、乳腺癌和皮肤癌。
在本文所述任何方法的一些实施方式中,STING拮抗剂或cGAS抑制剂是抑制性核酸(例如,短干扰RNA、反义核酸、环状二核苷酸或核酶)。在本文所述任何方法的一些实施方式中,STING拮抗剂或cGAS抑制剂是本文所述的任何化合物,或其药学上可接受的盐、溶剂化物或共晶体,但前提是在与STING中的功能获得突变相关的实施方式中,在本文所述的方法中不使用cGAS抑制剂。
在本文所述的任何治疗方法的一些实施方式中,该方法可降低对象发生合并症的风险(例如,降低1%至99%,或本文所述的该范围的任何子范围)(例如,与具有类似ATM水平和/或活性降低和/或cGAS/STING信号转导途径活性增加的癌细胞,但给予不同治疗或安慰剂的对象发生合并症的风险相比)。
本文描述了可在这些方法中使用或结合的其他示例性方面。
为对象选择治疗的方法
本文提供了为有需要的对象(例如,本文所述的任何示例性对象)选择治疗的方法,包括:(a)鉴定对象,其在肿瘤样品中具有细胞(例如癌细胞),其具有(例如与参考水平相比)降低的ATM水平和/或活性(例如降低约1%至约99%,或本文所述的该范围内任何子范围);和(b)为经鉴定的对象选择治疗,所述治疗包括治疗有效量的STING拮抗剂或cGAS抑制剂(例如本文所述的任何示例性STING拮抗剂或cGAS抑制剂)或其药学上可接受的盐、溶剂化物,或共晶体。
本文提供了为有需要的对象(例如,本文所述的任何示例性对象)选择治疗的方法,包括:为经鉴定的对象选择治疗,所述对象被鉴定为在肿瘤样品中具有细胞(例如癌细胞),其具有(例如与参考水平相比)降低的ATM水平和/或活性(例如降低约1%至约99%,或本文所述的该范围内任何子范围),所述治疗包括治疗有效量的STING拮抗剂或cGAS抑制剂(例如本文所述的任何示例性STING拮抗剂或cGAS抑制剂)或其药学上可接受的盐、溶剂化物或共晶体。
在一些实施方式中,对象被鉴定为具有ATM水平降低的癌细胞。在一些实施方式中,ATM水平是癌细胞中ATM蛋白的水平。在一些实施方式中,将对象鉴定为具有ATM水平降低的癌细胞包括检测癌细胞中降低的ATM蛋白水平。在一些实施方式中,ATM水平是癌细胞中ATM mRNA的水平。在一些实施方式中,将对象鉴定为具有ATM水平降低的癌细胞包括检测癌细胞中降低的ATM mRNA水平。
在一些实施方式中,ATM水平和/或活性降低是癌细胞中ATM基因缺失的结果。在一些实施方式中,ATM基因缺失是ATM基因的一个等位基因的缺失。在一些实施方式中,ATM基因缺失是ATM基因的两个等位基因同时缺失。在一些实施方式中,将对象鉴定为具有ATM水平和/或活性降低的癌细胞包括检测癌细胞中的ATM基因缺失。
在一些实施方式中,ATM水平和/或活性降低是癌细胞中ATM基因编码的蛋白质的一个或多个氨基酸缺失、插入或翻译后修饰的结果。在一些实施方式中,将对象鉴定为具有ATM水平和/或活性降低的癌细胞包括检测癌细胞中由ATM基因编码的蛋白质中的一个或多个氨基酸缺失、插入或翻译后修饰。在一些实施方式中,ATM水平和/或活性降低是癌细胞中ATM基因编码的蛋白质中的一个或多个失活性氨基酸取代的结果。在一些实施方式中,将对象鉴定为具有ATM表达和/或活性降低的癌细胞包括检测癌细胞中由ATM基因编码的蛋白质中的一个或多个失活性氨基酸取代。
在一些实施方式中,对象进一步被鉴定为获自对象的血清或肿瘤样品中(例如,与参考水平相比)具有升高的cGAMP水平(例如,增加1%至1000%,或本文所述的该范围的任何子范围)。在一些实施方式中,对象进一步被鉴定为(例如,与参考水平相比)具有cGAS/STING信号转导途径活性增加(例如,增加1%至1000%,或本文所述的该范围的任何子范围)的癌细胞。
在一些实施方式中,对象已被诊断或鉴定为患有癌症。在一些实施方式中,癌症选自下组:肾透明细胞癌、肾乳头状细胞癌、嫌色肾细胞癌、葡萄膜黑色素瘤、舌鳞状细胞癌、乳腺癌、骨肉瘤和皮肤癌。在一些实施方式中,癌症选自下组:肾透明细胞癌、葡萄膜黑色素瘤、舌鳞状细胞癌、乳腺癌和皮肤癌。在一些实施方式中,所述方法还包括向对象给予所选治疗。
在本文所述任何方法的一些实施方式中,STING拮抗剂或cGAS抑制剂是抑制性核酸(例如,短干扰RNA、反义核酸、环状二核苷酸或核酶)。在本文所述的任何方法的一些实施方式中,STING拮抗剂或cGAS抑制剂是本文所述的任何STING拮抗剂或cGAS抑制剂,或其药学上可接受的盐、溶剂化物或共晶体。在包括STING中的功能获得性突变的一些实施方式中,本发明的方法中未使用cGAS抑制剂。
本文所述的任何方法的一些实施方式还可以包括在对象的临床记录(例如,计算机可读介质)中记录所选治疗。本文所述的任何方法的一些实施方式还可包括向所鉴定的对象给予一剂或多剂(例如,至少两剂、至少四剂、至少六剂、至少八剂、至少十剂)所选治疗。
本文描述了可在这些方法中使用或结合的其他示例性方面。
选择治疗对象的方法
本文还提供了选择治疗对象的方法,所述方法包括:(a)鉴定对象(例如本文所述的任何对象),其在肿瘤样品中具有细胞(例如癌细胞),其具有(例如与参考水平相比)降低的ATM水平和/或活性(例如降低约1%至约99%,或本文所述的该范围内任何子范围);和(b)选择经鉴定的对象用治疗有效量的STING拮抗剂或cGAS抑制剂(例如本文所述的或本领域已知的任何示例性STING拮抗剂或cGAS抑制剂)或其药学上可接受的盐、溶剂化物或共晶体进行治疗。
本文还提供了选择治疗对象的方法,其包括选择对象(例如本文所述的任何对象),其被鉴定为在肿瘤样品中具有细胞(例如癌细胞),其具有(例如与参考水平相比)降低的ATM水平和/或活性(例如降低约1%至约99%,或本文所述的该范围内任何子范围),用治疗有效量的STING拮抗剂或cGAS抑制剂(例如本文所述的或本领域已知的任何示例性STING拮抗剂或cGAS抑制剂)或其药学上可接受的盐、溶剂化物或共晶体进行治疗。
在一些实施方式中,对象被鉴定为具有ATM水平降低的癌细胞。在一些实施方式中,ATM水平是癌细胞中ATM蛋白的水平。在一些实施方式中,将对象鉴定为具有ATM水平降低的癌细胞包括检测癌细胞中降低的ATM蛋白水平。在一些实施方式中,ATM水平是癌细胞中ATM mRNA的水平。在一些实施方式中,将对象鉴定为具有ATM水平降低的癌细胞包括检测癌细胞中降低的ATM mRNA水平。
在一些实施方式中,ATM水平和/或活性降低是癌细胞中ATM基因缺失的结果。在一些实施方式中,ATM基因缺失是ATM基因的一个等位基因的缺失。在一些实施方式中,ATM基因缺失是ATM基因的两个等位基因同时缺失。在一些实施方式中,将对象鉴定为具有ATM水平和/或活性降低的癌细胞包括检测癌细胞中的ATM基因缺失。
在一些实施方式中,ATM水平和/或活性降低是癌细胞中ATM基因编码的蛋白质的一个或多个氨基酸缺失、插入或翻译后修饰的结果。在一些实施方式中,将对象鉴定为具有ATM水平和/或活性降低的癌细胞包括检测癌细胞中由ATM基因编码的蛋白质中的一个或多个氨基酸缺失、插入或翻译后修饰。在一些实施方式中,ATM水平和/或活性降低是癌细胞中ATM基因编码的蛋白质中的一个或多个失活性氨基酸取代的结果。在一些实施方式中,将对象鉴定为具有ATM表达和/或活性降低的癌细胞包括检测癌细胞中由ATM基因编码的蛋白质中的一个或多个失活性氨基酸取代。
在一些实施方式中,对象进一步被鉴定为获自对象的血清或肿瘤样品中(例如,与参考水平相比)具有升高的cGAMP水平(例如,增加1%至1000%,或本文所述的该范围的任何子范围)。在一些实施方式中,对象进一步被鉴定为(例如,与参考水平相比)具有cGAS/STING信号转导途径活性增加(例如,增加1%至1000%,或本文所述的该范围的任何子范围)的癌细胞。
在一些实施方式中,对象已被诊断或鉴定为患有癌症。在一些实施方式中,癌症选自下组:肾透明细胞癌、肾乳头状细胞癌、嫌色肾细胞癌、葡萄膜黑色素瘤、舌鳞状细胞癌、乳腺癌、骨肉瘤和皮肤癌。在一些实施方式中,癌症选自下组:肾透明细胞癌、葡萄膜黑色素瘤、舌鳞状细胞癌、乳腺癌和皮肤癌。
在本文所述任何方法的一些实施方式中,STING拮抗剂是抑制性核酸(例如,短干扰RNA、反义核酸、环状二核苷酸或核酶)。在本文所述的任何方法的一些实施方式中,STING拮抗剂或cGAS抑制剂是本文所述的任何本文所述的化合物,或其药学上可接受的盐、溶剂化物或共晶体。
本文描述了可在这些方法中使用或结合的其他示例性方面。
选择参与临床试验的对象的方法
本文还提供了选择对象(例如,本文所述任何示例性对象)参与临床试验的方法,所述方法包括:(a)鉴定对象,其在肿瘤样品中具有癌细胞,其具有(例如与参考水平相比)降低的ATM水平和/或活性(例如降低约1%至约99%,或本文所述的该范围内任何子范围);和(b)选择经鉴定的对象参与临床试验,所述临床试验包括给予治疗有效量的STING拮抗剂或cGAS抑制剂(例如本文所述的任何示例性STING拮抗剂或cGAS抑制剂)或其药学上可接受的盐、溶剂化物或共晶体的治疗。
本文还提供了选择对象(例如,本文所述任何示例性对象)参与临床试验的方法,所述方法包括:选择经鉴定具有细胞(例如癌细胞)的对象参与临床试验,所述对象在肿瘤样品中具有(例如与参考水平相比)降低的ATM水平和/或活性(例如降低约1%至约99%,或本文所述的该范围内任何子范围),所述临床试验包括给予治疗有效量的STING拮抗剂或cGAS抑制剂(例如本文所述的任何示例性STING拮抗剂或cGAS抑制剂)或其药学上可接受的盐、溶剂化物,或共晶体的治疗。
在一些实施方式中,对象被鉴定为具有ATM水平降低的癌细胞。在一些实施方式中,ATM水平是癌细胞中ATM蛋白的水平。在一些实施方式中,将对象鉴定为具有ATM水平降低的癌细胞包括检测癌细胞中降低的ATM蛋白水平。在一些实施方式中,ATM水平是癌细胞中ATM mRNA的水平。在一些实施方式中,将对象鉴定为具有ATM水平降低的癌细胞包括检测癌细胞中降低的ATM mRNA水平。
在一些实施方式中,ATM水平和/或活性降低是癌细胞中ATM基因缺失的结果。在一些实施方式中,ATM基因缺失是ATM基因的一个等位基因的缺失。在一些实施方式中,ATM基因缺失是ATM基因的两个等位基因同时缺失。在一些实施方式中,将对象鉴定为具有ATM水平和/或活性降低的癌细胞包括检测癌细胞中的ATM基因缺失。
在一些实施方式中,ATM水平和/或活性降低是癌细胞中ATM基因编码的蛋白质的一个或多个氨基酸缺失、插入或翻译后修饰的结果。在一些实施方式中,将对象鉴定为具有ATM水平和/或活性降低的癌细胞包括检测癌细胞中由ATM基因编码的蛋白质中的一个或多个氨基酸缺失、插入或翻译后修饰。在一些实施方式中,ATM水平和/或活性降低是癌细胞中ATM基因编码的蛋白质中的一个或多个失活性氨基酸取代的结果。在一些实施方式中,将对象鉴定为具有ATM表达和/或活性降低的癌细胞包括检测癌细胞中由ATM基因编码的蛋白质中的一个或多个失活性氨基酸取代。
在一些实施方式中,对象进一步被鉴定为来自对象的血清或肿瘤样品中(例如,与参考水平相比)具有升高的cGAMP水平(例如,增加1%至1000%,或本文所述的该范围的任何子范围)。在一些实施方式中,对象进一步被鉴定为(例如,与参考水平相比)具有cGAS/STING信号转导途径活性增加(例如,增加1%至1000%,或本文所述的该范围的任何子范围)的癌细胞。
在一些实施方式中,对象已被诊断或鉴定为患有癌症。在一些实施方式中,癌症选自下组:肾透明细胞癌、肾乳头状细胞癌、嫌色肾细胞癌、葡萄膜黑色素瘤、舌鳞状细胞癌、乳腺癌、骨肉瘤和皮肤癌。在一些实施方式中,癌症选自下组:肾透明细胞癌、葡萄膜黑色素瘤、舌鳞状细胞癌、乳腺癌和皮肤癌。
在本文所述任何方法的一些实施方式中,STING拮抗剂是抑制性核酸(例如,短干扰RNA、反义核酸、环状二核苷酸或核酶)。在本文所述的任何方法的一些实施方式中,STING拮抗剂或cGAS抑制剂是任何本文所述的化合物,或其药学上可接受的盐、溶剂化物或共晶体。
本文描述了可在这些方法中使用或结合的其他示例性方面。
预测对象对STING拮抗剂或cGAS抑制剂的反应性的方法
本文提供了预测对象(例如,本文所述的任何示例性对象)对具有式I-XXIV或式M1-M6的任一化合物的反应性的方法,包括:(a)确定对象在肿瘤样品中具有癌细胞,其(例如,与参考水平相比)具有降低的ATM水平和/或活性(例如,降低约1%至约99%,或本文所述的该范围的任何子范围);和(b)将步骤(a)中被确定在肿瘤样品中(例如,与参考水平相比)具有降低的ATM水平和/或活性(例如,降低约1%至约99%,或本文所述的该范围的任何子范围)的对象鉴定为对式I-XXIV或式M1-M6中任一个化合物的治疗有反应的可能性增加。
本文提供预测对象(例如,本文所述的任何示例性对象)对STING拮抗剂或cGAS抑制剂的反应性的方法,包括:(a)确定对象在肿瘤样品中具有癌细胞,其(例如,与参考水平相比)具有降低的ATM水平和/或活性(例如,降低约1%至约99%,或本文所述的该范围的任何子范围);和(b)将步骤(a)中被确定在肿瘤样品中(例如,与参考水平相比)具有降低的ATM水平和/或活性(例如,降低约1%至约99%,或本文所述的该范围的任何子范围)的对象鉴定为对STING拮抗剂或cGAS抑制剂的治疗有反应的可能性增加。
本文还提供了预测对象(例如,本文所述的任何示例性对象)对具有式I-XXIV或式M1-M6的任一化合物的反应性的方法,包括:将确定为在肿瘤样品中(例如,与参考水平相比)具有ATM水平和/或活性降低(例如,约1%至约99%的降低,或本文所述的该范围的任何子范围)的细胞(例如,癌细胞)的对象鉴定为对式I-XXIV或式M1-M6中任一个化合物的治疗有反应的可能性增加。
本文还提供预测对象(例如,本文所述的任何示例性对象)对STING拮抗剂或cGAS抑制剂的反应性的方法,包括:将确定为在肿瘤样品中(例如,与参考水平相比)具有ATM水平和/或活性降低(例如,约1%至约99%的降低,或本文所述的该范围的任何子范围)的细胞(例如,癌细胞)的对象鉴定为对STING拮抗剂或cGAS抑制剂的治疗有反应的可能性增加。
在一些实施方式中,对象被鉴定为具有ATM水平降低的癌细胞。在一些实施方式中,ATM水平是癌细胞中ATM蛋白的水平。在一些实施方式中,将对象鉴定为具有ATM水平降低的癌细胞包括检测癌细胞中降低的ATM蛋白水平。在一些实施方式中,ATM水平是癌细胞中ATM mRNA的水平。在一些实施方式中,将对象鉴定为具有ATM水平降低的癌细胞包括检测癌细胞中降低的ATM mRNA水平。
在一些实施方式中,ATM水平和/或活性降低是癌细胞中ATM基因缺失的结果。在一些实施方式中,ATM基因缺失是ATM基因的一个等位基因的缺失。在一些实施方式中,ATM基因缺失是ATM基因的两个等位基因同时缺失。在一些实施方式中,将对象鉴定为具有ATM水平和/或活性降低的癌细胞包括检测癌细胞中的ATM基因缺失。
在一些实施方式中,ATM水平和/或活性降低是癌细胞中ATM基因编码的蛋白质的一个或多个氨基酸缺失、插入或翻译后修饰的结果。在一些实施方式中,将对象鉴定为具有ATM水平和/或活性降低的癌细胞包括检测癌细胞中由ATM基因编码的蛋白质中的一个或多个氨基酸缺失、插入或翻译后修饰。在一些实施方式中,ATM水平和/或活性降低是癌细胞中ATM基因编码的蛋白质中的一个或多个失活性氨基酸取代的结果。在一些实施方式中,将对象鉴定为具有ATM表达和/或活性降低的癌细胞包括检测癌细胞中由ATM基因编码的蛋白质中的一个或多个失活性氨基酸取代。
在一些实施方式中,对象进一步被鉴定为来自对象的血清或肿瘤样品中(例如,与参考水平相比)具有升高的cGAMP水平(例如,增加1%至1000%,或本文所述的该范围的任何子范围)。在一些实施方式中,对象进一步被鉴定为(例如,与参考水平相比)具有cGAS/STING信号转导途径活性增加(例如,增加1%至1000%,或本文所述的该范围的任何子范围)的癌细胞。
在一些实施方式中,对象已被诊断或鉴定为患有癌症。在一些实施方式中,癌症选自下组:肾透明细胞癌、肾乳头状细胞癌、嫌色肾细胞癌、葡萄膜黑色素瘤、舌鳞状细胞癌、乳腺癌、骨肉瘤和皮肤癌。在一些实施方式中,癌症选自下组:肾透明细胞癌、葡萄膜黑色素瘤、舌鳞状细胞癌、乳腺癌和皮肤癌。
在一些实施方式中,方法还包括向经鉴定为对使用STING拮抗剂或cGAS抑制剂的治疗有反应的可能性增加的对象给予治疗有效量的STING拮抗剂或cGAS抑制剂。
在本文所述任何方法的一些实施方式中,STING拮抗剂是抑制性核酸(例如,短干扰RNA、反义核酸、环状二核苷酸或核酶)。在本文所述的任何方法的一些实施方式中,STING拮抗剂或cGAS抑制剂是任何本文所述的化合物,或其药学上可接受的盐、溶剂化物或共晶体。
本文描述了可在这些方法中使用或结合的其他示例性方面。
适应症
在一些实施方式中,提供了治疗具有病况、疾病或病症的对象的方法,其中cGAS/STING信号转导活性的增加和/或ATM水平和/或活性的降低引起该病况、疾病或病症的病理学和/或症状和/或进展,包括向对象给予有效量的本文所述化学实体(例如,本文一般或具体描述的化合物或其药学上可接受的盐或含有该化合物的组合物)。在本文所述的任何方法的一些实施方式中,对象可患有、或被鉴定为或诊断为患有任何病况、疾病或病症,其中cGAS/STING信号转导活性增加和/或ATM水平和/或活性降低导致病况、疾病或病症的病理和/或症状和/或进展。在本文描述的任何方法的一些实施方式中,可怀疑对象具有或呈现本文描述的任何病况、疾病或病症的一种或多种症状。
在一些实施方式中,所述病况、疾病或病症是癌症(例如,肾透明细胞癌、肾乳头状细胞癌、嫌色肾细胞癌、葡萄膜黑色素瘤、舌鳞状细胞癌、乳腺癌、骨肉瘤和皮肤癌)。在一些实施方式中,所述病况、疾病或病症是癌症(例如,肾透明细胞癌、葡萄膜黑色素瘤、舌鳞状细胞癌、乳腺癌和皮肤癌)。
组合疗法
本公开内容涵盖单一疗法方案以及联合疗法方案。
在一些实施方式中,本文所述的方法还可包括结合给予STING拮抗剂或cGAS抑制剂(例如,本文所述或本领域已知的任何STING拮抗剂或cGAS抑制剂)来给予一种或多种其它治疗(例如,一种或多种其它治疗剂和/或一种或多种治疗方案)。
在一些实施方式中,在接触或给予STING拮抗剂或cGAS抑制剂之前(例如,在约一小时前,或约6小时前,或约12小时前,或约24小时前,或大约48小时之前,或大约1周之前或大约1个月之前)给予对象第二治疗剂或方案。
在其它实施方式中,在接触或给予STING拮抗剂或cGAS抑制剂的大约相同时间给予对象第二治疗剂或方案。举例来说,第二治疗剂或方案和STING拮抗剂或cGAS抑制剂以相同的剂型同时提供给对象。作为另一个例子,以单独的剂型同时向对象提供第二治疗剂或方案以及STING拮抗剂或cGAS抑制剂。
在其它实施方式中,在接触或给予STING拮抗剂或cGAS抑制剂之后(例如,在约一小时后,或约6小时后,或约12小时后,或约24小时后,或约48小时后,或约1周后或约1个月后)给予对象第二治疗剂或方案。
患者选择
在一些实施方式中,本文所述的方法包括将需要治疗的对象(例如,患者)鉴定为具有ATM水平和/或活性降低的细胞(例如,癌细胞)的步骤。
在一些实施方式中,本文描述的方法还包括进一步鉴定需要治疗的对象(例如患者)具有(例如,与参考水平相比)cGAS/STING信号转导途径活性增加(例如,1%至1000%之间的增加,或本文描述的该范围的任何子范围)的细胞(例如癌细胞)的步骤。在一些实施方式中,本文描述的方法还包括鉴定需要治疗的对象(例如患者)为血清或肿瘤样品中(例如,与参考水平相比)cGAMP水平升高(例如,1%至1000%之间的增加,或本文描述的该范围的任何子范围)。
在一些实施方式中,对象被鉴定为具有ATM水平降低的癌细胞。在一些实施方式中,ATM水平是癌细胞中ATM蛋白的水平。在一些实施方式中,将对象鉴定为具有ATM水平降低的癌细胞包括检测癌细胞中降低的ATM蛋白水平。在一些实施方式中,ATM水平是癌细胞中ATM mRNA的水平。在一些实施方式中,将对象鉴定为具有ATM水平降低的癌细胞包括检测癌细胞中降低的ATM mRNA水平。
在一些实施方式中,ATM水平和/或活性降低是癌细胞中ATM基因缺失的结果。在一些实施方式中,ATM基因缺失是ATM基因的一个等位基因的缺失。在一些实施方式中,ATM基因缺失是ATM基因的两个等位基因同时缺失。在一些实施方式中,将对象鉴定为具有ATM水平和/或活性降低的癌细胞包括检测癌细胞中的ATM基因缺失。
在一些实施方式中,ATM水平和/或活性降低是癌细胞中ATM基因编码的蛋白质的一个或多个氨基酸缺失、插入或翻译后修饰的结果。在一些实施方式中,将对象鉴定为具有ATM水平和/或活性降低的癌细胞包括检测癌细胞中由ATM基因编码的蛋白质中的一个或多个氨基酸缺失、插入或翻译后修饰。在一些实施方式中,ATM水平和/或活性降低是癌细胞中ATM基因编码的蛋白质中的一个或多个失活性氨基酸取代的结果。在一些实施方式中,将对象鉴定为具有ATM表达和/或活性降低的癌细胞包括检测癌细胞中由ATM基因编码的蛋白质中的一个或多个失活性氨基酸取代。
检测ATM活性和/或表达水平的方法
在本文所述的任何方法的一些实施方式中,可通过例如检测ATM基因中是否存在突变(例如本文所述的ATM基因中的任何示例性突变,例如ATM基因缺失(例如ATM的一个或两个等位基因缺失)、ATM基因编码的蛋白质中的氨基酸缺失、ATM基因编码的蛋白质中氨基酸插入或ATM基因编码的蛋白质中失活性氨基酸取代)来鉴定具有降低的ATM水平和/或活性的哺乳动物细胞。可用于确定任何这些突变(例如,本文所述的任何突变)的存在水平的分析法的非限制性示例包括Southern印迹分析、Northern印迹分析、质谱、UV吸光度、芯片实验室、微流体、基因芯片、嵌入染料(例如,溴乙锭)、凝胶电泳、限制性消化和电泳,以及测序(例如,使用本文所述或本领域已知的多种测序方法中的任何一种,包括基于聚合酶链式反应(PCR)的方法,例如,下一代测序、逆转录聚合酶链式反应(RT-PCR)、TaqMan和微阵列分析。
例如,基因组DNA的检测可包括检测基因组DNA(例如人类基因组DNA)中一个或多个独特序列的存在(例如,存在于着丝粒或异染色质中的卫星DNA序列、小卫星序列、微卫星序列、可转座元件序列、端粒序列、包含一个或多个SNP的特定序列(例如,250个碱基对到大约300个碱基对),或编码基因的特定序列)。可使用标记探针(例如荧光团、放射性同位素、酶、猝灭剂和酶标记探针)进行检测,例如通过将标记探针与分离的基因组DNA样品或对照样品中存在的基因组DNA杂交(例如在电泳凝胶中),或将标记探针与PCR分析(例如实时PCR分析)或包括利用分离的基因组DNA测试样品或对照样品作为模板的PCR分析的分析试验中的产物杂交。可用于产生探针的方法的非限制性例子包括缺口平移、随机寡聚引物合成和末端标记。
本领域已知用于确定基因的基因型的各种分析。这些分析(可用于本文所述的任何方法)的非限制性例子包括:动态等位基因特异性杂交(见例如Howell等人,NatureBiotechnol.17:87-88,1999),分子信标分析(见例如Marras等人,“Genotyping SingleNucleotide Polymorphisms with Molecular Beacons,”于Kwok编,《单核苷酸多态性:方法与方案》(Single Nucleotide Polymorphisms:Methods and Protocols),胡马纳出版社(Humana Press,Inc.),新泽西州托托瓦,第212卷,第111-128页,2003),微阵列(见例如Affymetrix Human SNP 5.0GeneChip),限制性片段长度多态性(RFLP)(见例如Ota等人,Nature Protocols 2:2857-2864,2007),基于PCR的分析(例如四引物ARMS-PCR(见例如Zhang等人,Plos One 8:e62126,2013),实时PCR,等位基因特异性PCR(见例如Gaudet等人,Methods Mol.Biol.578:415-424,2009),和TaqMan分析SNP基因分型(见例如Woodward,Methods Mol.Biol.1145:67-74,2014,和基因分型板,来自LifeTechnologies)),Flap内切核酸酶分析(也称作Invader(入侵者)分析(见例如Olivier等人,Mutat.Res.573:103-110,2005),寡核苷酸连接分析(见例如Bruse等人,Biotechniques45:559-571,2008),单链构型多态性分析(见例如Tahira等人,Human Mutat.26:69-77,2005),温度梯度凝胶电泳(见例如Jones等人,“Temporal Temperature GradientElectrophoresis for Detection ofSingle Nucleotide Polymorphisms,”于《单核苷酸多态性:方法与方案》(Single Nucleotide Polymophisms:Methods and Protocols),卷578,第153-165页,2008)或温度梯度毛细电泳,变性高效液相层析(见例如Yu等人,J.Clin.Pathol.58:479-485,2005),含有SNP的扩增序列的高分辨解链(见例如Wittwer等人,Clinical Chemistry 49:853-860,2003),或测序(例如Maxam-Gilbert测序,链终止法,鸟枪法测序,桥式PCR,和下一代测序法(例如大规模平行特征测序,聚合酶克隆(polony)测序,454焦磷酸测序,Illumina(Solexa)测序,SOLiD测序,离子流半导体序列,DNA纳米球测序,螺旋单分子测序和单分子实时测序)。Koboldt等人,Cell 155:27-382013中描述了各种下一代测序方法的更多细节和总结。
在本文所述的任何方法的一些实施方式中,基因的基因分型包括PCR分析(例如,实时PCR分析)(有或没有预先的预扩增步骤(例如本文所述的任何预扩增方法))。在本文所述任何方法的一些实施方式中,可使用基于的测序(例如,基于测序,例如基于高通量测序)进行基因分型(有或没有预先的预扩增步骤(例如,本文所述的任何预扩增方法))。
在本文所述任何方法的一些实施方式中,可在包括血液、血清、外泌体、血浆、组织、尿液、粪便、痰和脑脊液的生物样品中检测蛋白质或mRNA的水平。
可以使用市售可得的分析法(例如,RayBiotch、Novus Bio、LSBio、RockyMountain Diagnostics)进行ATM蛋白水平的确定。可以使用免疫印迹和蛋白质组学技术进行确定ATM蛋白质水平的其他方法。
ATM激酶活性的非限制性分析法描述于,例如Adams等人,MethodsMol.Biol.1599:43-56,2017;和Nyati等人,Methods Mol.Biol.1596:131-145,2017。确定ATM激酶活性的其他方法是本领域已知的。
检测cGAS/STING信号转导途径活性水平和/或表达的方法
在本文所述任何方法的一些实施方式中,cGAS/STING信号转导途径活性是I型IFN或III型IFN的分泌。在本文所述任何方法的一些实施方式中,cGAS/STING信号转导途径活性是IFN-α的分泌。在本文所述任何方法的一些实施方式中,cGAS/STING信号转导途径活性是IFN-β的分泌。可用于检测IFN-α和IFN-β分泌的非限制性方法包括免疫组织化学、免疫分析,例如酶联免疫吸附试验(ELISA)、夹心ELISA、免疫沉淀和免疫荧光分析。
检测血清或组织中cGAMP的非限制性方法包括免疫分析法,例如酶联免疫吸附试验(ELISA)、夹心ELISA、免疫沉淀和免疫荧光分析法和质谱分析。
在本文所述的任何方法的一些实施方式中,cGAS/STING信号转导途径活性可以是哺乳动物细胞(例如,从对象获得的哺乳动物细胞)中的cGAS/STING信号转导途径中的上游活化物的水平和/或活性(例如,MUS81 mRNA、MUS81蛋白、IFI16 mRNA、IFI16蛋白、cGASmRNA、cGAS蛋白、DDX41 mRNA、DDX41蛋白、EXO1 mRNA、EXO1蛋白、DNA2 mRNA、DNA2蛋白、RBBP8 mRNA、RBBP8蛋白、MRE11 mRNA或MRE11蛋白的一个或多个(例如,两个、三个、四个、五个或六个)的水平。在本文所述的任何方法的一些实施方式中,可通过检测哺乳动物细胞(例如,从对象获得的哺乳动物细胞)中cGAS/STING信号转导途径的上游抑制物的水平和/或活性(例如,BRCA1 mRNA、BRCA1蛋白、BRCA2mRNA、BRCA2蛋白、SAMHD1 mRNA、SAMHD1蛋白质、DNASE2 mRNA、DNASE2蛋白质、BLM mRNA、BLM蛋白质、PARP1 mRNA、PARP1蛋白质、RPA1mRNA、RPA1蛋白质、RAD51 mRNA或RAD51蛋白质中的一个或多个(例如,两个、三个、四个、五个或六个)的水平来确定cGAS/STING信号途径活性。
可用于确定STING途径上游活化物或上游抑制物水平和/或活性的非限制性分析包括:Southern印迹分析、Northern印迹分析、基于聚合酶链反应(PCR)的方法,例如下一代测序、逆转录聚合酶链反应(RT-PCR)、TaqManTM,微阵列分析、免疫组织化学、免疫分析,例如酶联免疫吸附试验(ELISA)、夹心ELISA、免疫沉淀、免疫荧光分析、质谱、免疫印迹(Western印迹)、RIA和流式细胞术。
在本文所述任何方法的一些实施方式中,可通过检测以下一种或多种哺乳动物细胞的存在来鉴定具有cGAS/STING信号转导途径活性提高的哺乳动物细胞:在cGAS/STING信号转导途径基因中的功能获得性突变(例如,具有根据SEQ ID NO:15编号的E111Gfs*3移码插入的BRCA1蛋白质,具有根据SEQ ID NO:25编号的N1784Kfs*3移码插入的BRCA1蛋白质,具有根据SEQ ID NO:27编号的V133I氨基酸取代的SAMHD1蛋白质,具有根据SEQ ID NO:33编号的R314W氨基酸取代的DNASE2蛋白质,具有根据SEQ ID NO:37编号的N515Mfs*16移码缺失的BLM蛋白质,具有根据SEQ ID NO:43编号的S507Afs*17移码缺失的PARP1蛋白质,具有X12剪接突变的RPA1 mRNA剪接,或具有根据SEQ ID NO:51编号的R254*氨基酸取代的RAD51蛋白质)。
可用于确定任何这些突变(例如,本文所述的任何突变)的存在水平的分析法的非限制性示例包括Southern印迹分析、Northern印迹分析、质谱、UV吸光度、芯片实验室、微流体、基因芯片、嵌入染料(例如,溴乙锭)、凝胶电泳、限制性消化和电泳,以及测序(例如,使用本文所述或本领域已知的多种测序方法中的任何一种,包括基于聚合酶链式反应(PCR)的方法,例如,下一代测序、逆转录聚合酶链式反应(RT-PCR)、TaqManTM和微阵列分析。
例如,基因组DNA的检测可包括检测基因组DNA(例如人类基因组DNA)中一个或多个独特序列的存在(例如,存在于着丝粒或异染色质中的卫星DNA序列、小卫星序列、微卫星序列、可转座元件序列、端粒序列、包含一个或多个SNP的特定序列(例如,250个碱基对到大约300个碱基对),或编码基因的特定序列)。可使用标记探针(例如荧光团、放射性同位素、酶、猝灭剂和酶标记探针)进行检测,例如通过将标记探针与分离的基因组DNA样品或对照样品中存在的基因组DNA杂交(例如在电泳凝胶中),或将标记探针与PCR分析(例如实时PCR分析)或包括利用分离的基因组DNA测试样品或对照样品作为模板的PCR分析的分析试验中的产物杂交。可用于产生探针的方法的非限制性例子包括缺口平移、随机寡聚引物合成和末端标记。
本领域已知用于确定基因的基因型的各种分析。这些分析(可用于本文所述的任何方法)的非限制性例子包括:动态等位基因特异性杂交(见例如Howell等人,NatureBiotechnol.17:87-88,1999),分子信标分析(见例如Marras等人,“Genotyping SingleNucleotide Polymorphisms with Molecular Beacons,”于Kwok编,《单核苷酸多态性:方法与方案》(Single Nucleotide Polymorphisms:Methods and Protocols),胡马纳出版社(Humana Press,Inc.),新泽西州托托瓦,第212卷,第111-128页,2003),微阵列(见例如Affymetrix Human SNP 5.0GeneChip),限制性片段长度多态性(RFLP)(见例如Ota等人,Nature Protocols 2:2857-2864,2007),基于PCR的分析(例如四引物ARMS-PCR(见例如Zhang等人,Plos One 8:e62126,2013),实时PCR,等位基因特异性PCR(见例如Gaudet等人,Methods Mol.Biol.578:415-424,2009),和TaqMan分析SNP基因分型(见例如Woodward,Methods Mol.Biol.1145:67-74,2014,和基因分型板,来自LifeTechnologies)),Flap内切核酸酶分析(也称作Invader(入侵者)分析(见例如Olivier等人,Mutat.Res.573:103-110,2005),寡核苷酸连接分析(见例如Bruse等人,Biotechniques45:559-571,2008),单链构型多态性分析(见例如Tahira等人,HumanMutat.26:69-77,2005),温度梯度凝胶电泳(见例如Jones等人,“Temporal TemperatureGradient Electrophoresis for Detection of Single Nucleotide Polymorphisms,”于《单核苷酸多态性:方法与方案》(Single Nucleotide Polymophisms:Methods andProtocols),卷578,第153-165页,2008)或温度梯度毛细电泳,变性高效液相层析(见例如Yu等人,J.Clin.Pathol.58:479-485,2005),含有SNP的扩增序列的高分辨解链(见例如Wittwer等人,Clinical Chemistry 49:853-860,2003),或测序(例如Maxam-Gilbert测序,链终止法,鸟枪法测序,桥式PCR,和下一代测序法(例如大规模平行特征测序,聚合酶克隆(polony)测序,454焦磷酸测序,Illumina(Solexa)测序,SOLiD测序,离子流半导体序列,DNA纳米球测序,螺旋单分子测序和单分子实时测序)。Koboldt等人,Cell 155:27-382013中描述了各种下一代测序方法的更多细节和总结。
在本文所述的任何方法的一些实施方式中,基因的基因分型包括PCR分析(例如,实时PCR分析)(有或没有预先的预扩增步骤(例如本文所述的任何预扩增方法))。在本文所述任何方法的一些实施方式中,可使用基于的测序(例如,基于测序,例如基于高通量测序)进行基因分型(有或没有预先的预扩增步骤(例如,本文所述的任何预扩增方法))。
在本文所述任何方法的一些实施方式中,可在包括血液、血清、外泌体、血浆、组织、尿液、粪便、痰和脑脊液的生物样品中检测蛋白质或mRNA的水平。
在本文描述的任何方法的一些实施方式中,可以确定与cGAS/STING信号转导途径活性和/或表达相关的至少一个(例如,2、3、4、5、6、7或8个)参数的水平(例如以任何组合)。
在一个方面中,所述细胞可以是从已被筛选出存在癌症或与cGAS/STING信号转导途径活性增加和/或ATM水平或活性降低相关的指征的对象分离的细胞。
参考水平
在本文描述的任何方法的一些实施方式中,参考水平可以是从健康对象(例如,未被诊断或鉴定为患有癌症,或与cGAS/STING信号转导途径活性增加和/或ATM水平和/或活性降低相关的任何疾病的对象)获得的相似细胞或样品中检测到的相应水平(例如,未被怀疑或未增加患癌症,或与cGAS/STING信号转导途径增加和/或ATM水平和/或活性和/或表达降低相关的任何疾病风险增加的对象)(例如,未出现任何癌症,或与cGAS/STING信号转导途径活性增加和/或ATM水平和/或活性降低相关的任何疾病的症状的对象)。
在一些实施方式中,参考水平可以是在健康对象群体(例如,未被诊断或鉴定患有癌症或与cGAS/STING信号转导途径增加和/或ATM水平和/或活性降低相关的任何疾病的对象群体)(例如,未被怀疑或未增加癌症或与cGAS/STING信号转导途径增加和/或ATM水平和/或活性降低相关的任何疾病风险的对象群体)(例如,没有任何癌症或与cGAS/STING信号转导途径增加和/或ATM水平和/或活性降低相关的任何疾病症状的对象群体)的类似样品中检测到的相应水平的百分位值(例如平均值、99%百分位、95%百分位、90%百分位、85%百分位、80%百分位、75%百分位、70%百分位、65%百分位、60%百分位、55%百分位或50%百分位)。
在一些实施方式中,参考可以是在更早的时间点从对象获得的类似样品中检测到的对应水平。
STING拮抗剂
在本文所述的任何方法中,STING拮抗剂可以是本文所述的任何STING拮抗剂(例如,本节所述的任何化合物)。在本文所述的任何方法中,STING拮抗剂对于STING具有约1nM到约10μM之间的IC50
在一些实施方式中,STING拮抗剂是式(I)的化合物:
或其药学上可接受的盐或其N-氧化物,其中:
Z、Y1、Y2、Y3、Y4、X1、X2、W、Q和A可以如以下文献中任何位置处所定义:在2019年7月2日作为PCT/US2019/040317提交的WO 2020/010092;于2018年7月3日提交的美国临时文件62/693,768;以及2019年6月14日提交的美国临时文件62/861,825中,每一份文献均通过引用整体并入本文。
在这些实施方式的某些中,Z、Y1、Y2、Y3、Y4、X1、X2、W、Q和A如在2019年7月2日作为PCT/US2019/040317提交的WO 2020/010092中的权利要求1-255中的任一个所定义,其各自通过引用整体纳入本文。
在某些实施方式中,STING拮抗剂是如在2019年7月2日作为PCT/US2019/040317提交的WO 2020/010092中跨93至158页的表格中所述的化合物,其各自通过引用整体纳入本文。
在一些实施方式中,STING拮抗剂是式(II)的化合物:
或其药学上可接受的盐,其中:
Y1、Y2、X、Z、W、Q和A可以如以下文献中任何位置处所定义:在2019年7月2日作为PCT/US2019/040418提交的WO 2020/010155;于2018年7月3日提交的美国临时文件62/693,878;以及2019年6月13日提交的美国临时文件62/861,078中,每一份文献均通过引用整体并入本文。
在这些实施方式的某些中,Y1、Y2、X、Z、W、Q和A如在2019年7月2日作为PCT/US2019/040418提交的WO 2020/010155中的权利要求1-115中的任一个所定义,其各自通过引用整体纳入本文。
在某些实施方式中,STING拮抗剂是如在2019年7月2日作为PCT/US2019/040418提交的WO 2020/010155中跨34至44页的表格中所述的化合物,其各自通过引用整体纳入本文。
在一些实施方式中,STING拮抗剂是式(III)的化合物:
或其药学上可接受的盐,或其互变异构体,其中:
A、W1、W2和B可以如以下文献中任何位置处所定义:2020年1月16日作为PCT/US2020/013786提交的WO 2020/150417中;2019年1月17日提交的美国临时文件62/793,795;2019年6月14日提交的美国临时文件62/861,865;2019年7月2日提交的美国临时文件62/869,914;以及2019年12月31日提交的美国临时文件62/955,891,每一份文献均通过引用完整并入本文。
在这些实施方式的某些中,A、W1、W2和B如在2020年1月16日作为PCT/US2020/013786提交的WO 2020/150417中的权利要求1-116中的任一项所定义,其各自通过引用整体纳入本文。
在一些实施方式中,STING拮抗剂是式(IV)的化合物:
或其药学上可接受的盐,或其互变异构体,其中:
Z、Y1、Y2、Y3、R6、B、R2N、L3和R4可以如以下文献中任何位置处所定义:2020年1月16日作为PCT/US2020/013786提交的WO 2020/150417中;2019年1月17日提交的美国临时文件62/793,795;2019年6月14日提交的美国临时文件62/861,865;2019年7月2日提交的美国临时文件62/869,914;以及2019年12月31日提交的美国临时文件62/955,891,每一份文献均通过引用完整并入本文。
在这些实施方式的某些中,Z、Y1、Y2、Y3、R6、B、R2N、L3和R4如在2020年1月16日作为PCT/US2020/013786提交的WO 2020/150417中的权利要求117-223中的任一项所定义,其各自通过引用整体纳入本文。
在某些实施方式中,STING拮抗剂是如在2020年1月16日作为PCT/US2020/013786提交的WO 2020/150417中的表C1中所述的化合物,其各自通过引用整体纳入本文。
在一些实施方式中,STING拮抗剂是式(V)的化合物:
或其药学上可接受的盐,或其互变异构体,其中:
X1、X2、Y1、Y2、Y3、Y4、Z、Q、A和R6可以如以下文献中任何位置处所定义:在2020年5月15日作为PCT/US2020/033127提交的WO 2020/236586;于2019年5月17日提交的美国临时文件62/849,811;以及2019年6月14日提交的美国临时文件62/861,880中,其各自通过引用整体并入本文。
在这些实施方式的某些中,X1、X2、Y1、Y2、Y3、Y4、Z、Q、A和R6如在2020年5月15日作为PCT/US2020/033127提交的WO 2020/236586中的权利要求1-18中的任一个和编号1-271的条款中的任一个所定义,其各自通过引用整体纳入本文。
在某些实施方式中,STING拮抗剂是如在2020年5月15日作为PCT/US2020/033127提交的WO 2020/236586中的表C1中所述的化合物,其通过引用整体纳入本文。
在一些实施方式中,STING拮抗剂是式(VI)的化合物:
或其药学上可接受的盐,或其互变异构体,其中:
X1、X2、Y1、Y2、Y3、Y4、Z、W和R6可以如以下文献中任何位置处所定义:在2020年5月29日作为PCT/US2020/035249提交的WO 2020/243519;于2019年5月29日提交的美国临时文件62/854,288,其通过引用整体并入本文。
在这些实施方式的某些中,X1、X2、Y1、Y2、Y3、Y4、Z、W和R6如在2020年5月29日作为PCT/US2020/035249提交的WO 2020/243519中的权利要求1-16中的任一个和编号1-223和279-287的条款中的任一个所定义,其各自通过引用整体纳入本文。
在某些实施方式中,STING拮抗剂是如在2020年5月29日作为PCT/US2020/035249提交的WO 2020/243519中的表C1中所述的化合物,其通过引用整体纳入本文。
在一些实施方式中,STING拮抗剂是式(VII)的化合物:
或其药学上可接受的盐,或其互变异构体,其中:
Y1、Y2、Y3、Y4、Y5、R6、W和A可以如以下文献中任何位置处所定义:在2020年6月12日作为PCT/US2020/037403提交的WO 2020/252240;于2019年6月14日提交的美国临时文件62/861,714;以及2019年12月31日提交的美国临时文件62/955,924中,每一份文献均通过引用整体并入本文。
在这些实施方式的某些中,Y1、Y2、Y3、Y4、Y5、R6、W和A如在2020年6月12日提交的PCT/US2020/037403中的权利要求1-16中的任一个和编号1-328的条款中的任一个所定义,其各自通过引用整体纳入本文。
在某些实施方式中,STING拮抗剂是2020年6月12日提交的PCT/US2020/037403的表C1中描述的化学物,其全文通过引用并入本文。
在一些实施方式中,STING拮抗剂是式(VIII)的化合物:
或其药学上可接受的盐,其中:
R1、R2、R3、R4、R5、W、Q和A可以如以下文献中任何位置处所定义:在2019年11月19日作为PCT/US2019/062245提交的WO 2020/106741;于2018年11月19日提交的美国临时文件62/769,500;以及2019年6月13日提交的美国临时文件62/861,108中,每一份文献均通过引用整体并入本文。
在这些实施方式的某些中,R1、R2、R3、R4、R5、W、Q和A如在2019年11月19日作为PCT/US2019/062245提交的WO 2020/106741中的权利要求1-118中的任一个所定义,其各自通过引用整体纳入本文。
在某些实施方式中,STING拮抗剂是如在2019年11月19日作为PCT/US2019/062245提交的WO 2020/106741中跨56-69页的表格中所述的化合物,其各自通过引用整体纳入本文。
在一些实施方式中,STING拮抗剂是式(IX)的化合物:
或其药学上可接受的盐,或其互变异构体,其中:
A、B、W和RN可以如以下文献中任何位置处所定义:在2019年11月19日作为PCT/US2019/062238提交的WO 2020/106736;于2018年11月19日提交的美国临时文件62/769,327以及2019年6月14日提交的美国临时文件62/861,781,每一份文献均通过引用整体并入本文。
在这些实施方式的某些中,A、B、W和RN如在2019年11月19日作为PCT/US2019/062238提交的WO 2020/106736中的权利要求1-298中的任一项所定义,其各自通过引用整体纳入本文。
在某些实施方式中,STING拮抗剂是如在2019年11月19日作为PCT/US2019/062238提交的WO 2020/106736中表1A和表1B中所述的化合物,其各自通过引用整体纳入本文。
在一些实施方式中,STING拮抗剂是式(X)的化合物:
或其药学上可接受的盐,或其互变异构体,其中:
A、B和LAB可以如以下文献中任何位置处所定义:在2020年1月16日作为PCT/US2020/013824提交的WO 2020/150439;于2019年1月17日提交的美国临时文件62/793,623;以及2019年6月14日提交的美国临时文件62/861,702;每一份文献均通过引用整体并入本文。
在这些实施方式的某些中,A、B和LAB如在2020年1月16日作为PCT/US2020/013824提交的WO 2020/150439中的权利要求1-116和172-249中的任一项所定义,其各自通过引用整体纳入本文。
在某些实施方式中,STING拮抗剂是如在2020年1月16日作为PCT/US2020/013824提交的WO 2020/150439中的表C1中所述的化合物,其各自通过引用整体纳入本文。
在一些实施方式中,STING拮抗剂是式(XI)的化合物:
或其药学上可接受的盐,或其互变异构体,其中:
X1、X2、Y1、Y2、Y3、Y4、Z、Q、A和R6可以如以下文献中任何位置处所定义:在2020年10月2日作为PCT/US2020/054054提交的WO 2021/067791;2019年10月3日提交的美国临时文件62/910,162;以及2019年12月31日提交的美国临时文件62/955,921中;其各自通过引用整体并入本文。
在这些实施方式的某些中,X1、X2、Y1、Y2、Y3、Y4、Z、Q、A和R6如在2020年10月2日提交的PCT/US2020/054054中的权利要求1-16中的任一个和编号1-179的条款中的任一个所定义,其各自通过引用整体纳入本文。
在某些实施方式中,STING拮抗剂是2020年10月2日提交的PCT/US2020/054054的表C1中描述的化学物,其各自通过引用整体并入本文。
在一些实施方式中,STING拮抗剂是式(XII)的化合物:
或其药学上可接受的盐,或其互变异构体,其中:
R1a、R1b、R1c、R1d、X1、X2、Q、A和R6可以如以下文献中任何位置处所定义:在2020年10月2日作为PCT/US2020/054069提交的WO 2021/067805;2019年10月3日提交的美国临时文件62/910,160;以及2019年12月31日提交的美国临时文件62/955,867中;其各自通过引用整体并入本文。
在这些实施方式的某些中,R1a、R1b、R1c、R1d、X1、X2、Q、A和R6如在2020年10月2日提交的PCT/US2020/054069中的权利要求1-16中的任一个和编号1-296的条款中的任一个所定义,其各自通过引用整体纳入本文。
在某些实施方式中,STING拮抗剂是2020年10月2日提交的PCT/US2020/054069的表C1中描述的化学物,其各自通过引用整体并入本文。
在一些实施方式中,STING拮抗剂是式(XIII)的化合物:
或其药学上可接受的盐,或其互变异构体,其中:
R1a,R1b,R1c,R1d,X1,X2,W,Q,A和R6可以如以下文献中任何位置处所定义:在2020年10月2日作为PCT/US2020/054064提交的WO 2021/067801;2019年10月3日提交的美国临时文件62/910,230;以及2019年12月31日提交的美国临时文件62/955,899中;其各自通过引用整体并入本文。
在这些实施方式的某些中,R1a、R1b、R1c、R1d、X1、X2、W、Q、A和R6如在2020年10月2日提交的PCT/US2020/054064中的权利要求1-16中的任一个和编号1-181的条款中的任一个所定义,其各自通过引用整体纳入本文。
在某些实施方式中,STING拮抗剂是2020年10月2日提交的PCT/US2020/054064的表C1中描述的化学物,其各自通过引用整体并入本文。
在一些实施方式中,STING拮抗剂是式(XIV)的化合物:
其中:
Z、Y1、Y2、Y3、X1、X2、R6、W、Q、P1、P2、P3、P4和P5可以如以下文献中任何位置处所定义:在2020年12月30日作为PCT/US2020/067463提交的WO 2021/138419;于2020年10月12日提交的美国临时文件63/090,547;以及2019年12月31日提交的美国临时文件62/955,853中,其各自通过引用整体并入本文。
在这些实施方式的某些中,Z、Y1、Y2、Y3、X1、X2、R6、W、Q、P1、P2、P3、P4和P5如在2020年10月12日提交的美国临时文件63/090,547中的权利要求1-16中的任一个和编号1-220的条款中的任一个所定义,其各自通过引用整体纳入本文。
在某些实施方式中,STING拮抗剂是如在2020年10月12日提交的美国临时申请系列号63/090,547中的表C1中所述的化合物,其各自通过引用整体纳入本文。
在一些实施方式中,STING拮抗剂是式(XV)的化合物:
或其药学上可接受的盐或其互变异构体,其中:
R1a、R1b、R1c、R1d、X1、X2、R6、W、Q、P1、P2、P3、P4和P5可以如以下文献中任何位置处所定义:在2020年12月30日作为PCT/US2020/067483提交的WO 2021/138434;于2020年10月12日提交的美国临时文件63/090,538;以及2019年12月31日提交的美国临时文件62/955,839中,其各自通过引用整体并入本文。
在这些实施方式的某些中,R1a、R1b、R1c、R1d、X1、X2、R6、W、Q、P1、P2、P3、P4和P5如在2020年10月12日提交的美国临时文件63/090,538中的权利要求1-16中的任一个和编号1-240的条款中的任一个所定义,其各自通过引用整体纳入本文。
在某些实施方式中,STING拮抗剂是2020年10月12日提交的美国临时文件63/090,538的表C1中描述的化合物,其各自通过引用整体并入本文。
在一些实施方式中,STING拮抗剂是式(XVI)的化合物:
或其药学上可接受的盐或其互变异构体,其中
Q2、LA、a1、环Q1、Y1、Y2、Y3、X1、X2、R6和W可以如以下文献中任何位置处所定义:在2021年7月15日提交的PCT/US2021/041823中;和2020年7月15日提交的美国临时文件63/052,084中,其各自通过引用整体并入本文。
在这些实施方式的某些中,Q2、LA、a1、环Q1、Y1、Y2、Y3、X1、X2、R6和W如在2021年7月15日提交的PCT/US2021/041823中的权利要求1-20中的任一个和编号1-176的条款中的任一个所定义,其各自通过引用整体纳入本文。
在某些实施方式中,STING拮抗剂是2021年7月15日提交的PCT/US2021/041823的表C1中描述的化学物,其各自通过引用整体并入本文。
在一些实施方式中,STING拮抗剂是式(XVII)的化合物:
或其药学上可接受的盐或其互变异构体,其中
Z、Y1、Y2、Y3、X1、X2、R6、P1、P2、P3、P4和P5可以如以下文献中任何位置处所定义:在2021年7月15日提交的PCT/US2021/041820中;和2020年7月15日提交的美国临时文件63/052,086中,其各自通过引用整体并入本文。
在这些实施方式的某些中,Z、Y1、Y2、Y3、X1、X2、R6、P1、P2、P3、P4和P5如在2021年7月15日提交的PCT/US2021/041820中的权利要求1-19中的任一个和编号1-193的条款中的任一个所定义,其各自通过引用整体纳入本文。
在某些实施方式中,STING拮抗剂是2021年7月15日提交的PCT/US2021/041820的表C1中描述的化合物,其各自通过引用整体并入本文。
在一些实施方式中,STING拮抗剂是式(XVIII)的化合物:
或其药学上可接受的盐或其互变异构体,其中
Z、Y1、Y2、Y3、X1、X2、R6、环B、LA、a1和环C可以如以下文献中任何位置处所定义:在2021年7月15日提交的PCT/US2021/041817中;和2020年7月15日提交的美国临时文件63/052,080中,其各自通过引用整体并入本文。
在这些实施方式的某些中,Z、Y1、Y2、Y3、X1、X2、R6、环B、LA、a1和环C如在2021年7月15日提交的PCT/US2021/041817中的权利要求1-20中的任一个和编号1-196的条款中的任一个所定义,其各自通过引用整体纳入本文。
在某些实施方式中,STING拮抗剂是2021年7月15日提交的PCT/US2021/041817的表C1中描述的化合物,其各自通过引用整体并入本文。
在一些实施方式中,STING拮抗剂是式(XIX)的化合物:
或其药学上可接受的盐或其互变异构体,其中
Z、Y1、Y2、Y3、X1、X2、R6、环B、LA、a1、环C和R7可以如以下文献中任何位置处所定义:在2021年7月15日提交的PCT/US2021/041792中;和2020年7月15日提交的美国临时文件63/052,117中,其各自通过引用整体并入本文。
在这些实施方式的某些中,Z、Y1、Y2、Y3、X1、X2、R6、环B、LA、a1、环C和R7如在2021年7月15日提交的PCT/US2021/041792中的权利要求1-17中的任一个和编号1-173的条款中的任一个所定义,其各自通过引用整体纳入本文。
在某些实施方式中,STING拮抗剂是2021年7月15日提交的PCT/US2021/041792的表C1中描述的化合物,其各自通过引用整体并入本文。
在一些实施方式中,STING拮抗剂是式(XX)的化合物:
或其药学上可接受的盐或其互变异构体,其中
Q2、LA、a1、Q1、Y1、Y2、Y3、X1、X2、R6和W可以如以下文献中任何位置处所定义:在2021年7月15日提交的美国实用新型申请17/376,823中;和2020年7月15日提交的美国临时文件63/052,076中,其各自通过引用整体并入本文。
在这些实施方式的某些中,Q2,LA,a1,Q1,Y1,Y2,Y3,X1,X2,R6和W和环C如在2021年7月15日提交的美国实用新型申请17/376,823中的权利要求1-19中的任一个和编号1-186的条款中的任一个所定义,其各自通过引用整体纳入本文。
在某些实施方式中,STING拮抗剂是2021年7月15日提交的美国实用新型申请17/376,823的表C1中描述的化合物,其各自通过引用整体并入本文。
在一些实施方式中,STING拮抗剂是式(XXI)的化合物:
或其药学上可接受的盐或其互变异构体,其中
Z、Y1、Y2、Y3、X1、X2、R6、环B、LB、LA、a1、和环C可以如以下文献中任何位置处所定义:在2021年7月15日提交的美国实用新型申请17/376,829中;和2020年7月15日提交的美国临时文件63/052,052中,其各自通过引用整体并入本文。
在这些实施方式的某些中,Z、Y1、Y2、Y3、X1、X2、R6、环B、LB、LA、a1和环C如在2021年7月15日提交的美国实用新型申请17/376,829中的权利要求1-17中的任一个和编号1-181的条款中的任一个所定义,其各自通过引用整体纳入本文。
在某些实施方式中,STING拮抗剂是2021年7月15日提交的美国实用新型申请17/376,829的表C1中描述的化合物,其各自通过引用整体并入本文。
在一些实施方式中,STING拮抗剂是式(XXII)的化合物:
或其药学上可接受的盐或其互变异构体,其中
Z、Y1、Y2、Y3、X1、X2、R6和环B可以如以下文献中任何位置处所定义:在2021年7月15日提交的PCT/US2021/041758中;和2020年7月15日提交的美国临时文件63/052,083中,其各自通过引用整体并入本文。
在这些实施方式的某些中,Z、Y1、Y2、Y3、X1、X2、R6和环B如在2021年7月15日提交的PCT/US2021/041758中的权利要求1-18中的任一个和编号1-157的条款中的任一个所定义,其各自通过引用整体纳入本文。
在某些实施方式中,STING拮抗剂是2021年7月15日提交的PCT/US2021/041758的表C1中描述的化合物,其各自通过引用整体并入本文。
在一些实施方式中,STING拮抗剂是式(XXIII)的化合物:
或其药学上可接受的盐或其互变异构体,其中
X1、X2、X3、Y1、Y2、Y3、R3、R4、R5、R6和m可以如以下文献中任何位置处所定义:2020年12月16日提交的美国临时文件63/126,332中,其各自通过引用整体并入本文。
在这些实施方式的某些中,X1、X2、X3、Y1、Y2、Y3、R3、R4、R5、R6和m如在2020年12月16日提交的美国临时文件63/126,332中的权利要求1-20中的任一个和编号1-174的条款中的任一个所定义,其各自通过引用整体纳入本文。
在某些实施方式中,STING拮抗剂是2020年12月16日提交的美国临时文件63/126,332的表C1中描述的化合物,其各自通过引用整体并入本文。
在一些实施方式中,STING拮抗剂是式(XXIV)的化合物:
或其药学上可接受的盐或其互变异构体,其中
X1、X2、X3、Y1、Y2、Y3、R3和环A可以如以下文献中任何位置处所定义:2020年12月16日提交的美国临时文件63/126,286中,其各自通过引用整体并入本文。
在这些实施方式的某些中,X1、X2、X3、Y1、Y2、Y3、R3和环A如在2020年12月16日提交的美国临时文件63/126,286中的权利要求1-23中的任一个和编号1-183的条款中的任一个所定义,其各自通过引用整体纳入本文。
在某些实施方式中,STING拮抗剂是2020年12月16日提交的美国临时文件63/126,286的表C1中描述的化合物,其各自通过引用整体并入本文。
在一些实施方式中,STING拮抗剂是式(M1)的化合物:
或其药学上可接受的盐,其中:
环B选自下组:(B-1)、(B-2)和(B-3);
X1选自下组:O、S、N、NR2和CR5
X2选自下组:O、S、N、NR4和CR5
Z、Y1、Y2和Y3中的每一个各自独立地选自:CR1、N和NR2
Y4是C或N;
独立地是单键或双键;
·条件是在(B-1)、(B-2)和(B-3)中,包含X1和X2的五元环是杂芳基;
·条件是在(B-1)中,6元环是芳族的;
·条件是在(B-2)中,6元环是芳族,且(B-2)中的Z、Y1、Y2、Y3和Y4中的一个或多个是独立选择的杂原子;且
·条件是在(B-3)中,6元环是芳族的;
W选自下组:
·*C(=O)NRN,*C(=S)NRN,*C(=NRN)NRN,*C(=NCN)NRN,*C(=CNO2)NRN*S(O)1- 2NRN
·*C(=O),*S(O)2
·其中Q2选自下组:键、NRN、-S-和–O-;
每个RN从以下组中独立选择:H和Rd,且星号表示与NR6连接的点;
A是:
(i)-(YA1)n-YA2,其中:
·n是0或1;
·YA1是C1-6亚烷基,其任选地被1-6个Ra取代;
·YA2是:
(a)C3-20环烷基或C3-20环烯基,其各自任选地被1-4个Rb取代,
(b)C6-20芳基,其任选地被1-4个Rc取代;
(c)包含5-20个环原子的杂芳基,其中1-3个环原子是杂原子,各自独立地选自下组N、N(H)、N(Rd)、O和S(O)0-2,并且其中所述杂芳基环任选地被1-4个独立选择的Rc取代;或
(d)具有3-16个环原子的杂环基或杂环烯基,其中1-3个环原子是杂原子,其各自独立地选自下组:N、N(H)、N(Rd)、O和S(O)0-2,并且其中所述杂环基或杂环烯基环任选地被1-4个独立选择的Rb取代,
或者
(ii)C1-20烷基,其任选地被1-6个独立选择的Ra取代;
R1、R1a、R1b、R1c和R1d各自独立地选自:H;卤素;氰基;任选地被1-2个Ra取代的C1-6烷基;C2-6烯基;C2-6炔基;C1-4卤代烷基;C1-4烷氧基;C1-4卤代烷氧基;–L3-L4-Ri;-S(O)1-2(C1-4烷基);-S(O)(=NH)(C1-4烷基);SF5;-NReRf;–OH;氧代;-S(O)1-2(NR’R”);-C1-4硫代烷氧基;-NO2;-C(=O)(C1-4烷基);-C(=O)O(C1-4烷基);-C(=O)OH;和-C(=O)N(R’)(R”);
每次出现的R2独立地选自:
(i)C1-6烷基,其任选地被1-2个独立选择的Ra取代;
(ii)C3-6环烷基、C3-6环烯基或C6-10芳基;
(iii)3-10个环原子的杂环基或杂环烯基,其中1-3个环原子是杂原子,各自独立地选自:N、N(H)、N(Rd)、O和S(O)0-2
(iv)包括5-10个环原子的杂芳基,其中1-3个环原子为杂原子,每个杂原子独立地选自N、N(H)、N(Rd)、O和S(O)0-2
(v)-C(O)(C1-4烷基);-C(O)O(C1-4烷基);-CON(R’)(R”);-S(O)1-2(NR’R”);-S(O)1-2(C1-4烷基);-OH;C1-4烷氧基;和
(vi)H;
R4选自H和任选地被1-3个独立选择的Ra取代的C1-6烷基;
R5选自:H;卤素;–OH;-C1-4烷基;-C1-4卤代烷基;C1-4烷氧基;C1-4卤代烷氧基;-C(=O)O(C1-4烷基);-C(=O)(C1-4烷基);-C(=O)OH;-CON(R’)(R”);-S(O)1-2(NR’R”);-S(O)1-2(C1-4烷基);氰基;和C3-6环烷基或C3-6环烯基,各自任选地被1-4个独立选择的C1-4烷基取代;
R6选自:H;任选地被1-3个独立选择的Ra取代的C1-6烷基;-OH;C1-4烷氧基;C(=O)H;C(=O)(C1-4烷基);任选地被1-4个独立选择的C1-4烷基取代的C6-10芳基;和5-10的环原子的杂芳基,其中1-4个环原子是杂原子,各自独立地选自N、N(H)、N(Rd)、O和S(O)0-2,以及其中杂芳基环任选地被1-4个独立选择的C1-4烷基取代;
每次出现的Ra独立地选自下组:–OH;-F;-Cl;-Br;–NReRf;C1-4烷氧基;C1-4卤代烷氧基;-C(=O)O(C1-4烷基);-C(=O)(C1-4烷基);-C(=O)OH;-CON(R’)(R”);-S(O)1-2(NR’R”);-S(O)1-2(C1-4烷基);氰基;和C3-6环烷基或C3-6环烯基,各自任选地被1-4个独立选择的C1-4烷基取代;
每次出现的Rb独立地选自下组:被1-6个独立选择的Ra任选取代的C1-10烷基;C1-4卤代烷基;–OH;氧代;-F;-Cl;-Br;–NReRf;C1-4烷氧基;C1-4卤代烷氧基;-C(=O)(C1-10烷基);-C(=O)O(C1-4烷基);-C(=O)OH;-C(=O)N(R’)(R”);-S(O)1-2(NR’R”);-S(O)1-2(C1-4烷基);和氰基;
每次出现的Rc独立地选自下组:卤素;氰基;任选地被1-6个独立选择的Ra任选取代的C1-10烷基;C2-6烯基;C2-6炔基;氧代;任选地被1-2个独立选择的Ra任选取代的C1-4烷氧基;C1-4卤代烷氧基;-S(O)1-2(C1-4烷基)或–S(O)1-2(C1-4卤代烷基);-NReRf;–OH;-S(O)1-2(NR’R”);-C1-4硫代烷氧基或–C1-4硫代卤代烷氧基;-NO2;–SF5;-C(=O)(C1-10烷基);-C(=O)O(C1-4烷基);-C(=O)OH;-C(=O)N(R’)(R”);和–L1-L2-Rh
Rd选自下组:C1-6烷基,其任选地被1-3个各自独立地选自卤素和OH的取代基取代;C3-6环烷基或C3-6环烯基,各自任选地被1-3个各自独立地选自卤素和OH的取代基取代;-C(O)(C1-4烷基);-C(O)O(C1-4烷基);-CON(R’)(R”);-S(O)1-2N(R’)(R”);-S(O)1-2(C1-4烷基);-OH;和C1-4烷氧基;
每次出现的Re和Rf独立地选自下组:H;C1-6烷基;C1-6卤代烷基;C3-6环烷基或C3-6环烯基;-C(O)(C1-4烷基);-C(O)O(C1-4烷基);-CON(R’)(R”);-S(O)1-2(NR’R”);-S(O)1-2(C1-4烷基);-OH;和C1-4烷氧基;或者Re和Rf与它们各自连接的氮原子一起形成包含3-8个环原子的环,其中所述环具有:(a)1-7个环碳原子,每个碳原子被1-2个独立地选自H和C1-3烷基的取代基取代;和(b)0-3个环杂原子(除了与Re和Rf相连的氮原子外),它们各自独立地选自N(Rd)、NH、O和S;
-L1是键或C1-3亚烷基;
-L2是–O-、-N(H)-、-N(C1-3烷基)-、-S(O)0-2-或键;
-L3是键或C1-3亚烷基;
-L4是–O-、-N(H)-、-N(C1-3烷基)-、-S(O)0-2-或键;
每次出现的Rh和Ri独立地选自下组:
·C3-8环烷基或C3-8环烯基,各自任选地被1-4个独立地选自以下的取代基取代:卤素;任选地被1-2个独立选择的Ra取代的C1-4烷基;C1-4卤代烷基;氰基;C1-4烷氧基;和C1-4卤代烷氧基;
·杂环基或杂环烯基,其中杂环基或杂环烯基具有3-16个环原子,其中1-3个环原子是杂原子,各自独立地选自N、N(H)、N(Rd)、O和S(O)0-2,其中所述杂环基或杂环烯基任选地被1-4个独立地选自以下的取代基取代:卤素;任选地被1-2个独立选择的Ra取代的C1-4烷基;C1-4卤代烷基;氰基;C1-4烷氧基;和C1-4卤代烷氧基;
·5-10个环原子的杂芳基,其中1-4个环原子是杂原子,各自独立地选自N、N(H)、N(Rd)、O和S(O)0-2,并且其中杂芳环任选地被1-4个独立地选自以下的取代基取代:卤素;任选地被1-2个独立选择的Ra取代的C1-4烷基;C1-4卤代烷基;氰基;C1-4烷氧基;和C1-4卤代烷氧基;和
·C6-10芳基,其任选地被1-4个独立地选自以下的取代基取代:卤素;任选地被1-2个独立选择的Ra取代的C1-4烷基;C1-4卤代烷基;氰基;C1-4烷氧基;和C1-4卤代烷氧基;和
每次出现的R’和R”独立地选自下组:H;C1-4烷基;任选地被1-2个选自卤素、C1-4烷基和C1-4卤代烷基的取代基取代的C6-10芳基;和5-10个环原子的杂芳基,其中1-4个环原子是杂原子,各自独立地选自N、N(H)、N(Rd)、O和S(O)0-2,并且其中杂芳基环任选地被1-4个独立地选自以下的取代基取代:卤素、-OH、NH2、NH(C1-4烷基)、N(C1-4烷基)2、C1-4烷基和C1-4卤代烷基;或者R’和R”与它们各自连接的氮原子一起形成3-8个环原子的环,其中所述环具有:(a)1-7个环碳原子,每个碳原子被1-2个独立地选自H和C1-3烷基的取代基取代;和(b)0-3个环杂原子(除了与R’和R”相连的氮原子外),它们各自独立地选自:N(H)、N(C1-6烷基)、O和S。
在式(M1)的某些实施方式中,环B是(B-2)(例如,例如);且W选自:*C(=O)NRN,*C(=S)NRN,*C(=NRN)NRN,*C(=NCN)NRN,*C(=CNO2)NRN*S(O)1-2NRN(例如,C(=O)NRN,如C(=O)NH)。
在式(M1)的某些实施方式中,环B是(B-1)(例如,例如);或(B-2)(例如,例如);且W是*C(=O)。
在式(M1)的某些实施方式中,环B是(B-1)(例如,例如);或(B-2)(例如,例如);且W是*S(O)2
在式(M1)的某些实施方式中,环B是(B-1)(例如,例如);或(B-2)(例如,例如);且W是(例如,)。
在式(M1)的某些实施方式中,环B是(B-3)(例如,例如
);且W是C(=O)NRN(例如C(=O)NH)。
在式(M1)的某些实施方式中,环B是(B-1)(例如,例如);W是C(=O)NRN(例如,C(=O)NH);且R1a、R1b、R1c和R1d之一(例如,R1b)是–L3-L4-Ri(例如,-Ri)。
在一些实施方式中,STING拮抗剂是式(M2)的化合物:
或其药学上可接受的盐,其中:
W根据以下(AA)或(BB)的定义:
(AA)
W是Q1-Q2-A,其中
Q1选自下组:
(a)任选地由1-2个独立选择的Rq1取代的苯基;和
(b)包含5-6个环原子的杂芳基,其中1-4个环原子是杂原子,各自独立地选自下组N、N(H)、N(Rd)、O,和S(O)0-2,并且其中所述杂芳基环任选地被1-4个独立选择的Rq1取代;
Q2选自下组:键、-NH-、-N(C1-3烷基)-、-O-、-C(=O)和–S(O)0-2-;
A如本文式(M1)所定义;或
(BB)
W选自:
(a)C7-20双环或多环芳基,其任选地被1-4个Rc取代;和
(b)包含7-20个环原子的双环或多环杂芳基,其中1-4个环原子是杂原子,各自独立地选自下组:N、N(H)、N(Rd)、O,和S(O)0-2,并且其中所述杂芳基环任选地被1-4个独立选择的Rc取代;
每次出现的Rq1独立地选自下组:
(a)卤素;(b)氰基;(c)1-6个独立选择的Ra任选取代的C1-10烷基;(d)C2-6烯基;(e)C2-6炔基;(f)C3-6环烷基;(g)C1-4烷氧基;(h)C1-4卤代烷氧基;(i)-S(O)1-2(C1-4烷基);(j)-NReRf;(k)–OH;(l)-S(O)1-2(NR’R”);(m)-C1-4硫代烷氧基;(n)-NO2;(o)-C(=O)(C1-4烷基);(p)-C(=O)O(C1-4烷基);(q)-C(=O)OH;(r)-C(=O)N(R’)(R”);和(s)氧代;和
环B、R6、Ra、Rc、Rd、Re、Rf、R’和R”各自如本文式(M1)所定义。
在式(M2)的某些实施方式中,环B是(B-3)(例如,例如)。
在式(M2)的某些实施方式中,环B是(B-1)(例如,例如);或(B-2)(例如,例如)。
在一些实施方式中,STING拮抗剂是式(M3)的化合物:
或其药学上可接受的盐或其互变异构体,
其中:
X1选自下组:O、S、N、NR2和CR5
X2选自下组:O、S、N、NR4和CR5
独立地为单键或双键,条件是包含X1和X2的五元环是杂芳基;且6元环是芳族的;
Q-A根据以下(A)或(B)的定义:
(A)
Q选自:NH和N(C1-6烷基),其中,C1-6烷基任选地被1-2个独立选择的Ra取代;且
A是:
(i)-(YA1)n-YA2,其中:
·n是0或1;
·YA1为C1-6亚烷基,其任选地由1-6个取代基取代,每个取代基独立地选自下组:
°氧代;
°Ra
°任选被1-4个独立选择的C1-4烷基取代的C6-10芳基;和
°包含5-10个环原子的杂芳基,其中1-4个环原子是杂原子,各自独立地选自下组N、N(H)、N(Rd)、O和S(O)0-2,并且其中所述杂芳基环任选地被1-4个独立选择的C1-4烷基取代;或
·YA1是–YA3-YA4-YA5,通过YA3连接到Q,其中:
°YA3是任选地由1-2个各自独立选自氧代和Ra的取代基取代的C1-3亚烷基;
°YA4是–O-、-NH-、-N(C1-6烷基)-或-S-;且
°YA5是键或任选地被1-2个独立选择的Ra取代的C1-3亚烷基;和
·YA2是:
(a)C3-20环烷基或C3-20环烯基,其各自任选地被1-4个Rb取代,
(b)C6-20芳基,其任选地被1-4个Rc取代;
(c)包含5-20个环原子的杂芳基,其中1-3个环原子是杂原子,各自独立地选自下组:N、N(H)、N(Rd)、O和S(O)0-2,并且其中所述杂芳基环任选地被1-4个独立选择的Rc取代;或
(d)具有3-16个环原子的杂环基或杂环烯基,其中1-3个环原子是杂原子,其各自独立地选自下组:N、N(H)、N(Rd)、O和S(O)0-2,并且其中所述杂环基或杂环烯基环任选地被1-4个独立选择的Rb取代,
或者
(ii)-Z1-Z2-Z3,其中:
·Z1是C1-3亚烷基,其任选地被1-4个Ra取代;
·Z2是-N(H)-、-N(Rd)-、-O-或-S-;以及
·Z3是C2-7烷基,其任选地被1-4个Ra取代;
或者
(iii)C1-20烷基,其任选地被1-6个独立选择的Ra取代,
或者
(B)
Q和A一起形成:
E是包含3-16个环原子的环,其中(除了已经存在的氮原子),0-3个环原子是杂原子,各自独立地选自下组:N、N(H)、N(Rd)、O和S(O)0-2,并且其中所述环任选地被1-4个独立选择的Rb取代,
R1a、R1b、R1c和R1d各自独立地选自:H;卤素;氰基;任选地被1-2个Ra取代的C1-6烷基;C2-6烯基;C2-6炔基;C1-4卤代烷基;C1-4烷氧基;C1-4卤代烷氧基;–L3-L4-Ri;-S(O)1-2(C1-4烷基);-S(O)(=NH)(C1-4烷基);SF5;-NReRf;–OH;氧代;-S(O)1-2(NR’R”);-C1-4硫代烷氧基;-NO2;-C(=O)(C1-4烷基);-C(=O)O(C1-4烷基);-C(=O)OH;和-C(=O)N(R’)(R”);或
R1a和R1b、R1b和R1c或R1c和R1d与连接它们的原子一起形成一个包含3-10个环原子的环,其中0-2个环原子是杂原子,每个杂原子独立地选自N、N(H)、N(Rd)、O和S(O)0-2;并且其中所述环任选地被1-4个取代基取代,每个取代基独立地选自C1-6烷基、卤素、C1-6卤代烷基、-OH、NReRf、C1-6烷氧基和C1-6卤代烷氧基,
每次出现的R2独立地选自:
(i)C1-6烷基,其任选地被1-2个独立选择的Ra取代;
(ii)C3-6环烷基、C3-6环烯基或C6-10芳基;
(iii)3-10个环原子的杂环基或杂环烯基,其中1-3个环原子是杂原子,各自独立地选自:N、N(H)、N(Rd)、O和S(O)0-2
(iv)包括5-10个环原子的杂芳基,其中1-3个环原子为杂原子,每个杂原子独立地选自N、N(H)、N(Rd)、O和S(O)0-2
(v)-C(O)(C1-4烷基);-C(O)O(C1-4烷基);-CON(R’)(R”);-S(O)1-2(NR’R”);-S(O)1-2(C1-4烷基);-OH;C1-4烷氧基;和
(vi)H;
R4选自H和任选地被1-3个独立选择的Ra取代的C1-6烷基;
R5选自:H;卤素;–OH;-C1-4烷基;-C1-4卤代烷基;C1-4烷氧基;C1-4卤代烷氧基;-C(=O)O(C1-4烷基);-C(=O)(C1-4烷基);-C(=O)OH;-CON(R’)(R”);-S(O)1-2(NR’R”);-S(O)1-2(C1-4烷基);氰基;和C3-6环烷基或C3-6环烯基,各自任选地被1-4个独立选择的C1-4烷基取代;
R6选自:H;任选地被1-3个独立选择的Ra取代的C1-6烷基;-OH;C1-4烷氧基;C(=O)H;C(=O)(C1-4烷基);任选地被1-4个独立选择的C1-4烷基取代的C6-10芳基;和5-10的环原子的杂芳基,其中1-4个环原子是杂原子,各自独立地选自N、N(H)、N(Rd)、O和S(O)0-2,以及其中杂芳基环任选地被1-4个独立选择的C1-4烷基取代;
每次出现的Ra独立地选自下组:–OH;-F;-Cl;-Br;–NReRf;C1-4烷氧基;C1-4卤代烷氧基;-C(=O)O(C1-4烷基);-C(=O)(C1-4烷基);-C(=O)OH;-CON(R’)(R”);-S(O)1-2(NR’R”);-S(O)1-2(C1-4烷基);氰基;和C3-6环烷基或C3-6环烯基,各自任选地被1-4个独立选择的C1-4烷基取代;
每次出现的Rb独立地选自下组:被1-6个独立选择的Ra任选取代的C1-10烷基;C1-4卤代烷基;–OH;氧代;-F;-Cl;-Br;–NReRf;C1-4烷氧基;C1-4卤代烷氧基;-C(=O)(C1-10烷基);-C(=O)O(C1-4烷基);-C(=O)OH;-C(=O)N(R’)(R”);-S(O)1-2(NR’R”);-S(O)1-2(C1-4烷基);氰基;和–L1-L2-Rh
每次出现的Rc独立地选自下组:卤素;氰基;任选地被1-6个独立选择的Ra任选取代的C1-10烷基;C2-6烯基;C2-6炔基;氧代;任选地被1-2个独立选择的Ra任选取代的C1-4烷氧基;C1-4卤代烷氧基;-S(O)1-2(C1-4烷基)或–S(O)1-2(C1-4卤代烷基);-NReRf;–OH;-S(O)1-2(NR’R”);-C1-4硫代烷氧基或–C1-4硫代卤代烷氧基;-NO2;–SF5;-C(=O)(C1-10烷基);-C(=O)O(C1-4烷基);-C(=O)OH;-C(=O)N(R’)(R”);和–L1-L2-Rh
Rd选自下组:C1-6烷基,其任选地被1-3个各自独立地选自卤素和OH的取代基取代;C3-6环烷基或C3-6环烯基,各自任选地被1-3个各自独立地选自卤素和OH的取代基取代;-C(O)(C1-4烷基);-C(O)O(C1-4烷基);-CON(R’)(R”);-S(O)1-2N(R’)(R”);-S(O)1-2(C1-4烷基);-OH;和C1-4烷氧基;
每次出现的Re和Rf独立地选自下组:H;C1-6烷基;C1-6卤代烷基;C3-6环烷基或C3-6环烯基;-C(O)(C1-4烷基);-C(O)O(C1-4烷基);-CON(R’)(R”);-S(O)1-2(NR’R”);-S(O)1-2(C1-4烷基);-OH;和C1-4烷氧基;或者Re和Rf与它们各自连接的氮原子一起形成包含3-8个环原子的环,其中所述环具有:(a)1-7个环碳原子,每个碳原子被1-2个独立地选自H和C1-3烷基的取代基取代;和(b)0-3个环杂原子(除了与Re和Rf相连的氮原子外),它们各自独立地选自N(Rd)、NH、O和S;
-L1是键或C1-3亚烷基;
-L2是–O-、-N(H)-、-N(C1-3烷基)-、-S(O)0-2-或键;
Rh选自:
·C3-8环烷基或C3-8环烯基;各自任选地被1-4个独立地选自以下的取代基取代:卤素;任选地被1-2个独立选择的Ra取代的C1-4烷基;C1-4卤代烷基;氰基;C1-4烷氧基;和C1-4卤代烷氧基;
·杂环基或杂环烯基,其中杂环基或杂环烯基具有3-16个环原子,其中1-3个环原子是杂原子,各自独立地选自N、N(H)、N(Rd)、O和S(O)0-2,其中所述杂环基或杂环烯基任选地被1-4个独立地选自以下的取代基取代:卤素;任选地被1-2个独立选择的Ra取代的C1-4烷基;C1-4卤代烷基;氰基;C1-4烷氧基;和C1-4卤代烷氧基;
·5-10个环原子的杂芳基,其中1-4个环原子是杂原子,各自独立地选自N、N(H)、N(Rd)、O和S(O)0-2,并且其中杂芳环任选地被1-4个独立地选自以下的取代基取代:卤素;任选地被1-2个独立选择的Ra取代的C1-4烷基;C1-4卤代烷基;氰基;C1-4烷氧基;和C1-4卤代烷氧基;和
·C6-10芳基,其任选地被1-4个独立地选自以下的取代基取代:卤素;任选地被1-2个独立选择的Ra取代的C1-4烷基;C1-4卤代烷基;氰基;C1-4烷氧基;和C1-4卤代烷氧基;
-L3是键或C1-3亚烷基;
-L4是–O-、-N(H)-、-N(C1-3烷基)-、-S(O)0-2-或键;
Ri选自:
·C3-8环烷基或C3-8环烯基;各自任选地被1-4个独立地选自以下的取代基取代:卤素;任选地被1-2个独立选择的Ra取代的C1-4烷基;C1-4卤代烷基;氰基;C1-4烷氧基;和C1-4卤代烷氧基;
·杂环基或杂环烯基,其中杂环基或杂环烯基具有3-16个环原子,其中1-3个环原子是杂原子,各自独立地选自N、N(H)、N(Rd)、O和S(O)0-2,其中所述杂环基或杂环烯基任选地被1-4个独立地选自以下的取代基取代:卤素;任选地被1-2个独立选择的Ra取代的C1-4烷基;C1-4卤代烷基;氰基;C1-4烷氧基;和C1-4卤代烷氧基;
·5-10个环原子的杂芳基,其中1-4个环原子是杂原子,各自独立地选自N、N(H)、N(Rd)、O和S(O)0-2,并且其中杂芳环任选地被1-4个独立地选自以下的取代基取代:卤素;任选地被1-2个独立选择的Ra取代的C1-4烷基;C1-4卤代烷基;氰基;C1-4烷氧基;和C1-4卤代烷氧基;和
·C6-10芳基,其任选地被1-4个独立地选自以下的取代基取代:卤素;任选地被1-2个独立选择的Ra取代的C1-4烷基;C1-4卤代烷基;氰基;C1-4烷氧基;和C1-4卤代烷氧基;和
每次出现的R’和R”独立地选自下组:H;C1-4烷基;任选地被1-2个选自卤素、C1-4烷基和C1-4卤代烷基的取代基取代的C6-10芳基;和5-10个环原子的杂芳基,其中1-4个环原子是杂原子,各自独立地选自N、N(H)、N(Rd)、O和S(O)0-2,并且其中杂芳基环任选地被1-4个独立地选自以下的取代基取代:卤素、-OH、NH2、NH(C1-4烷基)、N(C1-4烷基)2、C1-4烷基和C1-4卤代烷基;或者R’和R”与它们各自连接的氮原子一起形成3-8个环原子的环,其中所述环具有:(a)1-7个环碳原子,每个碳原子被1-2个独立地选自H和C1-3烷基的取代基取代;和(b)0-3个环杂原子(除了与R’和R”相连的氮原子外),它们各自独立地选自:N(H)、N(C1-6烷基)、O和S。
在式(M3)的某些实施方式中,化合物是式(M3A)的化合物:
其中:
m1和m2独立地是0、1或2;
Q5是N或CH;
L5是键、CH2、-O-、-N(H)-或–N(C1-3烷基),条件是当Q5是N时,则L5是键或CH2
T1、T2、T3和T4各自独立地是N、CH或CRt,条件是T1-T4中的1-4个,例如2、3或4个是CH;且
Rt和Rs各自独立地选自:卤素;任选地被1-2个独立选择的Ra取代的C1-4烷基;C1-4卤代烷基;氰基;C1-4烷氧基;和C1-4卤代烷氧基,
任选地其中R2是H,且R5是H;且
任选地其中R1b是卤素,例如–F或-Cl;R1c是H或卤素,例如–H或–F;且R1a和R1d是H。
在一些实施方式中,STING拮抗剂是式(M4)的化合物:
或其药学上可接受的盐或其互变异构体,
其中:
Z选自:CR1、N和NR2
Y1、Y2和Y3各自独立地选自:CR1、N和NR2
Y4是C或N,条件是Z、Y1、Y2、Y3和Y4中的一个或多个是独立选择的杂原子;
X1选自下组:O、S、N、NR2和CR1
X2选自下组:O、S、N、NR4和CR5
每个独立地为单键或双键,条件是包含Y4、X1和X2的五元环是杂芳基;以及包含Z、Y1、Y2和Y3的6元环是杂芳基;
每次出现的R1独立地选自:
H;卤素;氰基;任选地被1-2个Ra取代的C1-6烷基;C2-6烯基;C2-6炔基;C1-4卤代烷基;C1-4烷氧基;C1-4卤代烷氧基;–L3-L4-Ri;-S(O)1-2(C1-4烷基);-S(O)(=NH)(C1-4烷基);SF5;-NReRf;–OH;氧代;-S(O)1-2(NR’R”);-C1-4硫代烷氧基;-NO2;-C(=O)(C1-4烷基);-C(=O)O(C1-4烷基);-C(=O)OH;和-C(=O)N(R’)(R”);
R2、R4、R5、R6、Q、A、Ra、Re、Rf、L3、L4、Ri、R’和R”各自如本文式M3所定义。
在一些实施方式中,STING拮抗剂是式(M5)的化合物:
或其药学上可接受的盐或其互变异构体,其中:
X1选自下组:O、S、N、NR2和CR1
X2选自下组:O、S、N、NR4和CR5
每个独立为单键或双键,条件是:
包含X1和X2的5元环是杂芳基;
6元环是芳族的;以及
包含P1、P2、P3、P4和P5的环是芳族的;
P1、P2、P3、P4和P5根据(AA)或(BB)定义:
(AA)
P1、P2、P3、P4和P5中的每一个独立地选自:N、CH、CR7和CRc,条件是P1、P2、P3、P4和P5中的1-2个是独立选择的CR7;或
(BB)
P1不存在,从而提供5-元环,
P2、P3、P4和P5中的每一个独立地选自:O、S、N、NH、NRd、NR7、CH、CR7和CRc,条件是P2、P3、P4和P5中的1-3个是O、S、N、NH、NRd、或NR7;以及P2、P3、P4和P5中的1-2个是独立选择的NR7或CR7
各R7独立地选自下组:-R8和–L3-R9
R8和R9独立地选自下组:
(a)C3-12环烷基或C3-12环烯基,其各自任选地被1-4个独立选择的R7’取代;
(b)3-12个环原子的杂环基或杂环烯基,其中1-3个环原子是杂原子,各自独立地选自N、N(H)、N(Rd)、O和S(O)0-2,以及其中杂环基或杂环烯基环的一个或多个环碳原子任选地被1-4个独立选择的R7’取代;
(c)5-12个环原子的杂芳基,其中1-3个环原子是杂原子,各自独立地选自N、N(H)、N(Rd)、O和S(O)0-2,以及其中杂芳基环的一个或多个环碳原子任选地被1-4个独立选择的R7’取代;和
(d)任选被1-4个独立选择的R7’取代的C6-10芳基;
-L3选自:–O-、-CH2-、-S-、-NH-、S(O)1-2、C(=O)NH、NHC(=O)、C(=O)O、OC(=O)、C(=O)、NHS(O)2和S(O)2NH;
每次出现的R7’独立地选自:卤素;-CN;-NO2;-OH;任选地被1-2个独立选择的Ra取代的-C1-4烷基;-C2-4烯基;-C2-4炔基;-C1-4卤代烷基;任选地被1-2个独立选择的Ra取代的-C1-6烷氧基;-C1-6卤代烷氧基;S(O)1-2(C1-4烷基);-NR’R”;氧代;-S(O)1-2(NR’R”);-C1-4硫代烷氧基;-C(=O)(C1-4烷基);-C(=O)O(C1-4烷基);-C(=O)OH;和-C(=O)N(R’)(R”);
W选自:
(i)C(=O);(ii)C(=S);(iii)S(O)1-2;(iv)C(=NRd)或C(=N-CN);(v)C(=NH);(vi)C(=C-NO2);(vii)S(=O)(=N(Rd));和(viii)S(=O)(=NH);
Q选自:NH、N(C1-6烷基)、*-NH-(C1-3亚烷基)-和*-N(C1-6烷基)-(C1-3亚烷基)-,其中,C1-6烷基任选地被1-2个独立选择的Ra取代,星号表示与W的连接点;
R1a、R1b、R1c和R1d各自独立地选自:H;卤素;氰基;任选地被1-2个Ra取代的C1-6烷基;C2-6烯基;C2-6炔基;C1-4卤代烷基;C1-4烷氧基;C1-4卤代烷氧基;-S(O)1-2(C1-4烷基);-S(O)(=NH)(C1-4烷基);SF5;-NReRf;–OH;-S(O)1-2(NR’R”);-C1-4硫代烷氧基;-NO2;-C(=O)(C1-4烷基);-C(=O)O(C1-4烷基);-C(=O)OH;和-C(=O)N(R’)(R”);
每次出现的R2独立地选自:
(i)H;
(ii)C1-6烷基,其任选地被1-3个独立选择的Ra取代;
(iii)任选地被1-3个独立选择的Ra取代的-C(O)(C1-6烷基);
(iv)任选地被1-3个独立选择的Ra取代的-C(O)O(C1-4烷基);
(v)-CON(R’)(R”);
(vi)-S(O)1-2(NR’R”);
(vii)任选地被1-3个独立选择的Ra取代的-S(O)1-2(C1-4烷基);
(viii)–OH;
(ix)C1-4烷氧基;以及
(x)–L4-L5-Ri
R4选自H和任选地被1-3个独立选择的Ra取代的C1-6烷基;
R5选自:H;卤素;–OH;-C1-4烷基;-C1-4卤代烷基;C1-4烷氧基;C1-4卤代烷氧基;-C(=O)O(C1-4烷基);-C(=O)(C1-4烷基);-C(=O)OH;-CON(R’)(R”);-S(O)1-2(NR’R”);-S(O)1-2(C1-4烷基);氰基;和C3-6环烷基或C3-6环烯基,各自任选地被1-4个独立选择的C1-4烷基取代;
R6选自:H;任选地被1-3个独立选择的Ra取代的C1-6烷基;-OH;C1-4烷氧基;C(=O)H;C(=O)(C1-4烷基);任选地被1-4个独立选择的C1-4烷基取代的C6-10芳基;和5-10的环原子的杂芳基,其中1-4个环原子是杂原子,各自独立地选自N、N(H)、N(Rd)、O和S(O)0-2,以及其中杂芳基环任选地被1-4个独立选择的C1-4烷基取代;
每次出现的Ra独立地选自下组:–OH;-F;-Cl;-Br;–NReRf;C1-4烷氧基;C1-4卤代烷氧基;-C(=O)O(C1-4烷基);-C(=O)(C1-4烷基);-C(=O)OH;-CON(R’)(R”);-S(O)1-2(NR’R”);-S(O)1-2(C1-4烷基);氰基;和C3-6环烷基或C3-6环烯基,各自任选地被1-4个独立选择的C1-4烷基取代;
每次出现的Rb独立地选自下组:任选地被1-6个独立选择的Ra取代的C1-10烷基;C1-4卤代烷基;–OH;氧代;-F;-Cl;-Br;–NReRf;C1-4烷氧基;C1-4卤代烷氧基;-C(=O)(C1-10烷基);-C(=O)O(C1-4烷基);-C(=O)OH;-C(=O)N(R’)(R”);-S(O)1-2(NR’R”);-S(O)1-2(C1-4烷基);氰基;和–L1-L2-Rh
每次出现的Rc独立地选自下组:卤素;氰基;任选地被1-6个独立选择的Ra任选取代的C1-10烷基;C2-6烯基;C2-6炔基;C1-4烷氧基;C1-4卤代烷氧基;-S(O)1-2(C1-4烷基);-NReRf;–OH;-S(O)1-2(NR’R”);-C1-4硫代烷氧基;-NO2;-C(=O)(C1-10烷基);-C(=O)O(C1-4烷基);-C(=O)OH;-C(=O)N(R’)(R”);和–L1-L2-Rh
Rd选自下组:C1-6烷基,其任选地被1-3个各自独立地选自卤素、C1-3烷氧基、C1-3卤代烷氧基和OH的取代基取代;C3-6环烷基或C3-6环烯基,各自任选地被1-3个各自独立地选自卤素和OH的取代基取代;-C(O)(C1-4烷基);-C(O)O(C1-4烷基);-CON(R’)(R”);-S(O)1-2N(R’)(R”);-S(O)1-2(C1-4烷基);-OH;和C1-4烷氧基;
每次出现的Re和Rf独立地选自下组:H;C1-6烷基;C1-6卤代烷基;C3-6环烷基或C3-6环烯基;-C(O)(C1-4烷基);-C(O)O(C1-4烷基);-CON(R’)(R”);-S(O)1-2N(R’)(R”);-S(O)1-2(C1-4烷基);-OH;和C1-4烷氧基;或
Re和Rf与它们各自连接的氮原子一起形成3-8个环原子的环,其中所述环包含:(a)1-7个环碳原子,每个碳原子被1-2个独立地选自H和C1-3烷基的取代基取代;和(b)0-3个环杂原子(除了与Re和Rf相连的氮原子外),它们各自独立地选自N(Rd)、NH、O和S;
-L1是键或C1-3亚烷基;-L2是–O-、-N(H)-、-S(O)0-2-或键;
Rh选自:
·C3-8环烷基或C3-8环烯基;各自任选地被1-4个独立地选自以下的取代基取代:卤素;任选地被1-2个独立选择的Ra取代的C1-4烷基;C1-4卤代烷基;氰基;C1-4烷氧基;和C1-4卤代烷氧基;
·杂环基或杂环烯基,其中杂环基或杂环烯基具有3-16个环原子,其中1-3个环原子是杂原子,各自独立地选自N、N(H)、N(Rd)、O和S(O)0-2,其中所述杂环基或杂环烯基任选地被1-4个独立地选自以下的取代基取代:卤素;任选地被1-2个独立选择的Ra取代的C1-4烷基;C1-4卤代烷基;氰基;C1-4烷氧基;和C1-4卤代烷氧基;
·5-10个环原子的杂芳基,其中1-4个环原子是杂原子,各自独立地选自N、N(H)、N(Rd)、O和S(O)0-2,并且其中杂芳环任选地被1-4个独立地选自以下的取代基取代:卤素;任选地被1-2个独立选择的Ra取代的C1-4烷基;C1-4卤代烷基;氰基;C1-4烷氧基;和C1-4卤代烷氧基;和
·C6-10芳基,其任选地被1-4个独立地选自以下的取代基取代:卤素;任选地被1-2个独立选择的Ra取代的C1-4烷基;C1-4卤代烷基;氰基;C1-4烷氧基;和C1-4卤代烷氧基;和
-L4-选自:键、-C(O)-、-C(O)O-、-C(O)NH-、C(O)NRd、S(O)1-2、S(O)1-2NH、和S(O)1- 2NRd
-L5-选自:键和C1-4亚烷基;
Ri选自:
·C3-8环烷基或C3-8环烯基;各自任选地被1-4个独立地选自以下的取代基取代:卤素;OH;NReRf;任选地被1-2个独立选择的Ra取代的C1-4烷基;C1-4卤代烷基;氰基;C1-4烷氧基;和C1-4卤代烷氧基;
·杂环基或杂环烯基,其中杂环基或杂环烯基具有3-16个环原子,其中1-3个环原子是杂原子,各自独立地选自N、N(H)、N(Rd)、O和S(O)0-2,其中所述杂环基或杂环烯基任选地被1-4个独立地选自以下的取代基取代:卤素;OH;NReRf;任选地被1-2个独立选择的Ra取代的C1-4烷基;C1-4卤代烷基;氰基;C1-4烷氧基;和C1-4卤代烷氧基;
·5-10个环原子的杂芳基,其中1-4个环原子是杂原子,各自独立地选自N、N(H)、N(Rd)、O和S(O)0-2,并且其中杂芳环任选地被1-4个独立地选自以下的取代基取代:卤素;OH;NReRf;任选地被1-2个独立选择的Ra取代的C1-4烷基;C1-4卤代烷基;氰基;C1-4烷氧基;和C1-4卤代烷氧基;和
·C6-10芳基,其任选地被1-4个独立地选自以下的取代基取代:卤素;OH;NReRf;任选地被1-2个独立选择的Ra取代的C1-4烷基;C1-4卤代烷基;氰基;C1-4烷氧基;和C1-4卤代烷氧基;和
每次出现的R’和R”独立地选自下组:H;-OH;C1-4烷基;任选地被1-2个选自卤素、C1-4烷基和C1-4卤代烷基的取代基取代的C6-10芳基;和5-10个环原子的杂芳基,其中1-4个环原子是杂原子,各自独立地选自N、N(H)、N(Rd)、O和S(O)0-2,并且其中杂芳基环任选地被1-4个独立地选自以下的取代基取代:卤素、-OH、NH2、NH(C1-4烷基)、N(C1-4烷基)2、C1-4烷基和C1-4卤代烷基;
或者R’和R”与它们各自连接的氮原子一起形成3-8个环原子的环,其中所述环具有:(a)1-7个环碳原子,每个碳原子被1-2个独立地选自H和C1-3烷基的取代基取代;(b)0-3个环杂原子(除了与R’和R”相连的氮原子外),它们各自独立地选自:N(H)、N(C1-6烷基)、O和S。
在式(M5)的某些实施方式中,化合物是式(M5-1a)、(M5-2a)或(M5-3a)的化合物:
或其药学上可接受的盐,其中:
R1a、R1b、R1c、R1d各自独立地选自:H;卤素;氰基;任选地被1-2个Ra取代的C1-6烷基;C1-4卤代烷基;C1-4烷氧基;和C1-4卤代烷氧基;
n2是0、1或2;
存在时,每个Rc独立选自:卤素、氰基、C1-3烷基和C1-3烷氧基;
R8选自下组:
·其中m1和m2独立地是0、1或2,以及T1是CH或N;以及
·6-12个环原子的螺环杂环基,其中1-3个环原子是杂原子,各自独立地选自N、N(H)、N(Rd)、O和S(O)0-2,以及其中杂环基环的一个或多个环碳原子任选地被1-4个独立选择的R7’取代。
在一些实施方式中,STING拮抗剂是式(M6)的化合物:
或其药学上可接受的盐,其中:
Z、Y1、Y2和Y3各自独立地选自下组:CR1、N和NR2,条件是Z、Y1、Y2和Y3中的1-3个是独立选择的N或NR2
X1选自下组:O、S、N、NR2和CR1
X2选自下组:O、S、N、NR4和CR5
独立地是单键或双键,条件是包含X1和X2的五元环是杂芳基;包含Z、Y1、Y2和Y3的六元环是杂芳基;并且包含P1、P2、P3、P4和P5的环是芳族的;
W选自:(i)C(=O);(ii)C(=S);(iii)S(O)1-2;(iv)C(=NRd)或C(=N-CN);(v)C(=NH);(vi)C(=C-NO2);(vii)S(=O)(=N(Rd));和(viii)S(=O)(=NH);
Q选自:NH、N(C1-6烷基)、*-NH-(C1-3亚烷基)-和*-N(C1-6烷基)-(C1-3亚烷基)-,其中,C1-6烷基任选地被1-2个独立选择的Ra取代,星号表示与W的连接点;
P1、P2、P3、P4和P5根据(AA)或(BB)定义:
(AA)
P1、P2、P3、P4和P5中的每一个都从以下组中独立选择:N、CH、CR7和CRc,条件是:P1、P2、P3、P4和P5中的1-2个是独立选择的CR7;或
(BB)
P1不存在,从而提供5-元环,
P2、P3、P4和P5中的每一个独立地选自:O、S、N、NH、NRd、NR7、CH、CR7和CRc
条件是P2、P3、P4和P5中的1-3个是O、S、N、NH、NRd、或NR7;并且
P2、P3、P4和P5中的1-2个是独立选择的NR7或CR7
各R7独立地选自下组:-R8和–L3-R9
-R8选自:
(a)C3-12环烷基或C3-12环烯基,其各自被1-4个独立选择的R7’取代;
(b)3-12个环原子的杂环基或杂环烯基,其中1-3个环原子是杂原子,各自独立地选自N、N(H)、N(Rd)、O和S(O)0-2,以及其中杂环基或杂环烯基环的一个或多个环碳原子被1-4个独立选择的R7’取代;
(c)C3环烷基、C3环烯基、C5环烷基或C5环烯基,其各自任选地被1-4个独立选择的C1-4烷基取代;
(d)C7-12环烷基或C7-12环烯基,其各自任选地被1-4个独立选择的C1-4烷基取代;
(e)3-12个环原子的杂环基或杂环烯基,其中1-3个环原子是杂原子,各自独立地选自N、N(H)、N(Rd)、O和S(O)0-2,条件是杂环基不是四氢吡喃基,以及其中杂环基或杂环烯基环的一个或多个环碳原子任选地被1-4个独立选择的C1-4烷基取代;
(f)5-12个环原子的杂芳基,其中1-3个环原子是杂原子,各自独立地选自N、N(H)、N(Rd)、O和S(O)0-2,以及其中杂芳基环的一个或多个环碳原子任选地被1-4个独立选择的R7’取代;和
(g)任选被1-4个独立选择的R7’取代的C6-10芳基;
-L3选自:–O-、-S-、-NH-、S(O)1-2、-CH2-、C(=O)NH、NHC(=O)、C(=O)O、OC(=O)、C(=O)、NHS(O)2和S(O)2NH;
-R9选自:
(a)C3-12环烷基或C3-12环烯基,其各自任选地被1-4个独立选择的R7’取代,
(b)3-12个环原子的杂环基或杂环烯基,其中1-3个环原子是杂原子,各自独立地选自N、N(H)、N(Rd)、O和S(O)0-2,以及其中杂环基或杂环烯基环的一个或多个环碳原子任选地被1-4个独立选择的R7’取代;
(c)5-12个环原子的杂芳基,其中1-3个环原子是杂原子,各自独立地选自N、N(H)、N(Rd)、O和S(O)0-2,以及其中杂芳基环的一个或多个环碳原子任选地被1-4个独立选择的R7’取代;和
(d)任选被1-4个独立选择的R7’取代的C6-10芳基;
每次出现的R7’独立地选自:
卤素;-CN;-NO2;-OH;任选地被1-2个独立选择的Ra取代的-C1-4烷基;-C2-4烯基;-C2-4炔基;-C1-4卤代烷基;任选地被1-2个独立选择的Ra取代的-C1-6烷氧基;-C1-6卤代烷氧基;S(O)1-2(C1-4烷基);-NR’R”;氧代;-S(O)1-2(NR’R”);-C1-4硫代烷氧基;-C(=O)(C1-4烷基);-C(=O)O(C1-4烷基);-C(=O)OH;和-C(=O)N(R’)(R”),
条件是当R7是R8;并且R8是环烷基、环烯基、杂环基、或杂环烯基并被1-4个R7’取代时,
R8无法被C1-4烷基单取代,并且
当R8被2-4个R7’取代时,至少一个R7’必须是C1-4烷基以外的取代基;
每次出现的R1独立地选自:
H;卤素;氰基;任选地被1-2个Ra取代的C1-6烷基;C2-6烯基;C2-6炔基;C1-4卤代烷基;C1-4烷氧基;C1-4卤代烷氧基;–L1-L2-Rh;-S(O)1-2(C1-4烷基);-S(O)(=NH)(C1-4烷基);SF5;-NReRf;–OH;氧代;-S(O)1-2(NR’R”);-C1-4硫代烷氧基;-NO2;-C(=O)(C1-4烷基);-C(=O)O(C1-4烷基);-C(=O)OH;和-C(=O)N(R’)(R”);
每次出现的R2独立地选自:
(i)H;
(ii)C1-6烷基,任选地被1-3个独立选择的Ra取代;
(iii)任选地被1-3个独立选择的Ra取代的-C(O)(C1-6烷基);
(iv)任选地被1-3个独立选择的Ra取代的-C(O)O(C1-4烷基);
(v)-CON(R’)(R”);
(vi)-S(O)1-2(NR’R”);
(vii)任选地被1-3个独立选择的Ra取代的-S(O)1-2(C1-4烷基);
(viii)–OH;
(ix)C1-4烷氧基;以及
(x)–L4-L5-Ri
R4选自H和任选地被1-3个独立选择的Ra取代的C1-6烷基;
R5选自:H;卤素;–OH;-C1-4烷基;-C1-4卤代烷基;C1-4烷氧基;C1-4卤代烷氧基;-C(=O)O(C1-4烷基);-C(=O)(C1-4烷基);-C(=O)OH;-CON(R’)(R”);-S(O)1-2(NR’R”);-S(O)1-2(C1-4烷基);氰基;和C3-6环烷基或C3-6环烯基,各自任选地被1-4个独立选择的C1-4烷基取代;
R6选自:H;任选地被1-3个独立选择的Ra取代的C1-6烷基;-OH;C1-4烷氧基;C(=O)H;C(=O)(C1-4烷基);任选地被1-4个独立选择的C1-4烷基取代的C6-10芳基;和5-10的环原子的杂芳基,其中1-4个环原子是杂原子,各自独立地选自N、N(H)、N(Rd)、O和S(O)0-2,其中杂芳基环任选地被1-4个独立选择的C1-4烷基取代;且
Ra、Rb、Rc、Rd、Re、Rf、-L1、-L2、Rh、-L4、L5、-Ri、R’和R”各自如本文式(M5)所定义。
在式(M6)的某些实施方式中,化合物是式(M6-3a)或(M6-3b)的化合物:
或其药学上可接受的盐,其中:
R1a、R1b和R1c各自独立地选自:H;卤素;氰基;任选地被1-2个Ra取代的C1-6烷基;C1-4卤代烷基;C1-4烷氧基;和C1-4卤代烷氧基;
Q1是N或CH;
R8选自下组:
n2是0、1或2;
存在时,每个Rc独立选自:卤素、氰基、C1-3烷基和C1-3烷氧基;
m1和m2独立地是0、1或2;m3、m4、m5和m6独立地是0或1;和
T1是CH或N,
任选地其中R2是H;
任选地其中n2是1,且Rc位于R8的邻位;且
任选地,其中每个R7’独立地为卤素,例如–F。
在一些实施方式中,STING拮抗剂选自表C1中化合物或其药学上可接受的盐。
表C1
STING抑制性核酸
在本文所述任何方法的一些实施方式中,STING拮抗剂是抑制性核酸。在一些实施方式中,抑制性核酸是短干扰RNA、反义核酸、环二核苷酸或核酶。
下面描述了这些不同寡核苷酸方面的例子。任何作为STING拮抗剂的抑制性核酸的例子都可以减少哺乳动物细胞(例如,人细胞)中STING mRNA的表达。本文所述的任何抑制性核酸均可在体外合成。
可减少哺乳动物细胞中STING mRNA表达的抑制性核酸包括反义核酸分子,即其核苷酸序列与STING mRNA的全部或部分互补的核酸分子(例如,与SEQ ID NO:1、3、5或7中任何一个的全部或部分互补)。
反义核酸分子可以与编码STING蛋白的核苷酸序列的编码链的全部或部分非编码区互补。非编码区(5'和3'非翻译区)是位于基因编码区两侧且不翻译成氨基酸的5'和3'序列。
基于本文公开的序列,本领域技术人员可以容易地选择和合成多条适当的反义核酸中的任一条,以靶向编码本文所述STING蛋白的核酸。针对编码STING蛋白的核酸的反义核酸可以使用集成DNA技术(Integrated DNA Technologies)网站上提供的软件进行设计。
可用于产生反义核酸的修饰核苷酸的例子包括1-甲基鸟嘌呤、1-甲基肌苷、2,2-二甲基鸟嘌呤、2-甲基腺嘌呤、2-甲基鸟嘌呤、3-甲基胞嘧啶、2-甲硫基-N6-异戊烯基鸟嘌呤、尿嘧啶-5-氧乙酸(v)、怀丁氧苷(Wybutoxine)、假尿嘧啶、奎苷(queosine)、2-硫胞嘧啶、5-氟尿嘧啶、5-溴尿嘧啶、5-氯尿嘧啶、5-碘尿嘧啶、次黄嘌呤、黄嘌呤、4-乙酰胞嘧啶、5-(羧羟甲基)尿嘧啶、5-羧甲基氨基甲基-2-硫尿苷、5-羧甲基氨基甲基尿嘧啶、二氢尿嘧啶、β-D-半乳糖基Q-核苷、肌苷、N6-异戊烯基腺嘌呤、5-甲基胞嘧啶、N6-腺嘌呤、7-甲基鸟嘌呤、5-甲基氨基甲基尿嘧啶、5-甲氧基氨基甲基-2-硫尿嘧啶、β-D-甘露糖基Q-核苷、5'-甲氧基羧甲基尿嘧啶、5-甲氧基尿嘧啶、5-甲基-2-硫尿嘧啶、2-硫尿嘧啶、4-硫尿嘧啶、5-甲基尿嘧啶、尿嘧啶-5-氧乙酸甲酯、尿嘧啶-5-氧乙酸(v)、5-甲基-2-硫尿嘧啶,3-(3-氨基-3-N-2-羧丙基)尿嘧啶,(acp3)w和2,6-二氨基嘌呤。或者,可以使用以反义朝向(即,从插入的核酸转录的RNA将具有与感兴趣的靶核酸反义朝向)亚克隆入核酸的表达载体以生物方式产生反义核酸。
本文所述的反义核酸分子可在体外制备并给予对象,例如人对象。或者,它们可以原位产生,从而与编码STING蛋白的细胞mRNA和/或基因组DNA杂交或结合,从而抑制表达,例如通过抑制转录和/或翻译。杂交可以通过常规核苷酸互补形成稳定的双链,或者例如,在反义核酸分子与DNA双链结合的情况下,通过双螺旋主沟中的特定相互作用。可使用载体(例如腺病毒载体、慢病毒或逆转录病毒)将反义核酸分子递送至哺乳动物细胞。
反义核酸可以是α-异头核酸分子。α-异头核酸分子与互补RNA形成特定的双链杂交,其中与通常的β-单元相反,链彼此平行(Gaultier等人,Nucleic Acids Res.15:6625-6641,1987)。反义核酸还可以包含嵌合RNA-DNA类似物(Inoue等人,FEBS Lett.215:327-330,1987)或2'-O-甲基核糖核酸(Inoue等人,Nucleic Acids Res.15:6131-6148,1987)。
抑制性核酸的另一个例子是核酶,其对编码STING mRNA的核酸具有特异性,例如,对SEQ ID NO:1、3、5或7中的任何一种具有特异性。核酶是具有核糖核酸酶活性的催化性RNA分子,能够切割与其具有互补区域的单链核酸例如mRNA。因此,核酶(例如锤头状核酶(Haselhoff和Gerlach,Nature 334:585-591,1988中描述))可用于催化性切割mRNA转录物,从而抑制由mRNA编码的蛋白质的翻译。STING mRNA可用于从RNA分子池中选择具有特定核糖核酸酶活性的催化性RNA。参见例如Bartel等,Science261:1411-1418,1993。
此外,本发明公开了一种对STING mRNA序列具有特异性的核酶。例如,可以构建四膜虫L-19IVS RNA的衍生物,其中活性位点的核苷酸序列与STING mRNA中要切割的核苷酸序列互补(参见例如美国专利号4,987,071和5,116,742)。
抑制性核酸也可以是形成三螺旋结构的核酸分子。例如通过靶向与编码STING多肽的基因的调控区互补的核苷酸序列(例如,启动子和/或增强子,例如转录起始开始状态上游至少1kb、2kb、3kb、4kb或5kb的序列)以形成三螺旋结构,阻止靶细胞中基因转录,可抑制STING多肽表达。一般参见Maher,Bioassays 14(12):807-15,1992;Helene,AnticancerDrug Des.6(6):569-84,1991;和Helene,Ann.N.Y.Acad.Sci.660:27-36,1992。
在各种实施方式中,抑制性核酸可在糖部分、碱基部分或磷酸主链处被修饰以改善分子的溶解性、稳定性或杂交等。例如,可修饰核酸的脱氧核糖磷酸主链以产生肽核酸(参见例如,Hyrup等人,Bioorganic Medicinal Chem.4(1):5-23,1996)。肽核酸(PNA)是核酸模拟物,例如DNA模拟物,其中脱氧核糖磷酸骨架被假肽主链取代,仅保留四种天然碱基。PNA的中性骨架允许在低离子强度条件下与RNA和DNA特异性杂交。PNA寡聚物可以使用标准固相肽合成法合成(例如,见Perry-O'Keefe等人,Proc.Natl.Acad.Sci.U.S.A.93:14670-675,1996)。PNA可作为反义或抗原剂,通过例如诱导转录或翻译停滞或抑制复制等方式,对基因表达进行序列特异性调节。
cGAS抑制剂
在本文所述的任何方法中,cGAS抑制剂可以是本文所述的任何cGAS抑制剂(例如,本节所述的任何化合物)。在本文所述的任何方法中,cGAS抑制剂对于cGAS具有约1nM到约10μM之间的IC50
在一个方面,cGAS抑制剂是从表C2中的化合物及其药学上可接受的盐组成的组中选择的化合物。
表C2
在一些实施方式中,cGAS抑制剂选自2016年6月28日提交的美国临时申请62/355,403中公开的化合物,其全文通过引用并入本文。
在一些实施方式中,cGAS抑制剂选自2016年4月5日提交的美国临时申请62/318,435中公开的化合物,其全文通过引用并入本文。
在一些实施方式中,cGAS抑制剂选自2018年8月16日公开的美国申请2018/0230115A1中公开的化合物,其全文通过引用并入本文。
在一些实施方式中,cGAS抑制剂选自Vincent,J.等人Nat.Commun.8(1):750中公开的化合物,其全部内容通过引用并入本文。
在一些实施方式中,cGAS抑制剂选自Hall,J.等人(2017)PLOS ONE 12(9):e184843中公开的化合物,其全部内容通过引用并入本文。
在一些实施方式中,cGAS抑制剂选自Wang,M.等人(2018)Future Med.Chem.10(11):1301-17中公开的化合物,其全部内容通过引用并入本文。
在一些实施方式中,cGAS抑制剂选自2017年9月15日提交的美国临时申请62/559,482中公开的化合物,其全文通过引用并入本文。
在一些实施方式中,cGAS抑制剂选自2018年2月21日提交的美国临时申请62/633,248中公开的化合物,其全文通过引用并入本文。
在一些实施方式中,cGAS抑制剂选自2018年6月20日提交的美国临时申请62/687,769中公开的化合物,其全文通过引用并入本文。
药物组合物
在一些实施方式中,将STING拮抗剂或cGAS抑制剂(例如,本文所述或本领域已知的任何STING拮抗剂或cGAS抑制剂)作为药物组合物给予,其包括化学实体和一种或多种药学上可接受的赋形剂,以及任选地一种或多种如本文所述的其它治疗剂。
在一些实施方式中,可与一种或多种常规药物赋形剂组合施用STING拮抗剂或cGAS抑制剂。药学上可接受的赋形剂包括但不限于:离子交换剂,氧化铝,硬脂酸铝,卵磷脂,自乳化药物递送系统(SEDDS),例如d-α-生育酚聚乙二醇1000琥珀酸酯,药物剂型中使用的表面活性剂,例如吐温(Tweens)、泊洛沙姆或其它类似的聚合物递送基质,血清蛋白,例如人血清白蛋白,缓冲物质,例如磷酸盐,三羟甲基氨基甲烷(tris),甘氨酸,山梨酸,山梨酸钾,饱和植物脂肪酸的部分甘油酯混合物,水,盐或电介质,例如硫酸鱼精蛋白,磷酸氢二钠,磷酸氢钾,氯化钠,锌盐,胶体二氧化硅,三硅酸镁,聚乙烯基吡咯烷酮,基于纤维素的物质,聚乙二醇,羧甲基纤维素钠,聚丙烯酸酯,蜡,聚乙烯-聚氧化丙烯-嵌段聚合物,以及羊毛脂。环糊精如α-、β和γ-环糊精,或化学改性的衍生物如羟烷基环糊精,包括2-和3-羟丙基-β-环糊精,或其它溶液化的衍生物也可用于增强文中所述的STING抑制剂或cGAS抑制剂的递送。可制备含有如本文所述的0.005%至100%范围内的STING拮抗剂或cGAS抑制剂,其余由无毒赋形剂组成的剂型或组合物。所考虑的组合物可包含0.001%-100%的STING拮抗剂,在一个实施方式中为0.1-95%,在另一个实施方式中为75-85%,在又一个实施方式中20-80%。制备这种剂型的实际方法是已知的,或是本领域技术人员所明白的;例如参见《雷明顿:药物科学和实践》(Remington:The Science and Practice ofPharmacy),第22版(英国伦敦的药物出版社(Pharmaceutical Press),2012)。
给药途径和组合物组分
在一些实施方式中,可通过任何可接受的给药途径向需要的对象施用STING拮抗剂或cGAS抑制剂(例如,本文所述或本领域已知的任何示例性STING拮抗剂或cGAS抑制剂)或其药物组合物。可接受的给药途径包括但不限于:含服,经皮,宫颈内,鼻窦内,气管内,肠内,硬膜上(epidural),间质,腹腔内,动脉内,支气管内,囊内(intrabursal),脑内,脑池内,冠状动脉内,真皮内,导管内,十二指肠内,硬脑膜内,表皮内,食道内,胃内,牙龈内,回肠内,淋巴管内,髓内,脑膜内,肌肉内,卵巢内,腹膜内,前列腺内,肺内,窦内,脊髓内,滑膜内,睾丸内,鞘内,肾小管内,肿瘤内,子宫内,血管内,静脉内,鼻,鼻胃,口服,胃肠外,经皮,硬膜外(peridural),直肠,呼吸(吸入),皮下,舌下,粘膜下,局部,透皮,经粘膜,经气管,输尿管,尿道和阴道。在一些实施方式中,优选的给药途径是胃肠外的(例如肿瘤内的)。
组合物可以配制用于胃肠外给药,例如配制用于通过静脉内,肌肉内,皮下或甚至腹膜内途径注射。通常,这种组合物可以制成注射剂,以液体溶液形式或悬浮液形式;也可以制备适合用于在注射前加入液体制备溶液或悬浮液的固体形式;并且,制剂也可以经乳化。根据本公开,此类制剂的制备对于本领域技术人员而言是已知的。
适于注射使用的药物形式包括无菌水溶液或分散液;包括芝麻油,花生油或丙二醇水溶液制剂;和用于临时制备无菌可注射溶液或分散液的无菌粉末。在所有情况下,该形式必须是无菌的,并且必须为易于注射的程度的流体。其也应该在制造和储存条件下稳定,并且必须在保存过程中能够抵抗微生物如细菌和真菌的污染作用。
运载体也可以是包含例如水、乙醇、多元醇(例如甘油、丙二醇和液体聚乙二醇等)及其合适的混合物以及植物油的溶剂或分散介质。可维持合适的流动性,例如通过使用诸如卵磷脂的包衣、分散情况下通过保持所需粒度以及通过使用表面活性剂来实现。可以通过各种抗菌剂和抗真菌剂来预防微生物的作用,例如对羟基苯甲酸酯类、氯丁醇、苯酚、山梨酸、硫柳汞等。在很多情况中,优选包括等渗剂,例如糖类或氯化钠。可通过将延迟吸收的试剂例如单硬脂酸铝和明胶用于组合物中来延长可注射组合物的吸收。
通过将合适溶剂中所需量的STING拮抗剂或cGAS抑制剂掺入不同的其它上述组分后根据需要过滤灭菌制得无菌注射液。通常,将各种经过灭菌的活性成分纳入含有碱性分散介质和上述其它所需成分的无菌载体中来制备分散液。当制备无菌注射液制备所需的无菌粉末时,优选的制备方法是真空干燥和冷冻干燥技术,由之前无菌过滤的溶液得到活性组分和任何其它所需组分的粉末。
瘤内注射例如参见Lammers等人,“瘤内注射对基于HPMA共聚物的药物递送系统的生物分布和治疗潜力的影响”(“Effect of Intratumoral Injection on theBiodistribution and the Therapeutic Potential of HPMACopolymer-Based DrugDelivery Systems”)Neoplasia.2006,10,788–795。
在某些实施方式中,STING拮抗剂或cGAS抑制剂或其药物组合物适合于局部、外用给药至消化道或胃肠道,例如直肠给药。直肠组合物包括但不限于灌肠剂、直肠凝胶剂、直肠泡沫剂、直肠气雾剂、栓剂、凝胶栓剂和灌肠剂(例如保留灌肠剂)。
在直肠组合物中可用作凝胶、乳膏、灌肠或直肠栓剂的药学上可接受的赋形剂包括但不限于下列物质中的一种或多种:可可脂甘油酯,合成聚合物(如聚乙烯吡咯烷酮,PEG(如PEG软膏)),甘油,甘油明胶,氢化植物油,泊洛沙姆,各种分子量的聚乙二醇和聚乙二醇的脂肪酸酯的混合物,凡士林,无水羊毛脂,鲨鱼肝油,糖精钠,薄荷醇,甜杏仁油,山梨糖醇,苯甲酸钠,Anoxid SBN,香草香精油,气雾剂,苯氧乙醇中的对羟基苯甲酸酯,对氧苯甲酸甲酯钠,对氧苯甲酸丙酯钠,二乙胺,卡波姆,卡波普,甲氧苯甲酸甲酯,聚乙二醇鲸蜡硬脂基醚,椰油酸辛酸癸酯,异丙醇,丙二醇,液体石蜡,黄原胶,羧基-焦亚硫酸盐,乙二胺四乙酸钠,苯甲酸钠,焦亚硫酸钾,葡萄柚籽提取物,甲基磺酰基甲烷(MSM),乳酸,甘氨酸,维生素(例如维生素A和E)和乙酸钾。
在一些实施方式中,可以通过将STING拮抗剂或cGAS抑制剂与合适的无刺激性的赋形剂或运载体例如可可脂、聚乙二醇或栓剂蜡混合来制备栓剂,所述赋形剂或运载体在环境温度下为固体,但在体温下为液体,因此在直肠融化并释放活性化合物。在其它实施方式中,用于直肠给药的组合物为灌肠剂形式。
在其它实施方式中,STING拮抗剂或cGAS抑制剂或其药物组合物适于通过口服给药(例如,固体或液体剂型)局部递送至消化道或胃肠道。
用于口服给予的固体剂型包括胶囊、片剂、丸剂、粉末剂和颗粒剂。在这些固体剂型中,将STING拮抗剂或cGAS抑制剂与一种或多种药学上可接受的赋形剂(例如柠檬酸钠或磷酸二钙)和/或以下混合:a)填充剂或增量剂,例如淀粉、乳糖、蔗糖、葡萄糖、甘露醇和硅酸;b)粘结剂,例如羧甲基纤维素、藻酸盐、明胶、聚乙烯吡咯烷酮、蔗糖和阿拉伯胶(acacia);c)保湿剂,例如甘油;d)崩解剂,例如琼脂-琼脂、碳酸钙、马铃薯或木薯淀粉、海藻酸、某些复合硅酸盐和碳酸钠;e)溶液缓凝剂,例如石蜡;f)吸收促进剂,例如季铵化合物;g)润湿剂,例如乙酰基醇和单硬脂酸甘油酯;h)吸附剂,例如高岭土和膨润土;以及i)润滑剂,例如滑石、硬脂酸钙、硬脂酸镁、固体聚乙二醇、十二烷基硫酸钠,或其混合物。就胶囊、片剂和丸剂而言,剂型中还可含有缓冲剂。相似类型的固体组合物也可作为填充剂用于软填充和硬填充明胶胶囊中,其使用例如乳糖或乳糖分以及高分子量聚乙二醇等赋形剂。
在一个实施方式中,组合物可采取诸如丸剂或片剂等单位剂型形式,因此该组合物除STING拮抗剂或cGAS抑制剂外还可包含:稀释剂如乳糖、蔗糖、磷酸二钙等;润滑剂如硬脂酸镁等;粘合剂如淀粉、阿拉伯胶、聚乙烯吡咯烷酮、明胶、纤维素、纤维素衍生物等。在另一种固体剂型中,粉末、药丸、溶液或混悬液(例如在碳酸亚丙酯、植物油、PEG剂、泊洛沙姆124或甘油三酸酯中)被包封在胶囊内(明胶或纤维素基胶囊)。也可以考虑其中一种或多种STING拮抗剂或cGAS抑制剂或其它活性剂物理上隔开的单位剂型,例如包含各药物颗粒的胶囊(或胶囊中的片剂);双层片剂;双室凝胶胶囊等。也考虑肠溶包衣或延迟释放的口服剂型。
其它生理学上可接受的化合物包括润湿剂、乳化剂、分散剂或防腐剂,防腐剂对于避免微生物生长或作用特别有用。各种防腐剂是众所周知的,包括例如苯酚和抗坏血酸。
在某些实施方式中,赋形剂是无菌的并且通常不含不希望的物质。可以通过常规的、众所周知的灭菌技术对组合物进行灭菌。对于各种口服剂型赋形剂,例如片剂和胶囊剂,不需要无菌。USP/NF标准通常就足够了。
在某些实施方式中,固体口服剂型可进一步包括一种或多种组分,所述组分在化学上和/或在结构上使所述组合物易于将STING拮抗剂或cGAS抑制剂递送至胃或下GI;例如,升结肠和/或横结肠和/或远端结肠和/或小肠。示例性的配制技术参见例如Filipski,K.J.等人,Current Topics in Medicinal Chemistry,2013,13,776-802,其通过引用整体并入本文。
示例包括上GI靶向技术,例如手风琴药丸(Accordion Pill)(Intec Pharma公司),浮动胶囊和能够粘附在粘膜壁上的材料。
其它例子包括下GI靶向技术。为了靶向肠道的各个区域,可以使用几种肠溶/pH响应性包衣和赋形剂。这些材料通常是被设计为在特定pH范围内溶解或溶蚀的聚合物,基于所需药物释放的GI区进行选择。在活性成分可能刺激上GI的情况下,这些材料还起到保护酸不稳定药物免受胃液侵蚀或限制暴露的作用(例如,羟丙基甲基纤维素邻苯二甲酸酯系列,Coateric(邻苯二甲酸乙酸乙烯酯),乙酸邻苯二甲酸纤维素,乙酸琥珀酸羟丙基甲基纤维素,Eudragit系列(甲基丙烯酸-甲基丙烯酸甲酯共聚物)和Marcoat。其它技术包括响应胃肠道局部菌群的剂型,压力控制的结肠递送胶囊和脉冲塞囊(Pulsincap)。
眼用组合物可包括但不限于任何下述中的一种或多种:粘性物质(例如,羧甲基纤维素、甘油、聚乙烯吡咯烷酮、聚乙二醇);稳定剂(例如,Pluronic(普兰尼克)(三嵌段共聚物)、环糊精);防腐剂(例如,苯扎氯铵、ETDA、SofZia(硼酸、丙二醇、山梨糖醇和氯化锌;爱尔康公司(Alcon Laboratories,Inc.)),Purite(稳定的氧氯络合物;爱力根公司(Allergan,Inc.))。
局部用组合物可包括软膏和霜剂。软膏剂是半固体制剂,通常基于凡士林或其它石油衍生物。含有STING拮抗剂或cGAS抑制剂的乳膏通常是粘性液体或半固体乳液,通常是水包油或油包水。乳膏基质通常是可水洗的,并且包含油相、乳化剂和水相。油相有时也称为“内”相,通常由凡士林和脂肪醇(如鲸蜡醇或硬脂醇)组成;尽管不一定,水相通常超过油相的体积,并且通常包含湿润剂。乳膏制剂中的乳化剂通常是非离子,阴离子,阳离子或两性表面活性剂。与其它运载体或载剂一样,软膏基质应是惰性的,稳定的,无刺激性和不敏感的。
在前述任一实施方式中,本文所述的药物组合物可包括下述中的一种或多种:脂质、双层间交联的多层囊泡、可生物降解的聚(D,L-乳酸-共-乙醇酸)[PLGA]基或聚酸酐基纳米颗粒或微颗粒,以及纳米多孔颗粒支撑的脂质双层。
灌肠制剂
在一些实施方式中,以“即用”形式提供含有STING拮抗剂或cGAS抑制剂的灌肠制剂。
在一些实施方式中,在一个或多个试剂盒或包装中提供含有STING拮抗剂或cGAS抑制剂的灌肠制剂。在某些实施方式中,试剂盒或包装包括两种或两种以上单独包含/包装的组分,例如两种组分,当它们混合在一起时,提供所需的配方(例如作为悬液)。在这些实施方式的某些中,双组分系统包括第一组分和第二组分,其中:(i)第一组分(例如,包含在小袋中)包括STING拮抗剂或cGAS抑制剂(如本文任何处所述)和任选的一种或多种药学上可接受的赋形剂(例如,共同配制成固体制剂,例如共同配制成湿造粒固体制剂);和(ii)第二组分(例如,包含在小瓶或瓶中)包括一种或多种液体以及任选地一种或多种其他药学上可接受的赋形剂,共同形成液体运载体。在使用之前(例如,在使用之前马上),将(i)和(ii)的内容物组合以形成所需的灌肠制剂,例如作为悬液。在其他实施方式中,组分(i)和(ii)都在其各自的单独试剂盒或包装中提供。
在一些实施方式中,一种或多种液体中的每一种都是水,或生理上可接受的溶剂,或水和一种或多种生理上可接受的溶剂的混合物。典型的此类溶剂包括但不限于甘油、乙二醇、丙二醇、聚乙二醇和聚丙二醇。在某些实施方式中,一种或多种液体中的每一种都是水。在其他实施方式中,一种或多种液体中的每一种都是油,例如常用于药物制剂中的天然和/或合成油。
本文所述药品中可能使用的其他药用赋形剂和运载体列于各种手册(例如D.E.Bugay和W.P.Findlay(编)《药学赋形剂》(Pharmaceutical excipients)(马塞尔·德克尔出版公司(Marcel Dekker),纽约,1999),E-M Hoepfner,A.Reng和P.C.Schmidt(编)《菲德勒药用、化妆品及相关领域辅料百科全书》(Fiedler Encyclopedia of Excipientsfor Pharmaceuticals,Cosmetics and Related Areas)(Cantor版,慕尼黑,2002)以及H.P.Fielder(编)《药学辅料词典》(Lexikon der Hilfsstoffe für Pharmazie),Kosmetik和angrenzende Gebiete(Cantor Aulendorf版,1989))。
在一些实施方式中,一种或多种药学上可接受的赋形剂中的每一种都可以独立选自增稠剂、增粘剂、填充剂、粘膜粘附剂、渗透促进剂、缓冲剂、防腐剂、稀释剂、粘合剂、润滑剂、助滑剂、崩解剂、填料、增溶剂、pH改性剂、防腐剂、稳定剂、抗氧化剂、润湿剂或乳化剂、悬浮剂、颜料、着色剂、等渗剂、螯合剂、乳化剂和诊断剂。
在某些实施方式中,一种或多种药学上可接受的赋形剂中的每一种可独立选自增稠剂、增粘剂、粘膜粘附剂、缓冲剂、防腐剂、稀释剂、粘合剂、润滑剂、助滑剂、崩解剂和填料。
在某些实施方式中,一种或多种药学上可接受的赋形剂中的每一种都可以独立选自增稠剂、增粘剂、填充剂、粘膜粘附剂、缓冲剂、防腐剂和填料。
在某些实施方式中,一种或多种药学上可接受的赋形剂中的每一种可独立选自稀释剂、粘合剂、润滑剂、助滑剂和崩解剂。
增稠剂、增粘剂和粘膜粘附剂的例子包括但不限于:树胶,例如黄原胶、瓜尔豆胶、刺槐豆胶、黄芩胶、卡拉牙胶、加蒂胶、仙人掌胶、洋车前子胶和阿拉伯胶;聚(含羧酸)基聚合物,例如具有强氢结合基团的聚(丙烯酸、马来酸、衣康酸、柠檬酸、羟乙基甲基丙烯酸或甲基丙烯酸),或其衍生物例如盐和酯;纤维素衍生物,例如甲基纤维素、乙基纤维素、甲乙基纤维素、羟甲基纤维素、羟乙基纤维素、羟丙基纤维素、羟乙基乙基纤维素、羧甲基纤维素、羟丙基甲基纤维素或纤维素酯或醚或其衍生物或盐;粘土,如蒙脱石粘土,如Veegun、绿坡缕石粘土;多糖,如葡聚糖、果胶、支链淀粉、琼脂、甘露聚糖或聚半乳糖酸,或淀粉,例如羟丙基淀粉或羧甲基淀粉;多肽,如酪蛋白、谷蛋白、明胶、纤维蛋白胶;壳聚糖,例如乳酸或谷氨酸或羧甲基甲壳素;糖胺聚糖,如透明质酸;海藻酸的金属或水溶性盐,如海藻酸钠或海藻酸镁;硬壳聚糖;含有氧化铋或氧化铝的粘合剂;粥样胶原(atherocollagen);聚乙烯聚合物,如羧乙烯基聚合物;聚乙烯吡咯烷酮(聚维酮);聚乙烯醇;聚乙酸乙烯酯、聚乙烯甲基醚、聚氯乙烯、聚偏二乙烯等;如上所述的聚丙烯酸等聚羧酸乙烯基聚合物;聚硅氧烷;聚醚;聚环氧乙烷和乙二醇;聚烷氧基和聚丙烯酰胺及其衍生物和盐。优选例可包括纤维素衍生物,例如甲基纤维素、乙基纤维素、甲乙基纤维素、羟甲基纤维素、羟乙基纤维素、羟丙基纤维素、羟乙基乙基纤维素、羧甲基纤维素、羟丙基甲基纤维素或纤维素酯或醚或其衍生物或盐(例如,甲基纤维素);以及聚乙烯聚合物,如聚乙烯吡咯烷酮(聚维酮)。
防腐剂的例子包括但不限于:苯扎氯铵、苯佐氯铵、苄索氯铵、西曲溴铵、氯化三苯唑、西吡氯铵、度米芬硫柳汞、硝酸苯汞、乙酸苯汞、硼酸苯汞、对羟基苯甲酸甲酯、对羟基苯丙酯、氯丁醇、苯甲醇、苯乙醇、氯己定、聚六亚甲基双胍、过硼酸钠、咪唑烷基脲、山梨酸、)、)和四水过硼酸钠等。
在某些实施方式中,防腐剂为对羟基苯甲酸酯类或其药学上可接受的盐。在一些实施方式中,对羟基苯甲酸酯是烷基取代的4-羟基苯甲酸酯,或其医药上可接受的盐或酯。在某些实施方式中,烷基为C1-C4烷基。在某些实施方式中,防腐剂为4-羟基苯甲酸甲酯(对羟基苯甲酸甲酯)或其药学上可接受的盐或酯、4-羟基苯甲酸丙酯(对羟基苯甲酸丙酯)或其药学上可接受的盐或酯,或其组合。
缓冲剂的例子包括但不限于:磷酸盐缓冲系统(无水磷酸二氢钠、十二水磷酸氢二钠、磷酸氢二钠、无水磷酸二氢钠)、碳酸氢盐缓冲系统和硫酸氢盐缓冲系统。
崩解剂的例子包括但不限于:羧甲纤维素钙、低取代羟丙基纤维素(L-HPC)、羧甲基纤维素、交联羧甲基纤维素钠、部分预糊化淀粉、干淀粉、羧甲基淀粉钠、交聚维酮、聚山梨酯80(聚氧乙烯酯山梨糖油酸酯)、淀粉、乙醇酸钠淀粉、羟丙基纤维素预糊化淀粉、粘土、纤维素、精氨酸、树胶或交联聚合物,如交联PVP(GAF Chemical Corp的Polyplasdone XL)。在某些实施方式中,崩解剂为交聚维酮。
助滑剂和润滑剂(聚集抑制剂)的例子包括但不限于:滑石粉、硬脂酸镁、硬脂酸钙、胶态二氧化硅、硬脂酸、水性二氧化硅、合成硅酸镁、细粒氧化硅、淀粉、月桂基硫酸钠、硼酸、氧化镁、蜡、氢化油、聚乙二醇、苯甲酸钠、硬脂酸甘油二十二烷酯、聚乙二醇和矿物油。在某些实施方式中,助滑剂/润滑剂为硬脂酸镁、滑石和/或胶态二氧化硅,例如硬脂酸镁和/或滑石。
稀释剂(也称为“填料”或“填充剂”)的例子包括但不限于:二水磷酸二钙、硫酸钙、乳糖(例如一水乳糖)、蔗糖、甘露醇、山梨醇、纤维素、微晶纤维素、高岭土、氯化钠、干淀粉、水解淀粉、预糊化淀粉、二氧化硅、氧化钛、硅酸镁铝和糖粉。在某些实施方式中,稀释剂为乳糖(例如,一水乳糖)。
粘合剂的例子包括但不限于:淀粉、预胶化淀粉、明胶、糖(包括蔗糖、葡萄糖、右旋糖、乳糖和山梨糖醇)、聚乙二醇、蜡、天然和合成胶如阿拉伯胶、黄蓍胶、藻酸钠、纤维素,包括羟丙基纤维素、乙基纤维素、和硅酸铝镁、和合成聚合物如丙烯酸和甲基丙烯酸共聚物、甲基丙烯酸共聚物、甲基丙烯酸甲酯共聚物、甲基丙烯酸氨基烷基酯共聚物、聚丙烯酸/聚甲基丙烯酸和聚乙烯吡咯烷酮(聚维酮)。在某些实施方式中,粘合剂为聚乙烯吡咯烷酮(聚维酮)。
在一些实施方式中,含有STING拮抗剂或cGAS抑制剂的灌肠制剂包括水和一种或多种(例如,全部)以下赋形剂:
一种或多种(例如,一种、两种或三种)增稠剂、增粘剂、粘合剂和/或粘膜粘附剂(例如,纤维素或纤维素酯或醚或其衍生物或盐(例如,甲基纤维素);以及聚乙烯聚合物,例如聚乙烯吡咯烷酮(聚维酮);
一种或多种(例如,一种或两种;例如,两种)防腐剂,例如对羟基苯甲酸酯,例如4-羟基苯甲酸甲酯(对羟基苯甲酸甲酯),或其药学上可接受的盐或酯,4-羟基苯甲酸丙酯(对羟基苯甲酸丙酯),或其药学上可接受的盐或酯,或其组合;
一种或多种(例如,一或两;例如,两种)缓冲剂,例如磷酸盐缓冲系统(例如脱水磷酸二氢钠、十二水合磷酸氢二钠);
一种或多种(例如一种或两种,例如两种)助滑剂和/或润滑剂,如硬脂酸镁和/或滑石;
一种或多种(例如,一种或两种;例如,一种)崩解剂,如交聚维酮;和
一种或多种(例如,一种或两种;例如,一种)稀释剂,例如乳糖(例如,一水乳糖)。
在这些实施方式的某些中,STING拮抗剂是式I-XXIV或式M1-M6的或表C1中任一所示的化合物中任一种的化合物,或其药学上可接受的盐和/或水合物和/或共晶体。
在某些实施方式中,含有STING拮抗剂或cGAS抑制剂的灌肠制剂包括水、甲基纤维素、聚维酮、对羟基苯甲酸甲酯、对羟基苯甲酸丙酯、脱水磷酸二氢钠、十二水合磷酸氢二钠、交聚维酮、一水乳糖、硬脂酸镁和滑石。在这些实施方式的某些中,STING拮抗剂是式I-XXIV或式M1-M6的或表C1所示的化合物中任一种的化合物,或其药学上可接受的盐和/或水合物和/或共晶体。
在某些实施方式中,在一个或多个试剂盒或包装中提供含有STING拮抗剂或cGAS抑制剂的灌肠制剂。在某些实施方式中,试剂盒或包装包括两种单独包含/包装的组分,当混合在一起时,它们提供所需的配方(例如,作为悬液)。在这些实施方式的某些中,双组分系统包括第一组分和第二组分,其中:(i)第一组分(例如,包含在小袋中)包括STING拮抗剂或cGAS抑制剂(如本文任何处所述)和一种或多种药学上可接受的赋形剂(例如,共同配制成固体制剂,例如共同配制成湿造粒固体制剂);和(ii)第二组分(例如,包含在小瓶或瓶中)包括一种或多种液体以及任选地一种或多种其他药学上可接受的赋形剂,共同形成液体运载体。在其他实施方式中,组分(i)和(ii)都在其各自的单独试剂盒或包装中提供。
在这些实施方式中的某些中,组分(i)包括STING拮抗剂或cGAS抑制剂(例如,式I-XXIV或式M1-M6的或表C1-C2所示的化合物中任何一种的化合物,或其药学上可接受的盐和/或水合物和/或共晶体)和一种或多种(例如全部)以下赋形剂:
(a)一种或多种(例如,一种)粘合剂(例如,聚乙烯聚合物,例如聚乙烯吡咯烷酮(聚维酮);
(b)一种或多种(例如一种或两种,例如两种)助滑剂和/或润滑剂,如硬脂酸镁和/或滑石;
(c)一种或多种(例如,一种或两种;例如,一种)崩解剂,如交聚维酮;和
(d)一种或多种(例如,一种或两种;例如,一种)稀释剂,例如乳糖(例如,一水乳糖)。
在某些实施方式中,组分(i)包括约40重量%至约80重量%(例如,约50重量%至约70重量%、约55重量%至约70重量%;约60重量%至约65重量%;例如约62.1重量%)的STING拮抗剂或cGAS抑制剂(例如,式I-XXIV或式M1-M6的或表C1-C2任一所示的化合物中任一种的化合物,或其药学上可接受的盐和/或水合物和/或共晶体)。
在某些实施方式中,组分(i)包括约0.5重量%至约5重量%(例如,约1.5重量%至约4.5重量%、约2重量%至约3.5重量%、约2.76重量%)的粘合剂(例如聚维酮)。
在某些实施方式中,组分(i)包括约0.5重量%至约5重量%(例如,约0.5重量%至约3重量%,约1重量%至约3重量%;约2重量%(例如,约1.9重量%)的崩解剂(例如交聚维酮)。
在某些实施方式中,组分(i)包括约10重量%至约50重量%(例如,约20重量%至约40重量%、约25重量%至约35重量%、约31.03重量%)的稀释剂(例如乳糖,例如一水乳糖)。
在某些实施方式中,组分(i)包括约0.05重量%至约5重量%(例如,约0.05重量%至约3重量%)的助滑剂和/或润滑剂。
在某些实施方式中(例如,当组分(i)包括一种或多种润滑剂,例如硬脂酸镁时),组分(i)包括约0.05重量%至约1重量%(例如约0.05重量%至约1重量%;约0.1重量%至约1重量%;约0.1重量%至约0.5重量%;例如约0.27重量%)的润滑剂(例如硬脂酸镁)。
在某些实施方式中(当组分(i)包括一种或多种润滑剂,例如滑石时),组分(i)包括约0.5重量%至约5重量%(例如,约0.5重量%至约3重量%,约1重量%至约3重量%,约1.5重量%至约2.5重量%,约1.8重量%至约2.2重量%,约1.93重量%)的润滑剂(如滑石)。
在这些实施方式的某些中,存在上述(a)、(b)、(c)和(d)中的每一个。
在某些实施方式中,组分(i)包括表A所示的成分和量。
表A.
在某些实施方式中,组分(i)包括表B所示的成分和量。
表B
在某些实施方式中,组分(i)配制为湿粒固体制剂。在这些实施方式的某些中,成分的内相(STING拮抗剂或cGAS抑制剂、崩解剂和稀释剂)在高剪切造粒机中合并和混合。将粘合剂(例如聚维酮)溶解在水中以形成造粒溶液。将该溶液添加到内相混合物中,形成颗粒。虽然不希望受到理论的约束,但据信聚合物粘合剂与内相物质的相互作用促进了颗粒的形成。造粒形成并干燥后,将外部相(例如,一种或多种润滑剂—不是干燥颗粒的固有成分)添加到干燥颗粒中。据信造粒的润滑对造粒的流动性非常重要,尤其是对于包装而言。
在上述某些实施方式中,组分(ii)包括水和一种或多种(例如全部)以下赋形剂:
(a')一种或多种(例如一种、两种;例如两种)增稠剂、增粘剂、粘合剂和/或粘膜粘附剂(例如纤维素或纤维素酯或醚或其衍生物或盐(例如甲基纤维素);以及聚乙烯聚合物,例如聚乙烯吡咯烷酮(聚维酮);
(b’)一种或多种(例如,一种或两种;例如,两种)防腐剂,例如对羟基苯甲酸酯,例如4-羟基苯甲酸甲酯(对羟基苯甲酸甲酯),或其药学上可接受的盐或酯,4-羟基苯甲酸丙酯(对羟基苯甲酸丙酯),或其药学上可接受的盐或酯,或其组合;和
(c’)一种或多种(例如,一或两;例如,两种)缓冲剂,例如磷酸盐缓冲系统(例如二水磷酸二氢钠、十二水合磷酸氢二钠);
在上述某些实施方式中,组分(ii)包括水和一种或多种(例如全部)以下赋形剂:
(a”)第一增稠剂、增粘剂、粘合剂和/或粘膜粘附剂(例如纤维素或纤维素酯或醚或其衍生物或盐(例如甲基纤维素));
(a”’)第二增稠剂、增粘剂、粘合剂和/或粘膜粘附剂(例如,聚乙烯聚合物,例如聚乙烯吡咯烷酮(聚维酮));
(b”)第一防腐剂,例如对羟基苯甲酸酯,如4-羟基苯甲酸丙酯(对羟基苯甲酸丙酯),或其药学上可接受的盐或酯;
(b”)第二防腐剂,例如对羟基苯甲酸酯,如4-羟基苯甲酸甲酯(对羟基苯甲酸甲酯),或其药学上可接受的盐或酯;
(c”)第一缓冲液,例如磷酸盐缓冲系统(例如十二水合磷酸氢二钠);
(c”’)第二缓冲剂,如磷酸盐缓冲系统(例如无水磷酸二氢钠),
在某些实施方式中,组分(ii)包括约0.05重量%至约5重量%(例如,约0.05重量%至约3重量%、约0.1重量%至约3重量%、约1.4重量%)的(a”)。
在某些实施方式中,组分(ii)包括约0.05重量%至约5重量%(例如,约0.05重量%至约3重量%、约0.1重量%至约2重量%、约1.0重量%)的(a”’)。
在某些实施方式中,组分(ii)包括约0.005重量%至约0.1重量%(例如,约0.005重量%至约0.05重量%;例如,约0.02重量%)的(b”)。
在某些实施方式中,组分(ii)包括约0.05重量%至约1重量%(例如,约0.05重量%至约0.5重量%;例如,约0.20重量%)的(b”’)。
在某些实施方式中,组分(ii)包括约0.05重量%至约1重量%(例如,约0.05重量%至约0.5重量%;例如,约0.15重量%)的(c”)。
在某些实施方式中,组分(ii)包括约0.005重量%至约0.5重量%(例如,约0.005重量%至约0.3重量%;例如,约0.15重量%)的(c”’)。
在这些实施方式的某些中,存在(a”)-(c”’)中的每一个。
在某些实施方式中,组分(ii)包括水(高达100%)以及表C中所示的成分和量。
表C
在某些实施方式中,组分(ii)包括水(高达100%)以及表D中所示的成分和量。
表D
“即用”灌肠剂通常装在“一次性使用”的密封塑料或玻璃容器中。由聚合物材料形成的材料优选具有足够的灵活性,以便于无人协助的患者使用。典型的塑料容器可以由聚乙烯制成。这些容器可包括用于直接导入直肠的尖端。此类容器还可包括容器和尖端之间的管。所述尖端优选具有在使用前移除的保护罩。还可以选择使用润滑剂来提高患者的依从性。
在一些实施方式中,灌肠制剂(例如,悬液)在单独容器中制备后倒入瓶子中以供递送。在某些实施方式中,瓶子是塑料瓶(例如,可弯曲以允许通过挤压瓶子进行递送),其可以是聚乙烯瓶(例如,白色)。在一些实施方式中,瓶子是单室瓶,其中含有悬液或溶液。在其他实施方式中,瓶是多室瓶,其中每个室包含独立混合物或溶液。在其他实施方式中,瓶子还可包括用于直接导入直肠的尖端或直肠套管。在一些实施方式中,灌肠制剂可在包括塑料瓶、易碎胶囊、直肠套管和单流包的装置中递送。
剂量
剂量可以根据患者的需要,所治疗疾病的严重程度和所使用的特定化合物而变化。对于特定情况的合适剂量的确定可以由医学领域的技术人员确定。可以将每日总剂量分开,并在一整天内或通过提供连续递送的方式分次给药。
在一些实施方式中,以约0.001mg/kg至约500mg/kg的剂量给予STING拮抗剂或cGAS抑制剂。
在一些实施方式中,灌肠制剂包括约0.5mg至约2500mg的化学实体,以及约1mL至约3000mL的液体运载体。
给药方案
前述剂量可以每天(例如,作为单剂量或作为两个或更多个分剂量)或非每天给予(例如,每隔一天,每两天,每三天,每周一次,每周两次,每两周一次,每月一次)。
在一些实施方式中,STING拮抗剂或cGAS抑制剂的给药时间为1天,2天,3天,4天,5天,6天,7天,8天,9天,10天,11天,12天,13天,14天,3周,4周,5周,6周,7周,8周,9周,10周,11周,12周,4个月,5个月,6个月,7个月,8个月,9个月,10个月,11个月,12个月或更长时间。在另一个实施方式中,给药停止时间为1天,2天,3天,4天,5天,6天,7天,8天,9天,10天,11天,12天,13天,14天,3周,4周,5周,6周,7周,8周,9周,10周,11周,12周,4个月,5个月,6个月,7个月,8个月,9个月,10个月,11个月,12个月或更长时间。在一个实施方式中,对个体给予一段时间的STING拮抗剂或cGAS抑制剂,随后是一段单独的时间。在另一个实施方式中,在第一段时间给予STING拮抗剂或cGAS抑制剂,在第一段时间之后的第二段时间停止给药,然后在第三段时间重新开始给予STING拮抗剂或cGAS抑制剂,然后在第三段时间之后的第四段时间停止给药。在该实施方式的一方面,在确定的或未确定的时间段内重复STING拮抗剂或cGAS抑制剂的给药时间段和随后的停止给药的时间段。在另一个实施方式中,给药时间为1天,2天,3天,4天,5天,6天,7天,8天,9天,10天,11天,12天,13天,14天,3周,4周,5周,6周,7周,8周,9周,10周,11周,12周,4个月,5个月,6个月,7个月,8个月,9个月,10个月,11个月,12个月或更长时间。在另一个实施方式中,停止给药的时间为1天,2天,3天,4天,5天,6天,7天,8天,9天,10天,11天,12天,13天,14天,3周,4周,5周,6周,7周,8周,9周,10周,11周,12周,4个月,5个月,6个月,7个月,8月,9个月,10个月,11个月,12个月或更长时间。
试剂盒
本文还提供包含本文所述任何药物组合物中的一种或多种(例如,至少1、2、3、4、5、6、7、8、9、10、11、12、14、15、16、18或20种)的试剂盒。在一些实施方式中,试剂盒可包括用于执行本文所述的任何方法的指令。在一些实施方式中,所述试剂盒可包含至少一剂本文所述的任何组合物(例如药物组合物)。在一些实施方式中,试剂盒可以提供用于给予本文所述任何药物组合物的注射器。本文所述的试剂盒不限于此;对于本领域的普通技术人员来说,其他变化是显而易见的。
其它实施方式
应理解,虽然本发明已经结合具体实施方式进行了描述,但前述描述旨在说明而不是限制由所附权利要求书的范围所限定的本发明的范围。其它方面、优点和改进均在权利要求书的范围内。
序列表
<110> 艾福姆德尤股份有限公司(IFM Due, Inc.)
<120> 治疗癌症的方法
<130> 47110-0062WO1
<150> 63/129,229
<151> 2020-12-22
<160> 91
<170> PatentIn version 3.5
<210> 1
<211> 1140
<212> DNA
<213> 智人(Homo sapiens)
<400> 1
atgccccact ccagcctgca tccatccatc ccgtgtccca ggggtcacgg ggcccagaag 60
gcagccttgg ttctgctgag tgcctgcctg gtgacccttt gggggctagg agagccacca 120
gagcacactc tccggtacct ggtgctccac ctagcctccc tgcagctggg actgctgtta 180
aacggggtct gcagcctggc tgaggagctg cgccacatcc actccaggta ccggggcagc 240
tactggagga ctgtgcgggc ctgcctgggc tgccccctcc gccgtggggc cctgttgctg 300
ctgtccatct atttctacta ctccctccca aatgcggtcg gcccgccctt cacttggatg 360
cttgccctcc tgggcctctc gcaggcactg aacatcctcc tgggcctcaa gggcctggcc 420
ccagctgaga tctctgcagt gtgtgaaaaa gggaatttca acgtggccca tgggctggca 480
tggtcatatt acatcggata tctgcggctg atcctgccag agctccaggc ccggattcga 540
acttacaatc agcattacaa caacctgcta cggggtgcag tgagccagcg gctgtatatt 600
ctcctcccat tggactgtgg ggtgcctgat aacctgagta tggctgaccc caacattcgc 660
ttcctggata aactgcccca gcagaccggt gaccatgctg gcatcaagga tcgggtttac 720
agcaacagca tctatgagct tctggagaac gggcagcggg cgggcacctg tgtcctggag 780
tacgccaccc ccttgcagac tttgtttgcc atgtcacaat acagtcaagc tggctttagc 840
cgggaggata ggcttgagca ggccaaactc ttctgccgga cacttgagga catcctggca 900
gatgcccctg agtctcagaa caactgccgc ctcattgcct accaggaacc tgcagatgac 960
agcagcttct cgctgtccca ggaggttctc cggcacctgc ggcaggagga aaaggaagag 1020
gttactgtgg gcagcttgaa gacctcagcg gtgcccagta cctccacgat gtcccaagag 1080
cctgagctcc tcatcagtgg aatggaaaag cccctccctc tccgcacgga tttctcttga 1140
<210> 2
<211> 379
<212> PRT
<213> 智人(Homo sapiens)
<400> 2
Met Pro His Ser Ser Leu His Pro Ser Ile Pro Cys Pro Arg Gly His
1 5 10 15
Gly Ala Gln Lys Ala Ala Leu Val Leu Leu Ser Ala Cys Leu Val Thr
20 25 30
Leu Trp Gly Leu Gly Glu Pro Pro Glu His Thr Leu Arg Tyr Leu Val
35 40 45
Leu His Leu Ala Ser Leu Gln Leu Gly Leu Leu Leu Asn Gly Val Cys
50 55 60
Ser Leu Ala Glu Glu Leu Arg His Ile His Ser Arg Tyr Arg Gly Ser
65 70 75 80
Tyr Trp Arg Thr Val Arg Ala Cys Leu Gly Cys Pro Leu Arg Arg Gly
85 90 95
Ala Leu Leu Leu Leu Ser Ile Tyr Phe Tyr Tyr Ser Leu Pro Asn Ala
100 105 110
Val Gly Pro Pro Phe Thr Trp Met Leu Ala Leu Leu Gly Leu Ser Gln
115 120 125
Ala Leu Asn Ile Leu Leu Gly Leu Lys Gly Leu Ala Pro Ala Glu Ile
130 135 140
Ser Ala Val Cys Glu Lys Gly Asn Phe Asn Val Ala His Gly Leu Ala
145 150 155 160
Trp Ser Tyr Tyr Ile Gly Tyr Leu Arg Leu Ile Leu Pro Glu Leu Gln
165 170 175
Ala Arg Ile Arg Thr Tyr Asn Gln His Tyr Asn Asn Leu Leu Arg Gly
180 185 190
Ala Val Ser Gln Arg Leu Tyr Ile Leu Leu Pro Leu Asp Cys Gly Val
195 200 205
Pro Asp Asn Leu Ser Met Ala Asp Pro Asn Ile Arg Phe Leu Asp Lys
210 215 220
Leu Pro Gln Gln Thr Gly Asp His Ala Gly Ile Lys Asp Arg Val Tyr
225 230 235 240
Ser Asn Ser Ile Tyr Glu Leu Leu Glu Asn Gly Gln Arg Ala Gly Thr
245 250 255
Cys Val Leu Glu Tyr Ala Thr Pro Leu Gln Thr Leu Phe Ala Met Ser
260 265 270
Gln Tyr Ser Gln Ala Gly Phe Ser Arg Glu Asp Arg Leu Glu Gln Ala
275 280 285
Lys Leu Phe Cys Arg Thr Leu Glu Asp Ile Leu Ala Asp Ala Pro Glu
290 295 300
Ser Gln Asn Asn Cys Arg Leu Ile Ala Tyr Gln Glu Pro Ala Asp Asp
305 310 315 320
Ser Ser Phe Ser Leu Ser Gln Glu Val Leu Arg His Leu Arg Gln Glu
325 330 335
Glu Lys Glu Glu Val Thr Val Gly Ser Leu Lys Thr Ser Ala Val Pro
340 345 350
Ser Thr Ser Thr Met Ser Gln Glu Pro Glu Leu Leu Ile Ser Gly Met
355 360 365
Glu Lys Pro Leu Pro Leu Arg Thr Asp Phe Ser
370 375
<210> 3
<211> 852
<212> DNA
<213> 智人(Homo sapiens)
<400> 3
atgccccact ccagcctgca tccatccatc ccgtgtccca ggggtcacgg ggcccagaag 60
gcagccttgg ttctgctgag tgcctgcctg gtgacccttt gggggctagg agagccacca 120
gagcacactc tccggtacct ggtgctccac ctagcctccc tgcagctggg actgctgtta 180
aacggggtct gcagcctggc tgaggagctg cgccacatcc actccaggta ccggggcagc 240
tactggagga ctgtgcgggc ctgcctgggc tgccccctcc gccgtggggc cctgttgctg 300
ctgtccatct atttctacta ctccctccca aatgcggtcg gcccgccctt cacttggatg 360
cttgccctcc tgggcctctc gcaggcactg aacatcctcc tgggcctcaa gggcctggcc 420
ccagctgaga tctctgcagt gtgtgaaaaa gggaatttca acgtggccca tgggctggca 480
tggtcatatt acatcggata tctgcggctg atcctgccag agctccaggc ccggattcga 540
acttacaatc agcattacaa caacctgcta cggggtgcag tgagccagcg gctgtatatt 600
ctcctcccat tggactgtgg ggtgcctgat aacctgagta tggctgaccc caacattcgc 660
ttcctggata aactgcccca gcagaccggt gaccatgctg gcatcaagga tcgggtttac 720
agcaacagca tctatgagct tctggagaac gggcagcgga acctgcagat gacagcagct 780
tctcgctgtc ccaggaggtt ctccggcacc tgcggcagga ggaaaaggaa gaggttactg 840
tgggcagctt ga 852
<210> 4
<211> 283
<212> PRT
<213> 智人(Homo sapiens)
<400> 4
Met Pro His Ser Ser Leu His Pro Ser Ile Pro Cys Pro Arg Gly His
1 5 10 15
Gly Ala Gln Lys Ala Ala Leu Val Leu Leu Ser Ala Cys Leu Val Thr
20 25 30
Leu Trp Gly Leu Gly Glu Pro Pro Glu His Thr Leu Arg Tyr Leu Val
35 40 45
Leu His Leu Ala Ser Leu Gln Leu Gly Leu Leu Leu Asn Gly Val Cys
50 55 60
Ser Leu Ala Glu Glu Leu Arg His Ile His Ser Arg Tyr Arg Gly Ser
65 70 75 80
Tyr Trp Arg Thr Val Arg Ala Cys Leu Gly Cys Pro Leu Arg Arg Gly
85 90 95
Ala Leu Leu Leu Leu Ser Ile Tyr Phe Tyr Tyr Ser Leu Pro Asn Ala
100 105 110
Val Gly Pro Pro Phe Thr Trp Met Leu Ala Leu Leu Gly Leu Ser Gln
115 120 125
Ala Leu Asn Ile Leu Leu Gly Leu Lys Gly Leu Ala Pro Ala Glu Ile
130 135 140
Ser Ala Val Cys Glu Lys Gly Asn Phe Asn Val Ala His Gly Leu Ala
145 150 155 160
Trp Ser Tyr Tyr Ile Gly Tyr Leu Arg Leu Ile Leu Pro Glu Leu Gln
165 170 175
Ala Arg Ile Arg Thr Tyr Asn Gln His Tyr Asn Asn Leu Leu Arg Gly
180 185 190
Ala Val Ser Gln Arg Leu Tyr Ile Leu Leu Pro Leu Asp Cys Gly Val
195 200 205
Pro Asp Asn Leu Ser Met Ala Asp Pro Asn Ile Arg Phe Leu Asp Lys
210 215 220
Leu Pro Gln Gln Thr Gly Asp Arg Ala Gly Ile Lys Asp Arg Val Tyr
225 230 235 240
Ser Asn Ser Ile Tyr Glu Leu Leu Glu Asn Gly Gln Arg Asn Leu Gln
245 250 255
Met Thr Ala Ala Ser Arg Cys Pro Arg Arg Phe Ser Gly Thr Cys Gly
260 265 270
Arg Arg Lys Arg Lys Arg Leu Leu Trp Ala Ala
275 280
<210> 5
<211> 783
<212> DNA
<213> 智人(Homo sapiens)
<400> 5
atgcttgccc tcctgggcct ctcgcaggca ctgaacatcc tcctgggcct caagggcctg 60
gccccagctg agatctctgc agtgtgtgaa aaagggaatt tcaacgtggc ccatgggctg 120
gcatggtcat attacatcgg atatctgcgg ctgatcctgc cagagctcca ggcccggatt 180
cgaacttaca atcagcatta caacaacctg ctacggggtg cagtgagcca gcggctgtat 240
attctcctcc cattggactg tggggtgcct gataacctga gtatggctga ccccaacatt 300
cgcttcctgg ataaactgcc ccagcagacc ggtgaccatg ctggcatcaa ggatcgggtt 360
tacagcaaca gcatctatga gcttctggag aacgggcagc gggcgggcac ctgtgtcctg 420
gagtacgcca cccccttgca gactttgttt gccatgtcac aatacagtca agctggcttt 480
agccgggagg ataggcttga gcaggccaaa ctcttctgcc ggacacttga ggacatcctg 540
gcagatgccc ctgagtctca gaacaactgc cgcctcattg cctaccagga acctgcagat 600
gacagcagct tctcgctgtc ccaggaggtt ctccggcacc tgcggcagga ggaaaaggaa 660
gaggttactg tgggcagctt gaagacctca gcggtgccca gtacctccac gatgtcccaa 720
gagcctgagc tcctcatcag tggaatggaa aagcccctcc ctctccgcac ggatttctct 780
tga 783
<210> 6
<211> 260
<212> PRT
<213> 智人(Homo sapiens)
<400> 6
Met Leu Ala Leu Leu Gly Leu Ser Gln Ala Leu Asn Ile Leu Leu Gly
1 5 10 15
Leu Lys Gly Leu Ala Pro Ala Glu Ile Ser Ala Val Cys Glu Lys Gly
20 25 30
Asn Phe Asn Val Ala His Gly Leu Ala Trp Ser Tyr Tyr Ile Gly Tyr
35 40 45
Leu Arg Leu Ile Leu Pro Glu Leu Gln Ala Arg Ile Arg Thr Tyr Asn
50 55 60
Gln His Tyr Asn Asn Leu Leu Arg Gly Ala Val Ser Gln Arg Leu Tyr
65 70 75 80
Ile Leu Leu Pro Leu Asp Cys Gly Val Pro Asp Asn Leu Ser Met Ala
85 90 95
Asp Pro Asn Ile Arg Phe Leu Asp Lys Leu Pro Gln Gln Thr Gly Asp
100 105 110
His Ala Gly Ile Lys Asp Arg Val Tyr Ser Asn Ser Ile Tyr Glu Leu
115 120 125
Leu Glu Asn Gly Gln Arg Ala Gly Thr Cys Val Leu Glu Tyr Ala Thr
130 135 140
Pro Leu Gln Thr Leu Phe Ala Met Ser Gln Tyr Ser Gln Ala Gly Phe
145 150 155 160
Ser Arg Glu Asp Arg Leu Glu Gln Ala Lys Leu Phe Cys Arg Thr Leu
165 170 175
Glu Asp Ile Leu Ala Asp Ala Pro Glu Ser Gln Asn Asn Cys Arg Leu
180 185 190
Ile Ala Tyr Gln Glu Pro Ala Asp Asp Ser Ser Phe Ser Leu Ser Gln
195 200 205
Glu Val Leu Arg His Leu Arg Gln Glu Glu Lys Glu Glu Val Thr Val
210 215 220
Gly Ser Leu Lys Thr Ser Ala Val Pro Ser Thr Ser Thr Met Ser Gln
225 230 235 240
Glu Pro Glu Leu Leu Ile Ser Gly Met Glu Lys Pro Leu Pro Leu Arg
245 250 255
Thr Asp Phe Ser
260
<210> 7
<211> 735
<212> DNA
<213> 智人(Homo sapiens)
<400> 7
ctcaagggcc tggccccagc tgagatctct gcagtgtgtg aaaaagggaa tttcaacgtg 60
gcccatgggc tggcatggtc atattacatc ggatatctgc ggctgatcct gccagagctc 120
caggcccgga ttcgaactta caatcagcat tacaacaacc tgctacgggg tgcagtgagc 180
cagcggctgt atattctcct cccattggac tgtggggtgc ctgataacct gagtatggct 240
gaccccaaca ttcgcttcct ggataaactg ccccagcaga ccggtgacca tgctggcatc 300
aaggatcggg tttacagcaa cagcatctat gagcttctgg agaacgggca gcgggcgggc 360
acctgtgtcc tggagtacgc cacccccttg cagactttgt ttgccatgtc acaatacagt 420
caagctggct ttagccggga ggataggctt gagcaggcca aactcttctg ccggacactt 480
gaggacatcc tggcagatgc ccctgagtct cagaacaact gccgcctcat tgcctaccag 540
gaacctgcag atgacagcag cttctcgctg tcccaggagg ttctccggca cctgcggcag 600
gaggaaaagg aagaggttac tgtgggcagc ttgaagacct cagcggtgcc cagtacctcc 660
acgatgtccc aagagcctga gctcctcatc agtggaatgg aaaagcccct ccctctccgc 720
acggatttct cttga 735
<210> 8
<211> 244
<212> PRT
<213> 智人(Homo sapiens)
<400> 8
Leu Lys Gly Leu Ala Pro Ala Glu Ile Ser Ala Val Cys Glu Lys Gly
1 5 10 15
Asn Phe Asn Val Ala His Gly Leu Ala Trp Ser Tyr Tyr Ile Gly Tyr
20 25 30
Leu Arg Leu Ile Leu Pro Glu Leu Gln Ala Arg Ile Arg Thr Tyr Asn
35 40 45
Gln His Tyr Asn Asn Leu Leu Arg Gly Ala Val Ser Gln Arg Leu Tyr
50 55 60
Ile Leu Leu Pro Leu Asp Cys Gly Val Pro Asp Asn Leu Ser Met Ala
65 70 75 80
Asp Pro Asn Ile Arg Phe Leu Asp Lys Leu Pro Gln Gln Thr Gly Asp
85 90 95
His Ala Gly Ile Lys Asp Arg Val Tyr Ser Asn Ser Ile Tyr Glu Leu
100 105 110
Leu Glu Asn Gly Gln Arg Ala Gly Thr Cys Val Leu Glu Tyr Ala Thr
115 120 125
Pro Leu Gln Thr Leu Phe Ala Met Ser Gln Tyr Ser Gln Ala Gly Phe
130 135 140
Ser Arg Glu Asp Arg Leu Glu Gln Ala Lys Leu Phe Cys Arg Thr Leu
145 150 155 160
Glu Asp Ile Leu Ala Asp Ala Pro Glu Ser Gln Asn Asn Cys Arg Leu
165 170 175
Ile Ala Tyr Gln Glu Pro Ala Asp Asp Ser Ser Phe Ser Leu Ser Gln
180 185 190
Glu Val Leu Arg His Leu Arg Gln Glu Glu Lys Glu Glu Val Thr Val
195 200 205
Gly Ser Leu Lys Thr Ser Ala Val Pro Ser Thr Ser Thr Met Ser Gln
210 215 220
Glu Pro Glu Leu Leu Ile Ser Gly Met Glu Lys Pro Leu Pro Leu Arg
225 230 235 240
Thr Asp Phe Ser
<210> 9
<211> 945
<212> DNA
<213> 智人(Homo sapiens)
<400> 9
atgggctcgc aggccctgcc cccggggccc atgcagaccc tcatcttttt cgacatggag 60
gccactggct tgcccttctc ccagcccaag gtcacggagc tgtgcctgct ggctgtccac 120
agatgtgccc tggagagccc ccccacctct caggggccac ctcccacagt tcctccacca 180
ccgcgtgtgg tagacaagct ctccctgtgt gtggctccgg ggaaggcctg cagccctgca 240
gccagcgaga tcacaggtct gagcacagct gtgctggcag cgcatgggcg tcaatgtttt 300
gatgacaacc tggccaacct gctcctagcc ttcctgcggc gccagccaca gccctggtgc 360
ctggtggcac acaatggtga ccgctacgac ttccccctgc tccaagcaga gctggctatg 420
ctgggcctca ccagtgctct ggatggtgcc ttctgtgtgg atagcatcac tgcgctgaag 480
gccctggagc gagcaagcag cccctcagaa cacggcccaa ggaagagcta tagcctaggc 540
agcatctaca ctcgcctgta tgggcagtcc cctccagact cgcacacggc tgagggtgat 600
gtcctggccc tgctcagcat ctgtcagtgg agaccacagg ccctgctgcg gtgggtggat 660
gctcacgcca ggcctttcgg caccatcagg cccatgtatg gggtcacagc ctctgctagg 720
accaagccaa gaccatctgc tgtcacaacc actgcacacc tggccacaac caggaacact 780
agtcccagcc ttggagagag caggggtacc aaggatcttc ctccagtgaa ggaccctgga 840
gccctatcca gggaggggct gctggcccca ctgggtctgc tggccatcct gaccttggca 900
gtagccacac tgtatggact atccctggcc acacctgggg agtag 945
<210> 10
<211> 314
<212> PRT
<213> 智人(Homo sapiens)
<400> 10
Met Gly Ser Gln Ala Leu Pro Pro Gly Pro Met Gln Thr Leu Ile Phe
1 5 10 15
Phe Asp Met Glu Ala Thr Gly Leu Pro Phe Ser Gln Pro Lys Val Thr
20 25 30
Glu Leu Cys Leu Leu Ala Val His Arg Cys Ala Leu Glu Ser Pro Pro
35 40 45
Thr Ser Gln Gly Pro Pro Pro Thr Val Pro Pro Pro Pro Arg Val Val
50 55 60
Asp Lys Leu Ser Leu Cys Val Ala Pro Gly Lys Ala Cys Ser Pro Ala
65 70 75 80
Ala Ser Glu Ile Thr Gly Leu Ser Thr Ala Val Leu Ala Ala His Gly
85 90 95
Arg Gln Cys Phe Asp Asp Asn Leu Ala Asn Leu Leu Leu Ala Phe Leu
100 105 110
Arg Arg Gln Pro Gln Pro Trp Cys Leu Val Ala His Asn Gly Asp Arg
115 120 125
Tyr Asp Phe Pro Leu Leu Gln Ala Glu Leu Ala Met Leu Gly Leu Thr
130 135 140
Ser Ala Leu Asp Gly Ala Phe Cys Val Asp Ser Ile Thr Ala Leu Lys
145 150 155 160
Ala Leu Glu Arg Ala Ser Ser Pro Ser Glu His Gly Pro Arg Lys Ser
165 170 175
Tyr Ser Leu Gly Ser Ile Tyr Thr Arg Leu Tyr Gly Gln Ser Pro Pro
180 185 190
Asp Ser His Thr Ala Glu Gly Asp Val Leu Ala Leu Leu Ser Ile Cys
195 200 205
Gln Trp Arg Pro Gln Ala Leu Leu Arg Trp Val Asp Ala His Ala Arg
210 215 220
Pro Phe Gly Thr Ile Arg Pro Met Tyr Gly Val Thr Ala Ser Ala Arg
225 230 235 240
Thr Lys Pro Arg Pro Ser Ala Val Thr Thr Thr Ala His Leu Ala Thr
245 250 255
Thr Arg Asn Thr Ser Pro Ser Leu Gly Glu Ser Arg Gly Thr Lys Asp
260 265 270
Leu Pro Pro Val Lys Asp Pro Gly Ala Leu Ser Arg Glu Gly Leu Leu
275 280 285
Ala Pro Leu Gly Leu Leu Ala Ile Leu Thr Leu Ala Val Ala Thr Leu
290 295 300
Tyr Gly Leu Ser Leu Ala Thr Pro Gly Glu
305 310
<210> 11
<211> 915
<212> DNA
<213> 智人(Homo sapiens)
<400> 11
atgcagaccc tcatcttttt cgacatggag gccactggct tgcccttctc ccagcccaag 60
gtcacggagc tgtgcctgct ggctgtccac agatgtgccc tggagagccc ccccacctct 120
caggggccac ctcccacagt tcctccacca ccgcgtgtgg tagacaagct ctccctgtgt 180
gtggctccgg ggaaggcctg cagccctgca gccagcgaga tcacaggtct gagcacagct 240
gtgctggcag cgcatgggcg tcaatgtttt gatgacaacc tggccaacct gctcctagcc 300
ttcctgcggc gccagccaca gccctggtgc ctggtggcac acaatggtga ccgctacgac 360
ttccccctgc tccaagcaga gctggctatg ctgggcctca ccagtgctct ggatggtgcc 420
ttctgtgtgg atagcatcac tgcgctgaag gccctggagc gagcaagcag cccctcagaa 480
cacggcccaa ggaagagcta tagcctaggc agcatctaca ctcgcctgta tgggcagtcc 540
cctccagact cgcacacggc tgagggtgat gtcctggccc tgctcagcat ctgtcagtgg 600
agaccacagg ccctgctgcg gtgggtggat gctcacgcca ggcctttcgg caccatcagg 660
cccatgtatg gggtcacagc ctctgctagg accaagccaa gaccatctgc tgtcacaacc 720
actgcacacc tggccacaac caggaacact agtcccagcc ttggagagag caggggtacc 780
aaggatcttc ctccagtgaa ggaccctgga gccctatcca gggaggggct gctggcccca 840
ctgggtctgc tggccatcct gaccttggca gtagccacac tgtatggact atccctggcc 900
acacctgggg agtag 915
<210> 12
<211> 304
<212> PRT
<213> 智人(Homo sapiens)
<400> 12
Met Gln Thr Leu Ile Phe Phe Asp Met Glu Ala Thr Gly Leu Pro Phe
1 5 10 15
Ser Gln Pro Lys Val Thr Glu Leu Cys Leu Leu Ala Val His Arg Cys
20 25 30
Ala Leu Glu Ser Pro Pro Thr Ser Gln Gly Pro Pro Pro Thr Val Pro
35 40 45
Pro Pro Pro Arg Val Val Asp Lys Leu Ser Leu Cys Val Ala Pro Gly
50 55 60
Lys Ala Cys Ser Pro Ala Ala Ser Glu Ile Thr Gly Leu Ser Thr Ala
65 70 75 80
Val Leu Ala Ala His Gly Arg Gln Cys Phe Asp Asp Asn Leu Ala Asn
85 90 95
Leu Leu Leu Ala Phe Leu Arg Arg Gln Pro Gln Pro Trp Cys Leu Val
100 105 110
Ala His Asn Gly Asp Arg Tyr Asp Phe Pro Leu Leu Gln Ala Glu Leu
115 120 125
Ala Met Leu Gly Leu Thr Ser Ala Leu Asp Gly Ala Phe Cys Val Asp
130 135 140
Ser Ile Thr Ala Leu Lys Ala Leu Glu Arg Ala Ser Ser Pro Ser Glu
145 150 155 160
His Gly Pro Arg Lys Ser Tyr Ser Leu Gly Ser Ile Tyr Thr Arg Leu
165 170 175
Tyr Gly Gln Ser Pro Pro Asp Ser His Thr Ala Glu Gly Asp Val Leu
180 185 190
Ala Leu Leu Ser Ile Cys Gln Trp Arg Pro Gln Ala Leu Leu Arg Trp
195 200 205
Val Asp Ala His Ala Arg Pro Phe Gly Thr Ile Arg Pro Met Tyr Gly
210 215 220
Val Thr Ala Ser Ala Arg Thr Lys Pro Arg Pro Ser Ala Val Thr Thr
225 230 235 240
Thr Ala His Leu Ala Thr Thr Arg Asn Thr Ser Pro Ser Leu Gly Glu
245 250 255
Ser Arg Gly Thr Lys Asp Leu Pro Pro Val Lys Asp Pro Gly Ala Leu
260 265 270
Ser Arg Glu Gly Leu Leu Ala Pro Leu Gly Leu Leu Ala Ile Leu Thr
275 280 285
Leu Ala Val Ala Thr Leu Tyr Gly Leu Ser Leu Ala Thr Pro Gly Glu
290 295 300
<210> 13
<211> 369
<212> PRT
<213> 智人(Homo sapiens)
<400> 13
Met Gly Pro Gly Ala Arg Arg Gln Gly Arg Ile Val Gln Gly Arg Pro
1 5 10 15
Glu Met Cys Phe Cys Pro Pro Pro Thr Pro Leu Pro Pro Leu Arg Ile
20 25 30
Leu Thr Leu Gly Thr His Thr Pro Thr Pro Cys Ser Ser Pro Gly Ser
35 40 45
Ala Ala Gly Thr Tyr Pro Thr Met Gly Ser Gln Ala Leu Pro Pro Gly
50 55 60
Pro Met Gln Thr Leu Ile Phe Phe Asp Met Glu Ala Thr Gly Leu Pro
65 70 75 80
Phe Ser Gln Pro Lys Val Thr Glu Leu Cys Leu Leu Ala Val His Arg
85 90 95
Cys Ala Leu Glu Ser Pro Pro Thr Ser Gln Gly Pro Pro Pro Thr Val
100 105 110
Pro Pro Pro Pro Arg Val Val Asp Lys Leu Ser Leu Cys Val Ala Pro
115 120 125
Gly Lys Ala Cys Ser Pro Ala Ala Ser Glu Ile Thr Gly Leu Ser Thr
130 135 140
Ala Val Leu Ala Ala His Gly Arg Gln Cys Phe Asp Asp Asn Leu Ala
145 150 155 160
Asn Leu Leu Leu Ala Phe Leu Arg Arg Gln Pro Gln Pro Trp Cys Leu
165 170 175
Val Ala His Asn Gly Asp Arg Tyr Asp Phe Pro Leu Leu Gln Ala Glu
180 185 190
Leu Ala Met Leu Gly Leu Thr Ser Ala Leu Asp Gly Ala Phe Cys Val
195 200 205
Asp Ser Ile Thr Ala Leu Lys Ala Leu Glu Arg Ala Ser Ser Pro Ser
210 215 220
Glu His Gly Pro Arg Lys Ser Tyr Ser Leu Gly Ser Ile Tyr Thr Arg
225 230 235 240
Leu Tyr Gly Gln Ser Pro Pro Asp Ser His Thr Ala Glu Gly Asp Val
245 250 255
Leu Ala Leu Leu Ser Ile Cys Gln Trp Arg Pro Gln Ala Leu Leu Arg
260 265 270
Trp Val Asp Ala His Ala Arg Pro Phe Gly Thr Ile Arg Pro Met Tyr
275 280 285
Gly Val Thr Ala Ser Ala Arg Thr Lys Pro Arg Pro Ser Ala Val Thr
290 295 300
Thr Thr Ala His Leu Ala Thr Thr Arg Asn Thr Ser Pro Ser Leu Gly
305 310 315 320
Glu Ser Arg Gly Thr Lys Asp Leu Pro Pro Val Lys Asp Pro Gly Ala
325 330 335
Leu Ser Arg Glu Gly Leu Leu Ala Pro Leu Gly Leu Leu Ala Ile Leu
340 345 350
Thr Leu Ala Val Ala Thr Leu Tyr Gly Leu Ser Leu Ala Thr Pro Gly
355 360 365
Glu
<210> 14
<211> 5592
<212> DNA
<213> 智人(Homo sapiens)
<400> 14
atggatttat ctgctcttcg cgttgaagaa gtacaaaatg tcattaatgc tatgcagaaa 60
atcttagagt gtcccatctg tctggagttg atcaaggaac ctgtctccac aaagtgtgac 120
cacatatttt gcaaattttg catgctgaaa cttctcaacc agaagaaagg gccttcacag 180
tgtcctttat gtaagaatga tataaccaaa aggagcctac aagaaagtac gagatttagt 240
caacttgttg aagagctatt gaaaatcatt tgtgcttttc agcttgacac aggtttggag 300
tatgcaaaca gctataattt tgcaaaaaag gaaaataact ctcctgaaca tctaaaagat 360
gaagtttcta tcatccaaag tatgggctac agaaaccgtg ccaaaagact tctacagagt 420
gaacccgaaa atccttcctt gcaggaaacc agtctcagtg tccaactctc taaccttgga 480
actgtgagaa ctctgaggac aaagcagcgg atacaacctc aaaagacgtc tgtctacatt 540
gaattgggat ctgattcttc tgaagatacc gttaataagg caacttattg cagtgtggga 600
gatcaagaat tgttacaaat cacccctcaa ggaaccaggg atgaaatcag tttggattct 660
gcaaaaaagg ctgcttgtga attttctgag acggatgtaa caaatactga acatcatcaa 720
cccagtaata atgatttgaa caccactgag aagcgtgcag ctgagaggca tccagaaaag 780
tatcagggta gttctgtttc aaacttgcat gtggagccat gtggcacaaa tactcatgcc 840
agctcattac agcatgagaa cagcagttta ttactcacta aagacagaat gaatgtagaa 900
aaggctgaat tctgtaataa aagcaaacag cctggcttag caaggagcca acataacaga 960
tgggctggaa gtaaggaaac atgtaatgat aggcggactc ccagcacaga aaaaaaggta 1020
gatctgaatg ctgatcccct gtgtgagaga aaagaatgga ataagcagaa actgccatgc 1080
tcagagaatc ctagagatac tgaagatgtt ccttggataa cactaaatag cagcattcag 1140
aaagttaatg agtggttttc cagaagtgat gaactgttag gttctgatga ctcacatgat 1200
ggggagtctg aatcaaatgc caaagtagct gatgtattgg acgttctaaa tgaggtagat 1260
gaatattctg gttcttcaga gaaaatagac ttactggcca gtgatcctca tgaggcttta 1320
atatgtaaaa gtgaaagagt tcactccaaa tcagtagaga gtaatattga agacaaaata 1380
tttgggaaaa cctatcggaa gaaggcaagc ctccccaact taagccatgt aactgaaaat 1440
ctaattatag gagcatttgt tactgagcca cagataatac aagagcgtcc cctcacaaat 1500
aaattaaagc gtaaaaggag acctacatca ggccttcatc ctgaggattt tatcaagaaa 1560
gcagatttgg cagttcaaaa gactcctgaa atgataaatc agggaactaa ccaaacggag 1620
cagaatggtc aagtgatgaa tattactaat agtggtcatg agaataaaac aaaaggtgat 1680
tctattcaga atgagaaaaa tcctaaccca atagaatcac tcgaaaaaga atctgctttc 1740
aaaacgaaag ctgaacctat aagcagcagt ataagcaata tggaactcga attaaatatc 1800
cacaattcaa aagcacctaa aaagaatagg ctgaggagga agtcttctac caggcatatt 1860
catgcgcttg aactagtagt cagtagaaat ctaagcccac ctaattgtac tgaattgcaa 1920
attgatagtt gttctagcag tgaagagata aagaaaaaaa agtacaacca aatgccagtc 1980
aggcacagca gaaacctaca actcatggaa ggtaaagaac ctgcaactgg agccaagaag 2040
agtaacaagc caaatgaaca gacaagtaaa agacatgaca gcgatacttt cccagagctg 2100
aagttaacaa atgcacctgg ttcttttact aagtgttcaa ataccagtga acttaaagaa 2160
tttgtcaatc ctagccttcc aagagaagaa aaagaagaga aactagaaac agttaaagtg 2220
tctaataatg ctgaagaccc caaagatctc atgttaagtg gagaaagggt tttgcaaact 2280
gaaagatctg tagagagtag cagtatttca ttggtacctg gtactgatta tggcactcag 2340
gaaagtatct cgttactgga agttagcact ctagggaagg caaaaacaga accaaataaa 2400
tgtgtgagtc agtgtgcagc atttgaaaac cccaagggac taattcatgg ttgttccaaa 2460
gataatagaa atgacacaga aggctttaag tatccattgg gacatgaagt taaccacagt 2520
cgggaaacaa gcatagaaat ggaagaaagt gaacttgatg ctcagtattt gcagaataca 2580
ttcaaggttt caaagcgcca gtcatttgct ccgttttcaa atccaggaaa tgcagaagag 2640
gaatgtgcaa cattctctgc ccactctggg tccttaaaga aacaaagtcc aaaagtcact 2700
tttgaatgtg aacaaaagga agaaaatcaa ggaaagaatg agtctaatat caagcctgta 2760
cagacagtta atatcactgc aggctttcct gtggttggtc agaaagataa gccagttgat 2820
aatgccaaat gtagtatcaa aggaggctct aggttttgtc tatcatctca gttcagaggc 2880
aacgaaactg gactcattac tccaaataaa catggacttt tacaaaaccc atatcgtata 2940
ccaccacttt ttcccatcaa gtcatttgtt aaaactaaat gtaagaaaaa tctgctagag 3000
gaaaactttg aggaacattc aatgtcacct gaaagagaaa tgggaaatga gaacattcca 3060
agtacagtga gcacaattag ccgtaataac attagagaaa atgtttttaa agaagccagc 3120
tcaagcaata ttaatgaagt aggttccagt actaatgaag tgggctccag tattaatgaa 3180
ataggttcca gtgatgaaaa cattcaagca gaactaggta gaaacagagg gccaaaattg 3240
aatgctatgc ttagattagg ggttttgcaa cctgaggtct ataaacaaag tcttcctgga 3300
agtaattgta agcatcctga aataaaaaag caagaatatg aagaagtagt tcagactgtt 3360
aatacagatt tctctccata tctgatttca gataacttag aacagcctat gggaagtagt 3420
catgcatctc aggtttgttc tgagacacct gatgacctgt tagatgatgg tgaaataaag 3480
gaagatacta gttttgctga aaatgacatt aaggaaagtt ctgctgtttt tagcaaaagc 3540
gtccagaaag gagagcttag caggagtcct agccctttca cccatacaca tttggctcag 3600
ggttaccgaa gaggggccaa gaaattagag tcctcagaag agaacttatc tagtgaggat 3660
gaagagcttc cctgcttcca acacttgtta tttggtaaag taaacaatat accttctcag 3720
tctactaggc atagcaccgt tgctaccgag tgtctgtcta agaacacaga ggagaattta 3780
ttatcattga agaatagctt aaatgactgc agtaaccagg taatattggc aaaggcatct 3840
caggaacatc accttagtga ggaaacaaaa tgttctgcta gcttgttttc ttcacagtgc 3900
agtgaattgg aagacttgac tgcaaataca aacacccagg atcctttctt gattggttct 3960
tccaaacaaa tgaggcatca gtctgaaagc cagggagttg gtctgagtga caaggaattg 4020
gtttcagatg atgaagaaag aggaacgggc ttggaagaaa ataatcaaga agagcaaagc 4080
atggattcaa acttaggtga agcagcatct gggtgtgaga gtgaaacaag cgtctctgaa 4140
gactgctcag ggctatcctc tcagagtgac attttaacca ctcagcagag ggataccatg 4200
caacataacc tgataaagct ccagcaggaa atggctgaac tagaagctgt gttagaacag 4260
catgggagcc agccttctaa cagctaccct tccatcataa gtgactcttc tgcccttgag 4320
gacctgcgaa atccagaaca aagcacatca gaaaaagcag tattaacttc acagaaaagt 4380
agtgaatacc ctataagcca gaatccagaa ggcctttctg ctgacaagtt tgaggtgtct 4440
gcagatagtt ctaccagtaa aaataaagaa ccaggagtgg aaaggtcatc cccttctaaa 4500
tgcccatcat tagatgatag gtggtacatg cacagttgct ctgggagtct tcagaataga 4560
aactacccat ctcaagagga gctcattaag gttgttgatg tggaggagca acagctggaa 4620
gagtctgggc cacacgattt gacggaaaca tcttacttgc caaggcaaga tctagaggga 4680
accccttacc tggaatctgg aatcagcctc ttctctgatg accctgaatc tgatccttct 4740
gaagacagag ccccagagtc agctcgtgtt ggcaacatac catcttcaac ctctgcattg 4800
aaagttcccc aattgaaagt tgcagaatct gcccagagtc cagctgctgc tcatactact 4860
gatactgctg ggtataatgc aatggaagaa agtgtgagca gggagaagcc agaattgaca 4920
gcttcaacag aaagggtcaa caaaagaatg tccatggtgg tgtctggcct gaccccagaa 4980
gaatttatgc tcgtgtacaa gtttgccaga aaacaccaca tcactttaac taatctaatt 5040
actgaagaga ctactcatgt tgttatgaaa acagatgctg agtttgtgtg tgaacggaca 5100
ctgaaatatt ttctaggaat tgcgggagga aaatgggtag ttagctattt ctgggtgacc 5160
cagtctatta aagaaagaaa aatgctgaat gagcatgatt ttgaagtcag aggagatgtg 5220
gtcaatggaa gaaaccacca aggtccaaag cgagcaagag aatcccagga cagaaagatc 5280
ttcagggggc tagaaatctg ttgctatggg cccttcacca acatgcccac agatcaactg 5340
gaatggatgg tacagctgtg tggtgcttct gtggtgaagg agctttcatc attcaccctt 5400
ggcacaggtg tccacccaat tgtggttgtg cagccagatg cctggacaga ggacaatggc 5460
ttccatgcaa ttgggcagat gtgtgaggca cctgtggtga cccgagagtg ggtgttggac 5520
agtgtagcac tctaccagtg ccaggagctg gacacctacc tgatacccca gatcccccac 5580
agccactact ga 5592
<210> 15
<211> 1863
<212> PRT
<213> 智人(Homo sapiens)
<400> 15
Met Asp Leu Ser Ala Leu Arg Val Glu Glu Val Gln Asn Val Ile Asn
1 5 10 15
Ala Met Gln Lys Ile Leu Glu Cys Pro Ile Cys Leu Glu Leu Ile Lys
20 25 30
Glu Pro Val Ser Thr Lys Cys Asp His Ile Phe Cys Lys Phe Cys Met
35 40 45
Leu Lys Leu Leu Asn Gln Lys Lys Gly Pro Ser Gln Cys Pro Leu Cys
50 55 60
Lys Asn Asp Ile Thr Lys Arg Ser Leu Gln Glu Ser Thr Arg Phe Ser
65 70 75 80
Gln Leu Val Glu Glu Leu Leu Lys Ile Ile Cys Ala Phe Gln Leu Asp
85 90 95
Thr Gly Leu Glu Tyr Ala Asn Ser Tyr Asn Phe Ala Lys Lys Glu Asn
100 105 110
Asn Ser Pro Glu His Leu Lys Asp Glu Val Ser Ile Ile Gln Ser Met
115 120 125
Gly Tyr Arg Asn Arg Ala Lys Arg Leu Leu Gln Ser Glu Pro Glu Asn
130 135 140
Pro Ser Leu Gln Glu Thr Ser Leu Ser Val Gln Leu Ser Asn Leu Gly
145 150 155 160
Thr Val Arg Thr Leu Arg Thr Lys Gln Arg Ile Gln Pro Gln Lys Thr
165 170 175
Ser Val Tyr Ile Glu Leu Gly Ser Asp Ser Ser Glu Asp Thr Val Asn
180 185 190
Lys Ala Thr Tyr Cys Ser Val Gly Asp Gln Glu Leu Leu Gln Ile Thr
195 200 205
Pro Gln Gly Thr Arg Asp Glu Ile Ser Leu Asp Ser Ala Lys Lys Ala
210 215 220
Ala Cys Glu Phe Ser Glu Thr Asp Val Thr Asn Thr Glu His His Gln
225 230 235 240
Pro Ser Asn Asn Asp Leu Asn Thr Thr Glu Lys Arg Ala Ala Glu Arg
245 250 255
His Pro Glu Lys Tyr Gln Gly Ser Ser Val Ser Asn Leu His Val Glu
260 265 270
Pro Cys Gly Thr Asn Thr His Ala Ser Ser Leu Gln His Glu Asn Ser
275 280 285
Ser Leu Leu Leu Thr Lys Asp Arg Met Asn Val Glu Lys Ala Glu Phe
290 295 300
Cys Asn Lys Ser Lys Gln Pro Gly Leu Ala Arg Ser Gln His Asn Arg
305 310 315 320
Trp Ala Gly Ser Lys Glu Thr Cys Asn Asp Arg Arg Thr Pro Ser Thr
325 330 335
Glu Lys Lys Val Asp Leu Asn Ala Asp Pro Leu Cys Glu Arg Lys Glu
340 345 350
Trp Asn Lys Gln Lys Leu Pro Cys Ser Glu Asn Pro Arg Asp Thr Glu
355 360 365
Asp Val Pro Trp Ile Thr Leu Asn Ser Ser Ile Gln Lys Val Asn Glu
370 375 380
Trp Phe Ser Arg Ser Asp Glu Leu Leu Gly Ser Asp Asp Ser His Asp
385 390 395 400
Gly Glu Ser Glu Ser Asn Ala Lys Val Ala Asp Val Leu Asp Val Leu
405 410 415
Asn Glu Val Asp Glu Tyr Ser Gly Ser Ser Glu Lys Ile Asp Leu Leu
420 425 430
Ala Ser Asp Pro His Glu Ala Leu Ile Cys Lys Ser Glu Arg Val His
435 440 445
Ser Lys Ser Val Glu Ser Asn Ile Glu Asp Lys Ile Phe Gly Lys Thr
450 455 460
Tyr Arg Lys Lys Ala Ser Leu Pro Asn Leu Ser His Val Thr Glu Asn
465 470 475 480
Leu Ile Ile Gly Ala Phe Val Thr Glu Pro Gln Ile Ile Gln Glu Arg
485 490 495
Pro Leu Thr Asn Lys Leu Lys Arg Lys Arg Arg Pro Thr Ser Gly Leu
500 505 510
His Pro Glu Asp Phe Ile Lys Lys Ala Asp Leu Ala Val Gln Lys Thr
515 520 525
Pro Glu Met Ile Asn Gln Gly Thr Asn Gln Thr Glu Gln Asn Gly Gln
530 535 540
Val Met Asn Ile Thr Asn Ser Gly His Glu Asn Lys Thr Lys Gly Asp
545 550 555 560
Ser Ile Gln Asn Glu Lys Asn Pro Asn Pro Ile Glu Ser Leu Glu Lys
565 570 575
Glu Ser Ala Phe Lys Thr Lys Ala Glu Pro Ile Ser Ser Ser Ile Ser
580 585 590
Asn Met Glu Leu Glu Leu Asn Ile His Asn Ser Lys Ala Pro Lys Lys
595 600 605
Asn Arg Leu Arg Arg Lys Ser Ser Thr Arg His Ile His Ala Leu Glu
610 615 620
Leu Val Val Ser Arg Asn Leu Ser Pro Pro Asn Cys Thr Glu Leu Gln
625 630 635 640
Ile Asp Ser Cys Ser Ser Ser Glu Glu Ile Lys Lys Lys Lys Tyr Asn
645 650 655
Gln Met Pro Val Arg His Ser Arg Asn Leu Gln Leu Met Glu Gly Lys
660 665 670
Glu Pro Ala Thr Gly Ala Lys Lys Ser Asn Lys Pro Asn Glu Gln Thr
675 680 685
Ser Lys Arg His Asp Ser Asp Thr Phe Pro Glu Leu Lys Leu Thr Asn
690 695 700
Ala Pro Gly Ser Phe Thr Lys Cys Ser Asn Thr Ser Glu Leu Lys Glu
705 710 715 720
Phe Val Asn Pro Ser Leu Pro Arg Glu Glu Lys Glu Glu Lys Leu Glu
725 730 735
Thr Val Lys Val Ser Asn Asn Ala Glu Asp Pro Lys Asp Leu Met Leu
740 745 750
Ser Gly Glu Arg Val Leu Gln Thr Glu Arg Ser Val Glu Ser Ser Ser
755 760 765
Ile Ser Leu Val Pro Gly Thr Asp Tyr Gly Thr Gln Glu Ser Ile Ser
770 775 780
Leu Leu Glu Val Ser Thr Leu Gly Lys Ala Lys Thr Glu Pro Asn Lys
785 790 795 800
Cys Val Ser Gln Cys Ala Ala Phe Glu Asn Pro Lys Gly Leu Ile His
805 810 815
Gly Cys Ser Lys Asp Asn Arg Asn Asp Thr Glu Gly Phe Lys Tyr Pro
820 825 830
Leu Gly His Glu Val Asn His Ser Arg Glu Thr Ser Ile Glu Met Glu
835 840 845
Glu Ser Glu Leu Asp Ala Gln Tyr Leu Gln Asn Thr Phe Lys Val Ser
850 855 860
Lys Arg Gln Ser Phe Ala Pro Phe Ser Asn Pro Gly Asn Ala Glu Glu
865 870 875 880
Glu Cys Ala Thr Phe Ser Ala His Ser Gly Ser Leu Lys Lys Gln Ser
885 890 895
Pro Lys Val Thr Phe Glu Cys Glu Gln Lys Glu Glu Asn Gln Gly Lys
900 905 910
Asn Glu Ser Asn Ile Lys Pro Val Gln Thr Val Asn Ile Thr Ala Gly
915 920 925
Phe Pro Val Val Gly Gln Lys Asp Lys Pro Val Asp Asn Ala Lys Cys
930 935 940
Ser Ile Lys Gly Gly Ser Arg Phe Cys Leu Ser Ser Gln Phe Arg Gly
945 950 955 960
Asn Glu Thr Gly Leu Ile Thr Pro Asn Lys His Gly Leu Leu Gln Asn
965 970 975
Pro Tyr Arg Ile Pro Pro Leu Phe Pro Ile Lys Ser Phe Val Lys Thr
980 985 990
Lys Cys Lys Lys Asn Leu Leu Glu Glu Asn Phe Glu Glu His Ser Met
995 1000 1005
Ser Pro Glu Arg Glu Met Gly Asn Glu Asn Ile Pro Ser Thr Val
1010 1015 1020
Ser Thr Ile Ser Arg Asn Asn Ile Arg Glu Asn Val Phe Lys Glu
1025 1030 1035
Ala Ser Ser Ser Asn Ile Asn Glu Val Gly Ser Ser Thr Asn Glu
1040 1045 1050
Val Gly Ser Ser Ile Asn Glu Ile Gly Ser Ser Asp Glu Asn Ile
1055 1060 1065
Gln Ala Glu Leu Gly Arg Asn Arg Gly Pro Lys Leu Asn Ala Met
1070 1075 1080
Leu Arg Leu Gly Val Leu Gln Pro Glu Val Tyr Lys Gln Ser Leu
1085 1090 1095
Pro Gly Ser Asn Cys Lys His Pro Glu Ile Lys Lys Gln Glu Tyr
1100 1105 1110
Glu Glu Val Val Gln Thr Val Asn Thr Asp Phe Ser Pro Tyr Leu
1115 1120 1125
Ile Ser Asp Asn Leu Glu Gln Pro Met Gly Ser Ser His Ala Ser
1130 1135 1140
Gln Val Cys Ser Glu Thr Pro Asp Asp Leu Leu Asp Asp Gly Glu
1145 1150 1155
Ile Lys Glu Asp Thr Ser Phe Ala Glu Asn Asp Ile Lys Glu Ser
1160 1165 1170
Ser Ala Val Phe Ser Lys Ser Val Gln Lys Gly Glu Leu Ser Arg
1175 1180 1185
Ser Pro Ser Pro Phe Thr His Thr His Leu Ala Gln Gly Tyr Arg
1190 1195 1200
Arg Gly Ala Lys Lys Leu Glu Ser Ser Glu Glu Asn Leu Ser Ser
1205 1210 1215
Glu Asp Glu Glu Leu Pro Cys Phe Gln His Leu Leu Phe Gly Lys
1220 1225 1230
Val Asn Asn Ile Pro Ser Gln Ser Thr Arg His Ser Thr Val Ala
1235 1240 1245
Thr Glu Cys Leu Ser Lys Asn Thr Glu Glu Asn Leu Leu Ser Leu
1250 1255 1260
Lys Asn Ser Leu Asn Asp Cys Ser Asn Gln Val Ile Leu Ala Lys
1265 1270 1275
Ala Ser Gln Glu His His Leu Ser Glu Glu Thr Lys Cys Ser Ala
1280 1285 1290
Ser Leu Phe Ser Ser Gln Cys Ser Glu Leu Glu Asp Leu Thr Ala
1295 1300 1305
Asn Thr Asn Thr Gln Asp Pro Phe Leu Ile Gly Ser Ser Lys Gln
1310 1315 1320
Met Arg His Gln Ser Glu Ser Gln Gly Val Gly Leu Ser Asp Lys
1325 1330 1335
Glu Leu Val Ser Asp Asp Glu Glu Arg Gly Thr Gly Leu Glu Glu
1340 1345 1350
Asn Asn Gln Glu Glu Gln Ser Met Asp Ser Asn Leu Gly Glu Ala
1355 1360 1365
Ala Ser Gly Cys Glu Ser Glu Thr Ser Val Ser Glu Asp Cys Ser
1370 1375 1380
Gly Leu Ser Ser Gln Ser Asp Ile Leu Thr Thr Gln Gln Arg Asp
1385 1390 1395
Thr Met Gln His Asn Leu Ile Lys Leu Gln Gln Glu Met Ala Glu
1400 1405 1410
Leu Glu Ala Val Leu Glu Gln His Gly Ser Gln Pro Ser Asn Ser
1415 1420 1425
Tyr Pro Ser Ile Ile Ser Asp Ser Ser Ala Leu Glu Asp Leu Arg
1430 1435 1440
Asn Pro Glu Gln Ser Thr Ser Glu Lys Ala Val Leu Thr Ser Gln
1445 1450 1455
Lys Ser Ser Glu Tyr Pro Ile Ser Gln Asn Pro Glu Gly Leu Ser
1460 1465 1470
Ala Asp Lys Phe Glu Val Ser Ala Asp Ser Ser Thr Ser Lys Asn
1475 1480 1485
Lys Glu Pro Gly Val Glu Arg Ser Ser Pro Ser Lys Cys Pro Ser
1490 1495 1500
Leu Asp Asp Arg Trp Tyr Met His Ser Cys Ser Gly Ser Leu Gln
1505 1510 1515
Asn Arg Asn Tyr Pro Ser Gln Glu Glu Leu Ile Lys Val Val Asp
1520 1525 1530
Val Glu Glu Gln Gln Leu Glu Glu Ser Gly Pro His Asp Leu Thr
1535 1540 1545
Glu Thr Ser Tyr Leu Pro Arg Gln Asp Leu Glu Gly Thr Pro Tyr
1550 1555 1560
Leu Glu Ser Gly Ile Ser Leu Phe Ser Asp Asp Pro Glu Ser Asp
1565 1570 1575
Pro Ser Glu Asp Arg Ala Pro Glu Ser Ala Arg Val Gly Asn Ile
1580 1585 1590
Pro Ser Ser Thr Ser Ala Leu Lys Val Pro Gln Leu Lys Val Ala
1595 1600 1605
Glu Ser Ala Gln Ser Pro Ala Ala Ala His Thr Thr Asp Thr Ala
1610 1615 1620
Gly Tyr Asn Ala Met Glu Glu Ser Val Ser Arg Glu Lys Pro Glu
1625 1630 1635
Leu Thr Ala Ser Thr Glu Arg Val Asn Lys Arg Met Ser Met Val
1640 1645 1650
Val Ser Gly Leu Thr Pro Glu Glu Phe Met Leu Val Tyr Lys Phe
1655 1660 1665
Ala Arg Lys His His Ile Thr Leu Thr Asn Leu Ile Thr Glu Glu
1670 1675 1680
Thr Thr His Val Val Met Lys Thr Asp Ala Glu Phe Val Cys Glu
1685 1690 1695
Arg Thr Leu Lys Tyr Phe Leu Gly Ile Ala Gly Gly Lys Trp Val
1700 1705 1710
Val Ser Tyr Phe Trp Val Thr Gln Ser Ile Lys Glu Arg Lys Met
1715 1720 1725
Leu Asn Glu His Asp Phe Glu Val Arg Gly Asp Val Val Asn Gly
1730 1735 1740
Arg Asn His Gln Gly Pro Lys Arg Ala Arg Glu Ser Gln Asp Arg
1745 1750 1755
Lys Ile Phe Arg Gly Leu Glu Ile Cys Cys Tyr Gly Pro Phe Thr
1760 1765 1770
Asn Met Pro Thr Asp Gln Leu Glu Trp Met Val Gln Leu Cys Gly
1775 1780 1785
Ala Ser Val Val Lys Glu Leu Ser Ser Phe Thr Leu Gly Thr Gly
1790 1795 1800
Val His Pro Ile Val Val Val Gln Pro Asp Ala Trp Thr Glu Asp
1805 1810 1815
Asn Gly Phe His Ala Ile Gly Gln Met Cys Glu Ala Pro Val Val
1820 1825 1830
Thr Arg Glu Trp Val Leu Asp Ser Val Ala Leu Tyr Gln Cys Gln
1835 1840 1845
Glu Leu Asp Thr Tyr Leu Ile Pro Gln Ile Pro His Ser His Tyr
1850 1855 1860
<210> 16
<211> 5451
<212> DNA
<213> 智人(Homo sapiens)
<400> 16
atgctgaaac ttctcaacca gaagaaaggg ccttcacagt gtcctttatg taagaatgat 60
ataaccaaaa ggagcctaca agaaagtacg agatttagtc aacttgttga agagctattg 120
aaaatcattt gtgcttttca gcttgacaca ggtttggagt atgcaaacag ctataatttt 180
gcaaaaaagg aaaataactc tcctgaacat ctaaaagatg aagtttctat catccaaagt 240
atgggctaca gaaaccgtgc caaaagactt ctacagagtg aacccgaaaa tccttccttg 300
caggaaacca gtctcagtgt ccaactctct aaccttggaa ctgtgagaac tctgaggaca 360
aagcagcgga tacaacctca aaagacgtct gtctacattg aattgggatc tgattcttct 420
gaagataccg ttaataaggc aacttattgc agtgtgggag atcaagaatt gttacaaatc 480
acccctcaag gaaccaggga tgaaatcagt ttggattctg caaaaaaggc tgcttgtgaa 540
ttttctgaga cggatgtaac aaatactgaa catcatcaac ccagtaataa tgatttgaac 600
accactgaga agcgtgcagc tgagaggcat ccagaaaagt atcagggtag ttctgtttca 660
aacttgcatg tggagccatg tggcacaaat actcatgcca gctcattaca gcatgagaac 720
agcagtttat tactcactaa agacagaatg aatgtagaaa aggctgaatt ctgtaataaa 780
agcaaacagc ctggcttagc aaggagccaa cataacagat gggctggaag taaggaaaca 840
tgtaatgata ggcggactcc cagcacagaa aaaaaggtag atctgaatgc tgatcccctg 900
tgtgagagaa aagaatggaa taagcagaaa ctgccatgct cagagaatcc tagagatact 960
gaagatgttc cttggataac actaaatagc agcattcaga aagttaatga gtggttttcc 1020
agaagtgatg aactgttagg ttctgatgac tcacatgatg gggagtctga atcaaatgcc 1080
aaagtagctg atgtattgga cgttctaaat gaggtagatg aatattctgg ttcttcagag 1140
aaaatagact tactggccag tgatcctcat gaggctttaa tatgtaaaag tgaaagagtt 1200
cactccaaat cagtagagag taatattgaa gacaaaatat ttgggaaaac ctatcggaag 1260
aaggcaagcc tccccaactt aagccatgta actgaaaatc taattatagg agcatttgtt 1320
actgagccac agataataca agagcgtccc ctcacaaata aattaaagcg taaaaggaga 1380
cctacatcag gccttcatcc tgaggatttt atcaagaaag cagatttggc agttcaaaag 1440
actcctgaaa tgataaatca gggaactaac caaacggagc agaatggtca agtgatgaat 1500
attactaata gtggtcatga gaataaaaca aaaggtgatt ctattcagaa tgagaaaaat 1560
cctaacccaa tagaatcact cgaaaaagaa tctgctttca aaacgaaagc tgaacctata 1620
agcagcagta taagcaatat ggaactcgaa ttaaatatcc acaattcaaa agcacctaaa 1680
aagaataggc tgaggaggaa gtcttctacc aggcatattc atgcgcttga actagtagtc 1740
agtagaaatc taagcccacc taattgtact gaattgcaaa ttgatagttg ttctagcagt 1800
gaagagataa agaaaaaaaa gtacaaccaa atgccagtca ggcacagcag aaacctacaa 1860
ctcatggaag gtaaagaacc tgcaactgga gccaagaaga gtaacaagcc aaatgaacag 1920
acaagtaaaa gacatgacag cgatactttc ccagagctga agttaacaaa tgcacctggt 1980
tcttttacta agtgttcaaa taccagtgaa cttaaagaat ttgtcaatcc tagccttcca 2040
agagaagaaa aagaagagaa actagaaaca gttaaagtgt ctaataatgc tgaagacccc 2100
aaagatctca tgttaagtgg agaaagggtt ttgcaaactg aaagatctgt agagagtagc 2160
agtatttcat tggtacctgg tactgattat ggcactcagg aaagtatctc gttactggaa 2220
gttagcactc tagggaaggc aaaaacagaa ccaaataaat gtgtgagtca gtgtgcagca 2280
tttgaaaacc ccaagggact aattcatggt tgttccaaag ataatagaaa tgacacagaa 2340
ggctttaagt atccattggg acatgaagtt aaccacagtc gggaaacaag catagaaatg 2400
gaagaaagtg aacttgatgc tcagtatttg cagaatacat tcaaggtttc aaagcgccag 2460
tcatttgctc cgttttcaaa tccaggaaat gcagaagagg aatgtgcaac attctctgcc 2520
cactctgggt ccttaaagaa acaaagtcca aaagtcactt ttgaatgtga acaaaaggaa 2580
gaaaatcaag gaaagaatga gtctaatatc aagcctgtac agacagttaa tatcactgca 2640
ggctttcctg tggttggtca gaaagataag ccagttgata atgccaaatg tagtatcaaa 2700
ggaggctcta ggttttgtct atcatctcag ttcagaggca acgaaactgg actcattact 2760
ccaaataaac atggactttt acaaaaccca tatcgtatac caccactttt tcccatcaag 2820
tcatttgtta aaactaaatg taagaaaaat ctgctagagg aaaactttga ggaacattca 2880
atgtcacctg aaagagaaat gggaaatgag aacattccaa gtacagtgag cacaattagc 2940
cgtaataaca ttagagaaaa tgtttttaaa gaagccagct caagcaatat taatgaagta 3000
ggttccagta ctaatgaagt gggctccagt attaatgaaa taggttccag tgatgaaaac 3060
attcaagcag aactaggtag aaacagaggg ccaaaattga atgctatgct tagattaggg 3120
gttttgcaac ctgaggtcta taaacaaagt cttcctggaa gtaattgtaa gcatcctgaa 3180
ataaaaaagc aagaatatga agaagtagtt cagactgtta atacagattt ctctccatat 3240
ctgatttcag ataacttaga acagcctatg ggaagtagtc atgcatctca ggtttgttct 3300
gagacacctg atgacctgtt agatgatggt gaaataaagg aagatactag ttttgctgaa 3360
aatgacatta aggaaagttc tgctgttttt agcaaaagcg tccagaaagg agagcttagc 3420
aggagtccta gccctttcac ccatacacat ttggctcagg gttaccgaag aggggccaag 3480
aaattagagt cctcagaaga gaacttatct agtgaggatg aagagcttcc ctgcttccaa 3540
cacttgttat ttggtaaagt aaacaatata ccttctcagt ctactaggca tagcaccgtt 3600
gctaccgagt gtctgtctaa gaacacagag gagaatttat tatcattgaa gaatagctta 3660
aatgactgca gtaaccaggt aatattggca aaggcatctc aggaacatca ccttagtgag 3720
gaaacaaaat gttctgctag cttgttttct tcacagtgca gtgaattgga agacttgact 3780
gcaaatacaa acacccagga tcctttcttg attggttctt ccaaacaaat gaggcatcag 3840
tctgaaagcc agggagttgg tctgagtgac aaggaattgg tttcagatga tgaagaaaga 3900
ggaacgggct tggaagaaaa taatcaagaa gagcaaagca tggattcaaa cttaggtgaa 3960
gcagcatctg ggtgtgagag tgaaacaagc gtctctgaag actgctcagg gctatcctct 4020
cagagtgaca ttttaaccac tcagcagagg gataccatgc aacataacct gataaagctc 4080
cagcaggaaa tggctgaact agaagctgtg ttagaacagc atgggagcca gccttctaac 4140
agctaccctt ccatcataag tgactcttct gcccttgagg acctgcgaaa tccagaacaa 4200
agcacatcag aaaaagcagt attaacttca cagaaaagta gtgaataccc tataagccag 4260
aatccagaag gcctttctgc tgacaagttt gaggtgtctg cagatagttc taccagtaaa 4320
aataaagaac caggagtgga aaggtcatcc ccttctaaat gcccatcatt agatgatagg 4380
tggtacatgc acagttgctc tgggagtctt cagaatagaa actacccatc tcaagaggag 4440
ctcattaagg ttgttgatgt ggaggagcaa cagctggaag agtctgggcc acacgatttg 4500
acggaaacat cttacttgcc aaggcaagat ctagagggaa ccccttacct ggaatctgga 4560
atcagcctct tctctgatga ccctgaatct gatccttctg aagacagagc cccagagtca 4620
gctcgtgttg gcaacatacc atcttcaacc tctgcattga aagttcccca attgaaagtt 4680
gcagaatctg cccagagtcc agctgctgct catactactg atactgctgg gtataatgca 4740
atggaagaaa gtgtgagcag ggagaagcca gaattgacag cttcaacaga aagggtcaac 4800
aaaagaatgt ccatggtggt gtctggcctg accccagaag aatttatgct cgtgtacaag 4860
tttgccagaa aacaccacat cactttaact aatctaatta ctgaagagac tactcatgtt 4920
gttatgaaaa cagatgctga gtttgtgtgt gaacggacac tgaaatattt tctaggaatt 4980
gcgggaggaa aatgggtagt tagctatttc tgggtgaccc agtctattaa agaaagaaaa 5040
atgctgaatg agcatgattt tgaagtcaga ggagatgtgg tcaatggaag aaaccaccaa 5100
ggtccaaagc gagcaagaga atcccaggac agaaagatct tcagggggct agaaatctgt 5160
tgctatgggc ccttcaccaa catgcccaca gatcaactgg aatggatggt acagctgtgt 5220
ggtgcttctg tggtgaagga gctttcatca ttcacccttg gcacaggtgt ccacccaatt 5280
gtggttgtgc agccagatgc ctggacagag gacaatggct tccatgcaat tgggcagatg 5340
tgtgaggcac ctgtggtgac ccgagagtgg gtgttggaca gtgtagcact ctaccagtgc 5400
caggagctgg acacctacct gataccccag atcccccaca gccactactg a 5451
<210> 17
<211> 1816
<212> PRT
<213> 智人(Homo sapiens)
<400> 17
Met Leu Lys Leu Leu Asn Gln Lys Lys Gly Pro Ser Gln Cys Pro Leu
1 5 10 15
Cys Lys Asn Asp Ile Thr Lys Arg Ser Leu Gln Glu Ser Thr Arg Phe
20 25 30
Ser Gln Leu Val Glu Glu Leu Leu Lys Ile Ile Cys Ala Phe Gln Leu
35 40 45
Asp Thr Gly Leu Glu Tyr Ala Asn Ser Tyr Asn Phe Ala Lys Lys Glu
50 55 60
Asn Asn Ser Pro Glu His Leu Lys Asp Glu Val Ser Ile Ile Gln Ser
65 70 75 80
Met Gly Tyr Arg Asn Arg Ala Lys Arg Leu Leu Gln Ser Glu Pro Glu
85 90 95
Asn Pro Ser Leu Gln Glu Thr Ser Leu Ser Val Gln Leu Ser Asn Leu
100 105 110
Gly Thr Val Arg Thr Leu Arg Thr Lys Gln Arg Ile Gln Pro Gln Lys
115 120 125
Thr Ser Val Tyr Ile Glu Leu Gly Ser Asp Ser Ser Glu Asp Thr Val
130 135 140
Asn Lys Ala Thr Tyr Cys Ser Val Gly Asp Gln Glu Leu Leu Gln Ile
145 150 155 160
Thr Pro Gln Gly Thr Arg Asp Glu Ile Ser Leu Asp Ser Ala Lys Lys
165 170 175
Ala Ala Cys Glu Phe Ser Glu Thr Asp Val Thr Asn Thr Glu His His
180 185 190
Gln Pro Ser Asn Asn Asp Leu Asn Thr Thr Glu Lys Arg Ala Ala Glu
195 200 205
Arg His Pro Glu Lys Tyr Gln Gly Ser Ser Val Ser Asn Leu His Val
210 215 220
Glu Pro Cys Gly Thr Asn Thr His Ala Ser Ser Leu Gln His Glu Asn
225 230 235 240
Ser Ser Leu Leu Leu Thr Lys Asp Arg Met Asn Val Glu Lys Ala Glu
245 250 255
Phe Cys Asn Lys Ser Lys Gln Pro Gly Leu Ala Arg Ser Gln His Asn
260 265 270
Arg Trp Ala Gly Ser Lys Glu Thr Cys Asn Asp Arg Arg Thr Pro Ser
275 280 285
Thr Glu Lys Lys Val Asp Leu Asn Ala Asp Pro Leu Cys Glu Arg Lys
290 295 300
Glu Trp Asn Lys Gln Lys Leu Pro Cys Ser Glu Asn Pro Arg Asp Thr
305 310 315 320
Glu Asp Val Pro Trp Ile Thr Leu Asn Ser Ser Ile Gln Lys Val Asn
325 330 335
Glu Trp Phe Ser Arg Ser Asp Glu Leu Leu Gly Ser Asp Asp Ser His
340 345 350
Asp Gly Glu Ser Glu Ser Asn Ala Lys Val Ala Asp Val Leu Asp Val
355 360 365
Leu Asn Glu Val Asp Glu Tyr Ser Gly Ser Ser Glu Lys Ile Asp Leu
370 375 380
Leu Ala Ser Asp Pro His Glu Ala Leu Ile Cys Lys Ser Glu Arg Val
385 390 395 400
His Ser Lys Ser Val Glu Ser Asn Ile Glu Asp Lys Ile Phe Gly Lys
405 410 415
Thr Tyr Arg Lys Lys Ala Ser Leu Pro Asn Leu Ser His Val Thr Glu
420 425 430
Asn Leu Ile Ile Gly Ala Phe Val Thr Glu Pro Gln Ile Ile Gln Glu
435 440 445
Arg Pro Leu Thr Asn Lys Leu Lys Arg Lys Arg Arg Pro Thr Ser Gly
450 455 460
Leu His Pro Glu Asp Phe Ile Lys Lys Ala Asp Leu Ala Val Gln Lys
465 470 475 480
Thr Pro Glu Met Ile Asn Gln Gly Thr Asn Gln Thr Glu Gln Asn Gly
485 490 495
Gln Val Met Asn Ile Thr Asn Ser Gly His Glu Asn Lys Thr Lys Gly
500 505 510
Asp Ser Ile Gln Asn Glu Lys Asn Pro Asn Pro Ile Glu Ser Leu Glu
515 520 525
Lys Glu Ser Ala Phe Lys Thr Lys Ala Glu Pro Ile Ser Ser Ser Ile
530 535 540
Ser Asn Met Glu Leu Glu Leu Asn Ile His Asn Ser Lys Ala Pro Lys
545 550 555 560
Lys Asn Arg Leu Arg Arg Lys Ser Ser Thr Arg His Ile His Ala Leu
565 570 575
Glu Leu Val Val Ser Arg Asn Leu Ser Pro Pro Asn Cys Thr Glu Leu
580 585 590
Gln Ile Asp Ser Cys Ser Ser Ser Glu Glu Ile Lys Lys Lys Lys Tyr
595 600 605
Asn Gln Met Pro Val Arg His Ser Arg Asn Leu Gln Leu Met Glu Gly
610 615 620
Lys Glu Pro Ala Thr Gly Ala Lys Lys Ser Asn Lys Pro Asn Glu Gln
625 630 635 640
Thr Ser Lys Arg His Asp Ser Asp Thr Phe Pro Glu Leu Lys Leu Thr
645 650 655
Asn Ala Pro Gly Ser Phe Thr Lys Cys Ser Asn Thr Ser Glu Leu Lys
660 665 670
Glu Phe Val Asn Pro Ser Leu Pro Arg Glu Glu Lys Glu Glu Lys Leu
675 680 685
Glu Thr Val Lys Val Ser Asn Asn Ala Glu Asp Pro Lys Asp Leu Met
690 695 700
Leu Ser Gly Glu Arg Val Leu Gln Thr Glu Arg Ser Val Glu Ser Ser
705 710 715 720
Ser Ile Ser Leu Val Pro Gly Thr Asp Tyr Gly Thr Gln Glu Ser Ile
725 730 735
Ser Leu Leu Glu Val Ser Thr Leu Gly Lys Ala Lys Thr Glu Pro Asn
740 745 750
Lys Cys Val Ser Gln Cys Ala Ala Phe Glu Asn Pro Lys Gly Leu Ile
755 760 765
His Gly Cys Ser Lys Asp Asn Arg Asn Asp Thr Glu Gly Phe Lys Tyr
770 775 780
Pro Leu Gly His Glu Val Asn His Ser Arg Glu Thr Ser Ile Glu Met
785 790 795 800
Glu Glu Ser Glu Leu Asp Ala Gln Tyr Leu Gln Asn Thr Phe Lys Val
805 810 815
Ser Lys Arg Gln Ser Phe Ala Pro Phe Ser Asn Pro Gly Asn Ala Glu
820 825 830
Glu Glu Cys Ala Thr Phe Ser Ala His Ser Gly Ser Leu Lys Lys Gln
835 840 845
Ser Pro Lys Val Thr Phe Glu Cys Glu Gln Lys Glu Glu Asn Gln Gly
850 855 860
Lys Asn Glu Ser Asn Ile Lys Pro Val Gln Thr Val Asn Ile Thr Ala
865 870 875 880
Gly Phe Pro Val Val Gly Gln Lys Asp Lys Pro Val Asp Asn Ala Lys
885 890 895
Cys Ser Ile Lys Gly Gly Ser Arg Phe Cys Leu Ser Ser Gln Phe Arg
900 905 910
Gly Asn Glu Thr Gly Leu Ile Thr Pro Asn Lys His Gly Leu Leu Gln
915 920 925
Asn Pro Tyr Arg Ile Pro Pro Leu Phe Pro Ile Lys Ser Phe Val Lys
930 935 940
Thr Lys Cys Lys Lys Asn Leu Leu Glu Glu Asn Phe Glu Glu His Ser
945 950 955 960
Met Ser Pro Glu Arg Glu Met Gly Asn Glu Asn Ile Pro Ser Thr Val
965 970 975
Ser Thr Ile Ser Arg Asn Asn Ile Arg Glu Asn Val Phe Lys Glu Ala
980 985 990
Ser Ser Ser Asn Ile Asn Glu Val Gly Ser Ser Thr Asn Glu Val Gly
995 1000 1005
Ser Ser Ile Asn Glu Ile Gly Ser Ser Asp Glu Asn Ile Gln Ala
1010 1015 1020
Glu Leu Gly Arg Asn Arg Gly Pro Lys Leu Asn Ala Met Leu Arg
1025 1030 1035
Leu Gly Val Leu Gln Pro Glu Val Tyr Lys Gln Ser Leu Pro Gly
1040 1045 1050
Ser Asn Cys Lys His Pro Glu Ile Lys Lys Gln Glu Tyr Glu Glu
1055 1060 1065
Val Val Gln Thr Val Asn Thr Asp Phe Ser Pro Tyr Leu Ile Ser
1070 1075 1080
Asp Asn Leu Glu Gln Pro Met Gly Ser Ser His Ala Ser Gln Val
1085 1090 1095
Cys Ser Glu Thr Pro Asp Asp Leu Leu Asp Asp Gly Glu Ile Lys
1100 1105 1110
Glu Asp Thr Ser Phe Ala Glu Asn Asp Ile Lys Glu Ser Ser Ala
1115 1120 1125
Val Phe Ser Lys Ser Val Gln Lys Gly Glu Leu Ser Arg Ser Pro
1130 1135 1140
Ser Pro Phe Thr His Thr His Leu Ala Gln Gly Tyr Arg Arg Gly
1145 1150 1155
Ala Lys Lys Leu Glu Ser Ser Glu Glu Asn Leu Ser Ser Glu Asp
1160 1165 1170
Glu Glu Leu Pro Cys Phe Gln His Leu Leu Phe Gly Lys Val Asn
1175 1180 1185
Asn Ile Pro Ser Gln Ser Thr Arg His Ser Thr Val Ala Thr Glu
1190 1195 1200
Cys Leu Ser Lys Asn Thr Glu Glu Asn Leu Leu Ser Leu Lys Asn
1205 1210 1215
Ser Leu Asn Asp Cys Ser Asn Gln Val Ile Leu Ala Lys Ala Ser
1220 1225 1230
Gln Glu His His Leu Ser Glu Glu Thr Lys Cys Ser Ala Ser Leu
1235 1240 1245
Phe Ser Ser Gln Cys Ser Glu Leu Glu Asp Leu Thr Ala Asn Thr
1250 1255 1260
Asn Thr Gln Asp Pro Phe Leu Ile Gly Ser Ser Lys Gln Met Arg
1265 1270 1275
His Gln Ser Glu Ser Gln Gly Val Gly Leu Ser Asp Lys Glu Leu
1280 1285 1290
Val Ser Asp Asp Glu Glu Arg Gly Thr Gly Leu Glu Glu Asn Asn
1295 1300 1305
Gln Glu Glu Gln Ser Met Asp Ser Asn Leu Gly Glu Ala Ala Ser
1310 1315 1320
Gly Cys Glu Ser Glu Thr Ser Val Ser Glu Asp Cys Ser Gly Leu
1325 1330 1335
Ser Ser Gln Ser Asp Ile Leu Thr Thr Gln Gln Arg Asp Thr Met
1340 1345 1350
Gln His Asn Leu Ile Lys Leu Gln Gln Glu Met Ala Glu Leu Glu
1355 1360 1365
Ala Val Leu Glu Gln His Gly Ser Gln Pro Ser Asn Ser Tyr Pro
1370 1375 1380
Ser Ile Ile Ser Asp Ser Ser Ala Leu Glu Asp Leu Arg Asn Pro
1385 1390 1395
Glu Gln Ser Thr Ser Glu Lys Ala Val Leu Thr Ser Gln Lys Ser
1400 1405 1410
Ser Glu Tyr Pro Ile Ser Gln Asn Pro Glu Gly Leu Ser Ala Asp
1415 1420 1425
Lys Phe Glu Val Ser Ala Asp Ser Ser Thr Ser Lys Asn Lys Glu
1430 1435 1440
Pro Gly Val Glu Arg Ser Ser Pro Ser Lys Cys Pro Ser Leu Asp
1445 1450 1455
Asp Arg Trp Tyr Met His Ser Cys Ser Gly Ser Leu Gln Asn Arg
1460 1465 1470
Asn Tyr Pro Ser Gln Glu Glu Leu Ile Lys Val Val Asp Val Glu
1475 1480 1485
Glu Gln Gln Leu Glu Glu Ser Gly Pro His Asp Leu Thr Glu Thr
1490 1495 1500
Ser Tyr Leu Pro Arg Gln Asp Leu Glu Gly Thr Pro Tyr Leu Glu
1505 1510 1515
Ser Gly Ile Ser Leu Phe Ser Asp Asp Pro Glu Ser Asp Pro Ser
1520 1525 1530
Glu Asp Arg Ala Pro Glu Ser Ala Arg Val Gly Asn Ile Pro Ser
1535 1540 1545
Ser Thr Ser Ala Leu Lys Val Pro Gln Leu Lys Val Ala Glu Ser
1550 1555 1560
Ala Gln Ser Pro Ala Ala Ala His Thr Thr Asp Thr Ala Gly Tyr
1565 1570 1575
Asn Ala Met Glu Glu Ser Val Ser Arg Glu Lys Pro Glu Leu Thr
1580 1585 1590
Ala Ser Thr Glu Arg Val Asn Lys Arg Met Ser Met Val Val Ser
1595 1600 1605
Gly Leu Thr Pro Glu Glu Phe Met Leu Val Tyr Lys Phe Ala Arg
1610 1615 1620
Lys His His Ile Thr Leu Thr Asn Leu Ile Thr Glu Glu Thr Thr
1625 1630 1635
His Val Val Met Lys Thr Asp Ala Glu Phe Val Cys Glu Arg Thr
1640 1645 1650
Leu Lys Tyr Phe Leu Gly Ile Ala Gly Gly Lys Trp Val Val Ser
1655 1660 1665
Tyr Phe Trp Val Thr Gln Ser Ile Lys Glu Arg Lys Met Leu Asn
1670 1675 1680
Glu His Asp Phe Glu Val Arg Gly Asp Val Val Asn Gly Arg Asn
1685 1690 1695
His Gln Gly Pro Lys Arg Ala Arg Glu Ser Gln Asp Arg Lys Ile
1700 1705 1710
Phe Arg Gly Leu Glu Ile Cys Cys Tyr Gly Pro Phe Thr Asn Met
1715 1720 1725
Pro Thr Asp Gln Leu Glu Trp Met Val Gln Leu Cys Gly Ala Ser
1730 1735 1740
Val Val Lys Glu Leu Ser Ser Phe Thr Leu Gly Thr Gly Val His
1745 1750 1755
Pro Ile Val Val Val Gln Pro Asp Ala Trp Thr Glu Asp Asn Gly
1760 1765 1770
Phe His Ala Ile Gly Gln Met Cys Glu Ala Pro Val Val Thr Arg
1775 1780 1785
Glu Trp Val Leu Asp Ser Val Ala Leu Tyr Gln Cys Gln Glu Leu
1790 1795 1800
Asp Thr Tyr Leu Ile Pro Gln Ile Pro His Ser His Tyr
1805 1810 1815
<210> 18
<211> 2280
<212> DNA
<213> 智人(Homo sapiens)
<400> 18
atggatttat ctgctcttcg cgttgaagaa gtacaaaatg tcattaatgc tatgcagaaa 60
atcttagagt gtcccatctg tctggagttg atcaaggaac ctgtctccac aaagtgtgac 120
cacatatttt gcaaattttg catgctgaaa cttctcaacc agaagaaagg gccttcacag 180
tgtcctttat gtaagaatga tataaccaaa aggagcctac aagaaagtac gagatttagt 240
caacttgttg aagagctatt gaaaatcatt tgtgcttttc agcttgacac aggtttggag 300
tatgcaaaca gctataattt tgcaaaaaag gaaaataact ctcctgaaca tctaaaagat 360
gaagtttcta tcatccaaag tatgggctac agaaaccgtg ccaaaagact tctacagagt 420
gaacccgaaa atccttcctt gcaggaaacc agtctcagtg tccaactctc taaccttgga 480
actgtgagaa ctctgaggac aaagcagcgg atacaacctc aaaagacgtc tgtctacatt 540
gaattgggat ctgattcttc tgaagatacc gttaataagg caacttattg cagtgtggga 600
gatcaagaat tgttacaaat cacccctcaa ggaaccaggg atgaaatcag tttggattct 660
gcaaaaaagg ctgcttgtga attttctgag acggatgtaa caaatactga acatcatcaa 720
cccagtaata atgatttgaa caccactgag aagcgtgcag ctgagaggca tccagaaaag 780
tatcagggtg aagcagcatc tgggtgtgag agtgaaacaa gcgtctctga agactgctca 840
gggctatcct ctcagagtga cattttaacc actcagcaga gggataccat gcaacataac 900
ctgataaagc tccagcagga aatggctgaa ctagaagctg tgttagaaca gcatgggagc 960
cagccttcta acagctaccc ttccatcata agtgactctt ctgcccttga ggacctgcga 1020
aatccagaac aaagcacatc agaaaaagta ttaacttcac agaaaagtag tgaataccct 1080
ataagccaga atccagaagg cctttctgct gacaagtttg aggtgtctgc agatagttct 1140
accagtaaaa ataaagaacc aggagtggaa aggtcatccc cttctaaatg cccatcatta 1200
gatgataggt ggtacatgca cagttgctct gggagtcttc agaatagaaa ctacccatct 1260
caagaggagc tcattaaggt tgttgatgtg gaggagcaac agctggaaga gtctgggcca 1320
cacgatttga cggaaacatc ttacttgcca aggcaagatc tagagggaac cccttacctg 1380
gaatctggaa tcagcctctt ctctgatgac cctgaatctg atccttctga agacagagcc 1440
ccagagtcag ctcgtgttgg caacatacca tcttcaacct ctgcattgaa agttccccaa 1500
ttgaaagttg cagaatctgc ccagagtcca gctgctgctc atactactga tactgctggg 1560
tataatgcaa tggaagaaag tgtgagcagg gagaagccag aattgacagc ttcaacagaa 1620
agggtcaaca aaagaatgtc catggtggtg tctggcctga ccccagaaga atttatgctc 1680
gtgtacaagt ttgccagaaa acaccacatc actttaacta atctaattac tgaagagact 1740
actcatgttg ttatgaaaac agatgctgag tttgtgtgtg aacggacact gaaatatttt 1800
ctaggaattg cgggaggaaa atgggtagtt agctatttct gggtgaccca gtctattaaa 1860
gaaagaaaaa tgctgaatga gcatgatttt gaagtcagag gagatgtggt caatggaaga 1920
aaccaccaag gtccaaagcg agcaagagaa tcccaggaca gaaagatctt cagggggcta 1980
gaaatctgtt gctatgggcc cttcaccaac atgcccacag atcaactgga atggatggta 2040
cagctgtgtg gtgcttctgt ggtgaaggag ctttcatcat tcacccttgg cacaggtgtc 2100
cacccaattg tggttgtgca gccagatgcc tggacagagg acaatggctt ccatgcaatt 2160
gggcagatgt gtgaggcacc tgtggtgacc cgagagtggg tgttggacag tgtagcactc 2220
taccagtgcc aggagctgga cacctacctg ataccccaga tcccccacag ccactactga 2280
<210> 19
<211> 759
<212> PRT
<213> 智人(Homo sapiens)
<400> 19
Met Asp Leu Ser Ala Leu Arg Val Glu Glu Val Gln Asn Val Ile Asn
1 5 10 15
Ala Met Gln Lys Ile Leu Glu Cys Pro Ile Cys Leu Glu Leu Ile Lys
20 25 30
Glu Pro Val Ser Thr Lys Cys Asp His Ile Phe Cys Lys Phe Cys Met
35 40 45
Leu Lys Leu Leu Asn Gln Lys Lys Gly Pro Ser Gln Cys Pro Leu Cys
50 55 60
Lys Asn Asp Ile Thr Lys Arg Ser Leu Gln Glu Ser Thr Arg Phe Ser
65 70 75 80
Gln Leu Val Glu Glu Leu Leu Lys Ile Ile Cys Ala Phe Gln Leu Asp
85 90 95
Thr Gly Leu Glu Tyr Ala Asn Ser Tyr Asn Phe Ala Lys Lys Glu Asn
100 105 110
Asn Ser Pro Glu His Leu Lys Asp Glu Val Ser Ile Ile Gln Ser Met
115 120 125
Gly Tyr Arg Asn Arg Ala Lys Arg Leu Leu Gln Ser Glu Pro Glu Asn
130 135 140
Pro Ser Leu Gln Glu Thr Ser Leu Ser Val Gln Leu Ser Asn Leu Gly
145 150 155 160
Thr Val Arg Thr Leu Arg Thr Lys Gln Arg Ile Gln Pro Gln Lys Thr
165 170 175
Ser Val Tyr Ile Glu Leu Gly Ser Asp Ser Ser Glu Asp Thr Val Asn
180 185 190
Lys Ala Thr Tyr Cys Ser Val Gly Asp Gln Glu Leu Leu Gln Ile Thr
195 200 205
Pro Gln Gly Thr Arg Asp Glu Ile Ser Leu Asp Ser Ala Lys Lys Ala
210 215 220
Ala Cys Glu Phe Ser Glu Thr Asp Val Thr Asn Thr Glu His His Gln
225 230 235 240
Pro Ser Asn Asn Asp Leu Asn Thr Thr Glu Lys Arg Ala Ala Glu Arg
245 250 255
His Pro Glu Lys Tyr Gln Gly Glu Ala Ala Ser Gly Cys Glu Ser Glu
260 265 270
Thr Ser Val Ser Glu Asp Cys Ser Gly Leu Ser Ser Gln Ser Asp Ile
275 280 285
Leu Thr Thr Gln Gln Arg Asp Thr Met Gln His Asn Leu Ile Lys Leu
290 295 300
Gln Gln Glu Met Ala Glu Leu Glu Ala Val Leu Glu Gln His Gly Ser
305 310 315 320
Gln Pro Ser Asn Ser Tyr Pro Ser Ile Ile Ser Asp Ser Ser Ala Leu
325 330 335
Glu Asp Leu Arg Asn Pro Glu Gln Ser Thr Ser Glu Lys Val Leu Thr
340 345 350
Ser Gln Lys Ser Ser Glu Tyr Pro Ile Ser Gln Asn Pro Glu Gly Leu
355 360 365
Ser Ala Asp Lys Phe Glu Val Ser Ala Asp Ser Ser Thr Ser Lys Asn
370 375 380
Lys Glu Pro Gly Val Glu Arg Ser Ser Pro Ser Lys Cys Pro Ser Leu
385 390 395 400
Asp Asp Arg Trp Tyr Met His Ser Cys Ser Gly Ser Leu Gln Asn Arg
405 410 415
Asn Tyr Pro Ser Gln Glu Glu Leu Ile Lys Val Val Asp Val Glu Glu
420 425 430
Gln Gln Leu Glu Glu Ser Gly Pro His Asp Leu Thr Glu Thr Ser Tyr
435 440 445
Leu Pro Arg Gln Asp Leu Glu Gly Thr Pro Tyr Leu Glu Ser Gly Ile
450 455 460
Ser Leu Phe Ser Asp Asp Pro Glu Ser Asp Pro Ser Glu Asp Arg Ala
465 470 475 480
Pro Glu Ser Ala Arg Val Gly Asn Ile Pro Ser Ser Thr Ser Ala Leu
485 490 495
Lys Val Pro Gln Leu Lys Val Ala Glu Ser Ala Gln Ser Pro Ala Ala
500 505 510
Ala His Thr Thr Asp Thr Ala Gly Tyr Asn Ala Met Glu Glu Ser Val
515 520 525
Ser Arg Glu Lys Pro Glu Leu Thr Ala Ser Thr Glu Arg Val Asn Lys
530 535 540
Arg Met Ser Met Val Val Ser Gly Leu Thr Pro Glu Glu Phe Met Leu
545 550 555 560
Val Tyr Lys Phe Ala Arg Lys His His Ile Thr Leu Thr Asn Leu Ile
565 570 575
Thr Glu Glu Thr Thr His Val Val Met Lys Thr Asp Ala Glu Phe Val
580 585 590
Cys Glu Arg Thr Leu Lys Tyr Phe Leu Gly Ile Ala Gly Gly Lys Trp
595 600 605
Val Val Ser Tyr Phe Trp Val Thr Gln Ser Ile Lys Glu Arg Lys Met
610 615 620
Leu Asn Glu His Asp Phe Glu Val Arg Gly Asp Val Val Asn Gly Arg
625 630 635 640
Asn His Gln Gly Pro Lys Arg Ala Arg Glu Ser Gln Asp Arg Lys Ile
645 650 655
Phe Arg Gly Leu Glu Ile Cys Cys Tyr Gly Pro Phe Thr Asn Met Pro
660 665 670
Thr Asp Gln Leu Glu Trp Met Val Gln Leu Cys Gly Ala Ser Val Val
675 680 685
Lys Glu Leu Ser Ser Phe Thr Leu Gly Thr Gly Val His Pro Ile Val
690 695 700
Val Val Gln Pro Asp Ala Trp Thr Glu Asp Asn Gly Phe His Ala Ile
705 710 715 720
Gly Gln Met Cys Glu Ala Pro Val Val Thr Arg Glu Trp Val Leu Asp
725 730 735
Ser Val Ala Leu Tyr Gln Cys Gln Glu Leu Asp Thr Tyr Leu Ile Pro
740 745 750
Gln Ile Pro His Ser His Tyr
755
<210> 20
<211> 2100
<212> DNA
<213> 智人(Homo sapiens)
<400> 20
atggatttat ctgctcttcg cgttgaagaa gtacaaaatg tcattaatgc tatgcagaaa 60
atcttagagt gtcccatctg tctggagttg atcaaggaac ctgtctccac aaagtgtgac 120
cacatatttt gcaaattttg catgctgaaa cttctcaacc agaagaaagg gccttcacag 180
tgtcctttat gtaagaatga tataaccaaa aggagcctac aagaaagtac gagatttagt 240
caacttgttg aagagctatt gaaaatcatt tgtgcttttc agcttgacac aggtttggag 300
tatgcaaaca gctataattt tgcaaaaaag gaaaataact ctcctgaaca tctaaaagat 360
gaagtttcta tcatccaaag tatgggctac agaaaccgtg ccaaaagact tctacagagt 420
gaacccgaaa atccttcctt gcaggaaacc agtctcagtg tccaactctc taaccttgga 480
actgtgagaa ctctgaggac aaagcagcgg atacaacctc aaaagacgtc tgtctacatt 540
gaattgggat ctgattcttc tgaagatacc gttaataagg caacttattg cagtgtggga 600
gatcaagaat tgttacaaat cacccctcaa ggaaccaggg atgaaatcag tttggattct 660
gcaaaaaagg ctgcttgtga attttctgag acggatgtaa caaatactga acatcatcaa 720
cccagtaata atgatttgaa caccactgag aagcgtgcag ctgagaggca tccagaaaag 780
tatcagggtg aagcagcatc tgggtgtgag agtgaaacaa gcgtctctga agactgctca 840
gggctatcct ctcagagtga cattttaacc actcagcaga gggataccat gcaacataac 900
ctgataaagc tccagcagga aatggctgaa ctagaagctg tgttagaaca gcatgggagc 960
cagccttcta acagctaccc ttccatcata agtgactctt ctgcccttga ggacctgcga 1020
aatccagaac aaagcacatc agaaaaagta ttaacttcac agaaaagtag tgaataccct 1080
ataagccaga atccagaagg cctttctgct gacaagtttg aggtgtctgc agatagttct 1140
accagtaaaa ataaagaacc aggagtggaa aggtcatccc cttctaaatg cccatcatta 1200
gatgataggt ggtacatgca cagttgctct gggagtcttc agaatagaaa ctacccatct 1260
caagaggagc tcattaaggt tgttgatgtg gaggagcaac agctggaaga gtctgggcca 1320
cacgatttga cggaaacatc ttacttgcca aggcaagatc tagagggaac cccttacctg 1380
gaatctggaa tcagcctctt ctctgatgac cctgaatctg atccttctga agacagagcc 1440
ccagagtcag ctcgtgttgg caacatacca tcttcaacct ctgcattgaa agttccccaa 1500
ttgaaagttg cagaatctgc ccagagtcca gctgctgctc atactactga tactgctggg 1560
tataatgcaa tggaagaaag tgtgagcagg gagaagccag aattgacagc ttcaacagaa 1620
agggtcaaca aaagaatgtc catggtggtg tctggcctga ccccagaaga atttatgctc 1680
gtgtacaagt ttgccagaaa acaccacatc actttaacta atctaattac tgaagagact 1740
actcatgttg ttatgaaaac agatgctgag tttgtgtgtg aacggacact gaaatatttt 1800
ctaggaattg cgggaggaaa atgggtagtt agctatttct gggtgaccca gtctattaaa 1860
gaaagaaaaa tgctgaatga gcatgatttt gaagtcagag gagatgtggt caatggaaga 1920
aaccaccaag gtccaaagcg agcaagagaa tcccaggaca gaaagatctt cagggggcta 1980
gaaatctgtt gctatgggcc cttcaccaac atgcccacag ggtgtccacc caattgtggt 2040
tgtgcagcca gatgcctgga cagaggacaa tggcttccat gcaattgggc agatgtgtga 2100
<210> 21
<211> 699
<212> PRT
<213> 智人(Homo sapiens)
<400> 21
Met Asp Leu Ser Ala Leu Arg Val Glu Glu Val Gln Asn Val Ile Asn
1 5 10 15
Ala Met Gln Lys Ile Leu Glu Cys Pro Ile Cys Leu Glu Leu Ile Lys
20 25 30
Glu Pro Val Ser Thr Lys Cys Asp His Ile Phe Cys Lys Phe Cys Met
35 40 45
Leu Lys Leu Leu Asn Gln Lys Lys Gly Pro Ser Gln Cys Pro Leu Cys
50 55 60
Lys Asn Asp Ile Thr Lys Arg Ser Leu Gln Glu Ser Thr Arg Phe Ser
65 70 75 80
Gln Leu Val Glu Glu Leu Leu Lys Ile Ile Cys Ala Phe Gln Leu Asp
85 90 95
Thr Gly Leu Glu Tyr Ala Asn Ser Tyr Asn Phe Ala Lys Lys Glu Asn
100 105 110
Asn Ser Pro Glu His Leu Lys Asp Glu Val Ser Ile Ile Gln Ser Met
115 120 125
Gly Tyr Arg Asn Arg Ala Lys Arg Leu Leu Gln Ser Glu Pro Glu Asn
130 135 140
Pro Ser Leu Gln Glu Thr Ser Leu Ser Val Gln Leu Ser Asn Leu Gly
145 150 155 160
Thr Val Arg Thr Leu Arg Thr Lys Gln Arg Ile Gln Pro Gln Lys Thr
165 170 175
Ser Val Tyr Ile Glu Leu Gly Ser Asp Ser Ser Glu Asp Thr Val Asn
180 185 190
Lys Ala Thr Tyr Cys Ser Val Gly Asp Gln Glu Leu Leu Gln Ile Thr
195 200 205
Pro Gln Gly Thr Arg Asp Glu Ile Ser Leu Asp Ser Ala Lys Lys Ala
210 215 220
Ala Cys Glu Phe Ser Glu Thr Asp Val Thr Asn Thr Glu His His Gln
225 230 235 240
Pro Ser Asn Asn Asp Leu Asn Thr Thr Glu Lys Arg Ala Ala Glu Arg
245 250 255
His Pro Glu Lys Tyr Gln Gly Glu Ala Ala Ser Gly Cys Glu Ser Glu
260 265 270
Thr Ser Val Ser Glu Asp Cys Ser Gly Leu Ser Ser Gln Ser Asp Ile
275 280 285
Leu Thr Thr Gln Gln Arg Asp Thr Met Gln His Asn Leu Ile Lys Leu
290 295 300
Gln Gln Glu Met Ala Glu Leu Glu Ala Val Leu Glu Gln His Gly Ser
305 310 315 320
Gln Pro Ser Asn Ser Tyr Pro Ser Ile Ile Ser Asp Ser Ser Ala Leu
325 330 335
Glu Asp Leu Arg Asn Pro Glu Gln Ser Thr Ser Glu Lys Val Leu Thr
340 345 350
Ser Gln Lys Ser Ser Glu Tyr Pro Ile Ser Gln Asn Pro Glu Gly Leu
355 360 365
Ser Ala Asp Lys Phe Glu Val Ser Ala Asp Ser Ser Thr Ser Lys Asn
370 375 380
Lys Glu Pro Gly Val Glu Arg Ser Ser Pro Ser Lys Cys Pro Ser Leu
385 390 395 400
Asp Asp Arg Trp Tyr Met His Ser Cys Ser Gly Ser Leu Gln Asn Arg
405 410 415
Asn Tyr Pro Ser Gln Glu Glu Leu Ile Lys Val Val Asp Val Glu Glu
420 425 430
Gln Gln Leu Glu Glu Ser Gly Pro His Asp Leu Thr Glu Thr Ser Tyr
435 440 445
Leu Pro Arg Gln Asp Leu Glu Gly Thr Pro Tyr Leu Glu Ser Gly Ile
450 455 460
Ser Leu Phe Ser Asp Asp Pro Glu Ser Asp Pro Ser Glu Asp Arg Ala
465 470 475 480
Pro Glu Ser Ala Arg Val Gly Asn Ile Pro Ser Ser Thr Ser Ala Leu
485 490 495
Lys Val Pro Gln Leu Lys Val Ala Glu Ser Ala Gln Ser Pro Ala Ala
500 505 510
Ala His Thr Thr Asp Thr Ala Gly Tyr Asn Ala Met Glu Glu Ser Val
515 520 525
Ser Arg Glu Lys Pro Glu Leu Thr Ala Ser Thr Glu Arg Val Asn Lys
530 535 540
Arg Met Ser Met Val Val Ser Gly Leu Thr Pro Glu Glu Phe Met Leu
545 550 555 560
Val Tyr Lys Phe Ala Arg Lys His His Ile Thr Leu Thr Asn Leu Ile
565 570 575
Thr Glu Glu Thr Thr His Val Val Met Lys Thr Asp Ala Glu Phe Val
580 585 590
Cys Glu Arg Thr Leu Lys Tyr Phe Leu Gly Ile Ala Gly Gly Lys Trp
595 600 605
Val Val Ser Tyr Phe Trp Val Thr Gln Ser Ile Lys Glu Arg Lys Met
610 615 620
Leu Asn Glu His Asp Phe Glu Val Arg Gly Asp Val Val Asn Gly Arg
625 630 635 640
Asn His Gln Gly Pro Lys Arg Ala Arg Glu Ser Gln Asp Arg Lys Ile
645 650 655
Phe Arg Gly Leu Glu Ile Cys Cys Tyr Gly Pro Phe Thr Asn Met Pro
660 665 670
Thr Gly Cys Pro Pro Asn Cys Gly Cys Ala Ala Arg Cys Leu Asp Arg
675 680 685
Gly Gln Trp Leu Pro Cys Asn Trp Ala Asp Val
690 695
<210> 22
<211> 5655
<212> DNA
<213> 智人(Homo sapiens)
<400> 22
atggatttat ctgctcttcg cgttgaagaa gtacaaaatg tcattaatgc tatgcagaaa 60
atcttagagt gtcccatctg tctggagttg atcaaggaac ctgtctccac aaagtgtgac 120
cacatatttt gcaaattttg catgctgaaa cttctcaacc agaagaaagg gccttcacag 180
tgtcctttat gtaagaatga tataaccaaa aggagcctac aagaaagtac gagatttagt 240
caacttgttg aagagctatt gaaaatcatt tgtgcttttc agcttgacac aggtttggag 300
tatgcaaaca gctataattt tgcaaaaaag gaaaataact ctcctgaaca tctaaaagat 360
gaagtttcta tcatccaaag tatgggctac agaaaccgtg ccaaaagact tctacagagt 420
gaacccgaaa atccttcctt gcaggaaacc agtctcagtg tccaactctc taaccttgga 480
actgtgagaa ctctgaggac aaagcagcgg atacaacctc aaaagacgtc tgtctacatt 540
gaattgggat ctgattcttc tgaagatacc gttaataagg caacttattg cagtgtggga 600
gatcaagaat tgttacaaat cacccctcaa ggaaccaggg atgaaatcag tttggattct 660
gcaaaaaagg ctgcttgtga attttctgag acggatgtaa caaatactga acatcatcaa 720
cccagtaata atgatttgaa caccactgag aagcgtgcag ctgagaggca tccagaaaag 780
tatcagggta gttctgtttc aaacttgcat gtggagccat gtggcacaaa tactcatgcc 840
agctcattac agcatgagaa cagcagttta ttactcacta aagacagaat gaatgtagaa 900
aaggctgaat tctgtaataa aagcaaacag cctggcttag caaggagcca acataacaga 960
tgggctggaa gtaaggaaac atgtaatgat aggcggactc ccagcacaga aaaaaaggta 1020
gatctgaatg ctgatcccct gtgtgagaga aaagaatgga ataagcagaa actgccatgc 1080
tcagagaatc ctagagatac tgaagatgtt ccttggataa cactaaatag cagcattcag 1140
aaagttaatg agtggttttc cagaagtgat gaactgttag gttctgatga ctcacatgat 1200
ggggagtctg aatcaaatgc caaagtagct gatgtattgg acgttctaaa tgaggtagat 1260
gaatattctg gttcttcaga gaaaatagac ttactggcca gtgatcctca tgaggcttta 1320
atatgtaaaa gtgaaagagt tcactccaaa tcagtagaga gtaatattga agacaaaata 1380
tttgggaaaa cctatcggaa gaaggcaagc ctccccaact taagccatgt aactgaaaat 1440
ctaattatag gagcatttgt tactgagcca cagataatac aagagcgtcc cctcacaaat 1500
aaattaaagc gtaaaaggag acctacatca ggccttcatc ctgaggattt tatcaagaaa 1560
gcagatttgg cagttcaaaa gactcctgaa atgataaatc agggaactaa ccaaacggag 1620
cagaatggtc aagtgatgaa tattactaat agtggtcatg agaataaaac aaaaggtgat 1680
tctattcaga atgagaaaaa tcctaaccca atagaatcac tcgaaaaaga atctgctttc 1740
aaaacgaaag ctgaacctat aagcagcagt ataagcaata tggaactcga attaaatatc 1800
cacaattcaa aagcacctaa aaagaatagg ctgaggagga agtcttctac caggcatatt 1860
catgcgcttg aactagtagt cagtagaaat ctaagcccac ctaattgtac tgaattgcaa 1920
attgatagtt gttctagcag tgaagagata aagaaaaaaa agtacaacca aatgccagtc 1980
aggcacagca gaaacctaca actcatggaa ggtaaagaac ctgcaactgg agccaagaag 2040
agtaacaagc caaatgaaca gacaagtaaa agacatgaca gcgatacttt cccagagctg 2100
aagttaacaa atgcacctgg ttcttttact aagtgttcaa ataccagtga acttaaagaa 2160
tttgtcaatc ctagccttcc aagagaagaa aaagaagaga aactagaaac agttaaagtg 2220
tctaataatg ctgaagaccc caaagatctc atgttaagtg gagaaagggt tttgcaaact 2280
gaaagatctg tagagagtag cagtatttca ttggtacctg gtactgatta tggcactcag 2340
gaaagtatct cgttactgga agttagcact ctagggaagg caaaaacaga accaaataaa 2400
tgtgtgagtc agtgtgcagc atttgaaaac cccaagggac taattcatgg ttgttccaaa 2460
gataatagaa atgacacaga aggctttaag tatccattgg gacatgaagt taaccacagt 2520
cgggaaacaa gcatagaaat ggaagaaagt gaacttgatg ctcagtattt gcagaataca 2580
ttcaaggttt caaagcgcca gtcatttgct ccgttttcaa atccaggaaa tgcagaagag 2640
gaatgtgcaa cattctctgc ccactctggg tccttaaaga aacaaagtcc aaaagtcact 2700
tttgaatgtg aacaaaagga agaaaatcaa ggaaagaatg agtctaatat caagcctgta 2760
cagacagtta atatcactgc aggctttcct gtggttggtc agaaagataa gccagttgat 2820
aatgccaaat gtagtatcaa aggaggctct aggttttgtc tatcatctca gttcagaggc 2880
aacgaaactg gactcattac tccaaataaa catggacttt tacaaaaccc atatcgtata 2940
ccaccacttt ttcccatcaa gtcatttgtt aaaactaaat gtaagaaaaa tctgctagag 3000
gaaaactttg aggaacattc aatgtcacct gaaagagaaa tgggaaatga gaacattcca 3060
agtacagtga gcacaattag ccgtaataac attagagaaa atgtttttaa agaagccagc 3120
tcaagcaata ttaatgaagt aggttccagt actaatgaag tgggctccag tattaatgaa 3180
ataggttcca gtgatgaaaa cattcaagca gaactaggta gaaacagagg gccaaaattg 3240
aatgctatgc ttagattagg ggttttgcaa cctgaggtct ataaacaaag tcttcctgga 3300
agtaattgta agcatcctga aataaaaaag caagaatatg aagaagtagt tcagactgtt 3360
aatacagatt tctctccata tctgatttca gataacttag aacagcctat gggaagtagt 3420
catgcatctc aggtttgttc tgagacacct gatgacctgt tagatgatgg tgaaataaag 3480
gaagatacta gttttgctga aaatgacatt aaggaaagtt ctgctgtttt tagcaaaagc 3540
gtccagaaag gagagcttag caggagtcct agccctttca cccatacaca tttggctcag 3600
ggttaccgaa gaggggccaa gaaattagag tcctcagaag agaacttatc tagtgaggat 3660
gaagagcttc cctgcttcca acacttgtta tttggtaaag taaacaatat accttctcag 3720
tctactaggc atagcaccgt tgctaccgag tgtctgtcta agaacacaga ggagaattta 3780
ttatcattga agaatagctt aaatgactgc agtaaccagg taatattggc aaaggcatct 3840
caggaacatc accttagtga ggaaacaaaa tgttctgcta gcttgttttc ttcacagtgc 3900
agtgaattgg aagacttgac tgcaaataca aacacccagg atcctttctt gattggttct 3960
tccaaacaaa tgaggcatca gtctgaaagc cagggagttg gtctgagtga caaggaattg 4020
gtttcagatg atgaagaaag aggaacgggc ttggaagaaa ataatcaaga agagcaaagc 4080
atggattcaa acttaggtga agcagcatct gggtgtgaga gtgaaacaag cgtctctgaa 4140
gactgctcag ggctatcctc tcagagtgac attttaacca ctcagcagag ggataccatg 4200
caacataacc tgataaagct ccagcaggaa atggctgaac tagaagctgt gttagaacag 4260
catgggagcc agccttctaa cagctaccct tccatcataa gtgactcttc tgcccttgag 4320
gacctgcgaa atccagaaca aagcacatca gaaaaagatt cgcatataca tggccaaagg 4380
aacaactcca tgttttctaa aaggcctaga gaacatatat cagtattaac ttcacagaaa 4440
agtagtgaat accctataag ccagaatcca gaaggccttt ctgctgacaa gtttgaggtg 4500
tctgcagata gttctaccag taaaaataaa gaaccaggag tggaaaggtc atccccttct 4560
aaatgcccat cattagatga taggtggtac atgcacagtt gctctgggag tcttcagaat 4620
agaaactacc catctcaaga ggagctcatt aaggttgttg atgtggagga gcaacagctg 4680
gaagagtctg ggccacacga tttgacggaa acatcttact tgccaaggca agatctagag 4740
ggaacccctt acctggaatc tggaatcagc ctcttctctg atgaccctga atctgatcct 4800
tctgaagaca gagccccaga gtcagctcgt gttggcaaca taccatcttc aacctctgca 4860
ttgaaagttc cccaattgaa agttgcagaa tctgcccaga gtccagctgc tgctcatact 4920
actgatactg ctgggtataa tgcaatggaa gaaagtgtga gcagggagaa gccagaattg 4980
acagcttcaa cagaaagggt caacaaaaga atgtccatgg tggtgtctgg cctgacccca 5040
gaagaattta tgctcgtgta caagtttgcc agaaaacacc acatcacttt aactaatcta 5100
attactgaag agactactca tgttgttatg aaaacagatg ctgagtttgt gtgtgaacgg 5160
acactgaaat attttctagg aattgcggga ggaaaatggg tagttagcta tttctgggtg 5220
acccagtcta ttaaagaaag aaaaatgctg aatgagcatg attttgaagt cagaggagat 5280
gtggtcaatg gaagaaacca ccaaggtcca aagcgagcaa gagaatccca ggacagaaag 5340
atcttcaggg ggctagaaat ctgttgctat gggcccttca ccaacatgcc cacagatcaa 5400
ctggaatgga tggtacagct gtgtggtgct tctgtggtga aggagctttc atcattcacc 5460
cttggcacag gtgtccaccc aattgtggtt gtgcagccag atgcctggac agaggacaat 5520
ggcttccatg caattgggca gatgtgtgag gcacctgtgg tgacccgaga gtgggtgttg 5580
gacagtgtag cactctacca gtgccaggag ctggacacct acctgatacc ccagatcccc 5640
cacagccact actga 5655
<210> 23
<211> 1884
<212> PRT
<213> 智人(Homo sapiens)
<400> 23
Met Asp Leu Ser Ala Leu Arg Val Glu Glu Val Gln Asn Val Ile Asn
1 5 10 15
Ala Met Gln Lys Ile Leu Glu Cys Pro Ile Cys Leu Glu Leu Ile Lys
20 25 30
Glu Pro Val Ser Thr Lys Cys Asp His Ile Phe Cys Lys Phe Cys Met
35 40 45
Leu Lys Leu Leu Asn Gln Lys Lys Gly Pro Ser Gln Cys Pro Leu Cys
50 55 60
Lys Asn Asp Ile Thr Lys Arg Ser Leu Gln Glu Ser Thr Arg Phe Ser
65 70 75 80
Gln Leu Val Glu Glu Leu Leu Lys Ile Ile Cys Ala Phe Gln Leu Asp
85 90 95
Thr Gly Leu Glu Tyr Ala Asn Ser Tyr Asn Phe Ala Lys Lys Glu Asn
100 105 110
Asn Ser Pro Glu His Leu Lys Asp Glu Val Ser Ile Ile Gln Ser Met
115 120 125
Gly Tyr Arg Asn Arg Ala Lys Arg Leu Leu Gln Ser Glu Pro Glu Asn
130 135 140
Pro Ser Leu Gln Glu Thr Ser Leu Ser Val Gln Leu Ser Asn Leu Gly
145 150 155 160
Thr Val Arg Thr Leu Arg Thr Lys Gln Arg Ile Gln Pro Gln Lys Thr
165 170 175
Ser Val Tyr Ile Glu Leu Gly Ser Asp Ser Ser Glu Asp Thr Val Asn
180 185 190
Lys Ala Thr Tyr Cys Ser Val Gly Asp Gln Glu Leu Leu Gln Ile Thr
195 200 205
Pro Gln Gly Thr Arg Asp Glu Ile Ser Leu Asp Ser Ala Lys Lys Ala
210 215 220
Ala Cys Glu Phe Ser Glu Thr Asp Val Thr Asn Thr Glu His His Gln
225 230 235 240
Pro Ser Asn Asn Asp Leu Asn Thr Thr Glu Lys Arg Ala Ala Glu Arg
245 250 255
His Pro Glu Lys Tyr Gln Gly Ser Ser Val Ser Asn Leu His Val Glu
260 265 270
Pro Cys Gly Thr Asn Thr His Ala Ser Ser Leu Gln His Glu Asn Ser
275 280 285
Ser Leu Leu Leu Thr Lys Asp Arg Met Asn Val Glu Lys Ala Glu Phe
290 295 300
Cys Asn Lys Ser Lys Gln Pro Gly Leu Ala Arg Ser Gln His Asn Arg
305 310 315 320
Trp Ala Gly Ser Lys Glu Thr Cys Asn Asp Arg Arg Thr Pro Ser Thr
325 330 335
Glu Lys Lys Val Asp Leu Asn Ala Asp Pro Leu Cys Glu Arg Lys Glu
340 345 350
Trp Asn Lys Gln Lys Leu Pro Cys Ser Glu Asn Pro Arg Asp Thr Glu
355 360 365
Asp Val Pro Trp Ile Thr Leu Asn Ser Ser Ile Gln Lys Val Asn Glu
370 375 380
Trp Phe Ser Arg Ser Asp Glu Leu Leu Gly Ser Asp Asp Ser His Asp
385 390 395 400
Gly Glu Ser Glu Ser Asn Ala Lys Val Ala Asp Val Leu Asp Val Leu
405 410 415
Asn Glu Val Asp Glu Tyr Ser Gly Ser Ser Glu Lys Ile Asp Leu Leu
420 425 430
Ala Ser Asp Pro His Glu Ala Leu Ile Cys Lys Ser Glu Arg Val His
435 440 445
Ser Lys Ser Val Glu Ser Asn Ile Glu Asp Lys Ile Phe Gly Lys Thr
450 455 460
Tyr Arg Lys Lys Ala Ser Leu Pro Asn Leu Ser His Val Thr Glu Asn
465 470 475 480
Leu Ile Ile Gly Ala Phe Val Thr Glu Pro Gln Ile Ile Gln Glu Arg
485 490 495
Pro Leu Thr Asn Lys Leu Lys Arg Lys Arg Arg Pro Thr Ser Gly Leu
500 505 510
His Pro Glu Asp Phe Ile Lys Lys Ala Asp Leu Ala Val Gln Lys Thr
515 520 525
Pro Glu Met Ile Asn Gln Gly Thr Asn Gln Thr Glu Gln Asn Gly Gln
530 535 540
Val Met Asn Ile Thr Asn Ser Gly His Glu Asn Lys Thr Lys Gly Asp
545 550 555 560
Ser Ile Gln Asn Glu Lys Asn Pro Asn Pro Ile Glu Ser Leu Glu Lys
565 570 575
Glu Ser Ala Phe Lys Thr Lys Ala Glu Pro Ile Ser Ser Ser Ile Ser
580 585 590
Asn Met Glu Leu Glu Leu Asn Ile His Asn Ser Lys Ala Pro Lys Lys
595 600 605
Asn Arg Leu Arg Arg Lys Ser Ser Thr Arg His Ile His Ala Leu Glu
610 615 620
Leu Val Val Ser Arg Asn Leu Ser Pro Pro Asn Cys Thr Glu Leu Gln
625 630 635 640
Ile Asp Ser Cys Ser Ser Ser Glu Glu Ile Lys Lys Lys Lys Tyr Asn
645 650 655
Gln Met Pro Val Arg His Ser Arg Asn Leu Gln Leu Met Glu Gly Lys
660 665 670
Glu Pro Ala Thr Gly Ala Lys Lys Ser Asn Lys Pro Asn Glu Gln Thr
675 680 685
Ser Lys Arg His Asp Ser Asp Thr Phe Pro Glu Leu Lys Leu Thr Asn
690 695 700
Ala Pro Gly Ser Phe Thr Lys Cys Ser Asn Thr Ser Glu Leu Lys Glu
705 710 715 720
Phe Val Asn Pro Ser Leu Pro Arg Glu Glu Lys Glu Glu Lys Leu Glu
725 730 735
Thr Val Lys Val Ser Asn Asn Ala Glu Asp Pro Lys Asp Leu Met Leu
740 745 750
Ser Gly Glu Arg Val Leu Gln Thr Glu Arg Ser Val Glu Ser Ser Ser
755 760 765
Ile Ser Leu Val Pro Gly Thr Asp Tyr Gly Thr Gln Glu Ser Ile Ser
770 775 780
Leu Leu Glu Val Ser Thr Leu Gly Lys Ala Lys Thr Glu Pro Asn Lys
785 790 795 800
Cys Val Ser Gln Cys Ala Ala Phe Glu Asn Pro Lys Gly Leu Ile His
805 810 815
Gly Cys Ser Lys Asp Asn Arg Asn Asp Thr Glu Gly Phe Lys Tyr Pro
820 825 830
Leu Gly His Glu Val Asn His Ser Arg Glu Thr Ser Ile Glu Met Glu
835 840 845
Glu Ser Glu Leu Asp Ala Gln Tyr Leu Gln Asn Thr Phe Lys Val Ser
850 855 860
Lys Arg Gln Ser Phe Ala Pro Phe Ser Asn Pro Gly Asn Ala Glu Glu
865 870 875 880
Glu Cys Ala Thr Phe Ser Ala His Ser Gly Ser Leu Lys Lys Gln Ser
885 890 895
Pro Lys Val Thr Phe Glu Cys Glu Gln Lys Glu Glu Asn Gln Gly Lys
900 905 910
Asn Glu Ser Asn Ile Lys Pro Val Gln Thr Val Asn Ile Thr Ala Gly
915 920 925
Phe Pro Val Val Gly Gln Lys Asp Lys Pro Val Asp Asn Ala Lys Cys
930 935 940
Ser Ile Lys Gly Gly Ser Arg Phe Cys Leu Ser Ser Gln Phe Arg Gly
945 950 955 960
Asn Glu Thr Gly Leu Ile Thr Pro Asn Lys His Gly Leu Leu Gln Asn
965 970 975
Pro Tyr Arg Ile Pro Pro Leu Phe Pro Ile Lys Ser Phe Val Lys Thr
980 985 990
Lys Cys Lys Lys Asn Leu Leu Glu Glu Asn Phe Glu Glu His Ser Met
995 1000 1005
Ser Pro Glu Arg Glu Met Gly Asn Glu Asn Ile Pro Ser Thr Val
1010 1015 1020
Ser Thr Ile Ser Arg Asn Asn Ile Arg Glu Asn Val Phe Lys Glu
1025 1030 1035
Ala Ser Ser Ser Asn Ile Asn Glu Val Gly Ser Ser Thr Asn Glu
1040 1045 1050
Val Gly Ser Ser Ile Asn Glu Ile Gly Ser Ser Asp Glu Asn Ile
1055 1060 1065
Gln Ala Glu Leu Gly Arg Asn Arg Gly Pro Lys Leu Asn Ala Met
1070 1075 1080
Leu Arg Leu Gly Val Leu Gln Pro Glu Val Tyr Lys Gln Ser Leu
1085 1090 1095
Pro Gly Ser Asn Cys Lys His Pro Glu Ile Lys Lys Gln Glu Tyr
1100 1105 1110
Glu Glu Val Val Gln Thr Val Asn Thr Asp Phe Ser Pro Tyr Leu
1115 1120 1125
Ile Ser Asp Asn Leu Glu Gln Pro Met Gly Ser Ser His Ala Ser
1130 1135 1140
Gln Val Cys Ser Glu Thr Pro Asp Asp Leu Leu Asp Asp Gly Glu
1145 1150 1155
Ile Lys Glu Asp Thr Ser Phe Ala Glu Asn Asp Ile Lys Glu Ser
1160 1165 1170
Ser Ala Val Phe Ser Lys Ser Val Gln Lys Gly Glu Leu Ser Arg
1175 1180 1185
Ser Pro Ser Pro Phe Thr His Thr His Leu Ala Gln Gly Tyr Arg
1190 1195 1200
Arg Gly Ala Lys Lys Leu Glu Ser Ser Glu Glu Asn Leu Ser Ser
1205 1210 1215
Glu Asp Glu Glu Leu Pro Cys Phe Gln His Leu Leu Phe Gly Lys
1220 1225 1230
Val Asn Asn Ile Pro Ser Gln Ser Thr Arg His Ser Thr Val Ala
1235 1240 1245
Thr Glu Cys Leu Ser Lys Asn Thr Glu Glu Asn Leu Leu Ser Leu
1250 1255 1260
Lys Asn Ser Leu Asn Asp Cys Ser Asn Gln Val Ile Leu Ala Lys
1265 1270 1275
Ala Ser Gln Glu His His Leu Ser Glu Glu Thr Lys Cys Ser Ala
1280 1285 1290
Ser Leu Phe Ser Ser Gln Cys Ser Glu Leu Glu Asp Leu Thr Ala
1295 1300 1305
Asn Thr Asn Thr Gln Asp Pro Phe Leu Ile Gly Ser Ser Lys Gln
1310 1315 1320
Met Arg His Gln Ser Glu Ser Gln Gly Val Gly Leu Ser Asp Lys
1325 1330 1335
Glu Leu Val Ser Asp Asp Glu Glu Arg Gly Thr Gly Leu Glu Glu
1340 1345 1350
Asn Asn Gln Glu Glu Gln Ser Met Asp Ser Asn Leu Gly Glu Ala
1355 1360 1365
Ala Ser Gly Cys Glu Ser Glu Thr Ser Val Ser Glu Asp Cys Ser
1370 1375 1380
Gly Leu Ser Ser Gln Ser Asp Ile Leu Thr Thr Gln Gln Arg Asp
1385 1390 1395
Thr Met Gln His Asn Leu Ile Lys Leu Gln Gln Glu Met Ala Glu
1400 1405 1410
Leu Glu Ala Val Leu Glu Gln His Gly Ser Gln Pro Ser Asn Ser
1415 1420 1425
Tyr Pro Ser Ile Ile Ser Asp Ser Ser Ala Leu Glu Asp Leu Arg
1430 1435 1440
Asn Pro Glu Gln Ser Thr Ser Glu Lys Asp Ser His Ile His Gly
1445 1450 1455
Gln Arg Asn Asn Ser Met Phe Ser Lys Arg Pro Arg Glu His Ile
1460 1465 1470
Ser Val Leu Thr Ser Gln Lys Ser Ser Glu Tyr Pro Ile Ser Gln
1475 1480 1485
Asn Pro Glu Gly Leu Ser Ala Asp Lys Phe Glu Val Ser Ala Asp
1490 1495 1500
Ser Ser Thr Ser Lys Asn Lys Glu Pro Gly Val Glu Arg Ser Ser
1505 1510 1515
Pro Ser Lys Cys Pro Ser Leu Asp Asp Arg Trp Tyr Met His Ser
1520 1525 1530
Cys Ser Gly Ser Leu Gln Asn Arg Asn Tyr Pro Ser Gln Glu Glu
1535 1540 1545
Leu Ile Lys Val Val Asp Val Glu Glu Gln Gln Leu Glu Glu Ser
1550 1555 1560
Gly Pro His Asp Leu Thr Glu Thr Ser Tyr Leu Pro Arg Gln Asp
1565 1570 1575
Leu Glu Gly Thr Pro Tyr Leu Glu Ser Gly Ile Ser Leu Phe Ser
1580 1585 1590
Asp Asp Pro Glu Ser Asp Pro Ser Glu Asp Arg Ala Pro Glu Ser
1595 1600 1605
Ala Arg Val Gly Asn Ile Pro Ser Ser Thr Ser Ala Leu Lys Val
1610 1615 1620
Pro Gln Leu Lys Val Ala Glu Ser Ala Gln Ser Pro Ala Ala Ala
1625 1630 1635
His Thr Thr Asp Thr Ala Gly Tyr Asn Ala Met Glu Glu Ser Val
1640 1645 1650
Ser Arg Glu Lys Pro Glu Leu Thr Ala Ser Thr Glu Arg Val Asn
1655 1660 1665
Lys Arg Met Ser Met Val Val Ser Gly Leu Thr Pro Glu Glu Phe
1670 1675 1680
Met Leu Val Tyr Lys Phe Ala Arg Lys His His Ile Thr Leu Thr
1685 1690 1695
Asn Leu Ile Thr Glu Glu Thr Thr His Val Val Met Lys Thr Asp
1700 1705 1710
Ala Glu Phe Val Cys Glu Arg Thr Leu Lys Tyr Phe Leu Gly Ile
1715 1720 1725
Ala Gly Gly Lys Trp Val Val Ser Tyr Phe Trp Val Thr Gln Ser
1730 1735 1740
Ile Lys Glu Arg Lys Met Leu Asn Glu His Asp Phe Glu Val Arg
1745 1750 1755
Gly Asp Val Val Asn Gly Arg Asn His Gln Gly Pro Lys Arg Ala
1760 1765 1770
Arg Glu Ser Gln Asp Arg Lys Ile Phe Arg Gly Leu Glu Ile Cys
1775 1780 1785
Cys Tyr Gly Pro Phe Thr Asn Met Pro Thr Asp Gln Leu Glu Trp
1790 1795 1800
Met Val Gln Leu Cys Gly Ala Ser Val Val Lys Glu Leu Ser Ser
1805 1810 1815
Phe Thr Leu Gly Thr Gly Val His Pro Ile Val Val Val Gln Pro
1820 1825 1830
Asp Ala Trp Thr Glu Asp Asn Gly Phe His Ala Ile Gly Gln Met
1835 1840 1845
Cys Glu Ala Pro Val Val Thr Arg Glu Trp Val Leu Asp Ser Val
1850 1855 1860
Ala Leu Tyr Gln Cys Gln Glu Leu Asp Thr Tyr Leu Ile Pro Gln
1865 1870 1875
Ile Pro His Ser His Tyr
1880
<210> 24
<211> 10257
<212> DNA
<213> 智人(Homo sapiens)
<400> 24
atgcctattg gatccaaaga gaggccaaca ttttttgaaa tttttaagac acgctgcaac 60
aaagcagatt taggaccaat aagtcttaat tggtttgaag aactttcttc agaagctcca 120
ccctataatt ctgaacctgc agaagaatct gaacataaaa acaacaatta cgaaccaaac 180
ctatttaaaa ctccacaaag gaaaccatct tataatcagc tggcttcaac tccaataata 240
ttcaaagagc aagggctgac tctgccgctg taccaatctc ctgtaaaaga attagataaa 300
ttcaaattag acttaggaag gaatgttccc aatagtagac ataaaagtct tcgcacagtg 360
aaaactaaaa tggatcaagc agatgatgtt tcctgtccac ttctaaattc ttgtcttagt 420
gaaagtcctg ttgttctaca atgtacacat gtaacaccac aaagagataa gtcagtggta 480
tgtgggagtt tgtttcatac accaaagttt gtgaagggtc gtcagacacc aaaacatatt 540
tctgaaagtc taggagctga ggtggatcct gatatgtctt ggtcaagttc tttagctaca 600
ccacccaccc ttagttctac tgtgctcata gtcagaaatg aagaagcatc tgaaactgta 660
tttcctcatg atactactgc taatgtgaaa agctattttt ccaatcatga tgaaagtctg 720
aagaaaaatg atagatttat cgcttctgtg acagacagtg aaaacacaaa tcaaagagaa 780
gctgcaagtc atggatttgg aaaaacatca gggaattcat ttaaagtaaa tagctgcaaa 840
gaccacattg gaaagtcaat gccaaatgtc ctagaagatg aagtatatga aacagttgta 900
gatacctctg aagaagatag tttttcatta tgtttttcta aatgtagaac aaaaaatcta 960
caaaaagtaa gaactagcaa gactaggaaa aaaattttcc atgaagcaaa cgctgatgaa 1020
tgtgaaaaat ctaaaaacca agtgaaagaa aaatactcat ttgtatctga agtggaacca 1080
aatgatactg atccattaga ttcaaatgta gcaaatcaga agccctttga gagtggaagt 1140
gacaaaatct ccaaggaagt tgtaccgtct ttggcctgtg aatggtctca actaaccctt 1200
tcaggtctaa atggagccca gatggagaaa atacccctat tgcatatttc ttcatgtgac 1260
caaaatattt cagaaaaaga cctattagac acagagaaca aaagaaagaa agattttctt 1320
acttcagaga attctttgcc acgtatttct agcctaccaa aatcagagaa gccattaaat 1380
gaggaaacag tggtaaataa gagagatgaa gagcagcatc ttgaatctca tacagactgc 1440
attcttgcag taaagcaggc aatatctgga acttctccag tggcttcttc atttcagggt 1500
atcaaaaagt ctatattcag aataagagaa tcacctaaag agactttcaa tgcaagtttt 1560
tcaggtcata tgactgatcc aaactttaaa aaagaaactg aagcctctga aagtggactg 1620
gaaatacata ctgtttgctc acagaaggag gactccttat gtccaaattt aattgataat 1680
ggaagctggc cagccaccac cacacagaat tctgtagctt tgaagaatgc aggtttaata 1740
tccactttga aaaagaaaac aaataagttt atttatgcta tacatgatga aacatcttat 1800
aaaggaaaaa aaataccgaa agaccaaaaa tcagaactaa ttaactgttc agcccagttt 1860
gaagcaaatg cttttgaagc accacttaca tttgcaaatg ctgattcagg tttattgcat 1920
tcttctgtga aaagaagctg ttcacagaat gattctgaag aaccaacttt gtccttaact 1980
agctcttttg ggacaattct gaggaaatgt tctagaaatg aaacatgttc taataataca 2040
gtaatctctc aggatcttga ttataaagaa gcaaaatgta ataaggaaaa actacagtta 2100
tttattaccc cagaagctga ttctctgtca tgcctgcagg aaggacagtg tgaaaatgat 2160
ccaaaaagca aaaaagtttc agatataaaa gaagaggtct tggctgcagc atgtcaccca 2220
gtacaacatt caaaagtgga atacagtgat actgactttc aatcccagaa aagtctttta 2280
tatgatcatg aaaatgccag cactcttatt ttaactccta cttccaagga tgttctgtca 2340
aacctagtca tgatttctag aggcaaagaa tcatacaaaa tgtcagacaa gctcaaaggt 2400
aacaattatg aatctgatgt tgaattaacc aaaaatattc ccatggaaaa gaatcaagat 2460
gtatgtgctt taaatgaaaa ttataaaaac gttgagctgt tgccacctga aaaatacatg 2520
agagtagcat caccttcaag aaaggtacaa ttcaaccaaa acacaaatct aagagtaatc 2580
caaaaaaatc aagaagaaac tacttcaatt tcaaaaataa ctgtcaatcc agactctgaa 2640
gaacttttct cagacaatga gaataatttt gtcttccaag tagctaatga aaggaataat 2700
cttgctttag gaaatactaa ggaacttcat gaaacagact tgacttgtgt aaacgaaccc 2760
attttcaaga actctaccat ggttttatat ggagacacag gtgataaaca agcaacccaa 2820
gtgtcaatta aaaaagattt ggtttatgtt cttgcagagg agaacaaaaa tagtgtaaag 2880
cagcatataa aaatgactct aggtcaagat ttaaaatcgg acatctcctt gaatatagat 2940
aaaataccag aaaaaaataa tgattacatg aacaaatggg caggactctt aggtccaatt 3000
tcaaatcaca gttttggagg tagcttcaga acagcttcaa ataaggaaat caagctctct 3060
gaacataaca ttaagaagag caaaatgttc ttcaaagata ttgaagaaca atatcctact 3120
agtttagctt gtgttgaaat tgtaaatacc ttggcattag ataatcaaaa gaaactgagc 3180
aagcctcagt caattaatac tgtatctgca catttacaga gtagtgtagt tgtttctgat 3240
tgtaaaaata gtcatataac ccctcagatg ttattttcca agcaggattt taattcaaac 3300
cataatttaa cacctagcca aaaggcagaa attacagaac tttctactat attagaagaa 3360
tcaggaagtc agtttgaatt tactcagttt agaaaaccaa gctacatatt gcagaagagt 3420
acatttgaag tgcctgaaaa ccagatgact atcttaaaga ccacttctga ggaatgcaga 3480
gatgctgatc ttcatgtcat aatgaatgcc ccatcgattg gtcaggtaga cagcagcaag 3540
caatttgaag gtacagttga aattaaacgg aagtttgctg gcctgttgaa aaatgactgt 3600
aacaaaagtg cttctggtta tttaacagat gaaaatgaag tggggtttag gggcttttat 3660
tctgctcatg gcacaaaact gaatgtttct actgaagctc tgcaaaaagc tgtgaaactg 3720
tttagtgata ttgagaatat tagtgaggaa acttctgcag aggtacatcc aataagttta 3780
tcttcaagta aatgtcatga ttctgttgtt tcaatgttta agatagaaaa tcataatgat 3840
aaaactgtaa gtgaaaaaaa taataaatgc caactgatat tacaaaataa tattgaaatg 3900
actactggca cttttgttga agaaattact gaaaattaca agagaaatac tgaaaatgaa 3960
gataacaaat atactgctgc cagtagaaat tctcataact tagaatttga tggcagtgat 4020
tcaagtaaaa atgatactgt ttgtattcat aaagatgaaa cggacttgct atttactgat 4080
cagcacaaca tatgtcttaa attatctggc cagtttatga aggagggaaa cactcagatt 4140
aaagaagatt tgtcagattt aacttttttg gaagttgcga aagctcaaga agcatgtcat 4200
ggtaatactt caaataaaga acagttaact gctactaaaa cggagcaaaa tataaaagat 4260
tttgagactt ctgatacatt ttttcagact gcaagtggga aaaatattag tgtcgccaaa 4320
gagtcattta ataaaattgt aaatttcttt gatcagaaac cagaagaatt gcataacttt 4380
tccttaaatt ctgaattaca ttctgacata agaaagaaca aaatggacat tctaagttat 4440
gaggaaacag acatagttaa acacaaaata ctgaaagaaa gtgtcccagt tggtactgga 4500
aatcaactag tgaccttcca gggacaaccc gaacgtgatg aaaagatcaa agaacctact 4560
ctattgggtt ttcatacagc tagcgggaaa aaagttaaaa ttgcaaagga atctttggac 4620
aaagtgaaaa acctttttga tgaaaaagag caaggtacta gtgaaatcac cagttttagc 4680
catcaatggg caaagaccct aaagtacaga gaggcctgta aagaccttga attagcatgt 4740
gagaccattg agatcacagc tgccccaaag tgtaaagaaa tgcagaattc tctcaataat 4800
gataaaaacc ttgtttctat tgagactgtg gtgccaccta agctcttaag tgataattta 4860
tgtagacaaa ctgaaaatct caaaacatca aaaagtatct ttttgaaagt taaagtacat 4920
gaaaatgtag aaaaagaaac agcaaaaagt cctgcaactt gttacacaaa tcagtcccct 4980
tattcagtca ttgaaaattc agccttagct ttttacacaa gttgtagtag aaaaacttct 5040
gtgagtcaga cttcattact tgaagcaaaa aaatggctta gagaaggaat atttgatggt 5100
caaccagaaa gaataaatac tgcagattat gtaggaaatt atttgtatga aaataattca 5160
aacagtacta tagctgaaaa tgacaaaaat catctctccg aaaaacaaga tacttattta 5220
agtaacagta gcatgtctaa cagctattcc taccattctg atgaggtata taatgattca 5280
ggatatctct caaaaaataa acttgattct ggtattgagc cagtattgaa gaatgttgaa 5340
gatcaaaaaa acactagttt ttccaaagta atatccaatg taaaagatgc aaatgcatac 5400
ccacaaactg taaatgaaga tatttgcgtt gaggaacttg tgactagctc ttcaccctgc 5460
aaaaataaaa atgcagccat taaattgtcc atatctaata gtaataattt tgaggtaggg 5520
ccacctgcat ttaggatagc cagtggtaaa atcgtttgtg tttcacatga aacaattaaa 5580
aaagtgaaag acatatttac agacagtttc agtaaagtaa ttaaggaaaa caacgagaat 5640
aaatcaaaaa tttgccaaac gaaaattatg gcaggttgtt acgaggcatt ggatgattca 5700
gaggatattc ttcataactc tctagataat gatgaatgta gcacgcattc acataaggtt 5760
tttgctgaca ttcagagtga agaaatttta caacataacc aaaatatgtc tggattggag 5820
aaagtttcta aaatatcacc ttgtgatgtt agtttggaaa cttcagatat atgtaaatgt 5880
agtataggga agcttcataa gtcagtctca tctgcaaata cttgtgggat ttttagcaca 5940
gcaagtggaa aatctgtcca ggtatcagat gcttcattac aaaacgcaag acaagtgttt 6000
tctgaaatag aagatagtac caagcaagtc ttttccaaag tattgtttaa aagtaacgaa 6060
cattcagacc agctcacaag agaagaaaat actgctatac gtactccaga acatttaata 6120
tcccaaaaag gcttttcata taatgtggta aattcatctg ctttctctgg atttagtaca 6180
gcaagtggaa agcaagtttc cattttagaa agttccttac acaaagttaa gggagtgtta 6240
gaggaatttg atttaatcag aactgagcat agtcttcact attcacctac gtctagacaa 6300
aatgtatcaa aaatacttcc tcgtgttgat aagagaaacc cagagcactg tgtaaactca 6360
gaaatggaaa aaacctgcag taaagaattt aaattatcaa ataacttaaa tgttgaaggt 6420
ggttcttcag aaaataatca ctctattaaa gtttctccat atctctctca atttcaacaa 6480
gacaaacaac agttggtatt aggaaccaaa gtgtcacttg ttgagaacat tcatgttttg 6540
ggaaaagaac aggcttcacc taaaaacgta aaaatggaaa ttggtaaaac tgaaactttt 6600
tctgatgttc ctgtgaaaac aaatatagaa gtttgttcta cttactccaa agattcagaa 6660
aactactttg aaacagaagc agtagaaatt gctaaagctt ttatggaaga tgatgaactg 6720
acagattcta aactgccaag tcatgccaca cattctcttt ttacatgtcc cgaaaatgag 6780
gaaatggttt tgtcaaattc aagaattgga aaaagaagag gagagcccct tatcttagtg 6840
ggagaaccct caatcaaaag aaacttatta aatgaatttg acaggataat agaaaatcaa 6900
gaaaaatcct taaaggcttc aaaaagcact ccagatggca caataaaaga tcgaagattg 6960
tttatgcatc atgtttcttt agagccgatt acctgtgtac cctttcgcac aactaaggaa 7020
cgtcaagaga tacagaatcc aaattttacc gcacctggtc aagaatttct gtctaaatct 7080
catttgtatg aacatctgac tttggaaaaa tcttcaagca atttagcagt ttcaggacat 7140
ccattttatc aagtttctgc tacaagaaat gaaaaaatga gacacttgat tactacaggc 7200
agaccaacca aagtctttgt tccacctttt aaaactaaat cacattttca cagagttgaa 7260
cagtgtgtta ggaatattaa cttggaggaa aacagacaaa agcaaaacat tgatggacat 7320
ggctctgatg atagtaaaaa taagattaat gacaatgaga ttcatcagtt taacaaaaac 7380
aactccaatc aagcagtagc tgtaactttc acaaagtgtg aagaagaacc tttagattta 7440
attacaagtc ttcagaatgc cagagatata caggatatgc gaattaagaa gaaacaaagg 7500
caacgcgtct ttccacagcc aggcagtctg tatcttgcaa aaacatccac tctgcctcga 7560
atctctctga aagcagcagt aggaggccaa gttccctctg cgtgttctca taaacagctg 7620
tatacgtatg gcgtttctaa acattgcata aaaattaaca gcaaaaatgc agagtctttt 7680
cagtttcaca ctgaagatta ttttggtaag gaaagtttat ggactggaaa aggaatacag 7740
ttggctgatg gtggatggct cataccctcc aatgatggaa aggctggaaa agaagaattt 7800
tatagggctc tgtgtgacac tccaggtgtg gatccaaagc ttatttctag aatttgggtt 7860
tataatcact atagatggat catatggaaa ctggcagcta tggaatgtgc ctttcctaag 7920
gaatttgcta atagatgcct aagcccagaa agggtgcttc ttcaactaaa atacagatat 7980
gatacggaaa ttgatagaag cagaagatcg gctataaaaa agataatgga aagggatgac 8040
acagctgcaa aaacacttgt tctctgtgtt tctgacataa tttcattgag cgcaaatata 8100
tctgaaactt ctagcaataa aactagtagt gcagataccc aaaaagtggc cattattgaa 8160
cttacagatg ggtggtatgc tgttaaggcc cagttagatc ctcccctctt agctgtctta 8220
aagaatggca gactgacagt tggtcagaag attattcttc atggagcaga actggtgggc 8280
tctcctgatg cctgtacacc tcttgaagcc ccagaatctc ttatgttaaa gatttctgct 8340
aacagtactc ggcctgctcg ctggtatacc aaacttggat tctttcctga ccctagacct 8400
tttcctctgc ccttatcatc gcttttcagt gatggaggaa atgttggttg tgttgatgta 8460
attattcaaa gagcataccc tatacagtgg atggagaaga catcatctgg attatacata 8520
tttcgcaatg aaagagagga agaaaaggaa gcagcaaaat atgtggaggc ccaacaaaag 8580
agactagaag ccttattcac taaaattcag gaggaatttg aagaacatga agaaaacaca 8640
acaaaaccat atttaccatc acgtgcacta acaagacagc aagttcgtgc tttgcaagat 8700
ggtgcagagc tttatgaagc agtgaagaat gcagcagacc cagcttacct tgagggttat 8760
ttcagtgaag agcagttaag agccttgaat aatcacaggc aaatgttgaa tgataagaaa 8820
caagctcaga tccagttgga aattaggaag gccatggaat ctgctgaaca aaaggaacaa 8880
ggtttatcaa gggatgtcac aaccgtgtgg aagttgcgta ttgtaagcta ttcaaaaaaa 8940
gaaaaagatt cagttatact gagtatttgg cgtccatcat cagatttata ttctctgtta 9000
acagaaggaa agagatacag aatttatcat cttgcaactt caaaatctaa aagtaaatct 9060
gaaagagcta acatacagtt agcagcgaca aaaaaaactc agtatcaaca actaccggtt 9120
tcagatgaaa ttttatttca gatttaccag ccacgggagc cccttcactt cagcaaattt 9180
ttagatccag actttcagcc atcttgttct gaggtggacc taataggatt tgtcgtttct 9240
gttgtgaaaa aaacaggact tgcccctttc gtctatttgt cagacgaatg ttacaattta 9300
ctggcaataa agttttggat agaccttaat gaggacatta ttaagcctca tatgttaatt 9360
gctgcaagca acctccagtg gcgaccagaa tccaaatcag gccttcttac tttatttgct 9420
ggagattttt ctgtgttttc tgctagtcca aaagagggcc actttcaaga gacattcaac 9480
aaaatgaaaa atactgttga gaatattgac atactttgca atgaagcaga aaacaagctt 9540
atgcatatac tgcatgcaaa tgatcccaag tggtccaccc caactaaaga ctgtacttca 9600
gggccgtaca ctgctcaaat cattcctggt acaggaaaca agcttctgat gtcttctcct 9660
aattgtgaga tatattatca aagtccttta tcactttgta tggccaaaag gaagtctgtt 9720
tccacacctg tctcagccca gatgacttca aagtcttgta aaggggagaa agagattgat 9780
gaccaaaaga actgcaaaaa gagaagagcc ttggatttct tgagtagact gcctttacct 9840
ccacctgtta gtcccatttg tacatttgtt tctccggctg cacagaaggc atttcagcca 9900
ccaaggagtt gtggcaccaa atacgaaaca cccataaaga aaaaagaact gaattctcct 9960
cagatgactc catttaaaaa attcaatgaa atttctcttt tggaaagtaa ttcaatagct 10020
gacgaagaac ttgcattgat aaatacccaa gctcttttgt ctggttcaac aggagaaaaa 10080
caatttatat ctgtcagtga atccactagg actgctccca ccagttcaga agattatctc 10140
agactgaaac gacgttgtac tacatctctg atcaaagaac aggagagttc ccaggccagt 10200
acggaagaat gtgagaaaaa taagcaggac acaattacaa ctaaaaaata tatctaa 10257
<210> 25
<211> 3418
<212> PRT
<213> 智人(Homo sapiens)
<400> 25
Met Pro Ile Gly Ser Lys Glu Arg Pro Thr Phe Phe Glu Ile Phe Lys
1 5 10 15
Thr Arg Cys Asn Lys Ala Asp Leu Gly Pro Ile Ser Leu Asn Trp Phe
20 25 30
Glu Glu Leu Ser Ser Glu Ala Pro Pro Tyr Asn Ser Glu Pro Ala Glu
35 40 45
Glu Ser Glu His Lys Asn Asn Asn Tyr Glu Pro Asn Leu Phe Lys Thr
50 55 60
Pro Gln Arg Lys Pro Ser Tyr Asn Gln Leu Ala Ser Thr Pro Ile Ile
65 70 75 80
Phe Lys Glu Gln Gly Leu Thr Leu Pro Leu Tyr Gln Ser Pro Val Lys
85 90 95
Glu Leu Asp Lys Phe Lys Leu Asp Leu Gly Arg Asn Val Pro Asn Ser
100 105 110
Arg His Lys Ser Leu Arg Thr Val Lys Thr Lys Met Asp Gln Ala Asp
115 120 125
Asp Val Ser Cys Pro Leu Leu Asn Ser Cys Leu Ser Glu Ser Pro Val
130 135 140
Val Leu Gln Cys Thr His Val Thr Pro Gln Arg Asp Lys Ser Val Val
145 150 155 160
Cys Gly Ser Leu Phe His Thr Pro Lys Phe Val Lys Gly Arg Gln Thr
165 170 175
Pro Lys His Ile Ser Glu Ser Leu Gly Ala Glu Val Asp Pro Asp Met
180 185 190
Ser Trp Ser Ser Ser Leu Ala Thr Pro Pro Thr Leu Ser Ser Thr Val
195 200 205
Leu Ile Val Arg Asn Glu Glu Ala Ser Glu Thr Val Phe Pro His Asp
210 215 220
Thr Thr Ala Asn Val Lys Ser Tyr Phe Ser Asn His Asp Glu Ser Leu
225 230 235 240
Lys Lys Asn Asp Arg Phe Ile Ala Ser Val Thr Asp Ser Glu Asn Thr
245 250 255
Asn Gln Arg Glu Ala Ala Ser His Gly Phe Gly Lys Thr Ser Gly Asn
260 265 270
Ser Phe Lys Val Asn Ser Cys Lys Asp His Ile Gly Lys Ser Met Pro
275 280 285
Asn Val Leu Glu Asp Glu Val Tyr Glu Thr Val Val Asp Thr Ser Glu
290 295 300
Glu Asp Ser Phe Ser Leu Cys Phe Ser Lys Cys Arg Thr Lys Asn Leu
305 310 315 320
Gln Lys Val Arg Thr Ser Lys Thr Arg Lys Lys Ile Phe His Glu Ala
325 330 335
Asn Ala Asp Glu Cys Glu Lys Ser Lys Asn Gln Val Lys Glu Lys Tyr
340 345 350
Ser Phe Val Ser Glu Val Glu Pro Asn Asp Thr Asp Pro Leu Asp Ser
355 360 365
Asn Val Ala Asn Gln Lys Pro Phe Glu Ser Gly Ser Asp Lys Ile Ser
370 375 380
Lys Glu Val Val Pro Ser Leu Ala Cys Glu Trp Ser Gln Leu Thr Leu
385 390 395 400
Ser Gly Leu Asn Gly Ala Gln Met Glu Lys Ile Pro Leu Leu His Ile
405 410 415
Ser Ser Cys Asp Gln Asn Ile Ser Glu Lys Asp Leu Leu Asp Thr Glu
420 425 430
Asn Lys Arg Lys Lys Asp Phe Leu Thr Ser Glu Asn Ser Leu Pro Arg
435 440 445
Ile Ser Ser Leu Pro Lys Ser Glu Lys Pro Leu Asn Glu Glu Thr Val
450 455 460
Val Asn Lys Arg Asp Glu Glu Gln His Leu Glu Ser His Thr Asp Cys
465 470 475 480
Ile Leu Ala Val Lys Gln Ala Ile Ser Gly Thr Ser Pro Val Ala Ser
485 490 495
Ser Phe Gln Gly Ile Lys Lys Ser Ile Phe Arg Ile Arg Glu Ser Pro
500 505 510
Lys Glu Thr Phe Asn Ala Ser Phe Ser Gly His Met Thr Asp Pro Asn
515 520 525
Phe Lys Lys Glu Thr Glu Ala Ser Glu Ser Gly Leu Glu Ile His Thr
530 535 540
Val Cys Ser Gln Lys Glu Asp Ser Leu Cys Pro Asn Leu Ile Asp Asn
545 550 555 560
Gly Ser Trp Pro Ala Thr Thr Thr Gln Asn Ser Val Ala Leu Lys Asn
565 570 575
Ala Gly Leu Ile Ser Thr Leu Lys Lys Lys Thr Asn Lys Phe Ile Tyr
580 585 590
Ala Ile His Asp Glu Thr Ser Tyr Lys Gly Lys Lys Ile Pro Lys Asp
595 600 605
Gln Lys Ser Glu Leu Ile Asn Cys Ser Ala Gln Phe Glu Ala Asn Ala
610 615 620
Phe Glu Ala Pro Leu Thr Phe Ala Asn Ala Asp Ser Gly Leu Leu His
625 630 635 640
Ser Ser Val Lys Arg Ser Cys Ser Gln Asn Asp Ser Glu Glu Pro Thr
645 650 655
Leu Ser Leu Thr Ser Ser Phe Gly Thr Ile Leu Arg Lys Cys Ser Arg
660 665 670
Asn Glu Thr Cys Ser Asn Asn Thr Val Ile Ser Gln Asp Leu Asp Tyr
675 680 685
Lys Glu Ala Lys Cys Asn Lys Glu Lys Leu Gln Leu Phe Ile Thr Pro
690 695 700
Glu Ala Asp Ser Leu Ser Cys Leu Gln Glu Gly Gln Cys Glu Asn Asp
705 710 715 720
Pro Lys Ser Lys Lys Val Ser Asp Ile Lys Glu Glu Val Leu Ala Ala
725 730 735
Ala Cys His Pro Val Gln His Ser Lys Val Glu Tyr Ser Asp Thr Asp
740 745 750
Phe Gln Ser Gln Lys Ser Leu Leu Tyr Asp His Glu Asn Ala Ser Thr
755 760 765
Leu Ile Leu Thr Pro Thr Ser Lys Asp Val Leu Ser Asn Leu Val Met
770 775 780
Ile Ser Arg Gly Lys Glu Ser Tyr Lys Met Ser Asp Lys Leu Lys Gly
785 790 795 800
Asn Asn Tyr Glu Ser Asp Val Glu Leu Thr Lys Asn Ile Pro Met Glu
805 810 815
Lys Asn Gln Asp Val Cys Ala Leu Asn Glu Asn Tyr Lys Asn Val Glu
820 825 830
Leu Leu Pro Pro Glu Lys Tyr Met Arg Val Ala Ser Pro Ser Arg Lys
835 840 845
Val Gln Phe Asn Gln Asn Thr Asn Leu Arg Val Ile Gln Lys Asn Gln
850 855 860
Glu Glu Thr Thr Ser Ile Ser Lys Ile Thr Val Asn Pro Asp Ser Glu
865 870 875 880
Glu Leu Phe Ser Asp Asn Glu Asn Asn Phe Val Phe Gln Val Ala Asn
885 890 895
Glu Arg Asn Asn Leu Ala Leu Gly Asn Thr Lys Glu Leu His Glu Thr
900 905 910
Asp Leu Thr Cys Val Asn Glu Pro Ile Phe Lys Asn Ser Thr Met Val
915 920 925
Leu Tyr Gly Asp Thr Gly Asp Lys Gln Ala Thr Gln Val Ser Ile Lys
930 935 940
Lys Asp Leu Val Tyr Val Leu Ala Glu Glu Asn Lys Asn Ser Val Lys
945 950 955 960
Gln His Ile Lys Met Thr Leu Gly Gln Asp Leu Lys Ser Asp Ile Ser
965 970 975
Leu Asn Ile Asp Lys Ile Pro Glu Lys Asn Asn Asp Tyr Met Asn Lys
980 985 990
Trp Ala Gly Leu Leu Gly Pro Ile Ser Asn His Ser Phe Gly Gly Ser
995 1000 1005
Phe Arg Thr Ala Ser Asn Lys Glu Ile Lys Leu Ser Glu His Asn
1010 1015 1020
Ile Lys Lys Ser Lys Met Phe Phe Lys Asp Ile Glu Glu Gln Tyr
1025 1030 1035
Pro Thr Ser Leu Ala Cys Val Glu Ile Val Asn Thr Leu Ala Leu
1040 1045 1050
Asp Asn Gln Lys Lys Leu Ser Lys Pro Gln Ser Ile Asn Thr Val
1055 1060 1065
Ser Ala His Leu Gln Ser Ser Val Val Val Ser Asp Cys Lys Asn
1070 1075 1080
Ser His Ile Thr Pro Gln Met Leu Phe Ser Lys Gln Asp Phe Asn
1085 1090 1095
Ser Asn His Asn Leu Thr Pro Ser Gln Lys Ala Glu Ile Thr Glu
1100 1105 1110
Leu Ser Thr Ile Leu Glu Glu Ser Gly Ser Gln Phe Glu Phe Thr
1115 1120 1125
Gln Phe Arg Lys Pro Ser Tyr Ile Leu Gln Lys Ser Thr Phe Glu
1130 1135 1140
Val Pro Glu Asn Gln Met Thr Ile Leu Lys Thr Thr Ser Glu Glu
1145 1150 1155
Cys Arg Asp Ala Asp Leu His Val Ile Met Asn Ala Pro Ser Ile
1160 1165 1170
Gly Gln Val Asp Ser Ser Lys Gln Phe Glu Gly Thr Val Glu Ile
1175 1180 1185
Lys Arg Lys Phe Ala Gly Leu Leu Lys Asn Asp Cys Asn Lys Ser
1190 1195 1200
Ala Ser Gly Tyr Leu Thr Asp Glu Asn Glu Val Gly Phe Arg Gly
1205 1210 1215
Phe Tyr Ser Ala His Gly Thr Lys Leu Asn Val Ser Thr Glu Ala
1220 1225 1230
Leu Gln Lys Ala Val Lys Leu Phe Ser Asp Ile Glu Asn Ile Ser
1235 1240 1245
Glu Glu Thr Ser Ala Glu Val His Pro Ile Ser Leu Ser Ser Ser
1250 1255 1260
Lys Cys His Asp Ser Val Val Ser Met Phe Lys Ile Glu Asn His
1265 1270 1275
Asn Asp Lys Thr Val Ser Glu Lys Asn Asn Lys Cys Gln Leu Ile
1280 1285 1290
Leu Gln Asn Asn Ile Glu Met Thr Thr Gly Thr Phe Val Glu Glu
1295 1300 1305
Ile Thr Glu Asn Tyr Lys Arg Asn Thr Glu Asn Glu Asp Asn Lys
1310 1315 1320
Tyr Thr Ala Ala Ser Arg Asn Ser His Asn Leu Glu Phe Asp Gly
1325 1330 1335
Ser Asp Ser Ser Lys Asn Asp Thr Val Cys Ile His Lys Asp Glu
1340 1345 1350
Thr Asp Leu Leu Phe Thr Asp Gln His Asn Ile Cys Leu Lys Leu
1355 1360 1365
Ser Gly Gln Phe Met Lys Glu Gly Asn Thr Gln Ile Lys Glu Asp
1370 1375 1380
Leu Ser Asp Leu Thr Phe Leu Glu Val Ala Lys Ala Gln Glu Ala
1385 1390 1395
Cys His Gly Asn Thr Ser Asn Lys Glu Gln Leu Thr Ala Thr Lys
1400 1405 1410
Thr Glu Gln Asn Ile Lys Asp Phe Glu Thr Ser Asp Thr Phe Phe
1415 1420 1425
Gln Thr Ala Ser Gly Lys Asn Ile Ser Val Ala Lys Glu Ser Phe
1430 1435 1440
Asn Lys Ile Val Asn Phe Phe Asp Gln Lys Pro Glu Glu Leu His
1445 1450 1455
Asn Phe Ser Leu Asn Ser Glu Leu His Ser Asp Ile Arg Lys Asn
1460 1465 1470
Lys Met Asp Ile Leu Ser Tyr Glu Glu Thr Asp Ile Val Lys His
1475 1480 1485
Lys Ile Leu Lys Glu Ser Val Pro Val Gly Thr Gly Asn Gln Leu
1490 1495 1500
Val Thr Phe Gln Gly Gln Pro Glu Arg Asp Glu Lys Ile Lys Glu
1505 1510 1515
Pro Thr Leu Leu Gly Phe His Thr Ala Ser Gly Lys Lys Val Lys
1520 1525 1530
Ile Ala Lys Glu Ser Leu Asp Lys Val Lys Asn Leu Phe Asp Glu
1535 1540 1545
Lys Glu Gln Gly Thr Ser Glu Ile Thr Ser Phe Ser His Gln Trp
1550 1555 1560
Ala Lys Thr Leu Lys Tyr Arg Glu Ala Cys Lys Asp Leu Glu Leu
1565 1570 1575
Ala Cys Glu Thr Ile Glu Ile Thr Ala Ala Pro Lys Cys Lys Glu
1580 1585 1590
Met Gln Asn Ser Leu Asn Asn Asp Lys Asn Leu Val Ser Ile Glu
1595 1600 1605
Thr Val Val Pro Pro Lys Leu Leu Ser Asp Asn Leu Cys Arg Gln
1610 1615 1620
Thr Glu Asn Leu Lys Thr Ser Lys Ser Ile Phe Leu Lys Val Lys
1625 1630 1635
Val His Glu Asn Val Glu Lys Glu Thr Ala Lys Ser Pro Ala Thr
1640 1645 1650
Cys Tyr Thr Asn Gln Ser Pro Tyr Ser Val Ile Glu Asn Ser Ala
1655 1660 1665
Leu Ala Phe Tyr Thr Ser Cys Ser Arg Lys Thr Ser Val Ser Gln
1670 1675 1680
Thr Ser Leu Leu Glu Ala Lys Lys Trp Leu Arg Glu Gly Ile Phe
1685 1690 1695
Asp Gly Gln Pro Glu Arg Ile Asn Thr Ala Asp Tyr Val Gly Asn
1700 1705 1710
Tyr Leu Tyr Glu Asn Asn Ser Asn Ser Thr Ile Ala Glu Asn Asp
1715 1720 1725
Lys Asn His Leu Ser Glu Lys Gln Asp Thr Tyr Leu Ser Asn Ser
1730 1735 1740
Ser Met Ser Asn Ser Tyr Ser Tyr His Ser Asp Glu Val Tyr Asn
1745 1750 1755
Asp Ser Gly Tyr Leu Ser Lys Asn Lys Leu Asp Ser Gly Ile Glu
1760 1765 1770
Pro Val Leu Lys Asn Val Glu Asp Gln Lys Asn Thr Ser Phe Ser
1775 1780 1785
Lys Val Ile Ser Asn Val Lys Asp Ala Asn Ala Tyr Pro Gln Thr
1790 1795 1800
Val Asn Glu Asp Ile Cys Val Glu Glu Leu Val Thr Ser Ser Ser
1805 1810 1815
Pro Cys Lys Asn Lys Asn Ala Ala Ile Lys Leu Ser Ile Ser Asn
1820 1825 1830
Ser Asn Asn Phe Glu Val Gly Pro Pro Ala Phe Arg Ile Ala Ser
1835 1840 1845
Gly Lys Ile Val Cys Val Ser His Glu Thr Ile Lys Lys Val Lys
1850 1855 1860
Asp Ile Phe Thr Asp Ser Phe Ser Lys Val Ile Lys Glu Asn Asn
1865 1870 1875
Glu Asn Lys Ser Lys Ile Cys Gln Thr Lys Ile Met Ala Gly Cys
1880 1885 1890
Tyr Glu Ala Leu Asp Asp Ser Glu Asp Ile Leu His Asn Ser Leu
1895 1900 1905
Asp Asn Asp Glu Cys Ser Thr His Ser His Lys Val Phe Ala Asp
1910 1915 1920
Ile Gln Ser Glu Glu Ile Leu Gln His Asn Gln Asn Met Ser Gly
1925 1930 1935
Leu Glu Lys Val Ser Lys Ile Ser Pro Cys Asp Val Ser Leu Glu
1940 1945 1950
Thr Ser Asp Ile Cys Lys Cys Ser Ile Gly Lys Leu His Lys Ser
1955 1960 1965
Val Ser Ser Ala Asn Thr Cys Gly Ile Phe Ser Thr Ala Ser Gly
1970 1975 1980
Lys Ser Val Gln Val Ser Asp Ala Ser Leu Gln Asn Ala Arg Gln
1985 1990 1995
Val Phe Ser Glu Ile Glu Asp Ser Thr Lys Gln Val Phe Ser Lys
2000 2005 2010
Val Leu Phe Lys Ser Asn Glu His Ser Asp Gln Leu Thr Arg Glu
2015 2020 2025
Glu Asn Thr Ala Ile Arg Thr Pro Glu His Leu Ile Ser Gln Lys
2030 2035 2040
Gly Phe Ser Tyr Asn Val Val Asn Ser Ser Ala Phe Ser Gly Phe
2045 2050 2055
Ser Thr Ala Ser Gly Lys Gln Val Ser Ile Leu Glu Ser Ser Leu
2060 2065 2070
His Lys Val Lys Gly Val Leu Glu Glu Phe Asp Leu Ile Arg Thr
2075 2080 2085
Glu His Ser Leu His Tyr Ser Pro Thr Ser Arg Gln Asn Val Ser
2090 2095 2100
Lys Ile Leu Pro Arg Val Asp Lys Arg Asn Pro Glu His Cys Val
2105 2110 2115
Asn Ser Glu Met Glu Lys Thr Cys Ser Lys Glu Phe Lys Leu Ser
2120 2125 2130
Asn Asn Leu Asn Val Glu Gly Gly Ser Ser Glu Asn Asn His Ser
2135 2140 2145
Ile Lys Val Ser Pro Tyr Leu Ser Gln Phe Gln Gln Asp Lys Gln
2150 2155 2160
Gln Leu Val Leu Gly Thr Lys Val Ser Leu Val Glu Asn Ile His
2165 2170 2175
Val Leu Gly Lys Glu Gln Ala Ser Pro Lys Asn Val Lys Met Glu
2180 2185 2190
Ile Gly Lys Thr Glu Thr Phe Ser Asp Val Pro Val Lys Thr Asn
2195 2200 2205
Ile Glu Val Cys Ser Thr Tyr Ser Lys Asp Ser Glu Asn Tyr Phe
2210 2215 2220
Glu Thr Glu Ala Val Glu Ile Ala Lys Ala Phe Met Glu Asp Asp
2225 2230 2235
Glu Leu Thr Asp Ser Lys Leu Pro Ser His Ala Thr His Ser Leu
2240 2245 2250
Phe Thr Cys Pro Glu Asn Glu Glu Met Val Leu Ser Asn Ser Arg
2255 2260 2265
Ile Gly Lys Arg Arg Gly Glu Pro Leu Ile Leu Val Gly Glu Pro
2270 2275 2280
Ser Ile Lys Arg Asn Leu Leu Asn Glu Phe Asp Arg Ile Ile Glu
2285 2290 2295
Asn Gln Glu Lys Ser Leu Lys Ala Ser Lys Ser Thr Pro Asp Gly
2300 2305 2310
Thr Ile Lys Asp Arg Arg Leu Phe Met His His Val Ser Leu Glu
2315 2320 2325
Pro Ile Thr Cys Val Pro Phe Arg Thr Thr Lys Glu Arg Gln Glu
2330 2335 2340
Ile Gln Asn Pro Asn Phe Thr Ala Pro Gly Gln Glu Phe Leu Ser
2345 2350 2355
Lys Ser His Leu Tyr Glu His Leu Thr Leu Glu Lys Ser Ser Ser
2360 2365 2370
Asn Leu Ala Val Ser Gly His Pro Phe Tyr Gln Val Ser Ala Thr
2375 2380 2385
Arg Asn Glu Lys Met Arg His Leu Ile Thr Thr Gly Arg Pro Thr
2390 2395 2400
Lys Val Phe Val Pro Pro Phe Lys Thr Lys Ser His Phe His Arg
2405 2410 2415
Val Glu Gln Cys Val Arg Asn Ile Asn Leu Glu Glu Asn Arg Gln
2420 2425 2430
Lys Gln Asn Ile Asp Gly His Gly Ser Asp Asp Ser Lys Asn Lys
2435 2440 2445
Ile Asn Asp Asn Glu Ile His Gln Phe Asn Lys Asn Asn Ser Asn
2450 2455 2460
Gln Ala Val Ala Val Thr Phe Thr Lys Cys Glu Glu Glu Pro Leu
2465 2470 2475
Asp Leu Ile Thr Ser Leu Gln Asn Ala Arg Asp Ile Gln Asp Met
2480 2485 2490
Arg Ile Lys Lys Lys Gln Arg Gln Arg Val Phe Pro Gln Pro Gly
2495 2500 2505
Ser Leu Tyr Leu Ala Lys Thr Ser Thr Leu Pro Arg Ile Ser Leu
2510 2515 2520
Lys Ala Ala Val Gly Gly Gln Val Pro Ser Ala Cys Ser His Lys
2525 2530 2535
Gln Leu Tyr Thr Tyr Gly Val Ser Lys His Cys Ile Lys Ile Asn
2540 2545 2550
Ser Lys Asn Ala Glu Ser Phe Gln Phe His Thr Glu Asp Tyr Phe
2555 2560 2565
Gly Lys Glu Ser Leu Trp Thr Gly Lys Gly Ile Gln Leu Ala Asp
2570 2575 2580
Gly Gly Trp Leu Ile Pro Ser Asn Asp Gly Lys Ala Gly Lys Glu
2585 2590 2595
Glu Phe Tyr Arg Ala Leu Cys Asp Thr Pro Gly Val Asp Pro Lys
2600 2605 2610
Leu Ile Ser Arg Ile Trp Val Tyr Asn His Tyr Arg Trp Ile Ile
2615 2620 2625
Trp Lys Leu Ala Ala Met Glu Cys Ala Phe Pro Lys Glu Phe Ala
2630 2635 2640
Asn Arg Cys Leu Ser Pro Glu Arg Val Leu Leu Gln Leu Lys Tyr
2645 2650 2655
Arg Tyr Asp Thr Glu Ile Asp Arg Ser Arg Arg Ser Ala Ile Lys
2660 2665 2670
Lys Ile Met Glu Arg Asp Asp Thr Ala Ala Lys Thr Leu Val Leu
2675 2680 2685
Cys Val Ser Asp Ile Ile Ser Leu Ser Ala Asn Ile Ser Glu Thr
2690 2695 2700
Ser Ser Asn Lys Thr Ser Ser Ala Asp Thr Gln Lys Val Ala Ile
2705 2710 2715
Ile Glu Leu Thr Asp Gly Trp Tyr Ala Val Lys Ala Gln Leu Asp
2720 2725 2730
Pro Pro Leu Leu Ala Val Leu Lys Asn Gly Arg Leu Thr Val Gly
2735 2740 2745
Gln Lys Ile Ile Leu His Gly Ala Glu Leu Val Gly Ser Pro Asp
2750 2755 2760
Ala Cys Thr Pro Leu Glu Ala Pro Glu Ser Leu Met Leu Lys Ile
2765 2770 2775
Ser Ala Asn Ser Thr Arg Pro Ala Arg Trp Tyr Thr Lys Leu Gly
2780 2785 2790
Phe Phe Pro Asp Pro Arg Pro Phe Pro Leu Pro Leu Ser Ser Leu
2795 2800 2805
Phe Ser Asp Gly Gly Asn Val Gly Cys Val Asp Val Ile Ile Gln
2810 2815 2820
Arg Ala Tyr Pro Ile Gln Trp Met Glu Lys Thr Ser Ser Gly Leu
2825 2830 2835
Tyr Ile Phe Arg Asn Glu Arg Glu Glu Glu Lys Glu Ala Ala Lys
2840 2845 2850
Tyr Val Glu Ala Gln Gln Lys Arg Leu Glu Ala Leu Phe Thr Lys
2855 2860 2865
Ile Gln Glu Glu Phe Glu Glu His Glu Glu Asn Thr Thr Lys Pro
2870 2875 2880
Tyr Leu Pro Ser Arg Ala Leu Thr Arg Gln Gln Val Arg Ala Leu
2885 2890 2895
Gln Asp Gly Ala Glu Leu Tyr Glu Ala Val Lys Asn Ala Ala Asp
2900 2905 2910
Pro Ala Tyr Leu Glu Gly Tyr Phe Ser Glu Glu Gln Leu Arg Ala
2915 2920 2925
Leu Asn Asn His Arg Gln Met Leu Asn Asp Lys Lys Gln Ala Gln
2930 2935 2940
Ile Gln Leu Glu Ile Arg Lys Ala Met Glu Ser Ala Glu Gln Lys
2945 2950 2955
Glu Gln Gly Leu Ser Arg Asp Val Thr Thr Val Trp Lys Leu Arg
2960 2965 2970
Ile Val Ser Tyr Ser Lys Lys Glu Lys Asp Ser Val Ile Leu Ser
2975 2980 2985
Ile Trp Arg Pro Ser Ser Asp Leu Tyr Ser Leu Leu Thr Glu Gly
2990 2995 3000
Lys Arg Tyr Arg Ile Tyr His Leu Ala Thr Ser Lys Ser Lys Ser
3005 3010 3015
Lys Ser Glu Arg Ala Asn Ile Gln Leu Ala Ala Thr Lys Lys Thr
3020 3025 3030
Gln Tyr Gln Gln Leu Pro Val Ser Asp Glu Ile Leu Phe Gln Ile
3035 3040 3045
Tyr Gln Pro Arg Glu Pro Leu His Phe Ser Lys Phe Leu Asp Pro
3050 3055 3060
Asp Phe Gln Pro Ser Cys Ser Glu Val Asp Leu Ile Gly Phe Val
3065 3070 3075
Val Ser Val Val Lys Lys Thr Gly Leu Ala Pro Phe Val Tyr Leu
3080 3085 3090
Ser Asp Glu Cys Tyr Asn Leu Leu Ala Ile Lys Phe Trp Ile Asp
3095 3100 3105
Leu Asn Glu Asp Ile Ile Lys Pro His Met Leu Ile Ala Ala Ser
3110 3115 3120
Asn Leu Gln Trp Arg Pro Glu Ser Lys Ser Gly Leu Leu Thr Leu
3125 3130 3135
Phe Ala Gly Asp Phe Ser Val Phe Ser Ala Ser Pro Lys Glu Gly
3140 3145 3150
His Phe Gln Glu Thr Phe Asn Lys Met Lys Asn Thr Val Glu Asn
3155 3160 3165
Ile Asp Ile Leu Cys Asn Glu Ala Glu Asn Lys Leu Met His Ile
3170 3175 3180
Leu His Ala Asn Asp Pro Lys Trp Ser Thr Pro Thr Lys Asp Cys
3185 3190 3195
Thr Ser Gly Pro Tyr Thr Ala Gln Ile Ile Pro Gly Thr Gly Asn
3200 3205 3210
Lys Leu Leu Met Ser Ser Pro Asn Cys Glu Ile Tyr Tyr Gln Ser
3215 3220 3225
Pro Leu Ser Leu Cys Met Ala Lys Arg Lys Ser Val Ser Thr Pro
3230 3235 3240
Val Ser Ala Gln Met Thr Ser Lys Ser Cys Lys Gly Glu Lys Glu
3245 3250 3255
Ile Asp Asp Gln Lys Asn Cys Lys Lys Arg Arg Ala Leu Asp Phe
3260 3265 3270
Leu Ser Arg Leu Pro Leu Pro Pro Pro Val Ser Pro Ile Cys Thr
3275 3280 3285
Phe Val Ser Pro Ala Ala Gln Lys Ala Phe Gln Pro Pro Arg Ser
3290 3295 3300
Cys Gly Thr Lys Tyr Glu Thr Pro Ile Lys Lys Lys Glu Leu Asn
3305 3310 3315
Ser Pro Gln Met Thr Pro Phe Lys Lys Phe Asn Glu Ile Ser Leu
3320 3325 3330
Leu Glu Ser Asn Ser Ile Ala Asp Glu Glu Leu Ala Leu Ile Asn
3335 3340 3345
Thr Gln Ala Leu Leu Ser Gly Ser Thr Gly Glu Lys Gln Phe Ile
3350 3355 3360
Ser Val Ser Glu Ser Thr Arg Thr Ala Pro Thr Ser Ser Glu Asp
3365 3370 3375
Tyr Leu Arg Leu Lys Arg Arg Cys Thr Thr Ser Leu Ile Lys Glu
3380 3385 3390
Gln Glu Ser Ser Gln Ala Ser Thr Glu Glu Cys Glu Lys Asn Lys
3395 3400 3405
Gln Asp Thr Ile Thr Thr Lys Lys Tyr Ile
3410 3415
<210> 26
<211> 1881
<212> DNA
<213> 智人(Homo sapiens)
<400> 26
atgcagcgag ccgattccga gcagccctcc aagcgtcccc gttgcgatga cagcccgaga 60
accccctcaa acaccccttc cgcagaggca gactggtccc cgggcctgga actccatccc 120
gactacaaga catggggtcc ggagcaggtg tgctccttcc tcaggcgcgg tggctttgaa 180
gagccggtgc tgctgaagaa catccgagaa aatgaaatca caggcgcatt actgccttgt 240
cttgatgagt ctcgttttga aaatcttgga gtaagttcct tgggggagag gaagaagctg 300
cttagttata tccagcgatt ggttcaaatc cacgttgata caatgaaggt aattaatgat 360
cctatccatg gccacattga gctccaccct ctcctcgtcc gaatcattga tacacctcaa 420
tttcaacgtc ttcgatacat caaacagctg ggaggtggtt actatgtttt tccaggagct 480
tcacacaatc gatttgagca tagtctaggg gtggggtatc tagcaggatg tctagttcac 540
gcactgggtg aaaaacaacc agagctgcag ataagtgaac gagatgttct ctgtgttcag 600
attgctggac tttgtcatga tctcggtcat gggccatttt ctcacatgtt tgatggacga 660
tttattccac ttgctcgccc ggaggtgaaa tggacgcatg aacaaggctc agttatgatg 720
tttgagcacc ttattaattc taatggaatt aagcctgtca tggaacaata tggtctcatc 780
cctgaagaag atatttgctt tataaaggaa caaattgtag gaccacttga atcacctgtc 840
gaagattcat tgtggccata taaagggcgt cctgaaaaca aaagcttcct ttatgagata 900
gtatctaata aaagaaatgg cattgatgtg gacaaatggg attattttgc cagggactgc 960
catcatcttg gaatccaaaa taattttgat tacaagcgct ttattaagtt tgcccgtgtc 1020
tgtgaagtag acaatgagtt gcgtatttgt gctagagata aggaagttgg aaatctgtat 1080
gacatgttcc acactcgcaa ctctttacac cgtagagctt atcaacacaa agttggcaac 1140
attattgata caatgattac agatgctttc ctcaaagcag atgactacat agagattaca 1200
ggtgctggag gaaaaaagta tcgcatttct acagcaattg acgacatgga agcctatact 1260
aagctgacag ataacatttt tctggagatt ttatactcta ctgatcccaa attgaaagac 1320
gcacgagaga ttttaaaaca aattgaatac cgtaatctat tcaagtatgt gggtgagacg 1380
cagccaacag gacaaataaa gattaaaagg gaggactatg aatctcttcc aaaagaggtt 1440
gccagtgcta aacccaaagt attgctagac gtgaaactga aggctgaaga ttttatagtg 1500
gatgttatca acatggatta tggaatgcaa gaaaagaatc caattgatca tgttagcttc 1560
tattgtaaga ctgcccccaa cagagcaatc aggattacta aaaaccaggt ttcacaactt 1620
ctgccagaga aatttgcaga gcagctgatt cgagtatatt gtaagaaggt ggacagaaag 1680
agtttgtatg ccgcaagaca atattttgtt cagtggtgtg cagacagaaa tttcaccaag 1740
ccgcaggatg gcgatgttat agccccactc ataacacctc aaaaaaagga atggaacgac 1800
agtacttcag tccaaaatcc aactcgcctc cgagaagcat ccaaaagcag agtccagctt 1860
tttaaagatg acccaatgtg a 1881
<210> 27
<211> 626
<212> PRT
<213> 智人(Homo sapiens)
<400> 27
Met Gln Arg Ala Asp Ser Glu Gln Pro Ser Lys Arg Pro Arg Cys Asp
1 5 10 15
Asp Ser Pro Arg Thr Pro Ser Asn Thr Pro Ser Ala Glu Ala Asp Trp
20 25 30
Ser Pro Gly Leu Glu Leu His Pro Asp Tyr Lys Thr Trp Gly Pro Glu
35 40 45
Gln Val Cys Ser Phe Leu Arg Arg Gly Gly Phe Glu Glu Pro Val Leu
50 55 60
Leu Lys Asn Ile Arg Glu Asn Glu Ile Thr Gly Ala Leu Leu Pro Cys
65 70 75 80
Leu Asp Glu Ser Arg Phe Glu Asn Leu Gly Val Ser Ser Leu Gly Glu
85 90 95
Arg Lys Lys Leu Leu Ser Tyr Ile Gln Arg Leu Val Gln Ile His Val
100 105 110
Asp Thr Met Lys Val Ile Asn Asp Pro Ile His Gly His Ile Glu Leu
115 120 125
His Pro Leu Leu Val Arg Ile Ile Asp Thr Pro Gln Phe Gln Arg Leu
130 135 140
Arg Tyr Ile Lys Gln Leu Gly Gly Gly Tyr Tyr Val Phe Pro Gly Ala
145 150 155 160
Ser His Asn Arg Phe Glu His Ser Leu Gly Val Gly Tyr Leu Ala Gly
165 170 175
Cys Leu Val His Ala Leu Gly Glu Lys Gln Pro Glu Leu Gln Ile Ser
180 185 190
Glu Arg Asp Val Leu Cys Val Gln Ile Ala Gly Leu Cys His Asp Leu
195 200 205
Gly His Gly Pro Phe Ser His Met Phe Asp Gly Arg Phe Ile Pro Leu
210 215 220
Ala Arg Pro Glu Val Lys Trp Thr His Glu Gln Gly Ser Val Met Met
225 230 235 240
Phe Glu His Leu Ile Asn Ser Asn Gly Ile Lys Pro Val Met Glu Gln
245 250 255
Tyr Gly Leu Ile Pro Glu Glu Asp Ile Cys Phe Ile Lys Glu Gln Ile
260 265 270
Val Gly Pro Leu Glu Ser Pro Val Glu Asp Ser Leu Trp Pro Tyr Lys
275 280 285
Gly Arg Pro Glu Asn Lys Ser Phe Leu Tyr Glu Ile Val Ser Asn Lys
290 295 300
Arg Asn Gly Ile Asp Val Asp Lys Trp Asp Tyr Phe Ala Arg Asp Cys
305 310 315 320
His His Leu Gly Ile Gln Asn Asn Phe Asp Tyr Lys Arg Phe Ile Lys
325 330 335
Phe Ala Arg Val Cys Glu Val Asp Asn Glu Leu Arg Ile Cys Ala Arg
340 345 350
Asp Lys Glu Val Gly Asn Leu Tyr Asp Met Phe His Thr Arg Asn Ser
355 360 365
Leu His Arg Arg Ala Tyr Gln His Lys Val Gly Asn Ile Ile Asp Thr
370 375 380
Met Ile Thr Asp Ala Phe Leu Lys Ala Asp Asp Tyr Ile Glu Ile Thr
385 390 395 400
Gly Ala Gly Gly Lys Lys Tyr Arg Ile Ser Thr Ala Ile Asp Asp Met
405 410 415
Glu Ala Tyr Thr Lys Leu Thr Asp Asn Ile Phe Leu Glu Ile Leu Tyr
420 425 430
Ser Thr Asp Pro Lys Leu Lys Asp Ala Arg Glu Ile Leu Lys Gln Ile
435 440 445
Glu Tyr Arg Asn Leu Phe Lys Tyr Val Gly Glu Thr Gln Pro Thr Gly
450 455 460
Gln Ile Lys Ile Lys Arg Glu Asp Tyr Glu Ser Leu Pro Lys Glu Val
465 470 475 480
Ala Ser Ala Lys Pro Lys Val Leu Leu Asp Val Lys Leu Lys Ala Glu
485 490 495
Asp Phe Ile Val Asp Val Ile Asn Met Asp Tyr Gly Met Gln Glu Lys
500 505 510
Asn Pro Ile Asp His Val Ser Phe Tyr Cys Lys Thr Ala Pro Asn Arg
515 520 525
Ala Ile Arg Ile Thr Lys Asn Gln Val Ser Gln Leu Leu Pro Glu Lys
530 535 540
Phe Ala Glu Gln Leu Ile Arg Val Tyr Cys Lys Lys Val Asp Arg Lys
545 550 555 560
Ser Leu Tyr Ala Ala Arg Gln Tyr Phe Val Gln Trp Cys Ala Asp Arg
565 570 575
Asn Phe Thr Lys Pro Gln Asp Gly Asp Val Ile Ala Pro Leu Ile Thr
580 585 590
Pro Gln Lys Lys Glu Trp Asn Asp Ser Thr Ser Val Gln Asn Pro Thr
595 600 605
Arg Leu Arg Glu Ala Ser Lys Ser Arg Val Gln Leu Phe Lys Asp Asp
610 615 620
Pro Met
625
<210> 28
<211> 1776
<212> DNA
<213> 智人(Homo sapiens)
<400> 28
atgcagcgag ccgattccga gcagccctcc aagcgtcccc gttgcgatga cagcccgaga 60
accccctcaa acaccccttc cgcagaggca gactggtccc cgggcctgga actccatccc 120
gactacaaga catggggtcc ggagcaggtg tgctccttcc tcaggcgcgg tggctttgaa 180
gagccggtgc tgctgaagaa catccgagaa aatgaaatca caggcgcatt actgccttgt 240
cttgatgagt ctcgttttga aaatcttgga gtaagttcct tgggggagag gaagaagctg 300
cttagttata tccagcgatt ggttcaaatc cacgttgata caatgaaggt aattaatgat 360
cctatccatg gccacattga gctccaccct ctcctcgtcc gaatcattga tacacctcaa 420
tttcaacgtc ttcgatacat caaacagctg ggaggtggtt actatgtttt tccaggagct 480
tcacacaatc gatttgagca tagtctaggg gtggggtatc tagcaggatg tctagttcac 540
gcactgggtg aaaaacaacc agagctgcag ataagtgaac gagatgttct ctgtgttcag 600
attgctggac tttgtcatga tctcggtcat gggccatttt ctcacatgtt tgatggacga 660
tttattccac ttgctcgccc ggaggtgaaa tggacgcatg aacaaggctc agttatgatg 720
tttgagcacc ttattaattc taatggaatt aagcctgtca tggaacaata tggtctcatc 780
cctgaagaag atatttgctt tataaaggaa caaattgtag gaccacttga atcacctgtc 840
gaagattcat tgtggccata taaagggcgt cctgaaaaca aaagcttcct ttatgagata 900
gtatctaata aaagaaatgg cattgatgtg gacaaatggg attattttgc cagggactgc 960
catcatcttg gaatccaaaa taattttgat tacaagcgct ttattaagtt tgcccgtgtc 1020
tgtgaagtag acaatgagtt gcgtatttgt gctagagata aggaagttgg aaatctgtat 1080
gacatgttcc acactcgcaa ctctttacac cgtagagctt atcaacacaa agttggcaac 1140
attattgata caatgattac agatgctttc ctcaaagcag atgactacat agagattaca 1200
ggtgctggag gaaaaaagta tcgcatttct acagcaattg acgacatgga agcctatact 1260
aagctgacag ataacatttt tctggagatt ttatactcta ctgatcccaa attgaaagac 1320
gcacgagaga ttttaaaaca aattgaatac cgtaatctat tcaagtatgt gggtgagacg 1380
cagccaacag gacaaataaa gattaaaagg gaggactatg aatctcttcc aaaagaggtt 1440
gccagtgcta aacccaaagt attgctagac gtgaaactga aggctgaaga ttttatagtg 1500
gatgtttcac aacttctgcc agagaaattt gcagagcagc tgattcgagt atattgtaag 1560
aaggtggaca gaaagagttt gtatgccgca agacaatatt ttgttcagtg gtgtgcagac 1620
agaaatttca ccaagccgca ggatggcgat gttatagccc cactcataac acctcaaaaa 1680
aaggaatgga acgacagtac ttcagtccaa aatccaactc gcctccgaga agcatccaaa 1740
agcagagtcc agctttttaa agatgaccca atgtga 1776
<210> 29
<211> 591
<212> PRT
<213> 智人(Homo sapiens)
<400> 29
Met Gln Arg Ala Asp Ser Glu Gln Pro Ser Lys Arg Pro Arg Cys Asp
1 5 10 15
Asp Ser Pro Arg Thr Pro Ser Asn Thr Pro Ser Ala Glu Ala Asp Trp
20 25 30
Ser Pro Gly Leu Glu Leu His Pro Asp Tyr Lys Thr Trp Gly Pro Glu
35 40 45
Gln Val Cys Ser Phe Leu Arg Arg Gly Gly Phe Glu Glu Pro Val Leu
50 55 60
Leu Lys Asn Ile Arg Glu Asn Glu Ile Thr Gly Ala Leu Leu Pro Cys
65 70 75 80
Leu Asp Glu Ser Arg Phe Glu Asn Leu Gly Val Ser Ser Leu Gly Glu
85 90 95
Arg Lys Lys Leu Leu Ser Tyr Ile Gln Arg Leu Val Gln Ile His Val
100 105 110
Asp Thr Met Lys Val Ile Asn Asp Pro Ile His Gly His Ile Glu Leu
115 120 125
His Pro Leu Leu Val Arg Ile Ile Asp Thr Pro Gln Phe Gln Arg Leu
130 135 140
Arg Tyr Ile Lys Gln Leu Gly Gly Gly Tyr Tyr Val Phe Pro Gly Ala
145 150 155 160
Ser His Asn Arg Phe Glu His Ser Leu Gly Val Gly Tyr Leu Ala Gly
165 170 175
Cys Leu Val His Ala Leu Gly Glu Lys Gln Pro Glu Leu Gln Ile Ser
180 185 190
Glu Arg Asp Val Leu Cys Val Gln Ile Ala Gly Leu Cys His Asp Leu
195 200 205
Gly His Gly Pro Phe Ser His Met Phe Asp Gly Arg Phe Ile Pro Leu
210 215 220
Ala Arg Pro Glu Val Lys Trp Thr His Glu Gln Gly Ser Val Met Met
225 230 235 240
Phe Glu His Leu Ile Asn Ser Asn Gly Ile Lys Pro Val Met Glu Gln
245 250 255
Tyr Gly Leu Ile Pro Glu Glu Asp Ile Cys Phe Ile Lys Glu Gln Ile
260 265 270
Val Gly Pro Leu Glu Ser Pro Val Glu Asp Ser Leu Trp Pro Tyr Lys
275 280 285
Gly Arg Pro Glu Asn Lys Ser Phe Leu Tyr Glu Ile Val Ser Asn Lys
290 295 300
Arg Asn Gly Ile Asp Val Asp Lys Trp Asp Tyr Phe Ala Arg Asp Cys
305 310 315 320
His His Leu Gly Ile Gln Asn Asn Phe Asp Tyr Lys Arg Phe Ile Lys
325 330 335
Phe Ala Arg Val Cys Glu Val Asp Asn Glu Leu Arg Ile Cys Ala Arg
340 345 350
Asp Lys Glu Val Gly Asn Leu Tyr Asp Met Phe His Thr Arg Asn Ser
355 360 365
Leu His Arg Arg Ala Tyr Gln His Lys Val Gly Asn Ile Ile Asp Thr
370 375 380
Met Ile Thr Asp Ala Phe Leu Lys Ala Asp Asp Tyr Ile Glu Ile Thr
385 390 395 400
Gly Ala Gly Gly Lys Lys Tyr Arg Ile Ser Thr Ala Ile Asp Asp Met
405 410 415
Glu Ala Tyr Thr Lys Leu Thr Asp Asn Ile Phe Leu Glu Ile Leu Tyr
420 425 430
Ser Thr Asp Pro Lys Leu Lys Asp Ala Arg Glu Ile Leu Lys Gln Ile
435 440 445
Glu Tyr Arg Asn Leu Phe Lys Tyr Val Gly Glu Thr Gln Pro Thr Gly
450 455 460
Gln Ile Lys Ile Lys Arg Glu Asp Tyr Glu Ser Leu Pro Lys Glu Val
465 470 475 480
Ala Ser Ala Lys Pro Lys Val Leu Leu Asp Val Lys Leu Lys Ala Glu
485 490 495
Asp Phe Ile Val Asp Val Ser Gln Leu Leu Pro Glu Lys Phe Ala Glu
500 505 510
Gln Leu Ile Arg Val Tyr Cys Lys Lys Val Asp Arg Lys Ser Leu Tyr
515 520 525
Ala Ala Arg Gln Tyr Phe Val Gln Trp Cys Ala Asp Arg Asn Phe Thr
530 535 540
Lys Pro Gln Asp Gly Asp Val Ile Ala Pro Leu Ile Thr Pro Gln Lys
545 550 555 560
Lys Glu Trp Asn Asp Ser Thr Ser Val Gln Asn Pro Thr Arg Leu Arg
565 570 575
Glu Ala Ser Lys Ser Arg Val Gln Leu Phe Lys Asp Asp Pro Met
580 585 590
<210> 30
<211> 1770
<212> DNA
<213> 智人(Homo sapiens)
<400> 30
atgcagcgag ccgattccga gcagccctcc aagcgtcccc gttgcgatga cagcccgaga 60
accccctcaa acaccccttc cgcagaggca gactggtccc cgggcctgga actccatccc 120
gactacaaga catggggtcc ggagcaggtg tgctccttcc tcaggcgcgg tggctttgaa 180
gagccggtgc tgctgaagaa catccgagaa aatgaaatca caggcgcatt actgccttgt 240
cttgatgagt ctcgttttga aaatcttgga gtaagttcct tgggggagag gaagaagctg 300
cttagttata tccagcgatt ggttcaaatc cacgttgata caatgaaggt aattaatgat 360
cctatccatg gccacattga gctccaccct ctcctcgtcc gaatcattga tacacctcaa 420
tttcaacgtc ttcgatacat caaacagctg ggaggtggtt actatgtttt tccaggagct 480
tcacacaatc gatttgagca tagtctaggg gtggggtatc tagcaggatg tctagttcac 540
gcactgggtg aaaaacaacc agagctgcag ataagtgaac gagatgttct ctgtgttcag 600
attgctggac tttgtcatga tctcggtcat gggccatttt ctcacatgtt tgatggacga 660
tttattccac ttgctcgccc ggaggtgaaa tggacgcatg aacaaggctc agttatgatg 720
tttgagcacc ttattaattc taatggaatt aagcctgtca tggaacaata tggtctcatc 780
cctgaagaag atatttgctt tataaaggaa caaattgtag gaccacttga atcacctgtc 840
gaagattcat tgtggccata taaagggcgt cctgaaaaca aaagcttcct ttatgagata 900
gtatctaata aaagaaatgg cattgatgtg gacaaatggg attattttgc cagggactgc 960
catcatcttg gaatccaaaa taattttgat tacaagcgct ttattaagtt tgcccgtgtc 1020
tgtgaagtag acaatgagtt gcgtatttgt gctagagata aggaagttgg aaatctgtat 1080
gacatgttcc acactcgcaa ctctttacac cgtagagctt atcaacacaa agttggcaac 1140
attattgata caatgattac agatgctttc ctcaaagcag atgactacat agagattaca 1200
ggtgctggag gaaaaaagta tcgcatttct acagcaattg acgacatgga agcctatact 1260
aagctgacag ataacatttt tctggagatt ttatactcta ctgatcccaa attgaaagac 1320
gcacgagaga ttttaaaaca aattgaatac cgtaatctat tcaagtatgt gggtgagacg 1380
cagccaacag gacaaataaa gattaaaagg gaggactatg aatctcttcc aaaagaggtt 1440
gccagtgcta aacccaaagt attgctagac gtgaaactga aggctgaaga ttttatagtg 1500
gatgttatca acatggatta tggaatgcaa gaaaagaatc caattgatca tgttagcttc 1560
tattgtaaga ctgcccccaa cagagcaatc aggattacta aaaaccaggt ttcacaactt 1620
ctgccagaga aatttgcaga gcagctgatt cgagtatatt gtaagaaggt ggacagaaag 1680
agtttgtatg ccgcaagaca atattttgtt cagtggtgtg cagacagaaa tttcaccaag 1740
ccgcagtctc ccaccagagc ctcccactga 1770
<210> 31
<211> 589
<212> PRT
<213> 智人(Homo sapiens)
<400> 31
Met Gln Arg Ala Asp Ser Glu Gln Pro Ser Lys Arg Pro Arg Cys Asp
1 5 10 15
Asp Ser Pro Arg Thr Pro Ser Asn Thr Pro Ser Ala Glu Ala Asp Trp
20 25 30
Ser Pro Gly Leu Glu Leu His Pro Asp Tyr Lys Thr Trp Gly Pro Glu
35 40 45
Gln Val Cys Ser Phe Leu Arg Arg Gly Gly Phe Glu Glu Pro Val Leu
50 55 60
Leu Lys Asn Ile Arg Glu Asn Glu Ile Thr Gly Ala Leu Leu Pro Cys
65 70 75 80
Leu Asp Glu Ser Arg Phe Glu Asn Leu Gly Val Ser Ser Leu Gly Glu
85 90 95
Arg Lys Lys Leu Leu Ser Tyr Ile Gln Arg Leu Val Gln Ile His Val
100 105 110
Asp Thr Met Lys Val Ile Asn Asp Pro Ile His Gly His Ile Glu Leu
115 120 125
His Pro Leu Leu Val Arg Ile Ile Asp Thr Pro Gln Phe Gln Arg Leu
130 135 140
Arg Tyr Ile Lys Gln Leu Gly Gly Gly Tyr Tyr Val Phe Pro Gly Ala
145 150 155 160
Ser His Asn Arg Phe Glu His Ser Leu Gly Val Gly Tyr Leu Ala Gly
165 170 175
Cys Leu Val His Ala Leu Gly Glu Lys Gln Pro Glu Leu Gln Ile Ser
180 185 190
Glu Arg Asp Val Leu Cys Val Gln Ile Ala Gly Leu Cys His Asp Leu
195 200 205
Gly His Gly Pro Phe Ser His Met Phe Asp Gly Arg Phe Ile Pro Leu
210 215 220
Ala Arg Pro Glu Val Lys Trp Thr His Glu Gln Gly Ser Val Met Met
225 230 235 240
Phe Glu His Leu Ile Asn Ser Asn Gly Ile Lys Pro Val Met Glu Gln
245 250 255
Tyr Gly Leu Ile Pro Glu Glu Asp Ile Cys Phe Ile Lys Glu Gln Ile
260 265 270
Val Gly Pro Leu Glu Ser Pro Val Glu Asp Ser Leu Trp Pro Tyr Lys
275 280 285
Gly Arg Pro Glu Asn Lys Ser Phe Leu Tyr Glu Ile Val Ser Asn Lys
290 295 300
Arg Asn Gly Ile Asp Val Asp Lys Trp Asp Tyr Phe Ala Arg Asp Cys
305 310 315 320
His His Leu Gly Ile Gln Asn Asn Phe Asp Tyr Lys Arg Phe Ile Lys
325 330 335
Phe Ala Arg Val Cys Glu Val Asp Asn Glu Leu Arg Ile Cys Ala Arg
340 345 350
Asp Lys Glu Val Gly Asn Leu Tyr Asp Met Phe His Thr Arg Asn Ser
355 360 365
Leu His Arg Arg Ala Tyr Gln His Lys Val Gly Asn Ile Ile Asp Thr
370 375 380
Met Ile Thr Asp Ala Phe Leu Lys Ala Asp Asp Tyr Ile Glu Ile Thr
385 390 395 400
Gly Ala Gly Gly Lys Lys Tyr Arg Ile Ser Thr Ala Ile Asp Asp Met
405 410 415
Glu Ala Tyr Thr Lys Leu Thr Asp Asn Ile Phe Leu Glu Ile Leu Tyr
420 425 430
Ser Thr Asp Pro Lys Leu Lys Asp Ala Arg Glu Ile Leu Lys Gln Ile
435 440 445
Glu Tyr Arg Asn Leu Phe Lys Tyr Val Gly Glu Thr Gln Pro Thr Gly
450 455 460
Gln Ile Lys Ile Lys Arg Glu Asp Tyr Glu Ser Leu Pro Lys Glu Val
465 470 475 480
Ala Ser Ala Lys Pro Lys Val Leu Leu Asp Val Lys Leu Lys Ala Glu
485 490 495
Asp Phe Ile Val Asp Val Ile Asn Met Asp Tyr Gly Met Gln Glu Lys
500 505 510
Asn Pro Ile Asp His Val Ser Phe Tyr Cys Lys Thr Ala Pro Asn Arg
515 520 525
Ala Ile Arg Ile Thr Lys Asn Gln Val Ser Gln Leu Leu Pro Glu Lys
530 535 540
Phe Ala Glu Gln Leu Ile Arg Val Tyr Cys Lys Lys Val Asp Arg Lys
545 550 555 560
Ser Leu Tyr Ala Ala Arg Gln Tyr Phe Val Gln Trp Cys Ala Asp Arg
565 570 575
Asn Phe Thr Lys Pro Gln Ser Pro Thr Arg Ala Ser His
580 585
<210> 32
<211> 1083
<212> DNA
<213> 智人(Homo sapiens)
<400> 32
atgatcccgc tgctgctggc agcgctgctg tgcgtccccg ccggggccct gacctgctac 60
ggggactccg ggcagcctgt agactggttc gtggtctaca agctgccagc tcttagaggg 120
tccggggagg cggcgcagag agggctgcag tacaagtatc tggacgagag ctccggaggc 180
tggcgggacg gcagggcact catcaacagc ccggaggggg ccgtgggccg aagcctgcag 240
ccgctgtacc ggagcaacac cagccagctc gccttcctgc tctacaatga ccaaccgcct 300
caacccagca aggctcagga ctcttccatg cgtgggcaca cgaagggtgt cctgctcctt 360
gaccacgatg ggggcttctg gctggtccac agtgtaccta acttccctcc accggcctcc 420
tctgctgcat acagctggcc tcatagcgcc tgtacctacg ggcagaccct gctctgtgtg 480
tcttttccct tcgctcagtt ctcgaagatg ggcaagcagc tgacctacac ctacccctgg 540
gtctataact accagctgga agggatcttt gcccaggaat tccccgactt ggagaatgtg 600
gtcaagggcc accacgttag ccaagaaccc tggaacagca gcatcacact cacatcccag 660
gccggggctg ttttccagag ctttgccaag ttcagcaaat ttggagatga cctgtactcc 720
ggctggttgg cagcagccct tggtaccaac ctgcaggtcc agttctggca caaaactgta 780
ggcatcctgc cctctaactg ctcggatatc tggcaggttc tgaatgtgaa ccagatagct 840
ttccctggac cagccggccc aagcttcaac agcacagagg accactccaa atggtgcgtg 900
tccccaaaag ggccctggac ctgcgtgggt gacatgaatc ggaaccaggg agaggagcaa 960
cggggtgggg gcacactgtg tgcccagctg ccagccctct ggaaagcctt ccagccgctg 1020
gtgaagaact accagccctg taatggcatg gccaggaagc ccagcagagc ttataagatc 1080
taa 1083
<210> 33
<211> 360
<212> PRT
<213> 智人(Homo sapiens)
<400> 33
Met Ile Pro Leu Leu Leu Ala Ala Leu Leu Cys Val Pro Ala Gly Ala
1 5 10 15
Leu Thr Cys Tyr Gly Asp Ser Gly Gln Pro Val Asp Trp Phe Val Val
20 25 30
Tyr Lys Leu Pro Ala Leu Arg Gly Ser Gly Glu Ala Ala Gln Arg Gly
35 40 45
Leu Gln Tyr Lys Tyr Leu Asp Glu Ser Ser Gly Gly Trp Arg Asp Gly
50 55 60
Arg Ala Leu Ile Asn Ser Pro Glu Gly Ala Val Gly Arg Ser Leu Gln
65 70 75 80
Pro Leu Tyr Arg Ser Asn Thr Ser Gln Leu Ala Phe Leu Leu Tyr Asn
85 90 95
Asp Gln Pro Pro Gln Pro Ser Lys Ala Gln Asp Ser Ser Met Arg Gly
100 105 110
His Thr Lys Gly Val Leu Leu Leu Asp His Asp Gly Gly Phe Trp Leu
115 120 125
Val His Ser Val Pro Asn Phe Pro Pro Pro Ala Ser Ser Ala Ala Tyr
130 135 140
Ser Trp Pro His Ser Ala Cys Thr Tyr Gly Gln Thr Leu Leu Cys Val
145 150 155 160
Ser Phe Pro Phe Ala Gln Phe Ser Lys Met Gly Lys Gln Leu Thr Tyr
165 170 175
Thr Tyr Pro Trp Val Tyr Asn Tyr Gln Leu Glu Gly Ile Phe Ala Gln
180 185 190
Glu Phe Pro Asp Leu Glu Asn Val Val Lys Gly His His Val Ser Gln
195 200 205
Glu Pro Trp Asn Ser Ser Ile Thr Leu Thr Ser Gln Ala Gly Ala Val
210 215 220
Phe Gln Ser Phe Ala Lys Phe Ser Lys Phe Gly Asp Asp Leu Tyr Ser
225 230 235 240
Gly Trp Leu Ala Ala Ala Leu Gly Thr Asn Leu Gln Val Gln Phe Trp
245 250 255
His Lys Thr Val Gly Ile Leu Pro Ser Asn Cys Ser Asp Ile Trp Gln
260 265 270
Val Leu Asn Val Asn Gln Ile Ala Phe Pro Gly Pro Ala Gly Pro Ser
275 280 285
Phe Asn Ser Thr Glu Asp His Ser Lys Trp Cys Val Ser Pro Lys Gly
290 295 300
Pro Trp Thr Cys Val Gly Asp Met Asn Arg Asn Gln Gly Glu Glu Gln
305 310 315 320
Arg Gly Gly Gly Thr Leu Cys Ala Gln Leu Pro Ala Leu Trp Lys Ala
325 330 335
Phe Gln Pro Leu Val Lys Asn Tyr Gln Pro Cys Asn Gly Met Ala Arg
340 345 350
Lys Pro Ser Arg Ala Tyr Lys Ile
355 360
<210> 34
<211> 1029
<212> DNA
<213> 智人(Homo sapiens)
<400> 34
tgctacgggg actccgggca gcctgtagac tggttcgtgg tctacaagct gccagctctt 60
agagggtccg gggaggcggc gcagagaggg ctgcagtaca agtatctgga cgagagctcc 120
ggaggctggc gggacggcag ggcactcatc aacagcccgg agggggccgt gggccgaagc 180
ctgcagccgc tgtaccggag caacaccagc cagctcgcct tcctgctcta caatgaccaa 240
ccgcctcaac ccagcaaggc tcaggactct tccatgcgtg ggcacacgaa gggtgtcctg 300
ctccttgacc acgatggggg cttctggctg gtccacagtg tacctaactt ccctccaccg 360
gcctcctctg ctgcatacag ctggcctcat agcgcctgta cctacgggca gaccctgctc 420
tgtgtgtctt ttcccttcgc tcagttctcg aagatgggca agcagctgac ctacacctac 480
ccctgggtct ataactacca gctggaaggg atctttgccc aggaattccc cgacttggag 540
aatgtggtca agggccacca cgttagccaa gaaccctgga acagcagcat cacactcaca 600
tcccaggccg gggctgtttt ccagagcttt gccaagttca gcaaatttgg agatgacctg 660
tactccggct ggttggcagc agcccttggt accaacctgc aggtccagtt ctggcacaaa 720
actgtaggca tcctgccctc taactgctcg gatatctggc aggttctgaa tgtgaaccag 780
atagctttcc ctggaccagc cggcccaagc ttcaacagca cagaggacca ctccaaatgg 840
tgcgtgtccc caaaagggcc ctggacctgc gtgggtgaca tgaatcggaa ccagggagag 900
gagcaacggg gtgggggcac actgtgtgcc cagctgccag ccctctggaa agccttccag 960
ccgctggtga agaactacca gccctgtaat ggcatggcca ggaagcccag cagagcttat 1020
aagatctaa 1029
<210> 35
<211> 342
<212> PRT
<213> 智人(Homo sapiens)
<400> 35
Cys Tyr Gly Asp Ser Gly Gln Pro Val Asp Trp Phe Val Val Tyr Lys
1 5 10 15
Leu Pro Ala Leu Arg Gly Ser Gly Glu Ala Ala Gln Arg Gly Leu Gln
20 25 30
Tyr Lys Tyr Leu Asp Glu Ser Ser Gly Gly Trp Arg Asp Gly Arg Ala
35 40 45
Leu Ile Asn Ser Pro Glu Gly Ala Val Gly Arg Ser Leu Gln Pro Leu
50 55 60
Tyr Arg Ser Asn Thr Ser Gln Leu Ala Phe Leu Leu Tyr Asn Asp Gln
65 70 75 80
Pro Pro Gln Pro Ser Lys Ala Gln Asp Ser Ser Met Arg Gly His Thr
85 90 95
Lys Gly Val Leu Leu Leu Asp His Asp Gly Gly Phe Trp Leu Val His
100 105 110
Ser Val Pro Asn Phe Pro Pro Pro Ala Ser Ser Ala Ala Tyr Ser Trp
115 120 125
Pro His Ser Ala Cys Thr Tyr Gly Gln Thr Leu Leu Cys Val Ser Phe
130 135 140
Pro Phe Ala Gln Phe Ser Lys Met Gly Lys Gln Leu Thr Tyr Thr Tyr
145 150 155 160
Pro Trp Val Tyr Asn Tyr Gln Leu Glu Gly Ile Phe Ala Gln Glu Phe
165 170 175
Pro Asp Leu Glu Asn Val Val Lys Gly His His Val Ser Gln Glu Pro
180 185 190
Trp Asn Ser Ser Ile Thr Leu Thr Ser Gln Ala Gly Ala Val Phe Gln
195 200 205
Ser Phe Ala Lys Phe Ser Lys Phe Gly Asp Asp Leu Tyr Ser Gly Trp
210 215 220
Leu Ala Ala Ala Leu Gly Thr Asn Leu Gln Val Gln Phe Trp His Lys
225 230 235 240
Thr Val Gly Ile Leu Pro Ser Asn Cys Ser Asp Ile Trp Gln Val Leu
245 250 255
Asn Val Asn Gln Ile Ala Phe Pro Gly Pro Ala Gly Pro Ser Phe Asn
260 265 270
Ser Thr Glu Asp His Ser Lys Trp Cys Val Ser Pro Lys Gly Pro Trp
275 280 285
Thr Cys Val Gly Asp Met Asn Arg Asn Gln Gly Glu Glu Gln Arg Gly
290 295 300
Gly Gly Thr Leu Cys Ala Gln Leu Pro Ala Leu Trp Lys Ala Phe Gln
305 310 315 320
Pro Leu Val Lys Asn Tyr Gln Pro Cys Asn Gly Met Ala Arg Lys Pro
325 330 335
Ser Arg Ala Tyr Lys Ile
340
<210> 36
<211> 4254
<212> DNA
<213> 智人(Homo sapiens)
<400> 36
atggctgctg ttcctcaaaa taatctacag gagcaactag aacgtcactc agccagaaca 60
cttaataata aattaagtct ttcaaaacca aaattttcag gtttcacttt taaaaagaaa 120
acatcttcag ataacaatgt atctgtaact aatgtgtcag tagcaaaaac acctgtatta 180
agaaataaag atgttaatgt taccgaagac ttttccttca gtgaacctct acccaacacc 240
acaaatcagc aaagggtcaa ggacttcttt aaaaatgctc cagcaggaca ggaaacacag 300
agaggtggat caaaatcatt attgccagat ttcttgcaga ctccgaagga agttgtatgc 360
actacccaaa acacaccaac tgtaaagaaa tcccgggata ctgctctcaa gaaattagaa 420
tttagttctt caccagattc tttaagtacc atcaatgatt gggatgatat ggatgacttt 480
gatacttctg agacttcaaa atcatttgtt acaccacccc aaagtcactt tgtaagagta 540
agcactgctc agaaatcaaa aaagggtaag agaaactttt ttaaagcaca gctttataca 600
acaaacacag taaagactga tttgcctcca ccctcctctg aaagcgagca aatagatttg 660
actgaggaac agaaggatga ctcagaatgg ttaagcagcg atgtgatttg catcgatgat 720
ggccccattg ctgaagtgca tataaatgaa gatgctcagg aaagtgactc tctgaaaact 780
catttggaag atgaaagaga taatagcgaa aagaagaaga atttggaaga agctgaatta 840
cattcaactg agaaagttcc atgtattgaa tttgatgatg atgattatga tacggatttt 900
gttccacctt ctccagaaga aattatttct gcttcttctt cctcttcaaa atgccttagt 960
acgttaaagg accttgacac ctctgacaga aaagaggatg ttcttagcac atcaaaagat 1020
cttttgtcaa aacctgagaa aatgagtatg caggagctga atccagaaac cagcacagac 1080
tgtgacgcta gacagataag tttacagcag cagcttattc atgtgatgga gcacatctgt 1140
aaattaattg atactattcc tgatgataaa ctgaaacttt tggattgtgg gaacgaactg 1200
cttcagcagc ggaacataag aaggaaactt ctaacggaag tagattttaa taaaagtgat 1260
gccagtcttc ttggctcatt gtggagatac aggcctgatt cacttgatgg ccctatggag 1320
ggtgattcct gccctacagg gaattctatg aaggagttaa atttttcaca ccttccctca 1380
aattctgttt ctcctgggga ctgtttactg actaccaccc taggaaagac aggattctct 1440
gccaccagga agaatctttt tgaaaggcct ttattcaata cccatttaca gaagtccttt 1500
gtaagtagca actgggctga aacaccaaga ctaggaaaaa aaaatgaaag ctcttatttc 1560
ccaggaaatg ttctcacaag cactgctgtg aaagatcaga ataaacatac tgcttcaata 1620
aatgacttag aaagagaaac ccaaccttcc tatgatattg ataattttga catagatgac 1680
tttgatgatg atgatgactg ggaagacata atgcataatt tagcagccag caaatcttcc 1740
acagctgcct atcaacccat caaggaaggt cggccaatta aatcagtatc agaaagactt 1800
tcctcagcca agacagactg tcttccagtg tcatctactg ctcaaaatat aaacttctca 1860
gagtcaattc agaattatac tgacaagtca gcacaaaatt tagcatccag aaatctgaaa 1920
catgagcgtt tccaaagtct tagttttcct catacaaagg aaatgatgaa gatttttcat 1980
aaaaaatttg gcctgcataa ttttagaact aatcagctag aggcgatcaa tgctgcactg 2040
cttggtgaag actgttttat cctgatgccg actggaggtg gtaagagttt gtgttaccag 2100
ctccctgcct gtgtttctcc tggggtcact gttgtcattt ctcccttgag atcacttatc 2160
gtagatcaag tccaaaagct gacttccttg gatattccag ctacatatct gacaggtgat 2220
aagactgact cagaagctac aaatatttac ctccagttat caaaaaaaga cccaatcata 2280
aaacttctat atgtcactcc agaaaagatc tgtgcaagta acagactcat ttctactctg 2340
gagaatctct atgagaggaa gctcttggca cgttttgtta ttgatgaagc acattgtgtc 2400
agtcagtggg gacatgattt tcgtcaagat tacaaaagaa tgaatatgct tcgccagaag 2460
tttccttctg ttccggtgat ggctcttacg gccacagcta atcccagggt acagaaggac 2520
atcctgactc agctgaagat tctcagacct caggtgttta gcatgagctt taacagacat 2580
aatctgaaat actatgtatt accgaaaaag cctaaaaagg tggcatttga ttgcctagaa 2640
tggatcagaa agcaccaccc atatgattca gggataattt actgcctctc caggcgagaa 2700
tgtgacacca tggctgacac gttacagaga gatgggctcg ctgctcttgc ttaccatgct 2760
ggcctcagtg attctgccag agatgaagtg cagcagaagt ggattaatca ggatggctgt 2820
caggttatct gtgctacaat tgcatttgga atggggattg acaaaccgga cgtgcgattt 2880
gtgattcatg catctctccc taaatctgtg gagggttact accaagaatc tggcagagct 2940
ggaagagatg gggaaatatc tcactgcctg cttttctata cctatcatga tgtgaccaga 3000
ctgaaaagac ttataatgat ggaaaaagat ggaaaccatc atacaagaga aactcacttc 3060
aataatttgt atagcatggt acattactgt gaaaatataa cggaatgcag gagaatacag 3120
cttttggcct actttggtga aaatggattt aatcctgatt tttgtaagaa acacccagat 3180
gtttcttgtg ataattgctg taaaacaaag gattataaaa caagagatgt gactgacgat 3240
gtgaaaagta ttgtaagatt tgttcaagaa catagttcat cacaaggaat gagaaatata 3300
aaacatgtag gtccttctgg aagatttact atgaatatgc tggtcgacat tttcttgggg 3360
agtaagagtg caaaaatcca gtcaggtata tttggaaaag gatctgctta ttcacgacac 3420
aatgccgaaa gactttttaa aaagctgata cttgacaaga ttttggatga agacttatat 3480
atcaatgcca atgaccaggc gatcgcttat gtgatgctcg gaaataaagc ccaaactgta 3540
ctaaatggca atttaaaggt agactttatg gaaacagaaa attccagcag tgtgaaaaaa 3600
caaaaagcgt tagtagcaaa agtgtctcag agggaagaga tggttaaaaa atgtcttgga 3660
gaacttacag aagtctgcaa atctctgggg aaagtttttg gtgtccatta cttcaatatt 3720
tttaataccg tcactctcaa gaagcttgca gaatctttat cttctgatcc tgaggttttg 3780
cttcaaattg atggtgttac tgaagacaaa ctggaaaaat atggtgcgga agtgatttca 3840
gtattacaga aatactctga atggacatcg ccagctgaag acagttcccc agggataagc 3900
ctgtccagca gcagaggccc cggaagaagt gccgctgagg agctcgacga ggaaataccc 3960
gtatcttccc actactttgc aagtaaaacc agaaatgaaa ggaagaggaa aaagatgcca 4020
gcctcccaaa ggtctaagag gagaaaaact gcttccagtg gttccaaggc aaaggggggg 4080
tctgccacat gtagaaagat atcttccaaa acgaaatcct ccagcatcat tggatccagt 4140
tcagcctcac atacttctca agcgacatca ggagccaata gcaaattggg gattatggct 4200
ccaccgaagc ctataaatag accgtttctt aagccttcat atgcattctc ataa 4254
<210> 37
<211> 1417
<212> PRT
<213> 智人(Homo sapiens)
<400> 37
Met Ala Ala Val Pro Gln Asn Asn Leu Gln Glu Gln Leu Glu Arg His
1 5 10 15
Ser Ala Arg Thr Leu Asn Asn Lys Leu Ser Leu Ser Lys Pro Lys Phe
20 25 30
Ser Gly Phe Thr Phe Lys Lys Lys Thr Ser Ser Asp Asn Asn Val Ser
35 40 45
Val Thr Asn Val Ser Val Ala Lys Thr Pro Val Leu Arg Asn Lys Asp
50 55 60
Val Asn Val Thr Glu Asp Phe Ser Phe Ser Glu Pro Leu Pro Asn Thr
65 70 75 80
Thr Asn Gln Gln Arg Val Lys Asp Phe Phe Lys Asn Ala Pro Ala Gly
85 90 95
Gln Glu Thr Gln Arg Gly Gly Ser Lys Ser Leu Leu Pro Asp Phe Leu
100 105 110
Gln Thr Pro Lys Glu Val Val Cys Thr Thr Gln Asn Thr Pro Thr Val
115 120 125
Lys Lys Ser Arg Asp Thr Ala Leu Lys Lys Leu Glu Phe Ser Ser Ser
130 135 140
Pro Asp Ser Leu Ser Thr Ile Asn Asp Trp Asp Asp Met Asp Asp Phe
145 150 155 160
Asp Thr Ser Glu Thr Ser Lys Ser Phe Val Thr Pro Pro Gln Ser His
165 170 175
Phe Val Arg Val Ser Thr Ala Gln Lys Ser Lys Lys Gly Lys Arg Asn
180 185 190
Phe Phe Lys Ala Gln Leu Tyr Thr Thr Asn Thr Val Lys Thr Asp Leu
195 200 205
Pro Pro Pro Ser Ser Glu Ser Glu Gln Ile Asp Leu Thr Glu Glu Gln
210 215 220
Lys Asp Asp Ser Glu Trp Leu Ser Ser Asp Val Ile Cys Ile Asp Asp
225 230 235 240
Gly Pro Ile Ala Glu Val His Ile Asn Glu Asp Ala Gln Glu Ser Asp
245 250 255
Ser Leu Lys Thr His Leu Glu Asp Glu Arg Asp Asn Ser Glu Lys Lys
260 265 270
Lys Asn Leu Glu Glu Ala Glu Leu His Ser Thr Glu Lys Val Pro Cys
275 280 285
Ile Glu Phe Asp Asp Asp Asp Tyr Asp Thr Asp Phe Val Pro Pro Ser
290 295 300
Pro Glu Glu Ile Ile Ser Ala Ser Ser Ser Ser Ser Lys Cys Leu Ser
305 310 315 320
Thr Leu Lys Asp Leu Asp Thr Ser Asp Arg Lys Glu Asp Val Leu Ser
325 330 335
Thr Ser Lys Asp Leu Leu Ser Lys Pro Glu Lys Met Ser Met Gln Glu
340 345 350
Leu Asn Pro Glu Thr Ser Thr Asp Cys Asp Ala Arg Gln Ile Ser Leu
355 360 365
Gln Gln Gln Leu Ile His Val Met Glu His Ile Cys Lys Leu Ile Asp
370 375 380
Thr Ile Pro Asp Asp Lys Leu Lys Leu Leu Asp Cys Gly Asn Glu Leu
385 390 395 400
Leu Gln Gln Arg Asn Ile Arg Arg Lys Leu Leu Thr Glu Val Asp Phe
405 410 415
Asn Lys Ser Asp Ala Ser Leu Leu Gly Ser Leu Trp Arg Tyr Arg Pro
420 425 430
Asp Ser Leu Asp Gly Pro Met Glu Gly Asp Ser Cys Pro Thr Gly Asn
435 440 445
Ser Met Lys Glu Leu Asn Phe Ser His Leu Pro Ser Asn Ser Val Ser
450 455 460
Pro Gly Asp Cys Leu Leu Thr Thr Thr Leu Gly Lys Thr Gly Phe Ser
465 470 475 480
Ala Thr Arg Lys Asn Leu Phe Glu Arg Pro Leu Phe Asn Thr His Leu
485 490 495
Gln Lys Ser Phe Val Ser Ser Asn Trp Ala Glu Thr Pro Arg Leu Gly
500 505 510
Lys Lys Asn Glu Ser Ser Tyr Phe Pro Gly Asn Val Leu Thr Ser Thr
515 520 525
Ala Val Lys Asp Gln Asn Lys His Thr Ala Ser Ile Asn Asp Leu Glu
530 535 540
Arg Glu Thr Gln Pro Ser Tyr Asp Ile Asp Asn Phe Asp Ile Asp Asp
545 550 555 560
Phe Asp Asp Asp Asp Asp Trp Glu Asp Ile Met His Asn Leu Ala Ala
565 570 575
Ser Lys Ser Ser Thr Ala Ala Tyr Gln Pro Ile Lys Glu Gly Arg Pro
580 585 590
Ile Lys Ser Val Ser Glu Arg Leu Ser Ser Ala Lys Thr Asp Cys Leu
595 600 605
Pro Val Ser Ser Thr Ala Gln Asn Ile Asn Phe Ser Glu Ser Ile Gln
610 615 620
Asn Tyr Thr Asp Lys Ser Ala Gln Asn Leu Ala Ser Arg Asn Leu Lys
625 630 635 640
His Glu Arg Phe Gln Ser Leu Ser Phe Pro His Thr Lys Glu Met Met
645 650 655
Lys Ile Phe His Lys Lys Phe Gly Leu His Asn Phe Arg Thr Asn Gln
660 665 670
Leu Glu Ala Ile Asn Ala Ala Leu Leu Gly Glu Asp Cys Phe Ile Leu
675 680 685
Met Pro Thr Gly Gly Gly Lys Ser Leu Cys Tyr Gln Leu Pro Ala Cys
690 695 700
Val Ser Pro Gly Val Thr Val Val Ile Ser Pro Leu Arg Ser Leu Ile
705 710 715 720
Val Asp Gln Val Gln Lys Leu Thr Ser Leu Asp Ile Pro Ala Thr Tyr
725 730 735
Leu Thr Gly Asp Lys Thr Asp Ser Glu Ala Thr Asn Ile Tyr Leu Gln
740 745 750
Leu Ser Lys Lys Asp Pro Ile Ile Lys Leu Leu Tyr Val Thr Pro Glu
755 760 765
Lys Ile Cys Ala Ser Asn Arg Leu Ile Ser Thr Leu Glu Asn Leu Tyr
770 775 780
Glu Arg Lys Leu Leu Ala Arg Phe Val Ile Asp Glu Ala His Cys Val
785 790 795 800
Ser Gln Trp Gly His Asp Phe Arg Gln Asp Tyr Lys Arg Met Asn Met
805 810 815
Leu Arg Gln Lys Phe Pro Ser Val Pro Val Met Ala Leu Thr Ala Thr
820 825 830
Ala Asn Pro Arg Val Gln Lys Asp Ile Leu Thr Gln Leu Lys Ile Leu
835 840 845
Arg Pro Gln Val Phe Ser Met Ser Phe Asn Arg His Asn Leu Lys Tyr
850 855 860
Tyr Val Leu Pro Lys Lys Pro Lys Lys Val Ala Phe Asp Cys Leu Glu
865 870 875 880
Trp Ile Arg Lys His His Pro Tyr Asp Ser Gly Ile Ile Tyr Cys Leu
885 890 895
Ser Arg Arg Glu Cys Asp Thr Met Ala Asp Thr Leu Gln Arg Asp Gly
900 905 910
Leu Ala Ala Leu Ala Tyr His Ala Gly Leu Ser Asp Ser Ala Arg Asp
915 920 925
Glu Val Gln Gln Lys Trp Ile Asn Gln Asp Gly Cys Gln Val Ile Cys
930 935 940
Ala Thr Ile Ala Phe Gly Met Gly Ile Asp Lys Pro Asp Val Arg Phe
945 950 955 960
Val Ile His Ala Ser Leu Pro Lys Ser Val Glu Gly Tyr Tyr Gln Glu
965 970 975
Ser Gly Arg Ala Gly Arg Asp Gly Glu Ile Ser His Cys Leu Leu Phe
980 985 990
Tyr Thr Tyr His Asp Val Thr Arg Leu Lys Arg Leu Ile Met Met Glu
995 1000 1005
Lys Asp Gly Asn His His Thr Arg Glu Thr His Phe Asn Asn Leu
1010 1015 1020
Tyr Ser Met Val His Tyr Cys Glu Asn Ile Thr Glu Cys Arg Arg
1025 1030 1035
Ile Gln Leu Leu Ala Tyr Phe Gly Glu Asn Gly Phe Asn Pro Asp
1040 1045 1050
Phe Cys Lys Lys His Pro Asp Val Ser Cys Asp Asn Cys Cys Lys
1055 1060 1065
Thr Lys Asp Tyr Lys Thr Arg Asp Val Thr Asp Asp Val Lys Ser
1070 1075 1080
Ile Val Arg Phe Val Gln Glu His Ser Ser Ser Gln Gly Met Arg
1085 1090 1095
Asn Ile Lys His Val Gly Pro Ser Gly Arg Phe Thr Met Asn Met
1100 1105 1110
Leu Val Asp Ile Phe Leu Gly Ser Lys Ser Ala Lys Ile Gln Ser
1115 1120 1125
Gly Ile Phe Gly Lys Gly Ser Ala Tyr Ser Arg His Asn Ala Glu
1130 1135 1140
Arg Leu Phe Lys Lys Leu Ile Leu Asp Lys Ile Leu Asp Glu Asp
1145 1150 1155
Leu Tyr Ile Asn Ala Asn Asp Gln Ala Ile Ala Tyr Val Met Leu
1160 1165 1170
Gly Asn Lys Ala Gln Thr Val Leu Asn Gly Asn Leu Lys Val Asp
1175 1180 1185
Phe Met Glu Thr Glu Asn Ser Ser Ser Val Lys Lys Gln Lys Ala
1190 1195 1200
Leu Val Ala Lys Val Ser Gln Arg Glu Glu Met Val Lys Lys Cys
1205 1210 1215
Leu Gly Glu Leu Thr Glu Val Cys Lys Ser Leu Gly Lys Val Phe
1220 1225 1230
Gly Val His Tyr Phe Asn Ile Phe Asn Thr Val Thr Leu Lys Lys
1235 1240 1245
Leu Ala Glu Ser Leu Ser Ser Asp Pro Glu Val Leu Leu Gln Ile
1250 1255 1260
Asp Gly Val Thr Glu Asp Lys Leu Glu Lys Tyr Gly Ala Glu Val
1265 1270 1275
Ile Ser Val Leu Gln Lys Tyr Ser Glu Trp Thr Ser Pro Ala Glu
1280 1285 1290
Asp Ser Ser Pro Gly Ile Ser Leu Ser Ser Ser Arg Gly Pro Gly
1295 1300 1305
Arg Ser Ala Ala Glu Glu Leu Asp Glu Glu Ile Pro Val Ser Ser
1310 1315 1320
His Tyr Phe Ala Ser Lys Thr Arg Asn Glu Arg Lys Arg Lys Lys
1325 1330 1335
Met Pro Ala Ser Gln Arg Ser Lys Arg Arg Lys Thr Ala Ser Ser
1340 1345 1350
Gly Ser Lys Ala Lys Gly Gly Ser Ala Thr Cys Arg Lys Ile Ser
1355 1360 1365
Ser Lys Thr Lys Ser Ser Ser Ile Ile Gly Ser Ser Ser Ala Ser
1370 1375 1380
His Thr Ser Gln Ala Thr Ser Gly Ala Asn Ser Lys Leu Gly Ile
1385 1390 1395
Met Ala Pro Pro Lys Pro Ile Asn Arg Pro Phe Leu Lys Pro Ser
1400 1405 1410
Tyr Ala Phe Ser
1415
<210> 38
<211> 3861
<212> DNA
<213> 智人(Homo sapiens)
<400> 38
atggctgctg ttcctcaaaa taatctacag gagcaactag aacgtcactc agccagaaca 60
cttaataata aattaagtct ttcaaaacca aaattttcag gtttcacttt taaaaagaaa 120
acatcttcag ataacaatgt atctgtaact aatgtgtcag tagcaaaaac acctgtatta 180
agaaataaag atgttaatgt taccgaagac ttttccttca gtgaacctct acccaacacc 240
acaaatcagc aaagggtcaa ggacttcttt aaaaatgctc cagcaggaca ggaaacacag 300
agaggtggat caaaatcatt attgccagat ttcttgcaga ctccgaagga agttgtatgc 360
actacccaaa acacaccaac tgtaaagaaa tcccgggata ctgctctcaa gaaattagaa 420
tttagttctt caccagattc tttaagtacc atcaatgatt gggatgatat ggatgacttt 480
gatacttctg agacttcaaa atcatttgtt acaccacccc aaagtcactt tgtaagagta 540
agcactgctc agaaatcaaa aaagggtaag agaaactttt ttaaagcaca gctttataca 600
acaaacacag taaagactga tttgcctcca ccctcctctg aaagcgagca aatagatttg 660
actgaggaac agaaggatga ctcagaatgg ttaagcagcg atgtgatttg catcgatgat 720
ggccccattg ctgaagtgca tataaatgaa gatgctcagg aaagtgactc tctgaaaact 780
catttggaag atgaaagaga taatagcgaa aagaagaaga atttggaaga agctgaatta 840
cattcaactg agaaagttcc atgtattgaa tttgatgatg atgattatga tacggatttt 900
gttccacctt ctccagaaga aattatttct gcttcttctt cctcttcaaa atgccttagt 960
acgttaaagg accttgacac ctctgacaga aaagaggatg ttcttagcac atcaaaagat 1020
cttttgtcaa aacctgagaa aatgagtatg caggagctga atccagaaac cagcacagac 1080
tgtgacgcta gacagataag tttacagcag cagcttattc atgtgatgga gcacatctgt 1140
aaattaattg atactattcc tgatgataaa ctgaaacttt tggattgtgg gaacgaactg 1200
cttcagcagc ggaacataag aaggaaactt ctaacggaag tagattttaa taaaagtgat 1260
gccagtcttc ttggctcatt gtggagatac aggcctgatt cacttgatgg ccctatggag 1320
ggtgattcct gccctacagg gaattctatg aaggagttaa atttttcaca ccttccctca 1380
aattctgttt ctcctgggga ctgtttactg actaccaccc taggaaagac aggattctct 1440
gccaccagga agaatctttt tgaaaggcct ttattcaata cccatttaca gaagtccttt 1500
gtaagtagca actgggctga aacaccaaga ctaggaaaaa aaaatgaaag ctcttatttc 1560
ccaggaaatg ttctcacaag cactgctgtg aaagatcaga ataaacatac tgcttcaata 1620
aatgacttag aaagagaaac ccaaccttcc tatgatattg ataattttga catagatgac 1680
tttgatgatg atgatgactg ggaagacata atgcataatt tagcagccag caaatcttcc 1740
acagctgcct atcaacccat caaggaaggt cggccaatta aatcagtatc agaaagactt 1800
tcctcagcca agacagactg tcttccagtg tcatctactg ctcaaaatat aaacttctca 1860
gagtcaattc agaattatac tgacaagtca gcacaaaatt tagcatccag aaatctgaaa 1920
catgagcgtt tccaaagtct tagttttcct catacaaagg aaatgatgaa gatttttcat 1980
aaaaaatttg gcctgcataa ttttagaact aatcagctag aggcgatcaa tgctgcactg 2040
cttggtgaag actgttttat cctgatgccg actggaggtg gtaagagttt gtgttaccag 2100
ctccctgcct gtgtttctcc tggggtcact gttgtcattt ctcccttgag atcacttatc 2160
gtagatcaag tccaaaagct gacttccttg gatattccag ctacatatct gacaggtgat 2220
aagactgact cagaagctac aaatatttac ctccagttat caaaaaaaga cccaatcata 2280
aaacttctat atgtcactcc agaaaagatc tgtgcaagta acagactcat ttctactctg 2340
gagaatctct atgagaggaa gctcttggca cgttttgtta ttgatgaagc acattgtgtc 2400
agtcagtggg gacatgattt tcgtcaagat tacaaaagaa tgaatatgct tcgccagaag 2460
tttccttctg ttccggtgat ggctcttacg gccacagcta atcccagggt acagaaggac 2520
atcctgactc agctgaagat tctcagacct caggtgttta gcatgagctt taacagacat 2580
aatctgaaat actatgtatt accgaaaaag cctaaaaagg tggcatttga ttgcctagaa 2640
tggatcagaa agcaccaccc atatgattca gggataattt actgcctctc caggcgagaa 2700
tgtgacacca tggctgacac gttacagaga gatgggctcg ctgctcttgc ttaccatgct 2760
ggcctcagtg attctgccag agatgaagtg cagcagaagt ggattaatca ggatggctgt 2820
caggttatct gtgctacaat tgcatttgga atggggattg acaaaccgga cgtgcgattt 2880
gtgattcatg catctctccc taaatctgtg gagggttact accaagaatc tggcagagct 2940
ggaagagatg gggaaatatc tcactgcctg cttttctata cctatcatga tgtgaccaga 3000
ctgaaaagac ttataatgat ggaaaaagat ggaaaccatc atacaagaga aactcacttc 3060
aataatttgt atagcatggt acattactgt gaaaatataa cggaatgcag gagaatacag 3120
cttttggcct actttggtga aaatggattt aatcctgatt tttgtaagaa acacccagat 3180
gtttcttgtg ataattgctg taaaacaaag gattataaaa caagagatgt gactgacgat 3240
gtgaaaagta ttgtaagatt tgttcaagaa catagttcat cacaaggaat gagaaatata 3300
aaacatgtag gtccttctgg aagatttact atgaatatgc tggtcgacat tttcttggaa 3360
tctttatctt ctgatcctga ggttttgctt caaattgatg gtgttactga agacaaactg 3420
gaaaaatatg gtgcggaagt gatttcagta ttacagaaat actctgaatg gacatcgcca 3480
gctgaagaca gttccccagg gataagcctg tccagcagca gaggccccgg aagaagtgcc 3540
gctgaggagc tcgacgagga aatacccgta tcttcccact actttgcaag taaaaccaga 3600
aatgaaagga agaggaaaaa gatgccagcc tcccaaaggt ctaagaggag aaaaactgct 3660
tccagtggtt ccaaggcaaa gggggggtct gccacatgta gaaagatatc ttccaaaacg 3720
aaatcctcca gcatcattgg atccagttca gcctcacata cttctcaagc gacatcagga 3780
gccaatagca aattggggat tatggctcca ccgaagccta taaatagacc gtttcttaag 3840
ccttcatatg cattctcata a 3861
<210> 39
<211> 1286
<212> PRT
<213> 智人(Homo sapiens)
<400> 39
Met Ala Ala Val Pro Gln Asn Asn Leu Gln Glu Gln Leu Glu Arg His
1 5 10 15
Ser Ala Arg Thr Leu Asn Asn Lys Leu Ser Leu Ser Lys Pro Lys Phe
20 25 30
Ser Gly Phe Thr Phe Lys Lys Lys Thr Ser Ser Asp Asn Asn Val Ser
35 40 45
Val Thr Asn Val Ser Val Ala Lys Thr Pro Val Leu Arg Asn Lys Asp
50 55 60
Val Asn Val Thr Glu Asp Phe Ser Phe Ser Glu Pro Leu Pro Asn Thr
65 70 75 80
Thr Asn Gln Gln Arg Val Lys Asp Phe Phe Lys Asn Ala Pro Ala Gly
85 90 95
Gln Glu Thr Gln Arg Gly Gly Ser Lys Ser Leu Leu Pro Asp Phe Leu
100 105 110
Gln Thr Pro Lys Glu Val Val Cys Thr Thr Gln Asn Thr Pro Thr Val
115 120 125
Lys Lys Ser Arg Asp Thr Ala Leu Lys Lys Leu Glu Phe Ser Ser Ser
130 135 140
Pro Asp Ser Leu Ser Thr Ile Asn Asp Trp Asp Asp Met Asp Asp Phe
145 150 155 160
Asp Thr Ser Glu Thr Ser Lys Ser Phe Val Thr Pro Pro Gln Ser His
165 170 175
Phe Val Arg Val Ser Thr Ala Gln Lys Ser Lys Lys Gly Lys Arg Asn
180 185 190
Phe Phe Lys Ala Gln Leu Tyr Thr Thr Asn Thr Val Lys Thr Asp Leu
195 200 205
Pro Pro Pro Ser Ser Glu Ser Glu Gln Ile Asp Leu Thr Glu Glu Gln
210 215 220
Lys Asp Asp Ser Glu Trp Leu Ser Ser Asp Val Ile Cys Ile Asp Asp
225 230 235 240
Gly Pro Ile Ala Glu Val His Ile Asn Glu Asp Ala Gln Glu Ser Asp
245 250 255
Ser Leu Lys Thr His Leu Glu Asp Glu Arg Asp Asn Ser Glu Lys Lys
260 265 270
Lys Asn Leu Glu Glu Ala Glu Leu His Ser Thr Glu Lys Val Pro Cys
275 280 285
Ile Glu Phe Asp Asp Asp Asp Tyr Asp Thr Asp Phe Val Pro Pro Ser
290 295 300
Pro Glu Glu Ile Ile Ser Ala Ser Ser Ser Ser Ser Lys Cys Leu Ser
305 310 315 320
Thr Leu Lys Asp Leu Asp Thr Ser Asp Arg Lys Glu Asp Val Leu Ser
325 330 335
Thr Ser Lys Asp Leu Leu Ser Lys Pro Glu Lys Met Ser Met Gln Glu
340 345 350
Leu Asn Pro Glu Thr Ser Thr Asp Cys Asp Ala Arg Gln Ile Ser Leu
355 360 365
Gln Gln Gln Leu Ile His Val Met Glu His Ile Cys Lys Leu Ile Asp
370 375 380
Thr Ile Pro Asp Asp Lys Leu Lys Leu Leu Asp Cys Gly Asn Glu Leu
385 390 395 400
Leu Gln Gln Arg Asn Ile Arg Arg Lys Leu Leu Thr Glu Val Asp Phe
405 410 415
Asn Lys Ser Asp Ala Ser Leu Leu Gly Ser Leu Trp Arg Tyr Arg Pro
420 425 430
Asp Ser Leu Asp Gly Pro Met Glu Gly Asp Ser Cys Pro Thr Gly Asn
435 440 445
Ser Met Lys Glu Leu Asn Phe Ser His Leu Pro Ser Asn Ser Val Ser
450 455 460
Pro Gly Asp Cys Leu Leu Thr Thr Thr Leu Gly Lys Thr Gly Phe Ser
465 470 475 480
Ala Thr Arg Lys Asn Leu Phe Glu Arg Pro Leu Phe Asn Thr His Leu
485 490 495
Gln Lys Ser Phe Val Ser Ser Asn Trp Ala Glu Thr Pro Arg Leu Gly
500 505 510
Lys Lys Asn Glu Ser Ser Tyr Phe Pro Gly Asn Val Leu Thr Ser Thr
515 520 525
Ala Val Lys Asp Gln Asn Lys His Thr Ala Ser Ile Asn Asp Leu Glu
530 535 540
Arg Glu Thr Gln Pro Ser Tyr Asp Ile Asp Asn Phe Asp Ile Asp Asp
545 550 555 560
Phe Asp Asp Asp Asp Asp Trp Glu Asp Ile Met His Asn Leu Ala Ala
565 570 575
Ser Lys Ser Ser Thr Ala Ala Tyr Gln Pro Ile Lys Glu Gly Arg Pro
580 585 590
Ile Lys Ser Val Ser Glu Arg Leu Ser Ser Ala Lys Thr Asp Cys Leu
595 600 605
Pro Val Ser Ser Thr Ala Gln Asn Ile Asn Phe Ser Glu Ser Ile Gln
610 615 620
Asn Tyr Thr Asp Lys Ser Ala Gln Asn Leu Ala Ser Arg Asn Leu Lys
625 630 635 640
His Glu Arg Phe Gln Ser Leu Ser Phe Pro His Thr Lys Glu Met Met
645 650 655
Lys Ile Phe His Lys Lys Phe Gly Leu His Asn Phe Arg Thr Asn Gln
660 665 670
Leu Glu Ala Ile Asn Ala Ala Leu Leu Gly Glu Asp Cys Phe Ile Leu
675 680 685
Met Pro Thr Gly Gly Gly Lys Ser Leu Cys Tyr Gln Leu Pro Ala Cys
690 695 700
Val Ser Pro Gly Val Thr Val Val Ile Ser Pro Leu Arg Ser Leu Ile
705 710 715 720
Val Asp Gln Val Gln Lys Leu Thr Ser Leu Asp Ile Pro Ala Thr Tyr
725 730 735
Leu Thr Gly Asp Lys Thr Asp Ser Glu Ala Thr Asn Ile Tyr Leu Gln
740 745 750
Leu Ser Lys Lys Asp Pro Ile Ile Lys Leu Leu Tyr Val Thr Pro Glu
755 760 765
Lys Ile Cys Ala Ser Asn Arg Leu Ile Ser Thr Leu Glu Asn Leu Tyr
770 775 780
Glu Arg Lys Leu Leu Ala Arg Phe Val Ile Asp Glu Ala His Cys Val
785 790 795 800
Ser Gln Trp Gly His Asp Phe Arg Gln Asp Tyr Lys Arg Met Asn Met
805 810 815
Leu Arg Gln Lys Phe Pro Ser Val Pro Val Met Ala Leu Thr Ala Thr
820 825 830
Ala Asn Pro Arg Val Gln Lys Asp Ile Leu Thr Gln Leu Lys Ile Leu
835 840 845
Arg Pro Gln Val Phe Ser Met Ser Phe Asn Arg His Asn Leu Lys Tyr
850 855 860
Tyr Val Leu Pro Lys Lys Pro Lys Lys Val Ala Phe Asp Cys Leu Glu
865 870 875 880
Trp Ile Arg Lys His His Pro Tyr Asp Ser Gly Ile Ile Tyr Cys Leu
885 890 895
Ser Arg Arg Glu Cys Asp Thr Met Ala Asp Thr Leu Gln Arg Asp Gly
900 905 910
Leu Ala Ala Leu Ala Tyr His Ala Gly Leu Ser Asp Ser Ala Arg Asp
915 920 925
Glu Val Gln Gln Lys Trp Ile Asn Gln Asp Gly Cys Gln Val Ile Cys
930 935 940
Ala Thr Ile Ala Phe Gly Met Gly Ile Asp Lys Pro Asp Val Arg Phe
945 950 955 960
Val Ile His Ala Ser Leu Pro Lys Ser Val Glu Gly Tyr Tyr Gln Glu
965 970 975
Ser Gly Arg Ala Gly Arg Asp Gly Glu Ile Ser His Cys Leu Leu Phe
980 985 990
Tyr Thr Tyr His Asp Val Thr Arg Leu Lys Arg Leu Ile Met Met Glu
995 1000 1005
Lys Asp Gly Asn His His Thr Arg Glu Thr His Phe Asn Asn Leu
1010 1015 1020
Tyr Ser Met Val His Tyr Cys Glu Asn Ile Thr Glu Cys Arg Arg
1025 1030 1035
Ile Gln Leu Leu Ala Tyr Phe Gly Glu Asn Gly Phe Asn Pro Asp
1040 1045 1050
Phe Cys Lys Lys His Pro Asp Val Ser Cys Asp Asn Cys Cys Lys
1055 1060 1065
Thr Lys Asp Tyr Lys Thr Arg Asp Val Thr Asp Asp Val Lys Ser
1070 1075 1080
Ile Val Arg Phe Val Gln Glu His Ser Ser Ser Gln Gly Met Arg
1085 1090 1095
Asn Ile Lys His Val Gly Pro Ser Gly Arg Phe Thr Met Asn Met
1100 1105 1110
Leu Val Asp Ile Phe Leu Glu Ser Leu Ser Ser Asp Pro Glu Val
1115 1120 1125
Leu Leu Gln Ile Asp Gly Val Thr Glu Asp Lys Leu Glu Lys Tyr
1130 1135 1140
Gly Ala Glu Val Ile Ser Val Leu Gln Lys Tyr Ser Glu Trp Thr
1145 1150 1155
Ser Pro Ala Glu Asp Ser Ser Pro Gly Ile Ser Leu Ser Ser Ser
1160 1165 1170
Arg Gly Pro Gly Arg Ser Ala Ala Glu Glu Leu Asp Glu Glu Ile
1175 1180 1185
Pro Val Ser Ser His Tyr Phe Ala Ser Lys Thr Arg Asn Glu Arg
1190 1195 1200
Lys Arg Lys Lys Met Pro Ala Ser Gln Arg Ser Lys Arg Arg Lys
1205 1210 1215
Thr Ala Ser Ser Gly Ser Lys Ala Lys Gly Gly Ser Ala Thr Cys
1220 1225 1230
Arg Lys Ile Ser Ser Lys Thr Lys Ser Ser Ser Ile Ile Gly Ser
1235 1240 1245
Ser Ser Ala Ser His Thr Ser Gln Ala Thr Ser Gly Ala Asn Ser
1250 1255 1260
Lys Leu Gly Ile Met Ala Pro Pro Lys Pro Ile Asn Arg Pro Phe
1265 1270 1275
Leu Lys Pro Ser Tyr Ala Phe Ser
1280 1285
<210> 40
<211> 3129
<212> DNA
<213> 智人(Homo sapiens)
<400> 40
atggagcaca tctgtaaatt aattgatact attcctgatg ataaactgaa acttttggat 60
tgtgggaacg aactgcttca gcagcggaac ataagaagga aacttctaac ggaagtagat 120
tttaataaaa gtgatgccag tcttcttggc tcattgtgga gatacaggcc tgattcactt 180
gatggcccta tggagggtga ttcctgccct acagggaatt ctatgaagga gttaaatttt 240
tcacaccttc cctcaaattc tgtttctcct ggggactgtt tactgactac caccctagga 300
aagacaggat tctctgccac caggaagaat ctttttgaaa ggcctttatt caatacccat 360
ttacagaagt cctttgtaag tagcaactgg gctgaaacac caagactagg aaaaaaaaat 420
gaaagctctt atttcccagg aaatgttctc acaagcactg ctgtgaaaga tcagaataaa 480
catactgctt caataaatga cttagaaaga gaaacccaac cttcctatga tattgataat 540
tttgacatag atgactttga tgatgatgat gactgggaag acataatgca taatttagca 600
gccagcaaat cttccacagc tgcctatcaa cccatcaagg aaggtcggcc aattaaatca 660
gtatcagaaa gactttcctc agccaagaca gactgtcttc cagtgtcatc tactgctcaa 720
aatataaact tctcagagtc aattcagaat tatactgaca agtcagcaca aaatttagca 780
tccagaaatc tgaaacatga gcgtttccaa agtcttagtt ttcctcatac aaaggaaatg 840
atgaagattt ttcataaaaa atttggcctg cataatttta gaactaatca gctagaggcg 900
atcaatgctg cactgcttgg tgaagactgt tttatcctga tgccgactgg aggtggtaag 960
agtttgtgtt accagctccc tgcctgtgtt tctcctgggg tcactgttgt catttctccc 1020
ttgagatcac ttatcgtaga tcaagtccaa aagctgactt ccttggatat tccagctaca 1080
tatctgacag gtgataagac tgactcagaa gctacaaata tttacctcca gttatcaaaa 1140
aaagacccaa tcataaaact tctatatgtc actccagaaa agatctgtgc aagtaacaga 1200
ctcatttcta ctctggagaa tctctatgag aggaagctct tggcacgttt tgttattgat 1260
gaagcacatt gtgtcagtca gtggggacat gattttcgtc aagattacaa aagaatgaat 1320
atgcttcgcc agaagtttcc ttctgttccg gtgatggctc ttacggccac agctaatccc 1380
agggtacaga aggacatcct gactcagctg aagattctca gacctcaggt gtttagcatg 1440
agctttaaca gacataatct gaaatactat gtattaccga aaaagcctaa aaaggtggca 1500
tttgattgcc tagaatggat cagaaagcac cacccatatg attcagggat aatttactgc 1560
ctctccaggc gagaatgtga caccatggct gacacgttac agagagatgg gctcgctgct 1620
cttgcttacc atgctggcct cagtgattct gccagagatg aagtgcagca gaagtggatt 1680
aatcaggatg gctgtcaggt tatctgtgct acaattgcat ttggaatggg gattgacaaa 1740
ccggacgtgc gatttgtgat tcatgcatct ctccctaaat ctgtggaggg ttactaccaa 1800
gaatctggca gagctggaag agatggggaa atatctcact gcctgctttt ctatacctat 1860
catgatgtga ccagactgaa aagacttata atgatggaaa aagatggaaa ccatcataca 1920
agagaaactc acttcaataa tttgtatagc atggtacatt actgtgaaaa tataacggaa 1980
tgcaggagaa tacagctttt ggcctacttt ggtgaaaatg gatttaatcc tgatttttgt 2040
aagaaacacc cagatgtttc ttgtgataat tgctgtaaaa caaaggatta taaaacaaga 2100
gatgtgactg acgatgtgaa aagtattgta agatttgttc aagaacatag ttcatcacaa 2160
ggaatgagaa atataaaaca tgtaggtcct tctggaagat ttactatgaa tatgctggtc 2220
gacattttct tggggagtaa gagtgcaaaa atccagtcag gtatatttgg aaaaggatct 2280
gcttattcac gacacaatgc cgaaagactt tttaaaaagc tgatacttga caagattttg 2340
gatgaagact tatatatcaa tgccaatgac caggcgatcg cttatgtgat gctcggaaat 2400
aaagcccaaa ctgtactaaa tggcaattta aaggtagact ttatggaaac agaaaattcc 2460
agcagtgtga aaaaacaaaa agcgttagta gcaaaagtgt ctcagaggga agagatggtt 2520
aaaaaatgtc ttggagaact tacagaagtc tgcaaatctc tggggaaagt ttttggtgtc 2580
cattacttca atatttttaa taccgtcact ctcaagaagc ttgcagaatc tttatcttct 2640
gatcctgagg ttttgcttca aattgatggt gttactgaag acaaactgga aaaatatggt 2700
gcggaagtga tttcagtatt acagaaatac tctgaatgga catcgccagc tgaagacagt 2760
tccccaggga taagcctgtc cagcagcaga ggccccggaa gaagtgccgc tgaggagctc 2820
gacgaggaaa tacccgtatc ttcccactac tttgcaagta aaaccagaaa tgaaaggaag 2880
aggaaaaaga tgccagcctc ccaaaggtct aagaggagaa aaactgcttc cagtggttcc 2940
aaggcaaagg gggggtctgc cacatgtaga aagatatctt ccaaaacgaa atcctccagc 3000
atcattggat ccagttcagc ctcacatact tctcaagcga catcaggagc caatagcaaa 3060
ttggggatta tggctccacc gaagcctata aatagaccgt ttcttaagcc ttcatatgca 3120
ttctcataa 3129
<210> 41
<211> 1042
<212> PRT
<213> 智人(Homo sapiens)
<400> 41
Met Glu His Ile Cys Lys Leu Ile Asp Thr Ile Pro Asp Asp Lys Leu
1 5 10 15
Lys Leu Leu Asp Cys Gly Asn Glu Leu Leu Gln Gln Arg Asn Ile Arg
20 25 30
Arg Lys Leu Leu Thr Glu Val Asp Phe Asn Lys Ser Asp Ala Ser Leu
35 40 45
Leu Gly Ser Leu Trp Arg Tyr Arg Pro Asp Ser Leu Asp Gly Pro Met
50 55 60
Glu Gly Asp Ser Cys Pro Thr Gly Asn Ser Met Lys Glu Leu Asn Phe
65 70 75 80
Ser His Leu Pro Ser Asn Ser Val Ser Pro Gly Asp Cys Leu Leu Thr
85 90 95
Thr Thr Leu Gly Lys Thr Gly Phe Ser Ala Thr Arg Lys Asn Leu Phe
100 105 110
Glu Arg Pro Leu Phe Asn Thr His Leu Gln Lys Ser Phe Val Ser Ser
115 120 125
Asn Trp Ala Glu Thr Pro Arg Leu Gly Lys Lys Asn Glu Ser Ser Tyr
130 135 140
Phe Pro Gly Asn Val Leu Thr Ser Thr Ala Val Lys Asp Gln Asn Lys
145 150 155 160
His Thr Ala Ser Ile Asn Asp Leu Glu Arg Glu Thr Gln Pro Ser Tyr
165 170 175
Asp Ile Asp Asn Phe Asp Ile Asp Asp Phe Asp Asp Asp Asp Asp Trp
180 185 190
Glu Asp Ile Met His Asn Leu Ala Ala Ser Lys Ser Ser Thr Ala Ala
195 200 205
Tyr Gln Pro Ile Lys Glu Gly Arg Pro Ile Lys Ser Val Ser Glu Arg
210 215 220
Leu Ser Ser Ala Lys Thr Asp Cys Leu Pro Val Ser Ser Thr Ala Gln
225 230 235 240
Asn Ile Asn Phe Ser Glu Ser Ile Gln Asn Tyr Thr Asp Lys Ser Ala
245 250 255
Gln Asn Leu Ala Ser Arg Asn Leu Lys His Glu Arg Phe Gln Ser Leu
260 265 270
Ser Phe Pro His Thr Lys Glu Met Met Lys Ile Phe His Lys Lys Phe
275 280 285
Gly Leu His Asn Phe Arg Thr Asn Gln Leu Glu Ala Ile Asn Ala Ala
290 295 300
Leu Leu Gly Glu Asp Cys Phe Ile Leu Met Pro Thr Gly Gly Gly Lys
305 310 315 320
Ser Leu Cys Tyr Gln Leu Pro Ala Cys Val Ser Pro Gly Val Thr Val
325 330 335
Val Ile Ser Pro Leu Arg Ser Leu Ile Val Asp Gln Val Gln Lys Leu
340 345 350
Thr Ser Leu Asp Ile Pro Ala Thr Tyr Leu Thr Gly Asp Lys Thr Asp
355 360 365
Ser Glu Ala Thr Asn Ile Tyr Leu Gln Leu Ser Lys Lys Asp Pro Ile
370 375 380
Ile Lys Leu Leu Tyr Val Thr Pro Glu Lys Ile Cys Ala Ser Asn Arg
385 390 395 400
Leu Ile Ser Thr Leu Glu Asn Leu Tyr Glu Arg Lys Leu Leu Ala Arg
405 410 415
Phe Val Ile Asp Glu Ala His Cys Val Ser Gln Trp Gly His Asp Phe
420 425 430
Arg Gln Asp Tyr Lys Arg Met Asn Met Leu Arg Gln Lys Phe Pro Ser
435 440 445
Val Pro Val Met Ala Leu Thr Ala Thr Ala Asn Pro Arg Val Gln Lys
450 455 460
Asp Ile Leu Thr Gln Leu Lys Ile Leu Arg Pro Gln Val Phe Ser Met
465 470 475 480
Ser Phe Asn Arg His Asn Leu Lys Tyr Tyr Val Leu Pro Lys Lys Pro
485 490 495
Lys Lys Val Ala Phe Asp Cys Leu Glu Trp Ile Arg Lys His His Pro
500 505 510
Tyr Asp Ser Gly Ile Ile Tyr Cys Leu Ser Arg Arg Glu Cys Asp Thr
515 520 525
Met Ala Asp Thr Leu Gln Arg Asp Gly Leu Ala Ala Leu Ala Tyr His
530 535 540
Ala Gly Leu Ser Asp Ser Ala Arg Asp Glu Val Gln Gln Lys Trp Ile
545 550 555 560
Asn Gln Asp Gly Cys Gln Val Ile Cys Ala Thr Ile Ala Phe Gly Met
565 570 575
Gly Ile Asp Lys Pro Asp Val Arg Phe Val Ile His Ala Ser Leu Pro
580 585 590
Lys Ser Val Glu Gly Tyr Tyr Gln Glu Ser Gly Arg Ala Gly Arg Asp
595 600 605
Gly Glu Ile Ser His Cys Leu Leu Phe Tyr Thr Tyr His Asp Val Thr
610 615 620
Arg Leu Lys Arg Leu Ile Met Met Glu Lys Asp Gly Asn His His Thr
625 630 635 640
Arg Glu Thr His Phe Asn Asn Leu Tyr Ser Met Val His Tyr Cys Glu
645 650 655
Asn Ile Thr Glu Cys Arg Arg Ile Gln Leu Leu Ala Tyr Phe Gly Glu
660 665 670
Asn Gly Phe Asn Pro Asp Phe Cys Lys Lys His Pro Asp Val Ser Cys
675 680 685
Asp Asn Cys Cys Lys Thr Lys Asp Tyr Lys Thr Arg Asp Val Thr Asp
690 695 700
Asp Val Lys Ser Ile Val Arg Phe Val Gln Glu His Ser Ser Ser Gln
705 710 715 720
Gly Met Arg Asn Ile Lys His Val Gly Pro Ser Gly Arg Phe Thr Met
725 730 735
Asn Met Leu Val Asp Ile Phe Leu Gly Ser Lys Ser Ala Lys Ile Gln
740 745 750
Ser Gly Ile Phe Gly Lys Gly Ser Ala Tyr Ser Arg His Asn Ala Glu
755 760 765
Arg Leu Phe Lys Lys Leu Ile Leu Asp Lys Ile Leu Asp Glu Asp Leu
770 775 780
Tyr Ile Asn Ala Asn Asp Gln Ala Ile Ala Tyr Val Met Leu Gly Asn
785 790 795 800
Lys Ala Gln Thr Val Leu Asn Gly Asn Leu Lys Val Asp Phe Met Glu
805 810 815
Thr Glu Asn Ser Ser Ser Val Lys Lys Gln Lys Ala Leu Val Ala Lys
820 825 830
Val Ser Gln Arg Glu Glu Met Val Lys Lys Cys Leu Gly Glu Leu Thr
835 840 845
Glu Val Cys Lys Ser Leu Gly Lys Val Phe Gly Val His Tyr Phe Asn
850 855 860
Ile Phe Asn Thr Val Thr Leu Lys Lys Leu Ala Glu Ser Leu Ser Ser
865 870 875 880
Asp Pro Glu Val Leu Leu Gln Ile Asp Gly Val Thr Glu Asp Lys Leu
885 890 895
Glu Lys Tyr Gly Ala Glu Val Ile Ser Val Leu Gln Lys Tyr Ser Glu
900 905 910
Trp Thr Ser Pro Ala Glu Asp Ser Ser Pro Gly Ile Ser Leu Ser Ser
915 920 925
Ser Arg Gly Pro Gly Arg Ser Ala Ala Glu Glu Leu Asp Glu Glu Ile
930 935 940
Pro Val Ser Ser His Tyr Phe Ala Ser Lys Thr Arg Asn Glu Arg Lys
945 950 955 960
Arg Lys Lys Met Pro Ala Ser Gln Arg Ser Lys Arg Arg Lys Thr Ala
965 970 975
Ser Ser Gly Ser Lys Ala Lys Gly Gly Ser Ala Thr Cys Arg Lys Ile
980 985 990
Ser Ser Lys Thr Lys Ser Ser Ser Ile Ile Gly Ser Ser Ser Ala Ser
995 1000 1005
His Thr Ser Gln Ala Thr Ser Gly Ala Asn Ser Lys Leu Gly Ile
1010 1015 1020
Met Ala Pro Pro Lys Pro Ile Asn Arg Pro Phe Leu Lys Pro Ser
1025 1030 1035
Tyr Ala Phe Ser
1040
<210> 42
<211> 3045
<212> DNA
<213> 智人(Homo sapiens)
<400> 42
atggcggagt cttcggataa gctctatcga gtcgagtacg ccaagagcgg gcgcgcctct 60
tgcaagaaat gcagcgagag catccccaag gactcgctcc ggatggccat catggtgcag 120
tcgcccatgt ttgatggaaa agtcccacac tggtaccact tctcctgctt ctggaaggtg 180
ggccactcca tccggcaccc tgacgttgag gtggatgggt tctctgagct tcggtgggat 240
gaccagcaga aagtcaagaa gacagcggaa gctggaggag tgacaggcaa aggccaggat 300
ggaattggta gcaaggcaga gaagactctg ggtgactttg cagcagagta tgccaagtcc 360
aacagaagta cgtgcaaggg gtgtatggag aagatagaaa agggccaggt gcgcctgtcc 420
aagaagatgg tggacccgga gaagccacag ctaggcatga ttgaccgctg gtaccatcca 480
ggctgctttg tcaagaacag ggaggagctg ggtttccggc ccgagtacag tgcgagtcag 540
ctcaagggct tcagcctcct tgctacagag gataaagaag ccctgaagaa gcagctccca 600
ggagtcaaga gtgaaggaaa gagaaaaggc gatgaggtgg atggagtgga tgaagtggcg 660
aagaagaaat ctaaaaaaga aaaagacaag gatagtaagc ttgaaaaagc cctaaaggct 720
cagaacgacc tgatctggaa catcaaggac gagctaaaga aagtgtgttc aactaatgac 780
ctgaaggagc tactcatctt caacaagcag caagtgcctt ctggggagtc ggcgatcttg 840
gaccgagtag ctgatggcat ggtgttcggt gccctccttc cctgcgagga atgctcgggt 900
cagctggtct tcaagagcga tgcctattac tgcactgggg acgtcactgc ctggaccaag 960
tgtatggtca agacacagac acccaaccgg aaggagtggg taaccccaaa ggaattccga 1020
gaaatctctt acctcaagaa attgaaggtt aaaaaacagg accgtatatt ccccccagaa 1080
accagcgcct ccgtggcggc cacgcctccg ccctccacag cctcggctcc tgctgctgtg 1140
aactcctctg cttcagcaga taagccatta tccaacatga agatcctgac tctcgggaag 1200
ctgtcccgga acaaggatga agtgaaggcc atgattgaga aactcggggg gaagttgacg 1260
gggacggcca acaaggcttc cctgtgcatc agcaccaaaa aggaggtgga aaagatgaat 1320
aagaagatgg aggaagtaaa ggaagccaac atccgagttg tgtctgagga cttcctccag 1380
gacgtctccg cctccaccaa gagccttcag gagttgttct tagcgcacat cttgtcccct 1440
tggggggcag aggtgaaggc agagcctgtt gaagttgtgg ccccaagagg gaagtcaggg 1500
gctgcgctct ccaaaaaaag caagggccag gtcaaggagg aaggtatcaa caaatctgaa 1560
aagagaatga aattaactct taaaggagga gcagctgtgg atcctgattc tggactggaa 1620
cactctgcgc atgtcctgga gaaaggtggg aaggtcttca gtgccaccct tggcctggtg 1680
gacatcgtta aaggaaccaa ctcctactac aagctgcagc ttctggagga cgacaaggaa 1740
aacaggtatt ggatattcag gtcctggggc cgtgtgggta cggtgatcgg tagcaacaaa 1800
ctggaacaga tgccgtccaa ggaggatgcc attgagcact tcatgaaatt atatgaagaa 1860
aaaaccggga acgcttggca ctccaaaaat ttcacgaagt atcccaaaaa gttctacccc 1920
ctggagattg actatggcca ggatgaagag gcagtgaaga agctgacagt aaatcctggc 1980
accaagtcca agctccccaa gccagttcag gacctcatca agatgatctt tgatgtggaa 2040
agtatgaaga aagccatggt ggagtatgag atcgaccttc agaagatgcc cttggggaag 2100
ctgagcaaaa ggcagatcca ggccgcatac tccatcctca gtgaggtcca gcaggcggtg 2160
tctcagggca gcagcgactc tcagatcctg gatctctcaa atcgctttta caccctgatc 2220
ccccacgact ttgggatgaa gaagcctccg ctcctgaaca atgcagacag tgtgcaggcc 2280
aaggtggaaa tgcttgacaa cctgctggac atcgaggtgg cctacagtct gctcagggga 2340
gggtctgatg atagcagcaa ggatcccatc gatgtcaact atgagaagct caaaactgac 2400
attaaggtgg ttgacagaga ttctgaagaa gccgagatca tcaggaagta tgttaagaac 2460
actcatgcaa ccacacacaa tgcgtatgac ttggaagtca tcgatatctt taagatagag 2520
cgtgaaggcg aatgccagcg ttacaagccc tttaagcagc ttcataaccg aagattgctg 2580
tggcacgggt ccaggaccac caactttgct gggatcctgt cccagggtct tcggatagcc 2640
ccgcctgaag cgcccgtgac aggctacatg tttggtaaag ggatctattt cgctgacatg 2700
gtctccaaga gtgccaacta ctgccatacg tctcagggag acccaatagg cttaatcctg 2760
ttgggagaag ttgcccttgg aaacatgtat gaactgaagc acgcttcaca tatcagcaag 2820
ttacccaagg gcaagcacag tgtcaaaggt ttgggcaaaa ctacccctga tccttcagct 2880
aacattagtc tggatggtgt agacgttcct cttgggaccg ggatttcatc tggtgtgaat 2940
gacacctctc tactatataa cgagtacatt gtctatgata ttgctcaggt aaatctgaag 3000
tatctgctga aactgaaatt caattttaag acctccctgt ggtaa 3045
<210> 43
<211> 1014
<212> PRT
<213> 智人(Homo sapiens)
<400> 43
Met Ala Glu Ser Ser Asp Lys Leu Tyr Arg Val Glu Tyr Ala Lys Ser
1 5 10 15
Gly Arg Ala Ser Cys Lys Lys Cys Ser Glu Ser Ile Pro Lys Asp Ser
20 25 30
Leu Arg Met Ala Ile Met Val Gln Ser Pro Met Phe Asp Gly Lys Val
35 40 45
Pro His Trp Tyr His Phe Ser Cys Phe Trp Lys Val Gly His Ser Ile
50 55 60
Arg His Pro Asp Val Glu Val Asp Gly Phe Ser Glu Leu Arg Trp Asp
65 70 75 80
Asp Gln Gln Lys Val Lys Lys Thr Ala Glu Ala Gly Gly Val Thr Gly
85 90 95
Lys Gly Gln Asp Gly Ile Gly Ser Lys Ala Glu Lys Thr Leu Gly Asp
100 105 110
Phe Ala Ala Glu Tyr Ala Lys Ser Asn Arg Ser Thr Cys Lys Gly Cys
115 120 125
Met Glu Lys Ile Glu Lys Gly Gln Val Arg Leu Ser Lys Lys Met Val
130 135 140
Asp Pro Glu Lys Pro Gln Leu Gly Met Ile Asp Arg Trp Tyr His Pro
145 150 155 160
Gly Cys Phe Val Lys Asn Arg Glu Glu Leu Gly Phe Arg Pro Glu Tyr
165 170 175
Ser Ala Ser Gln Leu Lys Gly Phe Ser Leu Leu Ala Thr Glu Asp Lys
180 185 190
Glu Ala Leu Lys Lys Gln Leu Pro Gly Val Lys Ser Glu Gly Lys Arg
195 200 205
Lys Gly Asp Glu Val Asp Gly Val Asp Glu Val Ala Lys Lys Lys Ser
210 215 220
Lys Lys Glu Lys Asp Lys Asp Ser Lys Leu Glu Lys Ala Leu Lys Ala
225 230 235 240
Gln Asn Asp Leu Ile Trp Asn Ile Lys Asp Glu Leu Lys Lys Val Cys
245 250 255
Ser Thr Asn Asp Leu Lys Glu Leu Leu Ile Phe Asn Lys Gln Gln Val
260 265 270
Pro Ser Gly Glu Ser Ala Ile Leu Asp Arg Val Ala Asp Gly Met Val
275 280 285
Phe Gly Ala Leu Leu Pro Cys Glu Glu Cys Ser Gly Gln Leu Val Phe
290 295 300
Lys Ser Asp Ala Tyr Tyr Cys Thr Gly Asp Val Thr Ala Trp Thr Lys
305 310 315 320
Cys Met Val Lys Thr Gln Thr Pro Asn Arg Lys Glu Trp Val Thr Pro
325 330 335
Lys Glu Phe Arg Glu Ile Ser Tyr Leu Lys Lys Leu Lys Val Lys Lys
340 345 350
Gln Asp Arg Ile Phe Pro Pro Glu Thr Ser Ala Ser Val Ala Ala Thr
355 360 365
Pro Pro Pro Ser Thr Ala Ser Ala Pro Ala Ala Val Asn Ser Ser Ala
370 375 380
Ser Ala Asp Lys Pro Leu Ser Asn Met Lys Ile Leu Thr Leu Gly Lys
385 390 395 400
Leu Ser Arg Asn Lys Asp Glu Val Lys Ala Met Ile Glu Lys Leu Gly
405 410 415
Gly Lys Leu Thr Gly Thr Ala Asn Lys Ala Ser Leu Cys Ile Ser Thr
420 425 430
Lys Lys Glu Val Glu Lys Met Asn Lys Lys Met Glu Glu Val Lys Glu
435 440 445
Ala Asn Ile Arg Val Val Ser Glu Asp Phe Leu Gln Asp Val Ser Ala
450 455 460
Ser Thr Lys Ser Leu Gln Glu Leu Phe Leu Ala His Ile Leu Ser Pro
465 470 475 480
Trp Gly Ala Glu Val Lys Ala Glu Pro Val Glu Val Val Ala Pro Arg
485 490 495
Gly Lys Ser Gly Ala Ala Leu Ser Lys Lys Ser Lys Gly Gln Val Lys
500 505 510
Glu Glu Gly Ile Asn Lys Ser Glu Lys Arg Met Lys Leu Thr Leu Lys
515 520 525
Gly Gly Ala Ala Val Asp Pro Asp Ser Gly Leu Glu His Ser Ala His
530 535 540
Val Leu Glu Lys Gly Gly Lys Val Phe Ser Ala Thr Leu Gly Leu Val
545 550 555 560
Asp Ile Val Lys Gly Thr Asn Ser Tyr Tyr Lys Leu Gln Leu Leu Glu
565 570 575
Asp Asp Lys Glu Asn Arg Tyr Trp Ile Phe Arg Ser Trp Gly Arg Val
580 585 590
Gly Thr Val Ile Gly Ser Asn Lys Leu Glu Gln Met Pro Ser Lys Glu
595 600 605
Asp Ala Ile Glu His Phe Met Lys Leu Tyr Glu Glu Lys Thr Gly Asn
610 615 620
Ala Trp His Ser Lys Asn Phe Thr Lys Tyr Pro Lys Lys Phe Tyr Pro
625 630 635 640
Leu Glu Ile Asp Tyr Gly Gln Asp Glu Glu Ala Val Lys Lys Leu Thr
645 650 655
Val Asn Pro Gly Thr Lys Ser Lys Leu Pro Lys Pro Val Gln Asp Leu
660 665 670
Ile Lys Met Ile Phe Asp Val Glu Ser Met Lys Lys Ala Met Val Glu
675 680 685
Tyr Glu Ile Asp Leu Gln Lys Met Pro Leu Gly Lys Leu Ser Lys Arg
690 695 700
Gln Ile Gln Ala Ala Tyr Ser Ile Leu Ser Glu Val Gln Gln Ala Val
705 710 715 720
Ser Gln Gly Ser Ser Asp Ser Gln Ile Leu Asp Leu Ser Asn Arg Phe
725 730 735
Tyr Thr Leu Ile Pro His Asp Phe Gly Met Lys Lys Pro Pro Leu Leu
740 745 750
Asn Asn Ala Asp Ser Val Gln Ala Lys Val Glu Met Leu Asp Asn Leu
755 760 765
Leu Asp Ile Glu Val Ala Tyr Ser Leu Leu Arg Gly Gly Ser Asp Asp
770 775 780
Ser Ser Lys Asp Pro Ile Asp Val Asn Tyr Glu Lys Leu Lys Thr Asp
785 790 795 800
Ile Lys Val Val Asp Arg Asp Ser Glu Glu Ala Glu Ile Ile Arg Lys
805 810 815
Tyr Val Lys Asn Thr His Ala Thr Thr His Asn Ala Tyr Asp Leu Glu
820 825 830
Val Ile Asp Ile Phe Lys Ile Glu Arg Glu Gly Glu Cys Gln Arg Tyr
835 840 845
Lys Pro Phe Lys Gln Leu His Asn Arg Arg Leu Leu Trp His Gly Ser
850 855 860
Arg Thr Thr Asn Phe Ala Gly Ile Leu Ser Gln Gly Leu Arg Ile Ala
865 870 875 880
Pro Pro Glu Ala Pro Val Thr Gly Tyr Met Phe Gly Lys Gly Ile Tyr
885 890 895
Phe Ala Asp Met Val Ser Lys Ser Ala Asn Tyr Cys His Thr Ser Gln
900 905 910
Gly Asp Pro Ile Gly Leu Ile Leu Leu Gly Glu Val Ala Leu Gly Asn
915 920 925
Met Tyr Glu Leu Lys His Ala Ser His Ile Ser Lys Leu Pro Lys Gly
930 935 940
Lys His Ser Val Lys Gly Leu Gly Lys Thr Thr Pro Asp Pro Ser Ala
945 950 955 960
Asn Ile Ser Leu Asp Gly Val Asp Val Pro Leu Gly Thr Gly Ile Ser
965 970 975
Ser Gly Val Asn Asp Thr Ser Leu Leu Tyr Asn Glu Tyr Ile Val Tyr
980 985 990
Asp Ile Ala Gln Val Asn Leu Lys Tyr Leu Leu Lys Leu Lys Phe Asn
995 1000 1005
Phe Lys Thr Ser Leu Trp
1010
<210> 44
<211> 1851
<212> DNA
<213> 智人(Homo sapiens)
<400> 44
atggtcggcc aactgagcga gggggccatt gcggccatca tgcagaaggg ggatacaaac 60
ataaagccca tcctccaagt catcaacatc cgtcccatta ctacggggaa tagtccgccg 120
cgttatcgac tgctcatgag tgatggattg aacactctat cctctttcat gttggcgaca 180
cagttgaacc ctctcgtgga ggaagaacaa ttgtccagca actgtgtatg ccagattcac 240
agatttattg tgaacactct gaaagacgga aggagagtag ttatcttgat ggaattagaa 300
gttttgaagt cagctgaagc agttggagtg aagattggca atccagtgcc ctataatgaa 360
ggactcgggc agccgcaagt agctcctcca gcgccagcag ccagcccagc agcaagcagc 420
aggccccagc cgcagaatgg aagctcggga atgggttcta ctgtttctaa ggcttatggt 480
gcttcaaaga catttggaaa agctgcaggt cccagcctgt cacacacttc tgggggaaca 540
cagtccaaag tggtgcccat tgccagcctc actccttacc agtccaagtg gaccatttgt 600
gctcgtgtta ccaacaaaag tcagatccgt acctggagca actcccgagg ggaagggaag 660
cttttctccc tagaactggt tgacgaaagt ggtgaaatcc gagctacagc tttcaatgag 720
caagtggaca agttctttcc tcttattgaa gtgaacaagg tgtattattt ctcgaaaggc 780
accctgaaga ttgctaacaa gcagttcaca gctgttaaaa atgactacga gatgaccttc 840
aataacgaga cttccgtcat gccctgtgag gacgaccatc atttacctac ggttcagttt 900
gatttcacgg ggattgatga cctcgagaac aagtcgaaag actcacttgt agacatcatc 960
gggatctgca agagctatga agacgccact aaaatcacag tgaggtctaa caacagagaa 1020
gttgccaaga ggaatatcta cttgatggac acatccggga aggtggtgac tgctacactg 1080
tggggggaag atgctgataa atttgatggt tctagacagc ccgtgttggc tatcaaagga 1140
gcccgagtct ctgatttcgg tggacggagc ctctccgtgc tgtcttcaag cactatcatt 1200
gcgaatcctg acatcccaga ggcctataag cttcgtggat ggtttgacgc agaaggacaa 1260
gccttagatg gtgtttccat ctctgatcta aagagcggcg gagtcggagg gagtaacacc 1320
aactggaaaa ccttgtatga ggtcaaatcc gagaacctgg gccaaggcga caagccggac 1380
tactttagtt ctgtggccac agtggtgtat cttcgcaaag agaactgcat gtaccaagcc 1440
tgcccgactc aggactgcaa taagaaagtg attgatcaac agaatggatt gtaccgctgt 1500
gagaagtgcg acaccgaatt tcccaatttc aagtaccgca tgatcctgtc agtaaatatt 1560
gcagattttc aagagaatca gtgggtgact tgtttccagg agtctgctga agctatcctt 1620
ggacaaaatg ctgcttatct tggggaatta aaagacaaga atgaacaggc atttgaagaa 1680
gttttccaga atgccaactt ccgatctttc atattcagag tcagggtcaa agtggagacc 1740
tacaacgacg agtctcgaat taaggccact gtgatggacg tgaagcccgt ggactacaga 1800
gagtatggcc gaaggctggt catgagcatc aggagaagtg cattgatgtg a 1851
<210> 45
<211> 616
<212> PRT
<213> 智人(Homo sapiens)
<400> 45
Met Val Gly Gln Leu Ser Glu Gly Ala Ile Ala Ala Ile Met Gln Lys
1 5 10 15
Gly Asp Thr Asn Ile Lys Pro Ile Leu Gln Val Ile Asn Ile Arg Pro
20 25 30
Ile Thr Thr Gly Asn Ser Pro Pro Arg Tyr Arg Leu Leu Met Ser Asp
35 40 45
Gly Leu Asn Thr Leu Ser Ser Phe Met Leu Ala Thr Gln Leu Asn Pro
50 55 60
Leu Val Glu Glu Glu Gln Leu Ser Ser Asn Cys Val Cys Gln Ile His
65 70 75 80
Arg Phe Ile Val Asn Thr Leu Lys Asp Gly Arg Arg Val Val Ile Leu
85 90 95
Met Glu Leu Glu Val Leu Lys Ser Ala Glu Ala Val Gly Val Lys Ile
100 105 110
Gly Asn Pro Val Pro Tyr Asn Glu Gly Leu Gly Gln Pro Gln Val Ala
115 120 125
Pro Pro Ala Pro Ala Ala Ser Pro Ala Ala Ser Ser Arg Pro Gln Pro
130 135 140
Gln Asn Gly Ser Ser Gly Met Gly Ser Thr Val Ser Lys Ala Tyr Gly
145 150 155 160
Ala Ser Lys Thr Phe Gly Lys Ala Ala Gly Pro Ser Leu Ser His Thr
165 170 175
Ser Gly Gly Thr Gln Ser Lys Val Val Pro Ile Ala Ser Leu Thr Pro
180 185 190
Tyr Gln Ser Lys Trp Thr Ile Cys Ala Arg Val Thr Asn Lys Ser Gln
195 200 205
Ile Arg Thr Trp Ser Asn Ser Arg Gly Glu Gly Lys Leu Phe Ser Leu
210 215 220
Glu Leu Val Asp Glu Ser Gly Glu Ile Arg Ala Thr Ala Phe Asn Glu
225 230 235 240
Gln Val Asp Lys Phe Phe Pro Leu Ile Glu Val Asn Lys Val Tyr Tyr
245 250 255
Phe Ser Lys Gly Thr Leu Lys Ile Ala Asn Lys Gln Phe Thr Ala Val
260 265 270
Lys Asn Asp Tyr Glu Met Thr Phe Asn Asn Glu Thr Ser Val Met Pro
275 280 285
Cys Glu Asp Asp His His Leu Pro Thr Val Gln Phe Asp Phe Thr Gly
290 295 300
Ile Asp Asp Leu Glu Asn Lys Ser Lys Asp Ser Leu Val Asp Ile Ile
305 310 315 320
Gly Ile Cys Lys Ser Tyr Glu Asp Ala Thr Lys Ile Thr Val Arg Ser
325 330 335
Asn Asn Arg Glu Val Ala Lys Arg Asn Ile Tyr Leu Met Asp Thr Ser
340 345 350
Gly Lys Val Val Thr Ala Thr Leu Trp Gly Glu Asp Ala Asp Lys Phe
355 360 365
Asp Gly Ser Arg Gln Pro Val Leu Ala Ile Lys Gly Ala Arg Val Ser
370 375 380
Asp Phe Gly Gly Arg Ser Leu Ser Val Leu Ser Ser Ser Thr Ile Ile
385 390 395 400
Ala Asn Pro Asp Ile Pro Glu Ala Tyr Lys Leu Arg Gly Trp Phe Asp
405 410 415
Ala Glu Gly Gln Ala Leu Asp Gly Val Ser Ile Ser Asp Leu Lys Ser
420 425 430
Gly Gly Val Gly Gly Ser Asn Thr Asn Trp Lys Thr Leu Tyr Glu Val
435 440 445
Lys Ser Glu Asn Leu Gly Gln Gly Asp Lys Pro Asp Tyr Phe Ser Ser
450 455 460
Val Ala Thr Val Val Tyr Leu Arg Lys Glu Asn Cys Met Tyr Gln Ala
465 470 475 480
Cys Pro Thr Gln Asp Cys Asn Lys Lys Val Ile Asp Gln Gln Asn Gly
485 490 495
Leu Tyr Arg Cys Glu Lys Cys Asp Thr Glu Phe Pro Asn Phe Lys Tyr
500 505 510
Arg Met Ile Leu Ser Val Asn Ile Ala Asp Phe Gln Glu Asn Gln Trp
515 520 525
Val Thr Cys Phe Gln Glu Ser Ala Glu Ala Ile Leu Gly Gln Asn Ala
530 535 540
Ala Tyr Leu Gly Glu Leu Lys Asp Lys Asn Glu Gln Ala Phe Glu Glu
545 550 555 560
Val Phe Gln Asn Ala Asn Phe Arg Ser Phe Ile Phe Arg Val Arg Val
565 570 575
Lys Val Glu Thr Tyr Asn Asp Glu Ser Arg Ile Lys Ala Thr Val Met
580 585 590
Asp Val Lys Pro Val Asp Tyr Arg Glu Tyr Gly Arg Arg Leu Val Met
595 600 605
Ser Ile Arg Arg Ser Ala Leu Met
610 615
<210> 46
<211> 1812
<212> DNA
<213> 智人(Homo sapiens)
<400> 46
atgcagaagg gggatacaaa cataaagccc atcctccaag tcatcaacat ccgtcccatt 60
actacgggga atagtccgcc gcgttatcga ctgctcatga gtgatggatt gaacactcta 120
tcctctttca tgttggcgac acagttgaac cctctcgtgg aggaagaaca attgtccagc 180
aactgtgtat gccagattca cagatttatt gtgaacactc tgaaagacgg aaggagagta 240
gttatcttga tggaattaga agttttgaag tcagctgaag cagttggagt gaagattggc 300
aatccagtgc cctataatga aggactcggg cagccgcaag tagctcctcc agcgccagca 360
gccagcccag cagcaagcag caggccccag ccgcagaatg gaagctcggg aatgggttct 420
actgtttcta aggcttatgg tgcttcaaag acatttggaa aagctgcagg tcccagcctg 480
tcacacactt ctgggggaac acagtccaaa gtggtgccca ttgccagcct cactccttac 540
cagtccaagt ggaccatttg tgctcgtgtt accaacaaaa gtcagatccg tacctggagc 600
aactcccgag gggaagggaa gcttttctcc ctagaactgg ttgacgaaag tggtgaaatc 660
cgagctacag ctttcaatga gcaagtggac aagttctttc ctcttattga agtgaacaag 720
gtgtattatt tctcgaaagg caccctgaag attgctaaca agcagttcac agctgttaaa 780
aatgactacg agatgacctt caataacgag acttccgtca tgccctgtga ggacgaccat 840
catttaccta cggttcagtt tgatttcacg gggattgatg acctcgagaa caagtcgaaa 900
gactcacttg tagacatcat cgggatctgc aagagctatg aagacgccac taaaatcaca 960
gtgaggtcta acaacagaga agttgccaag aggaatatct acttgatgga cacatccggg 1020
aaggtggtga ctgctacact gtggggggaa gatgctgata aatttgatgg ttctagacag 1080
cccgtgttgg ctatcaaagg agcccgagtc tctgatttcg gtggacggag cctctccgtg 1140
ctgtcttcaa gcactatcat tgcgaatcct gacatcccag aggcctataa gcttcgtgga 1200
tggtttgacg cagaaggaca agccttagat ggtgtttcca tctctgatct aaagagcggc 1260
ggagtcggag ggagtaacac caactggaaa accttgtatg aggtcaaatc cgagaacctg 1320
ggccaaggcg acaagccgga ctactttagt tctgtggcca cagtggtgta tcttcgcaaa 1380
gagaactgca tgtaccaagc ctgcccgact caggactgca ataagaaagt gattgatcaa 1440
cagaatggat tgtaccgctg tgagaagtgc gacaccgaat ttcccaattt caagtaccgc 1500
atgatcctgt cagtaaatat tgcagatttt caagagaatc agtgggtgac ttgtttccag 1560
gagtctgctg aagctatcct tggacaaaat gctgcttatc ttggggaatt aaaagacaag 1620
aatgaacagg catttgaaga agttttccag aatgccaact tccgatcttt catattcaga 1680
gtcagggtca aagtggagac ctacaacgac gagtctcgaa ttaaggccac tgtgatggac 1740
gtgaagcccg tggactacag agagtatggc cgaaggctgg tcatgagcat caggagaagt 1800
gcattgatgt ga 1812
<210> 47
<211> 603
<212> PRT
<213> 智人(Homo sapiens)
<400> 47
Met Gln Lys Gly Asp Thr Asn Ile Lys Pro Ile Leu Gln Val Ile Asn
1 5 10 15
Ile Arg Pro Ile Thr Thr Gly Asn Ser Pro Pro Arg Tyr Arg Leu Leu
20 25 30
Met Ser Asp Gly Leu Asn Thr Leu Ser Ser Phe Met Leu Ala Thr Gln
35 40 45
Leu Asn Pro Leu Val Glu Glu Glu Gln Leu Ser Ser Asn Cys Val Cys
50 55 60
Gln Ile His Arg Phe Ile Val Asn Thr Leu Lys Asp Gly Arg Arg Val
65 70 75 80
Val Ile Leu Met Glu Leu Glu Val Leu Lys Ser Ala Glu Ala Val Gly
85 90 95
Val Lys Ile Gly Asn Pro Val Pro Tyr Asn Glu Gly Leu Gly Gln Pro
100 105 110
Gln Val Ala Pro Pro Ala Pro Ala Ala Ser Pro Ala Ala Ser Ser Arg
115 120 125
Pro Gln Pro Gln Asn Gly Ser Ser Gly Met Gly Ser Thr Val Ser Lys
130 135 140
Ala Tyr Gly Ala Ser Lys Thr Phe Gly Lys Ala Ala Gly Pro Ser Leu
145 150 155 160
Ser His Thr Ser Gly Gly Thr Gln Ser Lys Val Val Pro Ile Ala Ser
165 170 175
Leu Thr Pro Tyr Gln Ser Lys Trp Thr Ile Cys Ala Arg Val Thr Asn
180 185 190
Lys Ser Gln Ile Arg Thr Trp Ser Asn Ser Arg Gly Glu Gly Lys Leu
195 200 205
Phe Ser Leu Glu Leu Val Asp Glu Ser Gly Glu Ile Arg Ala Thr Ala
210 215 220
Phe Asn Glu Gln Val Asp Lys Phe Phe Pro Leu Ile Glu Val Asn Lys
225 230 235 240
Val Tyr Tyr Phe Ser Lys Gly Thr Leu Lys Ile Ala Asn Lys Gln Phe
245 250 255
Thr Ala Val Lys Asn Asp Tyr Glu Met Thr Phe Asn Asn Glu Thr Ser
260 265 270
Val Met Pro Cys Glu Asp Asp His His Leu Pro Thr Val Gln Phe Asp
275 280 285
Phe Thr Gly Ile Asp Asp Leu Glu Asn Lys Ser Lys Asp Ser Leu Val
290 295 300
Asp Ile Ile Gly Ile Cys Lys Ser Tyr Glu Asp Ala Thr Lys Ile Thr
305 310 315 320
Val Arg Ser Asn Asn Arg Glu Val Ala Lys Arg Asn Ile Tyr Leu Met
325 330 335
Asp Thr Ser Gly Lys Val Val Thr Ala Thr Leu Trp Gly Glu Asp Ala
340 345 350
Asp Lys Phe Asp Gly Ser Arg Gln Pro Val Leu Ala Ile Lys Gly Ala
355 360 365
Arg Val Ser Asp Phe Gly Gly Arg Ser Leu Ser Val Leu Ser Ser Ser
370 375 380
Thr Ile Ile Ala Asn Pro Asp Ile Pro Glu Ala Tyr Lys Leu Arg Gly
385 390 395 400
Trp Phe Asp Ala Glu Gly Gln Ala Leu Asp Gly Val Ser Ile Ser Asp
405 410 415
Leu Lys Ser Gly Gly Val Gly Gly Ser Asn Thr Asn Trp Lys Thr Leu
420 425 430
Tyr Glu Val Lys Ser Glu Asn Leu Gly Gln Gly Asp Lys Pro Asp Tyr
435 440 445
Phe Ser Ser Val Ala Thr Val Val Tyr Leu Arg Lys Glu Asn Cys Met
450 455 460
Tyr Gln Ala Cys Pro Thr Gln Asp Cys Asn Lys Lys Val Ile Asp Gln
465 470 475 480
Gln Asn Gly Leu Tyr Arg Cys Glu Lys Cys Asp Thr Glu Phe Pro Asn
485 490 495
Phe Lys Tyr Arg Met Ile Leu Ser Val Asn Ile Ala Asp Phe Gln Glu
500 505 510
Asn Gln Trp Val Thr Cys Phe Gln Glu Ser Ala Glu Ala Ile Leu Gly
515 520 525
Gln Asn Ala Ala Tyr Leu Gly Glu Leu Lys Asp Lys Asn Glu Gln Ala
530 535 540
Phe Glu Glu Val Phe Gln Asn Ala Asn Phe Arg Ser Phe Ile Phe Arg
545 550 555 560
Val Arg Val Lys Val Glu Thr Tyr Asn Asp Glu Ser Arg Ile Lys Ala
565 570 575
Thr Val Met Asp Val Lys Pro Val Asp Tyr Arg Glu Tyr Gly Arg Arg
580 585 590
Leu Val Met Ser Ile Arg Arg Ser Ala Leu Met
595 600
<210> 48
<211> 1674
<212> DNA
<213> 智人(Homo sapiens)
<400> 48
atggtcggcc aactgagcga gggggccatt gcggccatca tgcagaaggg ggatacaaac 60
ataaagccca tcctccaagt catcaacatc cgtcccatta ctacggggaa tagtccgccg 120
cgttatcgac tgctcatgag tgatggattg aacactctat cctctttcat gttggcgaca 180
cagttgaacc ctctcgtgga ggaagaacaa ttgtccagca actgtgtatg ccagattcac 240
agatttattg tgaacactct gaaagacgga aggagagtag ttatcttgat ggaattagaa 300
gttttgaagt cagctgaagc agttggagtg aagattggca atccagtgcc ctataatgaa 360
ggactcgggc agccgcaagt agctcctcca gcgccagcag ccagcccagc agcaagcagc 420
aggccccagc cgcagaatgg aagctcggga atgggttcta ctgtttctaa ggcttatggt 480
gcttcaaaga catttggaaa agctgcaggt cccagcctgt cacacacttc tgggggaaca 540
cagtccaaag tggtgcccat tgccagcctc actccttacc agtccaagtg gaccatttgt 600
gctcgtgtta ccaacaaaag tcagatccgt acctggagca actcccgagg ggaagggaag 660
cttttctccc tagaactggt tgacgaaagt ggtgaaatcc gagctacagc tttcaatgag 720
caagtggaca agttctttcc tcttattgaa gtgaacaagg tgtattattt ctcgaaaggc 780
accctgaaga ttgctaacaa gcagttcaca gctgttaaaa atgactacga gatgaccttc 840
aataacgaga cttccgtcat gccctgtgag gacgaccatc atttacctac ggttcagttt 900
gatttcacgg ggattgatga cctcgagaac aagtcgaaag actcacttgt agacatcatc 960
gggatctgca agagctatga agacgccact aaaatcacag tgaggtctaa caacagagaa 1020
gttgccaaga ggaatatcta cttgatggac acatccggga aggtggtgac tgctacactg 1080
tggggggaag atgctgataa atttgatggt tctagacagc ccgtgttggc tatcaaagga 1140
gcccgagtct ctgatttcgg tggacggagc ctctccgtgc tgtcttcaag cactatcatt 1200
gcgaatcctg acatcccaga ggcctataag cttcgtggat ggtttgacgc agaaggacaa 1260
gccttagatg gtgtttccat ctctgatcta aagagcggcg gagtcggagg gagtaacacc 1320
aactggaaaa ccttgtatga ggtcaaatcc gagaacctgg gccaaggcga caaggtaaat 1380
attgcagatt ttcaagagaa tcagtgggtg acttgtttcc aggagtctgc tgaagctatc 1440
cttggacaaa atgctgctta tcttggggaa ttaaaagaca agaatgaaca ggcatttgaa 1500
gaagttttcc agaatgccaa cttccgatct ttcatattca gagtcagggt caaagtggag 1560
acctacaacg acgagtctcg aattaaggcc actgtgatgg acgtgaagcc cgtggactac 1620
agagagtatg gccgaaggct ggtcatgagc atcaggagaa gtgcattgat gtga 1674
<210> 49
<211> 557
<212> PRT
<213> 智人(Homo sapiens)
<400> 49
Met Val Gly Gln Leu Ser Glu Gly Ala Ile Ala Ala Ile Met Gln Lys
1 5 10 15
Gly Asp Thr Asn Ile Lys Pro Ile Leu Gln Val Ile Asn Ile Arg Pro
20 25 30
Ile Thr Thr Gly Asn Ser Pro Pro Arg Tyr Arg Leu Leu Met Ser Asp
35 40 45
Gly Leu Asn Thr Leu Ser Ser Phe Met Leu Ala Thr Gln Leu Asn Pro
50 55 60
Leu Val Glu Glu Glu Gln Leu Ser Ser Asn Cys Val Cys Gln Ile His
65 70 75 80
Arg Phe Ile Val Asn Thr Leu Lys Asp Gly Arg Arg Val Val Ile Leu
85 90 95
Met Glu Leu Glu Val Leu Lys Ser Ala Glu Ala Val Gly Val Lys Ile
100 105 110
Gly Asn Pro Val Pro Tyr Asn Glu Gly Leu Gly Gln Pro Gln Val Ala
115 120 125
Pro Pro Ala Pro Ala Ala Ser Pro Ala Ala Ser Ser Arg Pro Gln Pro
130 135 140
Gln Asn Gly Ser Ser Gly Met Gly Ser Thr Val Ser Lys Ala Tyr Gly
145 150 155 160
Ala Ser Lys Thr Phe Gly Lys Ala Ala Gly Pro Ser Leu Ser His Thr
165 170 175
Ser Gly Gly Thr Gln Ser Lys Val Val Pro Ile Ala Ser Leu Thr Pro
180 185 190
Tyr Gln Ser Lys Trp Thr Ile Cys Ala Arg Val Thr Asn Lys Ser Gln
195 200 205
Ile Arg Thr Trp Ser Asn Ser Arg Gly Glu Gly Lys Leu Phe Ser Leu
210 215 220
Glu Leu Val Asp Glu Ser Gly Glu Ile Arg Ala Thr Ala Phe Asn Glu
225 230 235 240
Gln Val Asp Lys Phe Phe Pro Leu Ile Glu Val Asn Lys Val Tyr Tyr
245 250 255
Phe Ser Lys Gly Thr Leu Lys Ile Ala Asn Lys Gln Phe Thr Ala Val
260 265 270
Lys Asn Asp Tyr Glu Met Thr Phe Asn Asn Glu Thr Ser Val Met Pro
275 280 285
Cys Glu Asp Asp His His Leu Pro Thr Val Gln Phe Asp Phe Thr Gly
290 295 300
Ile Asp Asp Leu Glu Asn Lys Ser Lys Asp Ser Leu Val Asp Ile Ile
305 310 315 320
Gly Ile Cys Lys Ser Tyr Glu Asp Ala Thr Lys Ile Thr Val Arg Ser
325 330 335
Asn Asn Arg Glu Val Ala Lys Arg Asn Ile Tyr Leu Met Asp Thr Ser
340 345 350
Gly Lys Val Val Thr Ala Thr Leu Trp Gly Glu Asp Ala Asp Lys Phe
355 360 365
Asp Gly Ser Arg Gln Pro Val Leu Ala Ile Lys Gly Ala Arg Val Ser
370 375 380
Asp Phe Gly Gly Arg Ser Leu Ser Val Leu Ser Ser Ser Thr Ile Ile
385 390 395 400
Ala Asn Pro Asp Ile Pro Glu Ala Tyr Lys Leu Arg Gly Trp Phe Asp
405 410 415
Ala Glu Gly Gln Ala Leu Asp Gly Val Ser Ile Ser Asp Leu Lys Ser
420 425 430
Gly Gly Val Gly Gly Ser Asn Thr Asn Trp Lys Thr Leu Tyr Glu Val
435 440 445
Lys Ser Glu Asn Leu Gly Gln Gly Asp Lys Val Asn Ile Ala Asp Phe
450 455 460
Gln Glu Asn Gln Trp Val Thr Cys Phe Gln Glu Ser Ala Glu Ala Ile
465 470 475 480
Leu Gly Gln Asn Ala Ala Tyr Leu Gly Glu Leu Lys Asp Lys Asn Glu
485 490 495
Gln Ala Phe Glu Glu Val Phe Gln Asn Ala Asn Phe Arg Ser Phe Ile
500 505 510
Phe Arg Val Arg Val Lys Val Glu Thr Tyr Asn Asp Glu Ser Arg Ile
515 520 525
Lys Ala Thr Val Met Asp Val Lys Pro Val Asp Tyr Arg Glu Tyr Gly
530 535 540
Arg Arg Leu Val Met Ser Ile Arg Arg Ser Ala Leu Met
545 550 555
<210> 50
<211> 1020
<212> DNA
<213> 智人(Homo sapiens)
<400> 50
atggcaatgc agatgcagct tgaagcaaat gcagatactt cagtggaaga agaaagcttt 60
ggcccacaac ccatttcacg gttagagcag tgtggcataa atgccaacga tgtgaagaaa 120
ttggaagaag ctggattcca tactgtggag gctgttgcct atgcgccaaa gaaggagcta 180
ataaatatta agggaattag tgaagccaaa gctgataaaa ttctggctga ggcagctaaa 240
ttagttccaa tgggtttcac cactgcaact gaattccacc aaaggcggtc agagatcata 300
cagattacta ctggctccaa agagcttgac aaactacttc aaggtggaat tgagactgga 360
tctatcacag aaatgtttgg agaattccga actgggaaga cccagatctg tcatacgcta 420
gctgtcacct gccagcttcc cattgaccgg ggtggaggtg aaggaaaggc catgtacatt 480
gacactgagg gtacctttag gccagaacgg ctgctggcag tggctgagag gtatggtctc 540
tctggcagtg atgtcctgga taatgtagca tatgctcgag cgttcaacac agaccaccag 600
acccagctcc tttatcaagc atcagccatg atggtagaat ctaggtatgc actgcttatt 660
gtagacagtg ccaccgccct ttacagaaca gactactcgg gtcgaggtga gctttcagcc 720
aggcagatgc acttggccag gtttctgcgg atgcttctgc gactcgctga tgagtttggt 780
gtagcagtgg taatcactaa tcaggtggta gctcaagtgg atggagcagc gatgtttgct 840
gctgatccca aaaaacctat tggaggaaat atcatcgccc atgcatcaac aaccagattg 900
tatctgagga aaggaagagg ggaaaccaga atctgcaaaa tctacgactc tccctgtctt 960
cctgaagctg aagctatgtt cgccattaat gcagatggag tgggagatgc caaagactga 1020
<210> 51
<211> 339
<212> PRT
<213> 智人(Homo sapiens)
<400> 51
Met Ala Met Gln Met Gln Leu Glu Ala Asn Ala Asp Thr Ser Val Glu
1 5 10 15
Glu Glu Ser Phe Gly Pro Gln Pro Ile Ser Arg Leu Glu Gln Cys Gly
20 25 30
Ile Asn Ala Asn Asp Val Lys Lys Leu Glu Glu Ala Gly Phe His Thr
35 40 45
Val Glu Ala Val Ala Tyr Ala Pro Lys Lys Glu Leu Ile Asn Ile Lys
50 55 60
Gly Ile Ser Glu Ala Lys Ala Asp Lys Ile Leu Ala Glu Ala Ala Lys
65 70 75 80
Leu Val Pro Met Gly Phe Thr Thr Ala Thr Glu Phe His Gln Arg Arg
85 90 95
Ser Glu Ile Ile Gln Ile Thr Thr Gly Ser Lys Glu Leu Asp Lys Leu
100 105 110
Leu Gln Gly Gly Ile Glu Thr Gly Ser Ile Thr Glu Met Phe Gly Glu
115 120 125
Phe Arg Thr Gly Lys Thr Gln Ile Cys His Thr Leu Ala Val Thr Cys
130 135 140
Gln Leu Pro Ile Asp Arg Gly Gly Gly Glu Gly Lys Ala Met Tyr Ile
145 150 155 160
Asp Thr Glu Gly Thr Phe Arg Pro Glu Arg Leu Leu Ala Val Ala Glu
165 170 175
Arg Tyr Gly Leu Ser Gly Ser Asp Val Leu Asp Asn Val Ala Tyr Ala
180 185 190
Arg Ala Phe Asn Thr Asp His Gln Thr Gln Leu Leu Tyr Gln Ala Ser
195 200 205
Ala Met Met Val Glu Ser Arg Tyr Ala Leu Leu Ile Val Asp Ser Ala
210 215 220
Thr Ala Leu Tyr Arg Thr Asp Tyr Ser Gly Arg Gly Glu Leu Ser Ala
225 230 235 240
Arg Gln Met His Leu Ala Arg Phe Leu Arg Met Leu Leu Arg Leu Ala
245 250 255
Asp Glu Phe Gly Val Ala Val Val Ile Thr Asn Gln Val Val Ala Gln
260 265 270
Val Asp Gly Ala Ala Met Phe Ala Ala Asp Pro Lys Lys Pro Ile Gly
275 280 285
Gly Asn Ile Ile Ala His Ala Ser Thr Thr Arg Leu Tyr Leu Arg Lys
290 295 300
Gly Arg Gly Glu Thr Arg Ile Cys Lys Ile Tyr Asp Ser Pro Cys Leu
305 310 315 320
Pro Glu Ala Glu Ala Met Phe Ala Ile Asn Ala Asp Gly Val Gly Asp
325 330 335
Ala Lys Asp
<210> 52
<211> 1023
<212> DNA
<213> 智人(Homo sapiens)
<400> 52
atggcaatgc agatgcagct tgaagcaaat gcagatactt cagtggaaga agaaagcttt 60
ggcccacaac ccatttcacg gttagagcag tgtggcataa atgccaacga tgtgaagaaa 120
ttggaagaag ctggattcca tactgtggag gctgttgcct atgcgccaaa gaaggagcta 180
ataaatatta agggaattag tgaagccaaa gctgataaaa ttctgacgga gtctcgctct 240
gttgccaggc tggagtgcaa tagcgtgatc ttggtctact gcaccctccg cctctcaggt 300
tcaagtgatt ctcctgcctc agcctcccga gtagttggga ctacaggtgg aattgagact 360
ggatctatca cagaaatgtt tggagaattc cgaactggga agacccagat ctgtcatacg 420
ctagctgtca cctgccagct tcccattgac cggggtggag gtgaaggaaa ggccatgtac 480
attgacactg agggtacctt taggccagaa cggctgctgg cagtggctga gaggtatggt 540
ctctctggca gtgatgtcct ggataatgta gcatatgctc gagcgttcaa cacagaccac 600
cagacccagc tcctttatca agcatcagcc atgatggtag aatctaggta tgcactgctt 660
attgtagaca gtgccaccgc cctttacaga acagactact cgggtcgagg tgagctttca 720
gccaggcaga tgcacttggc caggtttctg cggatgcttc tgcgactcgc tgatgagttt 780
ggtgtagcag tggtaatcac taatcaggtg gtagctcaag tggatggagc agcgatgttt 840
gctgctgatc ccaaaaaacc tattggagga aatatcatcg cccatgcatc aacaaccaga 900
ttgtatctga ggaaaggaag aggggaaacc agaatctgca aaatctacga ctctccctgt 960
cttcctgaag ctgaagctat gttcgccatt aatgcagatg gagtgggaga tgccaaagac 1020
tga 1023
<210> 53
<211> 340
<212> PRT
<213> 智人(Homo sapiens)
<400> 53
Met Ala Met Gln Met Gln Leu Glu Ala Asn Ala Asp Thr Ser Val Glu
1 5 10 15
Glu Glu Ser Phe Gly Pro Gln Pro Ile Ser Arg Leu Glu Gln Cys Gly
20 25 30
Ile Asn Ala Asn Asp Val Lys Lys Leu Glu Glu Ala Gly Phe His Thr
35 40 45
Val Glu Ala Val Ala Tyr Ala Pro Lys Lys Glu Leu Ile Asn Ile Lys
50 55 60
Gly Ile Ser Glu Ala Lys Ala Asp Lys Ile Leu Thr Glu Ser Arg Ser
65 70 75 80
Val Ala Arg Leu Glu Cys Asn Ser Val Ile Leu Val Tyr Cys Thr Leu
85 90 95
Arg Leu Ser Gly Ser Ser Asp Ser Pro Ala Ser Ala Ser Arg Val Val
100 105 110
Gly Thr Thr Gly Gly Ile Glu Thr Gly Ser Ile Thr Glu Met Phe Gly
115 120 125
Glu Phe Arg Thr Gly Lys Thr Gln Ile Cys His Thr Leu Ala Val Thr
130 135 140
Cys Gln Leu Pro Ile Asp Arg Gly Gly Gly Glu Gly Lys Ala Met Tyr
145 150 155 160
Ile Asp Thr Glu Gly Thr Phe Arg Pro Glu Arg Leu Leu Ala Val Ala
165 170 175
Glu Arg Tyr Gly Leu Ser Gly Ser Asp Val Leu Asp Asn Val Ala Tyr
180 185 190
Ala Arg Ala Phe Asn Thr Asp His Gln Thr Gln Leu Leu Tyr Gln Ala
195 200 205
Ser Ala Met Met Val Glu Ser Arg Tyr Ala Leu Leu Ile Val Asp Ser
210 215 220
Ala Thr Ala Leu Tyr Arg Thr Asp Tyr Ser Gly Arg Gly Glu Leu Ser
225 230 235 240
Ala Arg Gln Met His Leu Ala Arg Phe Leu Arg Met Leu Leu Arg Leu
245 250 255
Ala Asp Glu Phe Gly Val Ala Val Val Ile Thr Asn Gln Val Val Ala
260 265 270
Gln Val Asp Gly Ala Ala Met Phe Ala Ala Asp Pro Lys Lys Pro Ile
275 280 285
Gly Gly Asn Ile Ile Ala His Ala Ser Thr Thr Arg Leu Tyr Leu Arg
290 295 300
Lys Gly Arg Gly Glu Thr Arg Ile Cys Lys Ile Tyr Asp Ser Pro Cys
305 310 315 320
Leu Pro Glu Ala Glu Ala Met Phe Ala Ile Asn Ala Asp Gly Val Gly
325 330 335
Asp Ala Lys Asp
340
<210> 54
<211> 843
<212> DNA
<213> 智人(Homo sapiens)
<400> 54
atggcaatgc agatgcagct tgaagcaaat gcagatactt cagtggaaga agaaagcttt 60
ggcccacaac ccatttcacg gttagagcag tgtggcataa atgccaacga tgtgaagaaa 120
ttggaagaag ctggattcca tactgtggag gctgttgcct atgcgccaaa gaaggagcta 180
ataaatatta agggaattag tgaagccaaa gctgataaaa ttctggctga ggcagctaaa 240
ttagttccaa tgggtttcac cactgcaact gaattccacc aaaggcggtc agagatcata 300
cagattacta ctggctccaa agagcttgac aaactacttc aaggtggaat tgagactgga 360
tctatcacag aaatgtttgg agaattccga actgggaaga cccagatctg tcatacgcta 420
gctgtcacct gccagcttcc cattgaccgg ggtggaggtg aaggaaaggc catgtacatt 480
gacactgagg gtacctttag gccagaacgg ctgctggcag tggctgagag gtatggtctc 540
tctggcagtg atgtcctgga taatgtagca tatgctcgag cgttcaacac agaccaccag 600
acccagctcc tttatcaagc atcagccatg atggtagaat ctaggtatgc actgcttatt 660
gtagacagtg ccaccgccct ttacagaaca gactactcgg gtcgaggtga gctttcagcc 720
aggcagatgc acttggccag gtttctgcgg atgcttctgc gactcgctga tgagattgta 780
tctgaggaaa ggaagagggg aaaccagaat ctgcaaaatc tacgactctc cctgtcttcc 840
tga 843
<210> 55
<211> 280
<212> PRT
<213> 智人(Homo sapiens)
<400> 55
Met Ala Met Gln Met Gln Leu Glu Ala Asn Ala Asp Thr Ser Val Glu
1 5 10 15
Glu Glu Ser Phe Gly Pro Gln Pro Ile Ser Arg Leu Glu Gln Cys Gly
20 25 30
Ile Asn Ala Asn Asp Val Lys Lys Leu Glu Glu Ala Gly Phe His Thr
35 40 45
Val Glu Ala Val Ala Tyr Ala Pro Lys Lys Glu Leu Ile Asn Ile Lys
50 55 60
Gly Ile Ser Glu Ala Lys Ala Asp Lys Ile Leu Ala Glu Ala Ala Lys
65 70 75 80
Leu Val Pro Met Gly Phe Thr Thr Ala Thr Glu Phe His Gln Arg Arg
85 90 95
Ser Glu Ile Ile Gln Ile Thr Thr Gly Ser Lys Glu Leu Asp Lys Leu
100 105 110
Leu Gln Gly Gly Ile Glu Thr Gly Ser Ile Thr Glu Met Phe Gly Glu
115 120 125
Phe Arg Thr Gly Lys Thr Gln Ile Cys His Thr Leu Ala Val Thr Cys
130 135 140
Gln Leu Pro Ile Asp Arg Gly Gly Gly Glu Gly Lys Ala Met Tyr Ile
145 150 155 160
Asp Thr Glu Gly Thr Phe Arg Pro Glu Arg Leu Leu Ala Val Ala Glu
165 170 175
Arg Tyr Gly Leu Ser Gly Ser Asp Val Leu Asp Asn Val Ala Tyr Ala
180 185 190
Arg Ala Phe Asn Thr Asp His Gln Thr Gln Leu Leu Tyr Gln Ala Ser
195 200 205
Ala Met Met Val Glu Ser Arg Tyr Ala Leu Leu Ile Val Asp Ser Ala
210 215 220
Thr Ala Leu Tyr Arg Thr Asp Tyr Ser Gly Arg Gly Glu Leu Ser Ala
225 230 235 240
Arg Gln Met His Leu Ala Arg Phe Leu Arg Met Leu Leu Arg Leu Ala
245 250 255
Asp Glu Ile Val Ser Glu Glu Arg Lys Arg Gly Asn Gln Asn Leu Gln
260 265 270
Asn Leu Arg Leu Ser Leu Ser Ser
275 280
<210> 56
<211> 1659
<212> DNA
<213> 智人(Homo sapiens)
<400> 56
atggcggccc cggtccgcct gggccggaag cgcccgctgc ctgcctgtcc caacccgctc 60
ttcgttcgct ggctgaccga gtggcgggac gaggcgaccc gcagcaggcg ccgcacgcgc 120
ttcgtatttc agaaggcgct gcgttccctc cgacggtacc cactgccgct gcgcagcggg 180
aaggaagcta agatcctaca gcacttcgga gacgggctct gccggatgct ggacgagcgg 240
ctgcagcggc accgaacatc gggcggtgac catgccccgg actcaccatc tggagagaac 300
agtccagccc cgcaggggcg acttgcggaa gtccaggact cttccatgcc agttcctgcc 360
cagcccaaag cgggaggctc tggcagctac tggccagctc ggcactcagg agcccgagtg 420
atactgctgg tgctctaccg ggagcacctg aatcctaatg gtcaccactt cttaaccaag 480
gaggagctgc tgcagaggtg tgctcagaag tcccccaggg tagcccctgg gagtgctcga 540
ccctggccag ccctccgctc cctccttcac aggaacctgg tcctcaggac acaccagcca 600
gccaggtact cattgacccc agagggcctg gagctggccc agaagttggc cgagtcagaa 660
ggcctgagct tgctgaatgt gggcatcggg cccaaggagc cccctgggga ggagacagca 720
gtgccaggag cagcttcagc agagcttgcc agtgaagcag gggtccagca gcagccactg 780
gagctgaggc ctggagagta cagggtgctg ttgtgtgtgg acattggcga gacccggggg 840
ggcgggcaca ggccggagct gctccgagag ctacagcggc tgcacgtgac ccacacggtg 900
cgcaagctgc acgttggaga ttttgtgtgg gtggcccagg agaccaatcc tagagaccca 960
gcagcaaacc ctggggagtt ggtactggat cacattgtgg agcgcaagcg actggatgac 1020
ctttgcagca gcatcatcga cggccgcttc cgggagcaga agttccggct gaagcgctgt 1080
ggtctggagc gccgggtata cctggtggaa gagcatggtt ccgtccacaa cctcagcctt 1140
cctgagagca cactgctgca ggctgtcacc aacactcagg tcattgatgg cttttttgtg 1200
aagcgcacag cagacattaa ggagtcagcc gcctacctgg ccctcttgac gcggggcctg 1260
cagagactct accagggcca caccctacgc agccgcccct ggggaacccc tgggaaccct 1320
gaatcagggg ccatgacctc tccaaaccct ctctgctcac tcctcacctt cagtgacttc 1380
aacgcaggag ccatcaagaa taaggcccag tcggtgcgag aagtgtttgc ccggcagctg 1440
atgcaggtgc gcggagtgag tggggagaag gcagcagccc tggtggatcg atacagcacc 1500
cctgccagcc tcctggccgc ctatgatgcc tgtgccaccc ccaaggaaca agagacactg 1560
ctgagcacca ttaagtgtgg gcgtctacag aggaatctgg ggcctgctct gagcaggacc 1620
ttatcccagc tctactgcag ctacggcccc ttgacctga 1659
<210> 57
<211> 552
<212> PRT
<213> 智人(Homo sapiens)
<400> 57
Met Ala Ala Pro Val Arg Leu Gly Arg Lys Arg Pro Leu Pro Ala Cys
1 5 10 15
Pro Asn Pro Leu Phe Val Arg Trp Leu Thr Glu Trp Arg Asp Glu Ala
20 25 30
Thr Arg Ser Arg Arg Arg Thr Arg Phe Val Phe Gln Lys Ala Leu Arg
35 40 45
Ser Leu Arg Arg Tyr Pro Leu Pro Leu Arg Ser Gly Lys Glu Ala Lys
50 55 60
Ile Leu Gln His Phe Gly Asp Gly Leu Cys Arg Met Leu Asp Glu Arg
65 70 75 80
Leu Gln Arg His Arg Thr Ser Gly Gly Asp His Ala Pro Asp Ser Pro
85 90 95
Ser Gly Glu Asn Ser Pro Ala Pro Gln Gly Arg Leu Ala Glu Val Gln
100 105 110
Asp Ser Ser Met Pro Val Pro Ala Gln Pro Lys Ala Gly Gly Ser Gly
115 120 125
Ser Tyr Trp Pro Ala Arg His Ser Gly Ala Arg Val Ile Leu Leu Val
130 135 140
Leu Tyr Arg Glu His Leu Asn Pro Asn Gly His His Phe Leu Thr Lys
145 150 155 160
Glu Glu Leu Leu Gln Arg Cys Ala Gln Lys Ser Pro Arg Val Ala Pro
165 170 175
Gly Ser Ala Arg Pro Trp Pro Ala Leu Arg Ser Leu Leu His Arg Asn
180 185 190
Leu Val Leu Arg Thr His Gln Pro Ala Arg Tyr Ser Leu Thr Pro Glu
195 200 205
Gly Leu Glu Leu Ala Gln Lys Leu Ala Glu Ser Glu Gly Leu Ser Leu
210 215 220
Leu Asn Val Gly Ile Gly Pro Lys Glu Pro Pro Gly Glu Glu Thr Ala
225 230 235 240
Val Pro Gly Ala Ala Ser Ala Glu Leu Ala Ser Glu Ala Gly Val Gln
245 250 255
Gln Gln Pro Leu Glu Leu Arg Pro Gly Glu Tyr Arg Val Leu Leu Cys
260 265 270
Val Asp Ile Gly Glu Thr Arg Gly Gly Gly His Arg Pro Glu Leu Leu
275 280 285
Arg Glu Leu Gln Arg Leu His Val Thr His Thr Val Arg Lys Leu His
290 295 300
Val Gly Asp Phe Val Trp Val Ala Gln Glu Thr Asn Pro Arg Asp Pro
305 310 315 320
Ala Ala Asn Pro Gly Glu Leu Val Leu Asp His Ile Val Glu Arg Lys
325 330 335
Arg Leu Asp Asp Leu Cys Ser Ser Ile Ile Asp Gly Arg Phe Arg Glu
340 345 350
Gln Lys Phe Arg Leu Lys Arg Cys Gly Leu Glu Arg Arg Val Tyr Leu
355 360 365
Val Glu Glu His Gly Ser Val His Asn Leu Ser Leu Pro Glu Ser Thr
370 375 380
Leu Leu Gln Ala Val Thr Asn Thr Gln Val Ile Asp Gly Phe Phe Val
385 390 395 400
Lys Arg Thr Ala Asp Ile Lys Glu Ser Ala Ala Tyr Leu Ala Leu Leu
405 410 415
Thr Arg Gly Leu Gln Arg Leu Tyr Gln Gly His Thr Leu Arg Ser Arg
420 425 430
Pro Trp Gly Thr Pro Gly Asn Pro Glu Ser Gly Ala Met Thr Ser Pro
435 440 445
Asn Pro Leu Cys Ser Leu Leu Thr Phe Ser Asp Phe Asn Ala Gly Ala
450 455 460
Ile Lys Asn Lys Ala Gln Ser Val Arg Glu Val Phe Ala Arg Gln Leu
465 470 475 480
Met Gln Val Arg Gly Val Ser Gly Glu Lys Ala Ala Ala Leu Val Asp
485 490 495
Arg Tyr Ser Thr Pro Ala Ser Leu Leu Ala Ala Tyr Asp Ala Cys Ala
500 505 510
Thr Pro Lys Glu Gln Glu Thr Leu Leu Ser Thr Ile Lys Cys Gly Arg
515 520 525
Leu Gln Arg Asn Leu Gly Pro Ala Leu Ser Arg Thr Leu Ser Gln Leu
530 535 540
Tyr Cys Ser Tyr Gly Pro Leu Thr
545 550
<210> 58
<211> 1656
<212> DNA
<213> 智人(Homo sapiens)
<400> 58
atggcggccc cggtccgcct gggccggaag cgcccgctgc ctgcctgtcc caacccgctc 60
ttcgttcgct ggctgaccga gtggcgggac gaggcgaccc gcagcaggcg ccgcacgcgc 120
ttcgtatttc agaaggcgct gcgttccctc cgacggtacc cactgccgct gcgcagcggg 180
aaggaagcta agatcctaca gcacttcgga gacgggctct gccggatgct ggacgagcgg 240
ctgcagcggc accgaacatc gggcggtgac catgccccgg actcaccatc tggagagaac 300
agtccagccc cgcaggggcg acttgcggaa gtccaggact cttccatgcc agttcctgcc 360
cagcccaaag cgggaggctc tggcagctac tggccagctc ggcactcagg agcccgagtg 420
atactgctgg tgctctaccg ggagcacctg aatcctaatg gtcaccactt cttaaccaag 480
gaggagctgc tgcagaggtg tgctcagaag tcccccaggg tagcccctgg gagtgctcga 540
ccctggccag ccctccgctc cctccttcac aggaacctgg tcctcaggac acaccagcca 600
gccaggtact cattgacccc agagggcctg gagctggccc agaagttggc cgagtcagaa 660
ggcctgagct tgctgaatgt gggcatcggg cccaaggagc cccctgggga ggagacagca 720
gtgccaggag cagcttcagc agagcttgcc agtgaagcag gggtccagca gcagccactg 780
gagctgaggc ctggagagta cagggtgctg ttgtgtgtgg acattggcga gacccggggg 840
ggcgggcaca ggccggagct gctccgagag ctacagcggc tgcacgtgac ccacacggtg 900
cgcaagctgc acgttggaga ttttgtgtgg gtggcccagg agaccaatcc tagagaccca 960
gcaaaccctg gggagttggt actggatcac attgtggagc gcaagcgact ggatgacctt 1020
tgcagcagca tcatcgacgg ccgcttccgg gagcagaagt tccggctgaa gcgctgtggt 1080
ctggagcgcc gggtatacct ggtggaagag catggttccg tccacaacct cagccttcct 1140
gagagcacac tgctgcaggc tgtcaccaac actcaggtca ttgatggctt ttttgtgaag 1200
cgcacagcag acattaagga gtcagccgcc tacctggccc tcttgacgcg gggcctgcag 1260
agactctacc agggccacac cctacgcagc cgcccctggg gaacccctgg gaaccctgaa 1320
tcaggggcca tgacctctcc aaaccctctc tgctcactcc tcaccttcag tgacttcaac 1380
gcaggagcca tcaagaataa ggcccagtcg gtgcgagaag tgtttgcccg gcagctgatg 1440
caggtgcgcg gagtgagtgg ggagaaggca gcagccctgg tggatcgata cagcacccct 1500
gccagcctcc tggccgccta tgatgcctgt gccaccccca aggaacaaga gacactgctg 1560
agcaccatta agtgtgggcg tctacagagg aatctggggc ctgctctgag caggacctta 1620
tcccagctct actgcagcta cggccccttg acctga 1656
<210> 59
<211> 551
<212> PRT
<213> 智人(Homo sapiens)
<400> 59
Met Ala Ala Pro Val Arg Leu Gly Arg Lys Arg Pro Leu Pro Ala Cys
1 5 10 15
Pro Asn Pro Leu Phe Val Arg Trp Leu Thr Glu Trp Arg Asp Glu Ala
20 25 30
Thr Arg Ser Arg Arg Arg Thr Arg Phe Val Phe Gln Lys Ala Leu Arg
35 40 45
Ser Leu Arg Arg Tyr Pro Leu Pro Leu Arg Ser Gly Lys Glu Ala Lys
50 55 60
Ile Leu Gln His Phe Gly Asp Gly Leu Cys Arg Met Leu Asp Glu Arg
65 70 75 80
Leu Gln Arg His Arg Thr Ser Gly Gly Asp His Ala Pro Asp Ser Pro
85 90 95
Ser Gly Glu Asn Ser Pro Ala Pro Gln Gly Arg Leu Ala Glu Val Gln
100 105 110
Asp Ser Ser Met Pro Val Pro Ala Gln Pro Lys Ala Gly Gly Ser Gly
115 120 125
Ser Tyr Trp Pro Ala Arg His Ser Gly Ala Arg Val Ile Leu Leu Val
130 135 140
Leu Tyr Arg Glu His Leu Asn Pro Asn Gly His His Phe Leu Thr Lys
145 150 155 160
Glu Glu Leu Leu Gln Arg Cys Ala Gln Lys Ser Pro Arg Val Ala Pro
165 170 175
Gly Ser Ala Arg Pro Trp Pro Ala Leu Arg Ser Leu Leu His Arg Asn
180 185 190
Leu Val Leu Arg Thr His Gln Pro Ala Arg Tyr Ser Leu Thr Pro Glu
195 200 205
Gly Leu Glu Leu Ala Gln Lys Leu Ala Glu Ser Glu Gly Leu Ser Leu
210 215 220
Leu Asn Val Gly Ile Gly Pro Lys Glu Pro Pro Gly Glu Glu Thr Ala
225 230 235 240
Val Pro Gly Ala Ala Ser Ala Glu Leu Ala Ser Glu Ala Gly Val Gln
245 250 255
Gln Gln Pro Leu Glu Leu Arg Pro Gly Glu Tyr Arg Val Leu Leu Cys
260 265 270
Val Asp Ile Gly Glu Thr Arg Gly Gly Gly His Arg Pro Glu Leu Leu
275 280 285
Arg Glu Leu Gln Arg Leu His Val Thr His Thr Val Arg Lys Leu His
290 295 300
Val Gly Asp Phe Val Trp Val Ala Gln Glu Thr Asn Pro Arg Asp Pro
305 310 315 320
Ala Asn Pro Gly Glu Leu Val Leu Asp His Ile Val Glu Arg Lys Arg
325 330 335
Leu Asp Asp Leu Cys Ser Ser Ile Ile Asp Gly Arg Phe Arg Glu Gln
340 345 350
Lys Phe Arg Leu Lys Arg Cys Gly Leu Glu Arg Arg Val Tyr Leu Val
355 360 365
Glu Glu His Gly Ser Val His Asn Leu Ser Leu Pro Glu Ser Thr Leu
370 375 380
Leu Gln Ala Val Thr Asn Thr Gln Val Ile Asp Gly Phe Phe Val Lys
385 390 395 400
Arg Thr Ala Asp Ile Lys Glu Ser Ala Ala Tyr Leu Ala Leu Leu Thr
405 410 415
Arg Gly Leu Gln Arg Leu Tyr Gln Gly His Thr Leu Arg Ser Arg Pro
420 425 430
Trp Gly Thr Pro Gly Asn Pro Glu Ser Gly Ala Met Thr Ser Pro Asn
435 440 445
Pro Leu Cys Ser Leu Leu Thr Phe Ser Asp Phe Asn Ala Gly Ala Ile
450 455 460
Lys Asn Lys Ala Gln Ser Val Arg Glu Val Phe Ala Arg Gln Leu Met
465 470 475 480
Gln Val Arg Gly Val Ser Gly Glu Lys Ala Ala Ala Leu Val Asp Arg
485 490 495
Tyr Ser Thr Pro Ala Ser Leu Leu Ala Ala Tyr Asp Ala Cys Ala Thr
500 505 510
Pro Lys Glu Gln Glu Thr Leu Leu Ser Thr Ile Lys Cys Gly Arg Leu
515 520 525
Gln Arg Asn Leu Gly Pro Ala Leu Ser Arg Thr Leu Ser Gln Leu Tyr
530 535 540
Cys Ser Tyr Gly Pro Leu Thr
545 550
<210> 60
<211> 2358
<212> DNA
<213> 智人(Homo sapiens)
<400> 60
atgggaaaaa aatacaagaa cattgttcta ctaaaaggat tagaggtcat caatgattat 60
cattttagaa tggttaagtc cttactgagc aacgatttaa aacttaattt aaaaatgaga 120
gaagagtatg acaaaattca gattgctgac ttgatggaag aaaagttccg aggtgatgct 180
ggtttgggca aactaataaa aattttcgaa gatataccaa cgcttgaaga cctggctgaa 240
actcttaaaa aagaaaagtt aaaagtaaaa ggaccagccc tatcaagaaa gaggaagaag 300
gaagtggatg ctacttcacc tgcaccctcc acaagcagca ctgtcaaaac tgaaggagca 360
gaggcaactc ctggagctca gaaaagaaaa aaatcaacca aagaaaaggc tggacccaaa 420
gggagtaagg tgtccgagga acagactcag cctccctctc ctgcaggagc cggcatgtcc 480
acagccatgg gccgttcccc atctcccaag acctcattgt cagctccacc caacagttct 540
tcaactgaga acccgaaaac agtggccaaa tgtcaggtaa ctcccagaag aaatgttctc 600
caaaaacgcc cagtgatagt gaaggtactg agtacaacaa agccatttga atatgagacc 660
ccagaaatgg agaaaaaaat aatgtttcat gctacagtgg ctacacagac acagttcttc 720
catgtgaagg ttttaaacac cagcttgaag gagaaattca atggaaagaa aatcatcatc 780
atatcagatt atttggaata tgatagtctc ctagaggtca atgaagaatc tactgtatct 840
gaagctggtc ctaaccaaac gtttgaggtt ccaaataaaa tcatcaacag agcaaaggaa 900
actctgaaga ttgatattct tcacaaacaa gcttcaggaa atattgtata tggggtattt 960
atgctacata agaaaacagt aaatcagaag accacaatct acgaaattca ggatgataga 1020
ggaaaaatgg atgtagtggg gacaggacaa tgtcacaata tcccctgtga agaaggagat 1080
aagctccaac ttttctgctt tcgacttaga aaaaagaacc agatgtcaaa actgatttca 1140
gaaatgcata gttttatcca gataaagaaa aaaacaaacc cgagaaacaa tgaccccaag 1200
agcatgaagc taccccagga acagcgtcag cttccatatc cttcagaggc cagcacaacc 1260
ttccctgaga gccatcttcg gactcctcag atgccaccaa caactccatc cagcagtttc 1320
ttcaccaaga aaagtgaaga cacaatctcc aaaatgaatg acttcatgag gatgcagata 1380
ctgaaggaag ggagtcattt tccaggaccg ttcatgacca gcataggccc agctgagagc 1440
catccccaca ctcctcagat gcctccatca acaccaagca gcagtttctt aaccacgaaa 1500
agtgaagaca caatctccaa aatgaatgac ttcatgagga tgcagatact gaaggaaggg 1560
agtcattttc caggaccgtt catgaccagc ataggcccag ctgagagcca tccccacact 1620
cctcagatgc ctccatcaac accaagcagc agtttcttaa ccacgttgaa accaagactg 1680
aagactgaac ctgaagaagt ttccatagaa gacagtgccc agagtgacct caaagaagtg 1740
atggtgctga acgcaacaga atcatttgta tatgagccca aagagcagaa gaaaatgttt 1800
catgccacag tggcaactga gaatgaagtc ttccgagtga aggtttttaa tattgaccta 1860
aaggagaagt tcaccccaaa gaagatcatt gccatagcaa attatgtttg ccgcaatggg 1920
ttcctggagg tatatccttt cacacttgtg gctgatgtga atgctgaccg aaacatggag 1980
atcccaaaag gattgattag aagtgccagc gtaactccta aaatcaatca gctttgctca 2040
caaactaaag gaagttttgt gaatggggtg tttgaggtac ataagaaaaa tgtaaggggt 2100
gaattcactt attatgaaat acaagataat acagggaaga tggaagtggt ggtgcatgga 2160
cgactgacca caatcaactg tgaggaagga gataaactga aactcacctg ctttgaattg 2220
gcaccgaaaa gtgggaatac cggggagttg agatctgtaa ttcatagtca catcaaggtc 2280
atcaagacca ggaaaaacaa gaaagacata ctcaatcctg attcaagtat ggaaacttca 2340
ccagactttt tcttctaa 2358
<210> 61
<211> 785
<212> PRT
<213> 智人(Homo sapiens)
<400> 61
Met Gly Lys Lys Tyr Lys Asn Ile Val Leu Leu Lys Gly Leu Glu Val
1 5 10 15
Ile Asn Asp Tyr His Phe Arg Met Val Lys Ser Leu Leu Ser Asn Asp
20 25 30
Leu Lys Leu Asn Leu Lys Met Arg Glu Glu Tyr Asp Lys Ile Gln Ile
35 40 45
Ala Asp Leu Met Glu Glu Lys Phe Arg Gly Asp Ala Gly Leu Gly Lys
50 55 60
Leu Ile Lys Ile Phe Glu Asp Ile Pro Thr Leu Glu Asp Leu Ala Glu
65 70 75 80
Thr Leu Lys Lys Glu Lys Leu Lys Val Lys Gly Pro Ala Leu Ser Arg
85 90 95
Lys Arg Lys Lys Glu Val Asp Ala Thr Ser Pro Ala Pro Ser Thr Ser
100 105 110
Ser Thr Val Lys Thr Glu Gly Ala Glu Ala Thr Pro Gly Ala Gln Lys
115 120 125
Arg Lys Lys Ser Thr Lys Glu Lys Ala Gly Pro Lys Gly Ser Lys Val
130 135 140
Ser Glu Glu Gln Thr Gln Pro Pro Ser Pro Ala Gly Ala Gly Met Ser
145 150 155 160
Thr Ala Met Gly Arg Ser Pro Ser Pro Lys Thr Ser Leu Ser Ala Pro
165 170 175
Pro Asn Ser Ser Ser Thr Glu Asn Pro Lys Thr Val Ala Lys Cys Gln
180 185 190
Val Thr Pro Arg Arg Asn Val Leu Gln Lys Arg Pro Val Ile Val Lys
195 200 205
Val Leu Ser Thr Thr Lys Pro Phe Glu Tyr Glu Thr Pro Glu Met Glu
210 215 220
Lys Lys Ile Met Phe His Ala Thr Val Ala Thr Gln Thr Gln Phe Phe
225 230 235 240
His Val Lys Val Leu Asn Thr Ser Leu Lys Glu Lys Phe Asn Gly Lys
245 250 255
Lys Ile Ile Ile Ile Ser Asp Tyr Leu Glu Tyr Asp Ser Leu Leu Glu
260 265 270
Val Asn Glu Glu Ser Thr Val Ser Glu Ala Gly Pro Asn Gln Thr Phe
275 280 285
Glu Val Pro Asn Lys Ile Ile Asn Arg Ala Lys Glu Thr Leu Lys Ile
290 295 300
Asp Ile Leu His Lys Gln Ala Ser Gly Asn Ile Val Tyr Gly Val Phe
305 310 315 320
Met Leu His Lys Lys Thr Val Asn Gln Lys Thr Thr Ile Tyr Glu Ile
325 330 335
Gln Asp Asp Arg Gly Lys Met Asp Val Val Gly Thr Gly Gln Cys His
340 345 350
Asn Ile Pro Cys Glu Glu Gly Asp Lys Leu Gln Leu Phe Cys Phe Arg
355 360 365
Leu Arg Lys Lys Asn Gln Met Ser Lys Leu Ile Ser Glu Met His Ser
370 375 380
Phe Ile Gln Ile Lys Lys Lys Thr Asn Pro Arg Asn Asn Asp Pro Lys
385 390 395 400
Ser Met Lys Leu Pro Gln Glu Gln Arg Gln Leu Pro Tyr Pro Ser Glu
405 410 415
Ala Ser Thr Thr Phe Pro Glu Ser His Leu Arg Thr Pro Gln Met Pro
420 425 430
Pro Thr Thr Pro Ser Ser Ser Phe Phe Thr Lys Lys Ser Glu Asp Thr
435 440 445
Ile Ser Lys Met Asn Asp Phe Met Arg Met Gln Ile Leu Lys Glu Gly
450 455 460
Ser His Phe Pro Gly Pro Phe Met Thr Ser Ile Gly Pro Ala Glu Ser
465 470 475 480
His Pro His Thr Pro Gln Met Pro Pro Ser Thr Pro Ser Ser Ser Phe
485 490 495
Leu Thr Thr Lys Ser Glu Asp Thr Ile Ser Lys Met Asn Asp Phe Met
500 505 510
Arg Met Gln Ile Leu Lys Glu Gly Ser His Phe Pro Gly Pro Phe Met
515 520 525
Thr Ser Ile Gly Pro Ala Glu Ser His Pro His Thr Pro Gln Met Pro
530 535 540
Pro Ser Thr Pro Ser Ser Ser Phe Leu Thr Thr Leu Lys Pro Arg Leu
545 550 555 560
Lys Thr Glu Pro Glu Glu Val Ser Ile Glu Asp Ser Ala Gln Ser Asp
565 570 575
Leu Lys Glu Val Met Val Leu Asn Ala Thr Glu Ser Phe Val Tyr Glu
580 585 590
Pro Lys Glu Gln Lys Lys Met Phe His Ala Thr Val Ala Thr Glu Asn
595 600 605
Glu Val Phe Arg Val Lys Val Phe Asn Ile Asp Leu Lys Glu Lys Phe
610 615 620
Thr Pro Lys Lys Ile Ile Ala Ile Ala Asn Tyr Val Cys Arg Asn Gly
625 630 635 640
Phe Leu Glu Val Tyr Pro Phe Thr Leu Val Ala Asp Val Asn Ala Asp
645 650 655
Arg Asn Met Glu Ile Pro Lys Gly Leu Ile Arg Ser Ala Ser Val Thr
660 665 670
Pro Lys Ile Asn Gln Leu Cys Ser Gln Thr Lys Gly Ser Phe Val Asn
675 680 685
Gly Val Phe Glu Val His Lys Lys Asn Val Arg Gly Glu Phe Thr Tyr
690 695 700
Tyr Glu Ile Gln Asp Asn Thr Gly Lys Met Glu Val Val Val His Gly
705 710 715 720
Arg Leu Thr Thr Ile Asn Cys Glu Glu Gly Asp Lys Leu Lys Leu Thr
725 730 735
Cys Phe Glu Leu Ala Pro Lys Ser Gly Asn Thr Gly Glu Leu Arg Ser
740 745 750
Val Ile His Ser His Ile Lys Val Ile Lys Thr Arg Lys Asn Lys Lys
755 760 765
Asp Ile Leu Asn Pro Asp Ser Ser Met Glu Thr Ser Pro Asp Phe Phe
770 775 780
Phe
785
<210> 62
<211> 2190
<212> DNA
<213> 智人(Homo sapiens)
<400> 62
atgggaaaaa aatacaagaa cattgttcta ctaaaaggat tagaggtcat caatgattat 60
cattttagaa tggttaagtc cttactgagc aacgatttaa aacttaattt aaaaatgaga 120
gaagagtatg acaaaattca gattgctgac ttgatggaag aaaagttccg aggtgatgct 180
ggtttgggca aactaataaa aattttcgaa gatataccaa cgcttgaaga cctggctgaa 240
actcttaaaa aagaaaagtt aaaagtaaaa ggaccagccc tatcaagaaa gaggaagaag 300
gaagtggatg ctacttcacc tgcaccctcc acaagcagca ctgtcaaaac tgaaggagca 360
gaggcaactc ctggagctca gaaaagaaaa aaatcaacca aagaaaaggc tggacccaaa 420
gggagtaagg tgtccgagga acagactcag cctccctctc ctgcaggagc cggcatgtcc 480
acagccatgg gccgttcccc atctcccaag acctcattgt cagctccacc caacagttct 540
tcaactgaga acccgaaaac agtggccaaa tgtcaggtaa ctcccagaag aaatgttctc 600
caaaaacgcc cagtgatagt gaaggtactg agtacaacaa agccatttga atatgagacc 660
ccagaaatgg agaaaaaaat aatgtttcat gctacagtgg ctacacagac acagttcttc 720
catgtgaagg ttttaaacac cagcttgaag gagaaattca atggaaagaa aatcatcatc 780
atatcagatt atttggaata tgatagtctc ctagaggtca atgaagaatc tactgtatct 840
gaagctggtc ctaaccaaac gtttgaggtt ccaaataaaa tcatcaacag agcaaaggaa 900
actctgaaga ttgatattct tcacaaacaa gcttcaggaa atattgtata tggggtattt 960
atgctacata agaaaacagt aaatcagaag accacaatct acgaaattca ggatgataga 1020
ggaaaaatgg atgtagtggg gacaggacaa tgtcacaata tcccctgtga agaaggagat 1080
aagctccaac ttttctgctt tcgacttaga aaaaagaacc agatgtcaaa actgatttca 1140
gaaatgcata gttttatcca gataaagaaa aaaacaaacc cgagaaacaa tgaccccaag 1200
agcatgaagc taccccagga acagcgtcag cttccatatc cttcagaggc cagcacaacc 1260
ttccctgaga gccatcttcg gactcctcag atgccaccaa caactccatc cagcagtttc 1320
ttcaccaaga aaagtgaaga cacaatctcc aaaatgaatg acttcatgag gatgcagata 1380
ctgaaggaag ggagtcattt tccaggaccg ttcatgacca gcataggccc agctgagagc 1440
catccccaca ctcctcagat gcctccatca acaccaagca gcagtttctt aaccacgttg 1500
aaaccaagac tgaagactga acctgaagaa gtttccatag aagacagtgc ccagagtgac 1560
ctcaaagaag tgatggtgct gaacgcaaca gaatcatttg tatatgagcc caaagagcag 1620
aagaaaatgt ttcatgccac agtggcaact gagaatgaag tcttccgagt gaaggttttt 1680
aatattgacc taaaggagaa gttcacccca aagaagatca ttgccatagc aaattatgtt 1740
tgccgcaatg ggttcctgga ggtatatcct ttcacacttg tggctgatgt gaatgctgac 1800
cgaaacatgg agatcccaaa aggattgatt agaagtgcca gcgtaactcc taaaatcaat 1860
cagctttgct cacaaactaa aggaagtttt gtgaatgggg tgtttgaggt acataagaaa 1920
aatgtaaggg gtgaattcac ttattatgaa atacaagata atacagggaa gatggaagtg 1980
gtggtgcatg gacgactgac cacaatcaac tgtgaggaag gagataaact gaaactcacc 2040
tgctttgaat tggcaccgaa aagtgggaat accggggagt tgagatctgt aattcatagt 2100
cacatcaagg tcatcaagac caggaaaaac aagaaagaca tactcaatcc tgattcaagt 2160
atggaaactt caccagactt tttcttctaa 2190
<210> 63
<211> 729
<212> PRT
<213> 智人(Homo sapiens)
<400> 63
Met Gly Lys Lys Tyr Lys Asn Ile Val Leu Leu Lys Gly Leu Glu Val
1 5 10 15
Ile Asn Asp Tyr His Phe Arg Met Val Lys Ser Leu Leu Ser Asn Asp
20 25 30
Leu Lys Leu Asn Leu Lys Met Arg Glu Glu Tyr Asp Lys Ile Gln Ile
35 40 45
Ala Asp Leu Met Glu Glu Lys Phe Arg Gly Asp Ala Gly Leu Gly Lys
50 55 60
Leu Ile Lys Ile Phe Glu Asp Ile Pro Thr Leu Glu Asp Leu Ala Glu
65 70 75 80
Thr Leu Lys Lys Glu Lys Leu Lys Val Lys Gly Pro Ala Leu Ser Arg
85 90 95
Lys Arg Lys Lys Glu Val Asp Ala Thr Ser Pro Ala Pro Ser Thr Ser
100 105 110
Ser Thr Val Lys Thr Glu Gly Ala Glu Ala Thr Pro Gly Ala Gln Lys
115 120 125
Arg Lys Lys Ser Thr Lys Glu Lys Ala Gly Pro Lys Gly Ser Lys Val
130 135 140
Ser Glu Glu Gln Thr Gln Pro Pro Ser Pro Ala Gly Ala Gly Met Ser
145 150 155 160
Thr Ala Met Gly Arg Ser Pro Ser Pro Lys Thr Ser Leu Ser Ala Pro
165 170 175
Pro Asn Ser Ser Ser Thr Glu Asn Pro Lys Thr Val Ala Lys Cys Gln
180 185 190
Val Thr Pro Arg Arg Asn Val Leu Gln Lys Arg Pro Val Ile Val Lys
195 200 205
Val Leu Ser Thr Thr Lys Pro Phe Glu Tyr Glu Thr Pro Glu Met Glu
210 215 220
Lys Lys Ile Met Phe His Ala Thr Val Ala Thr Gln Thr Gln Phe Phe
225 230 235 240
His Val Lys Val Leu Asn Thr Ser Leu Lys Glu Lys Phe Asn Gly Lys
245 250 255
Lys Ile Ile Ile Ile Ser Asp Tyr Leu Glu Tyr Asp Ser Leu Leu Glu
260 265 270
Val Asn Glu Glu Ser Thr Val Ser Glu Ala Gly Pro Asn Gln Thr Phe
275 280 285
Glu Val Pro Asn Lys Ile Ile Asn Arg Ala Lys Glu Thr Leu Lys Ile
290 295 300
Asp Ile Leu His Lys Gln Ala Ser Gly Asn Ile Val Tyr Gly Val Phe
305 310 315 320
Met Leu His Lys Lys Thr Val Asn Gln Lys Thr Thr Ile Tyr Glu Ile
325 330 335
Gln Asp Asp Arg Gly Lys Met Asp Val Val Gly Thr Gly Gln Cys His
340 345 350
Asn Ile Pro Cys Glu Glu Gly Asp Lys Leu Gln Leu Phe Cys Phe Arg
355 360 365
Leu Arg Lys Lys Asn Gln Met Ser Lys Leu Ile Ser Glu Met His Ser
370 375 380
Phe Ile Gln Ile Lys Lys Lys Thr Asn Pro Arg Asn Asn Asp Pro Lys
385 390 395 400
Ser Met Lys Leu Pro Gln Glu Gln Arg Gln Leu Pro Tyr Pro Ser Glu
405 410 415
Ala Ser Thr Thr Phe Pro Glu Ser His Leu Arg Thr Pro Gln Met Pro
420 425 430
Pro Thr Thr Pro Ser Ser Ser Phe Phe Thr Lys Lys Ser Glu Asp Thr
435 440 445
Ile Ser Lys Met Asn Asp Phe Met Arg Met Gln Ile Leu Lys Glu Gly
450 455 460
Ser His Phe Pro Gly Pro Phe Met Thr Ser Ile Gly Pro Ala Glu Ser
465 470 475 480
His Pro His Thr Pro Gln Met Pro Pro Ser Thr Pro Ser Ser Ser Phe
485 490 495
Leu Thr Thr Leu Lys Pro Arg Leu Lys Thr Glu Pro Glu Glu Val Ser
500 505 510
Ile Glu Asp Ser Ala Gln Ser Asp Leu Lys Glu Val Met Val Leu Asn
515 520 525
Ala Thr Glu Ser Phe Val Tyr Glu Pro Lys Glu Gln Lys Lys Met Phe
530 535 540
His Ala Thr Val Ala Thr Glu Asn Glu Val Phe Arg Val Lys Val Phe
545 550 555 560
Asn Ile Asp Leu Lys Glu Lys Phe Thr Pro Lys Lys Ile Ile Ala Ile
565 570 575
Ala Asn Tyr Val Cys Arg Asn Gly Phe Leu Glu Val Tyr Pro Phe Thr
580 585 590
Leu Val Ala Asp Val Asn Ala Asp Arg Asn Met Glu Ile Pro Lys Gly
595 600 605
Leu Ile Arg Ser Ala Ser Val Thr Pro Lys Ile Asn Gln Leu Cys Ser
610 615 620
Gln Thr Lys Gly Ser Phe Val Asn Gly Val Phe Glu Val His Lys Lys
625 630 635 640
Asn Val Arg Gly Glu Phe Thr Tyr Tyr Glu Ile Gln Asp Asn Thr Gly
645 650 655
Lys Met Glu Val Val Val His Gly Arg Leu Thr Thr Ile Asn Cys Glu
660 665 670
Glu Gly Asp Lys Leu Lys Leu Thr Cys Phe Glu Leu Ala Pro Lys Ser
675 680 685
Gly Asn Thr Gly Glu Leu Arg Ser Val Ile His Ser His Ile Lys Val
690 695 700
Ile Lys Thr Arg Lys Asn Lys Lys Asp Ile Leu Asn Pro Asp Ser Ser
705 710 715 720
Met Glu Thr Ser Pro Asp Phe Phe Phe
725
<210> 64
<211> 2190
<212> DNA
<213> 智人(Homo sapiens)
<400> 64
atgggaaaaa aatacaagaa cattgttcta ctaaaaggat tagaggtcat caatgattat 60
cattttagaa tggttaagtc cttactgagc aacgatttaa aacttaattt aaaaatgaga 120
gaagagtatg acaaaattca gattgctgac ttgatggaag aaaagttccg aggtgatgct 180
ggtttgggca aactaataaa aattttcgaa gatataccaa cgcttgaaga cctggctgaa 240
actcttaaaa aagaaaagtt aaaagtaaaa ggaccagccc tatcaagaaa gaggaagaag 300
gaagtggatg ctacttcacc tgcaccctcc acaagcagca ctgtcaaaac tgaaggagca 360
gaggcaactc ctggagctca gaacccgaaa acagtggcca aatgtcaggt aactcccaga 420
agaaatgttc tccaaaaacg cccagtgata gtgaaggtac tgagtacaac aaagccattt 480
gaatatgaga ccccagaaat ggagaaaaaa ataatgtttc atgctacagt ggctacacag 540
acacagttct tccatgtgaa ggttttaaac accagcttga aggagaaatt caatggaaag 600
aaaatcatca tcatatcaga ttatttggaa tatgatagtc tcctagaggt caatgaagaa 660
tctactgtat ctgaagctgg tcctaaccaa acgtttgagg ttccaaataa aatcatcaac 720
agagcaaagg aaactctgaa gattgatatt cttcacaaac aagcttcagg aaatattgta 780
tatggggtat ttatgctaca taagaaaaca gtaaatcaga agaccacaat ctacgaaatt 840
caggatgata gaggaaaaat ggatgtagtg gggacaggac aatgtcacaa tatcccctgt 900
gaagaaggag ataagctcca acttttctgc tttcgactta gaaaaaagaa ccagatgtca 960
aaactgattt cagaaatgca tagttttatc cagataaaga aaaaaacaaa cccgagaaac 1020
aatgacccca agagcatgaa gctaccccag gaacagcgtc agcttccata tccttcagag 1080
gccagcacaa ccttccctga gagccatctt cggactcctc agatgccacc aacaactcca 1140
tccagcagtt tcttcaccaa gaaaagtgaa gacacaatct ccaaaatgaa tgacttcatg 1200
aggatgcaga tactgaagga agggagtcat tttccaggac cgttcatgac cagcataggc 1260
ccagctgaga gccatcccca cactcctcag atgcctccat caacaccaag cagcagtttc 1320
ttaaccacga aaagtgaaga cacaatctcc aaaatgaatg acttcatgag gatgcagata 1380
ctgaaggaag ggagtcattt tccaggaccg ttcatgacca gcataggccc agctgagagc 1440
catccccaca ctcctcagat gcctccatca acaccaagca gcagtttctt aaccacgttg 1500
aaaccaagac tgaagactga acctgaagaa gtttccatag aagacagtgc ccagagtgac 1560
ctcaaagaag tgatggtgct gaacgcaaca gaatcatttg tatatgagcc caaagagcag 1620
aagaaaatgt ttcatgccac agtggcaact gagaatgaag tcttccgagt gaaggttttt 1680
aatattgacc taaaggagaa gttcacccca aagaagatca ttgccatagc aaattatgtt 1740
tgccgcaatg ggttcctgga ggtatatcct ttcacacttg tggctgatgt gaatgctgac 1800
cgaaacatgg agatcccaaa aggattgatt agaagtgcca gcgtaactcc taaaatcaat 1860
cagctttgct cacaaactaa aggaagtttt gtgaatgggg tgtttgaggt acataagaaa 1920
aatgtaaggg gtgaattcac ttattatgaa atacaagata atacagggaa gatggaagtg 1980
gtggtgcatg gacgactgac cacaatcaac tgtgaggaag gagataaact gaaactcacc 2040
tgctttgaat tggcaccgaa aagtgggaat accggggagt tgagatctgt aattcatagt 2100
cacatcaagg tcatcaagac caggaaaaac aagaaagaca tactcaatcc tgattcaagt 2160
atggaaactt caccagactt tttcttctaa 2190
<210> 65
<211> 729
<212> PRT
<213> 智人(Homo sapiens)
<400> 65
Met Gly Lys Lys Tyr Lys Asn Ile Val Leu Leu Lys Gly Leu Glu Val
1 5 10 15
Ile Asn Asp Tyr His Phe Arg Met Val Lys Ser Leu Leu Ser Asn Asp
20 25 30
Leu Lys Leu Asn Leu Lys Met Arg Glu Glu Tyr Asp Lys Ile Gln Ile
35 40 45
Ala Asp Leu Met Glu Glu Lys Phe Arg Gly Asp Ala Gly Leu Gly Lys
50 55 60
Leu Ile Lys Ile Phe Glu Asp Ile Pro Thr Leu Glu Asp Leu Ala Glu
65 70 75 80
Thr Leu Lys Lys Glu Lys Leu Lys Val Lys Gly Pro Ala Leu Ser Arg
85 90 95
Lys Arg Lys Lys Glu Val Asp Ala Thr Ser Pro Ala Pro Ser Thr Ser
100 105 110
Ser Thr Val Lys Thr Glu Gly Ala Glu Ala Thr Pro Gly Ala Gln Asn
115 120 125
Pro Lys Thr Val Ala Lys Cys Gln Val Thr Pro Arg Arg Asn Val Leu
130 135 140
Gln Lys Arg Pro Val Ile Val Lys Val Leu Ser Thr Thr Lys Pro Phe
145 150 155 160
Glu Tyr Glu Thr Pro Glu Met Glu Lys Lys Ile Met Phe His Ala Thr
165 170 175
Val Ala Thr Gln Thr Gln Phe Phe His Val Lys Val Leu Asn Thr Ser
180 185 190
Leu Lys Glu Lys Phe Asn Gly Lys Lys Ile Ile Ile Ile Ser Asp Tyr
195 200 205
Leu Glu Tyr Asp Ser Leu Leu Glu Val Asn Glu Glu Ser Thr Val Ser
210 215 220
Glu Ala Gly Pro Asn Gln Thr Phe Glu Val Pro Asn Lys Ile Ile Asn
225 230 235 240
Arg Ala Lys Glu Thr Leu Lys Ile Asp Ile Leu His Lys Gln Ala Ser
245 250 255
Gly Asn Ile Val Tyr Gly Val Phe Met Leu His Lys Lys Thr Val Asn
260 265 270
Gln Lys Thr Thr Ile Tyr Glu Ile Gln Asp Asp Arg Gly Lys Met Asp
275 280 285
Val Val Gly Thr Gly Gln Cys His Asn Ile Pro Cys Glu Glu Gly Asp
290 295 300
Lys Leu Gln Leu Phe Cys Phe Arg Leu Arg Lys Lys Asn Gln Met Ser
305 310 315 320
Lys Leu Ile Ser Glu Met His Ser Phe Ile Gln Ile Lys Lys Lys Thr
325 330 335
Asn Pro Arg Asn Asn Asp Pro Lys Ser Met Lys Leu Pro Gln Glu Gln
340 345 350
Arg Gln Leu Pro Tyr Pro Ser Glu Ala Ser Thr Thr Phe Pro Glu Ser
355 360 365
His Leu Arg Thr Pro Gln Met Pro Pro Thr Thr Pro Ser Ser Ser Phe
370 375 380
Phe Thr Lys Lys Ser Glu Asp Thr Ile Ser Lys Met Asn Asp Phe Met
385 390 395 400
Arg Met Gln Ile Leu Lys Glu Gly Ser His Phe Pro Gly Pro Phe Met
405 410 415
Thr Ser Ile Gly Pro Ala Glu Ser His Pro His Thr Pro Gln Met Pro
420 425 430
Pro Ser Thr Pro Ser Ser Ser Phe Leu Thr Thr Lys Ser Glu Asp Thr
435 440 445
Ile Ser Lys Met Asn Asp Phe Met Arg Met Gln Ile Leu Lys Glu Gly
450 455 460
Ser His Phe Pro Gly Pro Phe Met Thr Ser Ile Gly Pro Ala Glu Ser
465 470 475 480
His Pro His Thr Pro Gln Met Pro Pro Ser Thr Pro Ser Ser Ser Phe
485 490 495
Leu Thr Thr Leu Lys Pro Arg Leu Lys Thr Glu Pro Glu Glu Val Ser
500 505 510
Ile Glu Asp Ser Ala Gln Ser Asp Leu Lys Glu Val Met Val Leu Asn
515 520 525
Ala Thr Glu Ser Phe Val Tyr Glu Pro Lys Glu Gln Lys Lys Met Phe
530 535 540
His Ala Thr Val Ala Thr Glu Asn Glu Val Phe Arg Val Lys Val Phe
545 550 555 560
Asn Ile Asp Leu Lys Glu Lys Phe Thr Pro Lys Lys Ile Ile Ala Ile
565 570 575
Ala Asn Tyr Val Cys Arg Asn Gly Phe Leu Glu Val Tyr Pro Phe Thr
580 585 590
Leu Val Ala Asp Val Asn Ala Asp Arg Asn Met Glu Ile Pro Lys Gly
595 600 605
Leu Ile Arg Ser Ala Ser Val Thr Pro Lys Ile Asn Gln Leu Cys Ser
610 615 620
Gln Thr Lys Gly Ser Phe Val Asn Gly Val Phe Glu Val His Lys Lys
625 630 635 640
Asn Val Arg Gly Glu Phe Thr Tyr Tyr Glu Ile Gln Asp Asn Thr Gly
645 650 655
Lys Met Glu Val Val Val His Gly Arg Leu Thr Thr Ile Asn Cys Glu
660 665 670
Glu Gly Asp Lys Leu Lys Leu Thr Cys Phe Glu Leu Ala Pro Lys Ser
675 680 685
Gly Asn Thr Gly Glu Leu Arg Ser Val Ile His Ser His Ile Lys Val
690 695 700
Ile Lys Thr Arg Lys Asn Lys Lys Asp Ile Leu Asn Pro Asp Ser Ser
705 710 715 720
Met Glu Thr Ser Pro Asp Phe Phe Phe
725
<210> 66
<211> 1569
<212> DNA
<213> 智人(Homo sapiens)
<400> 66
atgcagcctt ggcacggaaa ggccatgcag agagcttccg aggccggagc cactgccccc 60
aaggcttccg cacggaatgc caggggcgcc ccgatggatc ccaccgagtc tccggctgcc 120
cccgaggccg ccctgcctaa ggcgggaaag ttcggccccg ccaggaagtc gggatcccgg 180
cagaaaaaga gcgccccgga cacccaggag aggccgcccg tccgcgcaac tggggcccgc 240
gccaaaaagg cccctcagcg cgcccaggac acgcagccgt ctgacgccac cagcgcccct 300
ggggcagagg ggctggagcc tcctgcggct cgggagccgg ctctttccag ggctggttct 360
tgccgccaga ggggcgcgcg ctgctccacg aagccaagac ctccgcccgg gccctgggac 420
gtgcccagcc ccggcctgcc ggtctcggcc cccattctcg tacggaggga tgcggcgcct 480
ggggcctcga agctccgggc ggttttggag aagttgaagc tcagccgcga tgatatctcc 540
acggcggcgg ggatggtgaa aggggttgtg gaccacctgc tgctcagact gaagtgcgac 600
tccgcgttca gaggcgtcgg gctgctgaac accgggagct actatgagca cgtgaagatt 660
tctgcaccta atgaatttga tgtcatgttt aaactggaag tccccagaat tcaactagaa 720
gaatattcca acactcgtgc atattacttt gtgaaattta aaagaaatcc gaaagaaaat 780
cctctgagtc agtttttaga aggtgaaata ttatcagctt ctaagatgct gtcaaagttt 840
aggaaaatca ttaaggaaga aattaacgac attaaagata cagatgtcat catgaagagg 900
aaaagaggag ggagccctgc tgtaacactt cttattagtg aaaaaatatc tgtggatata 960
accctggctt tggaatcaaa aagtagctgg cctgctagca cccaagaagg cctgcgcatt 1020
caaaactggc tttcagcaaa agttaggaag caactacgac taaagccatt ttaccttgta 1080
cccaagcatg caaaggaagg aaatggtttc caagaagaaa catggcggct atccttctct 1140
cacatcgaaa aggaaatttt gaacaatcat ggaaaatcta aaacgtgctg tgaaaacaaa 1200
gaagagaaat gttgcaggaa agattgttta aaactaatga aatacctttt agaacagctg 1260
aaagaaaggt ttaaagacaa aaaacatctg gataaattct cttcttatca tgtgaaaact 1320
gccttctttc acgtatgtac ccagaaccct caagacagtc agtgggaccg caaagacctg 1380
ggcctctgct ttgataactg cgtgacatac tttcttcagt gcctcaggac agaaaaactt 1440
gagaattatt ttattcctga attcaatcta ttctctagca acttaattga caaaagaagt 1500
aaggaatttc tgacaaagca aattgaatat gaaagaaaca atgagtttcc agtttttgat 1560
gaattttga 1569
<210> 67
<211> 522
<212> PRT
<213> 智人(Homo sapiens)
<400> 67
Met Gln Pro Trp His Gly Lys Ala Met Gln Arg Ala Ser Glu Ala Gly
1 5 10 15
Ala Thr Ala Pro Lys Ala Ser Ala Arg Asn Ala Arg Gly Ala Pro Met
20 25 30
Asp Pro Thr Glu Ser Pro Ala Ala Pro Glu Ala Ala Leu Pro Lys Ala
35 40 45
Gly Lys Phe Gly Pro Ala Arg Lys Ser Gly Ser Arg Gln Lys Lys Ser
50 55 60
Ala Pro Asp Thr Gln Glu Arg Pro Pro Val Arg Ala Thr Gly Ala Arg
65 70 75 80
Ala Lys Lys Ala Pro Gln Arg Ala Gln Asp Thr Gln Pro Ser Asp Ala
85 90 95
Thr Ser Ala Pro Gly Ala Glu Gly Leu Glu Pro Pro Ala Ala Arg Glu
100 105 110
Pro Ala Leu Ser Arg Ala Gly Ser Cys Arg Gln Arg Gly Ala Arg Cys
115 120 125
Ser Thr Lys Pro Arg Pro Pro Pro Gly Pro Trp Asp Val Pro Ser Pro
130 135 140
Gly Leu Pro Val Ser Ala Pro Ile Leu Val Arg Arg Asp Ala Ala Pro
145 150 155 160
Gly Ala Ser Lys Leu Arg Ala Val Leu Glu Lys Leu Lys Leu Ser Arg
165 170 175
Asp Asp Ile Ser Thr Ala Ala Gly Met Val Lys Gly Val Val Asp His
180 185 190
Leu Leu Leu Arg Leu Lys Cys Asp Ser Ala Phe Arg Gly Val Gly Leu
195 200 205
Leu Asn Thr Gly Ser Tyr Tyr Glu His Val Lys Ile Ser Ala Pro Asn
210 215 220
Glu Phe Asp Val Met Phe Lys Leu Glu Val Pro Arg Ile Gln Leu Glu
225 230 235 240
Glu Tyr Ser Asn Thr Arg Ala Tyr Tyr Phe Val Lys Phe Lys Arg Asn
245 250 255
Pro Lys Glu Asn Pro Leu Ser Gln Phe Leu Glu Gly Glu Ile Leu Ser
260 265 270
Ala Ser Lys Met Leu Ser Lys Phe Arg Lys Ile Ile Lys Glu Glu Ile
275 280 285
Asn Asp Ile Lys Asp Thr Asp Val Ile Met Lys Arg Lys Arg Gly Gly
290 295 300
Ser Pro Ala Val Thr Leu Leu Ile Ser Glu Lys Ile Ser Val Asp Ile
305 310 315 320
Thr Leu Ala Leu Glu Ser Lys Ser Ser Trp Pro Ala Ser Thr Gln Glu
325 330 335
Gly Leu Arg Ile Gln Asn Trp Leu Ser Ala Lys Val Arg Lys Gln Leu
340 345 350
Arg Leu Lys Pro Phe Tyr Leu Val Pro Lys His Ala Lys Glu Gly Asn
355 360 365
Gly Phe Gln Glu Glu Thr Trp Arg Leu Ser Phe Ser His Ile Glu Lys
370 375 380
Glu Ile Leu Asn Asn His Gly Lys Ser Lys Thr Cys Cys Glu Asn Lys
385 390 395 400
Glu Glu Lys Cys Cys Arg Lys Asp Cys Leu Lys Leu Met Lys Tyr Leu
405 410 415
Leu Glu Gln Leu Lys Glu Arg Phe Lys Asp Lys Lys His Leu Asp Lys
420 425 430
Phe Ser Ser Tyr His Val Lys Thr Ala Phe Phe His Val Cys Thr Gln
435 440 445
Asn Pro Gln Asp Ser Gln Trp Asp Arg Lys Asp Leu Gly Leu Cys Phe
450 455 460
Asp Asn Cys Val Thr Tyr Phe Leu Gln Cys Leu Arg Thr Glu Lys Leu
465 470 475 480
Glu Asn Tyr Phe Ile Pro Glu Phe Asn Leu Phe Ser Ser Asn Leu Ile
485 490 495
Asp Lys Arg Ser Lys Glu Phe Leu Thr Lys Gln Ile Glu Tyr Glu Arg
500 505 510
Asn Asn Glu Phe Pro Val Phe Asp Glu Phe
515 520
<210> 68
<211> 1869
<212> DNA
<213> 智人(Homo sapiens)
<400> 68
atggaggagt cggaacccga acggaagcgg gctcgcaccg acgaggtgcc tgccggagga 60
agccgctccg aggcggaaga tgaggacgac gaggactacg tgccctatgt gccgttacgg 120
cagcgccggc agctactgct ccagaagctg ctgcagcgaa gacgcaaggg agctgcggag 180
gaagagcagc aggacagcgg tagtgaaccc cggggagatg aggacgacat cccgctaggc 240
cctcagtcca acgtcagcct cctggatcag caccagcacc ttaaagagaa ggctgaagcg 300
cgcaaagagt ctgccaagga gaagcagctg aaggaagaag agaagatcct ggagagtgtt 360
gccgagggcc gagcattgat gtcagtgaag gagatggcta agggcattac gtatgatgac 420
cccatcaaaa ccagctggac tccaccccgt tatgttctga gcatgtctga agagcgacat 480
gagcgcgtgc ggaagaaata ccacatcctg gtggagggag acggtatccc accacccatc 540
aagagcttca aggaaatgaa gtttcctgca gccatcctga gaggcctgaa gaagaaaggc 600
attcaccacc caacacccat tcagatccag ggcatcccca ccattctatc tggccgtgac 660
atgataggca tcgctttcac gggttcaggc aagacactgg tgttcacgtt gcccgtcatc 720
atgttctgcc tggaacaaga gaagaggtta cccttctcaa agcgcgaggg gccctatgga 780
ctcatcatct gcccctcgcg ggagctggcc cggcagaccc atggcatcct ggagtactac 840
tgccgcctgc tgcaggagga cagctcacca ctcctgcgct gcgccctctg cattgggggc 900
atgtccgtga aagagcagat ggagaccatc cgacacggtg tacacatgat ggtggccacc 960
ccggggcgcc tcatggattt gctgcagaag aagatggtca gcctagacat ctgtcgctac 1020
ctggccctgg acgaggctga ccgcatgatc gacatgggct tcgagggtga catccgtacc 1080
atcttctcct acttcaaggg ccagcgacag accctgctct tcagtgccac catgccgaag 1140
aagattcaga actttgctaa gagtgccctt gtaaagcctg tgaccatcaa tgtggggcgc 1200
gctggggctg ccagcctgga tgtcatccag gaggtagaat atgtgaagga ggaggccaag 1260
atggtgtacc tgctcgagtg cctgcagaag acacccccgc ctgtactcat ctttgcagag 1320
aagaaggcag acgtggacgc catccacgag tacctgctgc tcaagggggt tgaggccgta 1380
gccatccatg ggggcaaaga ccaggaggaa cggactaagg ccatcgaggc attccgggag 1440
ggcaagaagg atgtcctagt agccacagac gttgcctcca agggcctgga cttccctgcc 1500
atccagcacg tcatcaatta tgacatgcca gaggagattg agaactatgt acaccggatt 1560
ggccgcaccg ggcgctcggg aaacacaggc atcgccacta ccttcatcaa caaagcgtgt 1620
gatgagtcag tgctgatgga cctcaaagcg ctgctgctag aagccaagca gaaggtgccg 1680
cccgtgctgc aggtgctgca ttgcggggat gagtccatgc tggacattgg aggagagcgc 1740
ggctgtgcct tctgcggggg cctgggtcat cggatcactg actgccccaa actcgaggct 1800
atgcagacca agcaggtcag caacatcggt cgcaaggact acctggccca cagctccatg 1860
gacttctga 1869
<210> 69
<211> 622
<212> PRT
<213> 智人(Homo sapiens)
<400> 69
Met Glu Glu Ser Glu Pro Glu Arg Lys Arg Ala Arg Thr Asp Glu Val
1 5 10 15
Pro Ala Gly Gly Ser Arg Ser Glu Ala Glu Asp Glu Asp Asp Glu Asp
20 25 30
Tyr Val Pro Tyr Val Pro Leu Arg Gln Arg Arg Gln Leu Leu Leu Gln
35 40 45
Lys Leu Leu Gln Arg Arg Arg Lys Gly Ala Ala Glu Glu Glu Gln Gln
50 55 60
Asp Ser Gly Ser Glu Pro Arg Gly Asp Glu Asp Asp Ile Pro Leu Gly
65 70 75 80
Pro Gln Ser Asn Val Ser Leu Leu Asp Gln His Gln His Leu Lys Glu
85 90 95
Lys Ala Glu Ala Arg Lys Glu Ser Ala Lys Glu Lys Gln Leu Lys Glu
100 105 110
Glu Glu Lys Ile Leu Glu Ser Val Ala Glu Gly Arg Ala Leu Met Ser
115 120 125
Val Lys Glu Met Ala Lys Gly Ile Thr Tyr Asp Asp Pro Ile Lys Thr
130 135 140
Ser Trp Thr Pro Pro Arg Tyr Val Leu Ser Met Ser Glu Glu Arg His
145 150 155 160
Glu Arg Val Arg Lys Lys Tyr His Ile Leu Val Glu Gly Asp Gly Ile
165 170 175
Pro Pro Pro Ile Lys Ser Phe Lys Glu Met Lys Phe Pro Ala Ala Ile
180 185 190
Leu Arg Gly Leu Lys Lys Lys Gly Ile His His Pro Thr Pro Ile Gln
195 200 205
Ile Gln Gly Ile Pro Thr Ile Leu Ser Gly Arg Asp Met Ile Gly Ile
210 215 220
Ala Phe Thr Gly Ser Gly Lys Thr Leu Val Phe Thr Leu Pro Val Ile
225 230 235 240
Met Phe Cys Leu Glu Gln Glu Lys Arg Leu Pro Phe Ser Lys Arg Glu
245 250 255
Gly Pro Tyr Gly Leu Ile Ile Cys Pro Ser Arg Glu Leu Ala Arg Gln
260 265 270
Thr His Gly Ile Leu Glu Tyr Tyr Cys Arg Leu Leu Gln Glu Asp Ser
275 280 285
Ser Pro Leu Leu Arg Cys Ala Leu Cys Ile Gly Gly Met Ser Val Lys
290 295 300
Glu Gln Met Glu Thr Ile Arg His Gly Val His Met Met Val Ala Thr
305 310 315 320
Pro Gly Arg Leu Met Asp Leu Leu Gln Lys Lys Met Val Ser Leu Asp
325 330 335
Ile Cys Arg Tyr Leu Ala Leu Asp Glu Ala Asp Arg Met Ile Asp Met
340 345 350
Gly Phe Glu Gly Asp Ile Arg Thr Ile Phe Ser Tyr Phe Lys Gly Gln
355 360 365
Arg Gln Thr Leu Leu Phe Ser Ala Thr Met Pro Lys Lys Ile Gln Asn
370 375 380
Phe Ala Lys Ser Ala Leu Val Lys Pro Val Thr Ile Asn Val Gly Arg
385 390 395 400
Ala Gly Ala Ala Ser Leu Asp Val Ile Gln Glu Val Glu Tyr Val Lys
405 410 415
Glu Glu Ala Lys Met Val Tyr Leu Leu Glu Cys Leu Gln Lys Thr Pro
420 425 430
Pro Pro Val Leu Ile Phe Ala Glu Lys Lys Ala Asp Val Asp Ala Ile
435 440 445
His Glu Tyr Leu Leu Leu Lys Gly Val Glu Ala Val Ala Ile His Gly
450 455 460
Gly Lys Asp Gln Glu Glu Arg Thr Lys Ala Ile Glu Ala Phe Arg Glu
465 470 475 480
Gly Lys Lys Asp Val Leu Val Ala Thr Asp Val Ala Ser Lys Gly Leu
485 490 495
Asp Phe Pro Ala Ile Gln His Val Ile Asn Tyr Asp Met Pro Glu Glu
500 505 510
Ile Glu Asn Tyr Val His Arg Ile Gly Arg Thr Gly Arg Ser Gly Asn
515 520 525
Thr Gly Ile Ala Thr Thr Phe Ile Asn Lys Ala Cys Asp Glu Ser Val
530 535 540
Leu Met Asp Leu Lys Ala Leu Leu Leu Glu Ala Lys Gln Lys Val Pro
545 550 555 560
Pro Val Leu Gln Val Leu His Cys Gly Asp Glu Ser Met Leu Asp Ile
565 570 575
Gly Gly Glu Arg Gly Cys Ala Phe Cys Gly Gly Leu Gly His Arg Ile
580 585 590
Thr Asp Cys Pro Lys Leu Glu Ala Met Gln Thr Lys Gln Val Ser Asn
595 600 605
Ile Gly Arg Lys Asp Tyr Leu Ala His Ser Ser Met Asp Phe
610 615 620
<210> 70
<211> 1491
<212> DNA
<213> 智人(Homo sapiens)
<400> 70
atgtcagtga aggagatggc taagggcatt acgtatgatg accccatcaa aaccagctgg 60
actccacccc gttatgttct gagcatgtct gaagagcgac atgagcgcgt gcggaagaaa 120
taccacatcc tggtggaggg agacggtatc ccaccaccca tcaagagctt caaggaaatg 180
aagtttcctg cagccatcct gagaggcctg aagaagaaag gcattcacca cccaacaccc 240
attcagatcc agggcatccc caccattcta tctggccgtg acatgatagg catcgctttc 300
acgggttcag gcaagacact ggtgttcacg ttgcccgtca tcatgttctg cctggaacaa 360
gagaagaggt tacccttctc aaagcgcgag gggccctatg gactcatcat ctgcccctcg 420
cgggagctgg cccggcagac ccatggcatc ctggagtact actgccgcct gctgcaggag 480
gacagctcac cactcctgcg ctgcgccctc tgcattgggg gcatgtccgt gaaagagcag 540
atggagacca tccgacacgg tgtacacatg atggtggcca ccccggggcg cctcatggat 600
ttgctgcaga agaagatggt cagcctagac atctgtcgct acctggccct ggacgaggct 660
gaccgcatga tcgacatggg cttcgagggt gacatccgta ccatcttctc ctacttcaag 720
ggccagcgac agaccctgct cttcagtgcc accatgccga agaagattca gaactttgct 780
aagagtgccc ttgtaaagcc tgtgaccatc aatgtggggc gcgctggggc tgccagcctg 840
gatgtcatcc aggaggtaga atatgtgaag gaggaggcca agatggtgta cctgctcgag 900
tgcctgcaga agacaccccc gcctgtactc atctttgcag agaagaaggc agacgtggac 960
gccatccacg agtacctgct gctcaagggg gttgaggccg tagccatcca tgggggcaaa 1020
gaccaggagg aacggactaa ggccatcgag gcattccggg agggcaagaa ggatgtccta 1080
gtagccacag acgttgcctc caagggcctg gacttccctg ccatccagca cgtcatcaat 1140
tatgacatgc cagaggagat tgagaactat gtacaccgga ttggccgcac cgggcgctcg 1200
ggaaacacag gcatcgccac taccttcatc aacaaagcgt gtgatgagtc agtgctgatg 1260
gacctcaaag cgctgctgct agaagccaag cagaaggtgc cgcccgtgct gcaggtgctg 1320
cattgcgggg atgagtccat gctggacatt ggaggagagc gcggctgtgc cttctgcggg 1380
ggcctgggtc atcggatcac tgactgcccc aaactcgagg ctatgcagac caagcaggtc 1440
agcaacatcg gtcgcaagga ctacctggcc cacagctcca tggacttctg a 1491
<210> 71
<211> 496
<212> PRT
<213> 智人(Homo sapiens)
<400> 71
Met Ser Val Lys Glu Met Ala Lys Gly Ile Thr Tyr Asp Asp Pro Ile
1 5 10 15
Lys Thr Ser Trp Thr Pro Pro Arg Tyr Val Leu Ser Met Ser Glu Glu
20 25 30
Arg His Glu Arg Val Arg Lys Lys Tyr His Ile Leu Val Glu Gly Asp
35 40 45
Gly Ile Pro Pro Pro Ile Lys Ser Phe Lys Glu Met Lys Phe Pro Ala
50 55 60
Ala Ile Leu Arg Gly Leu Lys Lys Lys Gly Ile His His Pro Thr Pro
65 70 75 80
Ile Gln Ile Gln Gly Ile Pro Thr Ile Leu Ser Gly Arg Asp Met Ile
85 90 95
Gly Ile Ala Phe Thr Gly Ser Gly Lys Thr Leu Val Phe Thr Leu Pro
100 105 110
Val Ile Met Phe Cys Leu Glu Gln Glu Lys Arg Leu Pro Phe Ser Lys
115 120 125
Arg Glu Gly Pro Tyr Gly Leu Ile Ile Cys Pro Ser Arg Glu Leu Ala
130 135 140
Arg Gln Thr His Gly Ile Leu Glu Tyr Tyr Cys Arg Leu Leu Gln Glu
145 150 155 160
Asp Ser Ser Pro Leu Leu Arg Cys Ala Leu Cys Ile Gly Gly Met Ser
165 170 175
Val Lys Glu Gln Met Glu Thr Ile Arg His Gly Val His Met Met Val
180 185 190
Ala Thr Pro Gly Arg Leu Met Asp Leu Leu Gln Lys Lys Met Val Ser
195 200 205
Leu Asp Ile Cys Arg Tyr Leu Ala Leu Asp Glu Ala Asp Arg Met Ile
210 215 220
Asp Met Gly Phe Glu Gly Asp Ile Arg Thr Ile Phe Ser Tyr Phe Lys
225 230 235 240
Gly Gln Arg Gln Thr Leu Leu Phe Ser Ala Thr Met Pro Lys Lys Ile
245 250 255
Gln Asn Phe Ala Lys Ser Ala Leu Val Lys Pro Val Thr Ile Asn Val
260 265 270
Gly Arg Ala Gly Ala Ala Ser Leu Asp Val Ile Gln Glu Val Glu Tyr
275 280 285
Val Lys Glu Glu Ala Lys Met Val Tyr Leu Leu Glu Cys Leu Gln Lys
290 295 300
Thr Pro Pro Pro Val Leu Ile Phe Ala Glu Lys Lys Ala Asp Val Asp
305 310 315 320
Ala Ile His Glu Tyr Leu Leu Leu Lys Gly Val Glu Ala Val Ala Ile
325 330 335
His Gly Gly Lys Asp Gln Glu Glu Arg Thr Lys Ala Ile Glu Ala Phe
340 345 350
Arg Glu Gly Lys Lys Asp Val Leu Val Ala Thr Asp Val Ala Ser Lys
355 360 365
Gly Leu Asp Phe Pro Ala Ile Gln His Val Ile Asn Tyr Asp Met Pro
370 375 380
Glu Glu Ile Glu Asn Tyr Val His Arg Ile Gly Arg Thr Gly Arg Ser
385 390 395 400
Gly Asn Thr Gly Ile Ala Thr Thr Phe Ile Asn Lys Ala Cys Asp Glu
405 410 415
Ser Val Leu Met Asp Leu Lys Ala Leu Leu Leu Glu Ala Lys Gln Lys
420 425 430
Val Pro Pro Val Leu Gln Val Leu His Cys Gly Asp Glu Ser Met Leu
435 440 445
Asp Ile Gly Gly Glu Arg Gly Cys Ala Phe Cys Gly Gly Leu Gly His
450 455 460
Arg Ile Thr Asp Cys Pro Lys Leu Glu Ala Met Gln Thr Lys Gln Val
465 470 475 480
Ser Asn Ile Gly Arg Lys Asp Tyr Leu Ala His Ser Ser Met Asp Phe
485 490 495
<210> 72
<211> 2541
<212> DNA
<213> 智人(Homo sapiens)
<400> 72
atggggatac agggattgct acaatttatc aaagaagctt cagaacccat ccatgtgagg 60
aagtataaag ggcaggtagt agctgtggat acatattgct ggcttcacaa aggagctatt 120
gcttgtgctg aaaaactagc caaaggtgaa cctactgata ggtatgtagg attttgtatg 180
aaatttgtaa atatgttact atctcatggg atcaagccta ttctcgtatt tgatggatgt 240
actttacctt ctaaaaagga agtagagaga tctagaagag aaagacgaca agccaatctt 300
cttaagggaa agcaacttct tcgtgagggg aaagtctcgg aagctcgaga gtgtttcacc 360
cggtctatca atatcacaca tgccatggcc cacaaagtaa ttaaagctgc ccggtctcag 420
ggggtagatt gcctcgtggc tccctatgaa gctgatgcgc agttggccta tcttaacaaa 480
gcgggaattg tgcaagccat aattacagag gactcggatc tcctagcttt tggctgtaaa 540
aaggtaattt taaagatgga ccagtttgga aatggacttg aaattgatca agctcggcta 600
ggaatgtgca gacagcttgg ggatgtattc acggaagaga agtttcgtta catgtgtatt 660
ctttcaggtt gtgactacct gtcatcactg cgtgggattg gattagcaaa ggcatgcaaa 720
gtcctaagac tagccaataa tccagatata gtaaaggtta tcaagaaaat tggacattat 780
ctcaagatga atatcacggt accagaggat tacatcaacg ggtttattcg ggccaacaat 840
accttcctct atcagctagt ttttgatccc atcaaaagga aacttattcc tctgaacgcc 900
tatgaagatg atgttgatcc tgaaacacta agctacgctg ggcaatatgt tgatgattcc 960
atagctcttc aaatagcact tggaaataaa gatataaata cttttgaaca gatcgatgac 1020
tacaatccag acactgctat gcctgcccat tcaagaagtc atagttggga tgacaaaaca 1080
tgtcaaaagt cagctaatgt tagcagcatt tggcatagga attactctcc cagaccagag 1140
tcgggtactg tttcagatgc cccacaattg aaggaaaatc caagtactgt gggagtggaa 1200
cgagtgatta gtactaaagg gttaaatctc ccaaggaaat catccattgt gaaaagacca 1260
agaagtgcag agctgtcaga agatgacctg ttgagtcagt attctctttc atttacgaag 1320
aagaccaaga aaaatagctc tgaaggcaat aaatcattga gcttttctga agtgtttgtg 1380
cctgacctgg taaatggacc tactaacaaa aagagtgtaa gcactccacc taggacgaga 1440
aataaatttg caacattttt acaaaggaaa aatgaagaaa gtggtgcagt tgtggttcca 1500
gggaccagaa gcaggttttt ttgcagttca gattctactg actgtgtatc aaacaaagtg 1560
agcatccagc ctctggatga aactgctgtc acagataaag agaacaatct gcatgaatca 1620
gagtatggag accaagaagg caagagactg gttgacacag atgtagcacg taattcaagt 1680
gatgacattc cgaataatca tattccaggt gatcatattc cagacaaggc aacagtgttt 1740
acagatgaag agtcctactc ttttgagagc agcaaattta caaggaccat ttcaccaccc 1800
actttgggaa cactaagaag ttgttttagt tggtctggag gtcttggaga tttttcaaga 1860
acgccgagcc cctctccaag cacagcattg cagcagttcc gaagaaagag cgattccccc 1920
acctctttgc ctgagaataa tatgtctgat gtgtcgcagt taaagagcga ggagtccagt 1980
gacgatgagt ctcatccctt acgagaagag gcatgttctt cacagtccca ggaaagtgga 2040
gaattctcac tgcagagttc aaatgcatca aagctttctc agtgctctag taaggactct 2100
gattcagagg aatctgattg caatattaag ttacttgaca gtcaaagtga ccagacctcc 2160
aagctacgtt tatctcattt ctcaaaaaaa gacacacctc taaggaacaa ggttcctggg 2220
ctatataagt ccagttctgc agactctctt tctacaacca agatcaaacc tctaggacct 2280
gccagagcca gtgggctgag caagaagccg gcaagcatcc agaagagaaa gcatcataat 2340
gccgagaaca agccggggtt acagatcaaa ctcaatgagc tctggaaaaa ctttggattt 2400
aaaaaagatt ctgaaaagct tcctccttgt aagaaacccc tgtccccagt cagagataac 2460
atccaactaa ctccagaagc ggaagaggat atatttaaca aacctgaatg tggccgtgtt 2520
caaagagcaa tattccagta a 2541
<210> 73
<211> 846
<212> PRT
<213> 智人(Homo sapiens)
<400> 73
Met Gly Ile Gln Gly Leu Leu Gln Phe Ile Lys Glu Ala Ser Glu Pro
1 5 10 15
Ile His Val Arg Lys Tyr Lys Gly Gln Val Val Ala Val Asp Thr Tyr
20 25 30
Cys Trp Leu His Lys Gly Ala Ile Ala Cys Ala Glu Lys Leu Ala Lys
35 40 45
Gly Glu Pro Thr Asp Arg Tyr Val Gly Phe Cys Met Lys Phe Val Asn
50 55 60
Met Leu Leu Ser His Gly Ile Lys Pro Ile Leu Val Phe Asp Gly Cys
65 70 75 80
Thr Leu Pro Ser Lys Lys Glu Val Glu Arg Ser Arg Arg Glu Arg Arg
85 90 95
Gln Ala Asn Leu Leu Lys Gly Lys Gln Leu Leu Arg Glu Gly Lys Val
100 105 110
Ser Glu Ala Arg Glu Cys Phe Thr Arg Ser Ile Asn Ile Thr His Ala
115 120 125
Met Ala His Lys Val Ile Lys Ala Ala Arg Ser Gln Gly Val Asp Cys
130 135 140
Leu Val Ala Pro Tyr Glu Ala Asp Ala Gln Leu Ala Tyr Leu Asn Lys
145 150 155 160
Ala Gly Ile Val Gln Ala Ile Ile Thr Glu Asp Ser Asp Leu Leu Ala
165 170 175
Phe Gly Cys Lys Lys Val Ile Leu Lys Met Asp Gln Phe Gly Asn Gly
180 185 190
Leu Glu Ile Asp Gln Ala Arg Leu Gly Met Cys Arg Gln Leu Gly Asp
195 200 205
Val Phe Thr Glu Glu Lys Phe Arg Tyr Met Cys Ile Leu Ser Gly Cys
210 215 220
Asp Tyr Leu Ser Ser Leu Arg Gly Ile Gly Leu Ala Lys Ala Cys Lys
225 230 235 240
Val Leu Arg Leu Ala Asn Asn Pro Asp Ile Val Lys Val Ile Lys Lys
245 250 255
Ile Gly His Tyr Leu Lys Met Asn Ile Thr Val Pro Glu Asp Tyr Ile
260 265 270
Asn Gly Phe Ile Arg Ala Asn Asn Thr Phe Leu Tyr Gln Leu Val Phe
275 280 285
Asp Pro Ile Lys Arg Lys Leu Ile Pro Leu Asn Ala Tyr Glu Asp Asp
290 295 300
Val Asp Pro Glu Thr Leu Ser Tyr Ala Gly Gln Tyr Val Asp Asp Ser
305 310 315 320
Ile Ala Leu Gln Ile Ala Leu Gly Asn Lys Asp Ile Asn Thr Phe Glu
325 330 335
Gln Ile Asp Asp Tyr Asn Pro Asp Thr Ala Met Pro Ala His Ser Arg
340 345 350
Ser His Ser Trp Asp Asp Lys Thr Cys Gln Lys Ser Ala Asn Val Ser
355 360 365
Ser Ile Trp His Arg Asn Tyr Ser Pro Arg Pro Glu Ser Gly Thr Val
370 375 380
Ser Asp Ala Pro Gln Leu Lys Glu Asn Pro Ser Thr Val Gly Val Glu
385 390 395 400
Arg Val Ile Ser Thr Lys Gly Leu Asn Leu Pro Arg Lys Ser Ser Ile
405 410 415
Val Lys Arg Pro Arg Ser Ala Glu Leu Ser Glu Asp Asp Leu Leu Ser
420 425 430
Gln Tyr Ser Leu Ser Phe Thr Lys Lys Thr Lys Lys Asn Ser Ser Glu
435 440 445
Gly Asn Lys Ser Leu Ser Phe Ser Glu Val Phe Val Pro Asp Leu Val
450 455 460
Asn Gly Pro Thr Asn Lys Lys Ser Val Ser Thr Pro Pro Arg Thr Arg
465 470 475 480
Asn Lys Phe Ala Thr Phe Leu Gln Arg Lys Asn Glu Glu Ser Gly Ala
485 490 495
Val Val Val Pro Gly Thr Arg Ser Arg Phe Phe Cys Ser Ser Asp Ser
500 505 510
Thr Asp Cys Val Ser Asn Lys Val Ser Ile Gln Pro Leu Asp Glu Thr
515 520 525
Ala Val Thr Asp Lys Glu Asn Asn Leu His Glu Ser Glu Tyr Gly Asp
530 535 540
Gln Glu Gly Lys Arg Leu Val Asp Thr Asp Val Ala Arg Asn Ser Ser
545 550 555 560
Asp Asp Ile Pro Asn Asn His Ile Pro Gly Asp His Ile Pro Asp Lys
565 570 575
Ala Thr Val Phe Thr Asp Glu Glu Ser Tyr Ser Phe Glu Ser Ser Lys
580 585 590
Phe Thr Arg Thr Ile Ser Pro Pro Thr Leu Gly Thr Leu Arg Ser Cys
595 600 605
Phe Ser Trp Ser Gly Gly Leu Gly Asp Phe Ser Arg Thr Pro Ser Pro
610 615 620
Ser Pro Ser Thr Ala Leu Gln Gln Phe Arg Arg Lys Ser Asp Ser Pro
625 630 635 640
Thr Ser Leu Pro Glu Asn Asn Met Ser Asp Val Ser Gln Leu Lys Ser
645 650 655
Glu Glu Ser Ser Asp Asp Glu Ser His Pro Leu Arg Glu Glu Ala Cys
660 665 670
Ser Ser Gln Ser Gln Glu Ser Gly Glu Phe Ser Leu Gln Ser Ser Asn
675 680 685
Ala Ser Lys Leu Ser Gln Cys Ser Ser Lys Asp Ser Asp Ser Glu Glu
690 695 700
Ser Asp Cys Asn Ile Lys Leu Leu Asp Ser Gln Ser Asp Gln Thr Ser
705 710 715 720
Lys Leu Arg Leu Ser His Phe Ser Lys Lys Asp Thr Pro Leu Arg Asn
725 730 735
Lys Val Pro Gly Leu Tyr Lys Ser Ser Ser Ala Asp Ser Leu Ser Thr
740 745 750
Thr Lys Ile Lys Pro Leu Gly Pro Ala Arg Ala Ser Gly Leu Ser Lys
755 760 765
Lys Pro Ala Ser Ile Gln Lys Arg Lys His His Asn Ala Glu Asn Lys
770 775 780
Pro Gly Leu Gln Ile Lys Leu Asn Glu Leu Trp Lys Asn Phe Gly Phe
785 790 795 800
Lys Lys Asp Ser Glu Lys Leu Pro Pro Cys Lys Lys Pro Leu Ser Pro
805 810 815
Val Arg Asp Asn Ile Gln Leu Thr Pro Glu Ala Glu Glu Asp Ile Phe
820 825 830
Asn Lys Pro Glu Cys Gly Arg Val Gln Arg Ala Ile Phe Gln
835 840 845
<210> 74
<211> 2538
<212> DNA
<213> 智人(Homo sapiens)
<400> 74
atggggatac agggattgct acaatttatc aaagaagctt cagaacccat ccatgtgagg 60
aagtataaag ggcaggtagt agctgtggat acatattgct ggcttcacaa aggagctatt 120
gcttgtgctg aaaaactagc caaaggtgaa cctactgata ggtatgtagg attttgtatg 180
aaatttgtaa atatgttact atctcatggg atcaagccta ttctcgtatt tgatggatgt 240
actttacctt ctaaaaagga agtagagaga tctagaagag aaagacgaca agccaatctt 300
cttaagggaa agcaacttct tcgtgagggg aaagtctcgg aagctcgaga gtgtttcacc 360
cggtctatca atatcacaca tgccatggcc cacaaagtaa ttaaagctgc ccggtctcag 420
ggggtagatt gcctcgtggc tccctatgaa gctgatgcgc agttggccta tcttaacaaa 480
gcgggaattg tgcaagccat aattacagag gactcggatc tcctagcttt tggctgtaaa 540
aaggtaattt taaagatgga ccagtttgga aatggacttg aaattgatca agctcggcta 600
ggaatgtgca gacagcttgg ggatgtattc acggaagaga agtttcgtta catgtgtatt 660
ctttcaggtt gtgactacct gtcatcactg cgtgggattg gattagcaaa ggcatgcaaa 720
gtcctaagac tagccaataa tccagatata gtaaaggtta tcaagaaaat tggacattat 780
ctcaagatga atatcacggt accagaggat tacatcaacg ggtttattcg ggccaacaat 840
accttcctct atcagctagt ttttgatccc atcaaaagga aacttattcc tctgaacgcc 900
tatgaagatg atgttgatcc tgaaacacta agctacgctg ggcaatatgt tgatgattcc 960
atagctcttc aaatagcact tggaaataaa gatataaata cttttgaaca gatcgatgac 1020
tacaatccag acactgctat gcctgcccat tcaagaagtc atagttggga tgacaaaaca 1080
tgtcaaaagt cagctaatgt tagcagcatt tggcatagga attactctcc cagaccagag 1140
tcgggtactg tttcagatgc cccacaattg aaggaaaatc caagtactgt gggagtggaa 1200
cgagtgatta gtactaaagg gttaaatctc ccaaggaaat catccattgt gaaaagacca 1260
agaagtgagc tgtcagaaga tgacctgttg agtcagtatt ctctttcatt tacgaagaag 1320
accaagaaaa atagctctga aggcaataaa tcattgagct tttctgaagt gtttgtgcct 1380
gacctggtaa atggacctac taacaaaaag agtgtaagca ctccacctag gacgagaaat 1440
aaatttgcaa catttttaca aaggaaaaat gaagaaagtg gtgcagttgt ggttccaggg 1500
accagaagca ggtttttttg cagttcagat tctactgact gtgtatcaaa caaagtgagc 1560
atccagcctc tggatgaaac tgctgtcaca gataaagaga acaatctgca tgaatcagag 1620
tatggagacc aagaaggcaa gagactggtt gacacagatg tagcacgtaa ttcaagtgat 1680
gacattccga ataatcatat tccaggtgat catattccag acaaggcaac agtgtttaca 1740
gatgaagagt cctactcttt tgagagcagc aaatttacaa ggaccatttc accacccact 1800
ttgggaacac taagaagttg ttttagttgg tctggaggtc ttggagattt ttcaagaacg 1860
ccgagcccct ctccaagcac agcattgcag cagttccgaa gaaagagcga ttcccccacc 1920
tctttgcctg agaataatat gtctgatgtg tcgcagttaa agagcgagga gtccagtgac 1980
gatgagtctc atcccttacg agaagaggca tgttcttcac agtcccagga aagtggagaa 2040
ttctcactgc agagttcaaa tgcatcaaag ctttctcagt gctctagtaa ggactctgat 2100
tcagaggaat ctgattgcaa tattaagtta cttgacagtc aaagtgacca gacctccaag 2160
ctacgtttat ctcatttctc aaaaaaagac acacctctaa ggaacaaggt tcctgggcta 2220
tataagtcca gttctgcaga ctctctttct acaaccaaga tcaaacctct aggacctgcc 2280
agagccagtg ggctgagcaa gaagccggca agcatccaga agagaaagca tcataatgcc 2340
gagaacaagc cggggttaca gatcaaactc aatgagctct ggaaaaactt tggatttaaa 2400
aaagattctg aaaagcttcc tccttgtaag aaacccctgt ccccagtcag agataacatc 2460
caactaactc cagaagcgga agaggatata tttaacaaac ctgaatgtgg ccgtgttcaa 2520
agagcaatat tccagtaa 2538
<210> 75
<211> 845
<212> PRT
<213> 智人(Homo sapiens)
<400> 75
Met Gly Ile Gln Gly Leu Leu Gln Phe Ile Lys Glu Ala Ser Glu Pro
1 5 10 15
Ile His Val Arg Lys Tyr Lys Gly Gln Val Val Ala Val Asp Thr Tyr
20 25 30
Cys Trp Leu His Lys Gly Ala Ile Ala Cys Ala Glu Lys Leu Ala Lys
35 40 45
Gly Glu Pro Thr Asp Arg Tyr Val Gly Phe Cys Met Lys Phe Val Asn
50 55 60
Met Leu Leu Ser His Gly Ile Lys Pro Ile Leu Val Phe Asp Gly Cys
65 70 75 80
Thr Leu Pro Ser Lys Lys Glu Val Glu Arg Ser Arg Arg Glu Arg Arg
85 90 95
Gln Ala Asn Leu Leu Lys Gly Lys Gln Leu Leu Arg Glu Gly Lys Val
100 105 110
Ser Glu Ala Arg Glu Cys Phe Thr Arg Ser Ile Asn Ile Thr His Ala
115 120 125
Met Ala His Lys Val Ile Lys Ala Ala Arg Ser Gln Gly Val Asp Cys
130 135 140
Leu Val Ala Pro Tyr Glu Ala Asp Ala Gln Leu Ala Tyr Leu Asn Lys
145 150 155 160
Ala Gly Ile Val Gln Ala Ile Ile Thr Glu Asp Ser Asp Leu Leu Ala
165 170 175
Phe Gly Cys Lys Lys Val Ile Leu Lys Met Asp Gln Phe Gly Asn Gly
180 185 190
Leu Glu Ile Asp Gln Ala Arg Leu Gly Met Cys Arg Gln Leu Gly Asp
195 200 205
Val Phe Thr Glu Glu Lys Phe Arg Tyr Met Cys Ile Leu Ser Gly Cys
210 215 220
Asp Tyr Leu Ser Ser Leu Arg Gly Ile Gly Leu Ala Lys Ala Cys Lys
225 230 235 240
Val Leu Arg Leu Ala Asn Asn Pro Asp Ile Val Lys Val Ile Lys Lys
245 250 255
Ile Gly His Tyr Leu Lys Met Asn Ile Thr Val Pro Glu Asp Tyr Ile
260 265 270
Asn Gly Phe Ile Arg Ala Asn Asn Thr Phe Leu Tyr Gln Leu Val Phe
275 280 285
Asp Pro Ile Lys Arg Lys Leu Ile Pro Leu Asn Ala Tyr Glu Asp Asp
290 295 300
Val Asp Pro Glu Thr Leu Ser Tyr Ala Gly Gln Tyr Val Asp Asp Ser
305 310 315 320
Ile Ala Leu Gln Ile Ala Leu Gly Asn Lys Asp Ile Asn Thr Phe Glu
325 330 335
Gln Ile Asp Asp Tyr Asn Pro Asp Thr Ala Met Pro Ala His Ser Arg
340 345 350
Ser His Ser Trp Asp Asp Lys Thr Cys Gln Lys Ser Ala Asn Val Ser
355 360 365
Ser Ile Trp His Arg Asn Tyr Ser Pro Arg Pro Glu Ser Gly Thr Val
370 375 380
Ser Asp Ala Pro Gln Leu Lys Glu Asn Pro Ser Thr Val Gly Val Glu
385 390 395 400
Arg Val Ile Ser Thr Lys Gly Leu Asn Leu Pro Arg Lys Ser Ser Ile
405 410 415
Val Lys Arg Pro Arg Ser Glu Leu Ser Glu Asp Asp Leu Leu Ser Gln
420 425 430
Tyr Ser Leu Ser Phe Thr Lys Lys Thr Lys Lys Asn Ser Ser Glu Gly
435 440 445
Asn Lys Ser Leu Ser Phe Ser Glu Val Phe Val Pro Asp Leu Val Asn
450 455 460
Gly Pro Thr Asn Lys Lys Ser Val Ser Thr Pro Pro Arg Thr Arg Asn
465 470 475 480
Lys Phe Ala Thr Phe Leu Gln Arg Lys Asn Glu Glu Ser Gly Ala Val
485 490 495
Val Val Pro Gly Thr Arg Ser Arg Phe Phe Cys Ser Ser Asp Ser Thr
500 505 510
Asp Cys Val Ser Asn Lys Val Ser Ile Gln Pro Leu Asp Glu Thr Ala
515 520 525
Val Thr Asp Lys Glu Asn Asn Leu His Glu Ser Glu Tyr Gly Asp Gln
530 535 540
Glu Gly Lys Arg Leu Val Asp Thr Asp Val Ala Arg Asn Ser Ser Asp
545 550 555 560
Asp Ile Pro Asn Asn His Ile Pro Gly Asp His Ile Pro Asp Lys Ala
565 570 575
Thr Val Phe Thr Asp Glu Glu Ser Tyr Ser Phe Glu Ser Ser Lys Phe
580 585 590
Thr Arg Thr Ile Ser Pro Pro Thr Leu Gly Thr Leu Arg Ser Cys Phe
595 600 605
Ser Trp Ser Gly Gly Leu Gly Asp Phe Ser Arg Thr Pro Ser Pro Ser
610 615 620
Pro Ser Thr Ala Leu Gln Gln Phe Arg Arg Lys Ser Asp Ser Pro Thr
625 630 635 640
Ser Leu Pro Glu Asn Asn Met Ser Asp Val Ser Gln Leu Lys Ser Glu
645 650 655
Glu Ser Ser Asp Asp Glu Ser His Pro Leu Arg Glu Glu Ala Cys Ser
660 665 670
Ser Gln Ser Gln Glu Ser Gly Glu Phe Ser Leu Gln Ser Ser Asn Ala
675 680 685
Ser Lys Leu Ser Gln Cys Ser Ser Lys Asp Ser Asp Ser Glu Glu Ser
690 695 700
Asp Cys Asn Ile Lys Leu Leu Asp Ser Gln Ser Asp Gln Thr Ser Lys
705 710 715 720
Leu Arg Leu Ser His Phe Ser Lys Lys Asp Thr Pro Leu Arg Asn Lys
725 730 735
Val Pro Gly Leu Tyr Lys Ser Ser Ser Ala Asp Ser Leu Ser Thr Thr
740 745 750
Lys Ile Lys Pro Leu Gly Pro Ala Arg Ala Ser Gly Leu Ser Lys Lys
755 760 765
Pro Ala Ser Ile Gln Lys Arg Lys His His Asn Ala Glu Asn Lys Pro
770 775 780
Gly Leu Gln Ile Lys Leu Asn Glu Leu Trp Lys Asn Phe Gly Phe Lys
785 790 795 800
Lys Asp Ser Glu Lys Leu Pro Pro Cys Lys Lys Pro Leu Ser Pro Val
805 810 815
Arg Asp Asn Ile Gln Leu Thr Pro Glu Ala Glu Glu Asp Ile Phe Asn
820 825 830
Lys Pro Glu Cys Gly Arg Val Gln Arg Ala Ile Phe Gln
835 840 845
<210> 76
<211> 2412
<212> DNA
<213> 智人(Homo sapiens)
<400> 76
atggggatac agggattgct acaatttatc aaagaagctt cagaacccat ccatgtgagg 60
aagtataaag ggcaggtagt agctgtggat acatattgct ggcttcacaa aggagctatt 120
gcttgtgctg aaaaactagc caaaggtgaa cctactgata ggtatgtagg attttgtatg 180
aaatttgtaa atatgttact atctcatggg atcaagccta ttctcgtatt tgatggatgt 240
actttacctt ctaaaaagga agtagagaga tctagaagag aaagacgaca agccaatctt 300
cttaagggaa agcaacttct tcgtgagggg aaagtctcgg aagctcgaga gtgtttcacc 360
cggtctatca atatcacaca tgccatggcc cacaaagtaa ttaaagctgc ccggtctcag 420
ggggtagatt gcctcgtggc tccctatgaa gctgatgcgc agttggccta tcttaacaaa 480
gcgggaattg tgcaagccat aattacagag gactcggatc tcctagcttt tggctgtaaa 540
aaggtaattt taaagatgga ccagtttgga aatggacttg aaattgatca agctcggcta 600
ggaatgtgca gacagcttgg ggatgtattc acggaagaga agtttcgtta catgtgtatt 660
ctttcaggtt gtgactacct gtcatcactg cgtgggattg gattagcaaa ggcatgcaaa 720
gtcctaagac tagccaataa tccagatata gtaaaggtta tcaagaaaat tggacattat 780
ctcaagatga atatcacggt accagaggat tacatcaacg ggtttattcg ggccaacaat 840
accttcctct atcagctagt ttttgatccc atcaaaagga aacttattcc tctgaacgcc 900
tatgaagatg atgttgatcc tgaaacacta agctacgctg ggcaatatgt tgatgattcc 960
atagctcttc aaatagcact tggaaataaa gatataaata cttttgaaca gatcgatgac 1020
tacaatccag acactgctat gcctgcccat tcaagaagtc atagttggga tgacaaaaca 1080
tgtcaaaagt cagctaatgt tagcagcatt tggcatagga attactctcc cagaccagag 1140
tcgggtactg tttcagatgc cccacaattg aaggaaaatc caagtactgt gggagtggaa 1200
cgagtgatta gtactaaagg gttaaatctc ccaaggaaat catccattgt gaaaagacca 1260
agaagtgcag agctgtcaga agatgacctg ttgagtcagt attctctttc atttacgaag 1320
aagaccaaga aaaatagctc tgaaggcaat aaatcattga gcttttctga agtgtttgtg 1380
cctgacctgg taaatggacc tactaacaaa aagagtgtaa gcactccacc taggacgaga 1440
aataaatttg caacattttt acaaaggaaa aatgaagaaa gtggtgcagt tgtggttcca 1500
gggaccagaa gcaggttttt ttgcagttca gattctactg actgtgtatc aaacaaagtg 1560
agcatccagc ctctggatga aactgctgtc acagataaag agaacaatct gcatgaatca 1620
gagtatggag accaagaagg caagagactg gttgacacag atgtagcacg taattcaagt 1680
gatgacattc cgaataatca tattccaggt gatcatattc cagacaaggc aacagtgttt 1740
acagatgaag agtcctactc ttttgagagc agcaaattta caaggaccat ttcaccaccc 1800
actttgggaa cactaagaag ttgttttagt tggtctggag gtcttggaga tttttcaaga 1860
acgccgagcc cctctccaag cacagcattg cagcagttcc gaagaaagag cgattccccc 1920
acctctttgc ctgagaataa tatgtctgat gtgtcgcagt taaagagcga ggagtccagt 1980
gacgatgagt ctcatccctt acgagaagag gcatgttctt cacagtccca ggaaagtgga 2040
gaattctcac tgcagagttc aaatgcatca aagctttctc agtgctctag taaggactct 2100
gattcagagg aatctgattg caatattaag ttacttgaca gtcaaagtga ccagacctcc 2160
aagctacgtt tatctcattt ctcaaaaaaa gacacacctc taaggaacaa ggttcctggg 2220
ctatataagt ccagttctgc agactctctt tctacaacca agatcaaacc tctaggacct 2280
gccagagcca gtgggctgag caagaagccg gcaagcatcc agaagagaaa gcatcataat 2340
gccgagaaca agccggggtt acagatcaaa ctcaatgagc tctggaaaaa ctttggattt 2400
aaaaaattct ga 2412
<210> 77
<211> 803
<212> PRT
<213> 智人(Homo sapiens)
<400> 77
Met Gly Ile Gln Gly Leu Leu Gln Phe Ile Lys Glu Ala Ser Glu Pro
1 5 10 15
Ile His Val Arg Lys Tyr Lys Gly Gln Val Val Ala Val Asp Thr Tyr
20 25 30
Cys Trp Leu His Lys Gly Ala Ile Ala Cys Ala Glu Lys Leu Ala Lys
35 40 45
Gly Glu Pro Thr Asp Arg Tyr Val Gly Phe Cys Met Lys Phe Val Asn
50 55 60
Met Leu Leu Ser His Gly Ile Lys Pro Ile Leu Val Phe Asp Gly Cys
65 70 75 80
Thr Leu Pro Ser Lys Lys Glu Val Glu Arg Ser Arg Arg Glu Arg Arg
85 90 95
Gln Ala Asn Leu Leu Lys Gly Lys Gln Leu Leu Arg Glu Gly Lys Val
100 105 110
Ser Glu Ala Arg Glu Cys Phe Thr Arg Ser Ile Asn Ile Thr His Ala
115 120 125
Met Ala His Lys Val Ile Lys Ala Ala Arg Ser Gln Gly Val Asp Cys
130 135 140
Leu Val Ala Pro Tyr Glu Ala Asp Ala Gln Leu Ala Tyr Leu Asn Lys
145 150 155 160
Ala Gly Ile Val Gln Ala Ile Ile Thr Glu Asp Ser Asp Leu Leu Ala
165 170 175
Phe Gly Cys Lys Lys Val Ile Leu Lys Met Asp Gln Phe Gly Asn Gly
180 185 190
Leu Glu Ile Asp Gln Ala Arg Leu Gly Met Cys Arg Gln Leu Gly Asp
195 200 205
Val Phe Thr Glu Glu Lys Phe Arg Tyr Met Cys Ile Leu Ser Gly Cys
210 215 220
Asp Tyr Leu Ser Ser Leu Arg Gly Ile Gly Leu Ala Lys Ala Cys Lys
225 230 235 240
Val Leu Arg Leu Ala Asn Asn Pro Asp Ile Val Lys Val Ile Lys Lys
245 250 255
Ile Gly His Tyr Leu Lys Met Asn Ile Thr Val Pro Glu Asp Tyr Ile
260 265 270
Asn Gly Phe Ile Arg Ala Asn Asn Thr Phe Leu Tyr Gln Leu Val Phe
275 280 285
Asp Pro Ile Lys Arg Lys Leu Ile Pro Leu Asn Ala Tyr Glu Asp Asp
290 295 300
Val Asp Pro Glu Thr Leu Ser Tyr Ala Gly Gln Tyr Val Asp Asp Ser
305 310 315 320
Ile Ala Leu Gln Ile Ala Leu Gly Asn Lys Asp Ile Asn Thr Phe Glu
325 330 335
Gln Ile Asp Asp Tyr Asn Pro Asp Thr Ala Met Pro Ala His Ser Arg
340 345 350
Ser His Ser Trp Asp Asp Lys Thr Cys Gln Lys Ser Ala Asn Val Ser
355 360 365
Ser Ile Trp His Arg Asn Tyr Ser Pro Arg Pro Glu Ser Gly Thr Val
370 375 380
Ser Asp Ala Pro Gln Leu Lys Glu Asn Pro Ser Thr Val Gly Val Glu
385 390 395 400
Arg Val Ile Ser Thr Lys Gly Leu Asn Leu Pro Arg Lys Ser Ser Ile
405 410 415
Val Lys Arg Pro Arg Ser Ala Glu Leu Ser Glu Asp Asp Leu Leu Ser
420 425 430
Gln Tyr Ser Leu Ser Phe Thr Lys Lys Thr Lys Lys Asn Ser Ser Glu
435 440 445
Gly Asn Lys Ser Leu Ser Phe Ser Glu Val Phe Val Pro Asp Leu Val
450 455 460
Asn Gly Pro Thr Asn Lys Lys Ser Val Ser Thr Pro Pro Arg Thr Arg
465 470 475 480
Asn Lys Phe Ala Thr Phe Leu Gln Arg Lys Asn Glu Glu Ser Gly Ala
485 490 495
Val Val Val Pro Gly Thr Arg Ser Arg Phe Phe Cys Ser Ser Asp Ser
500 505 510
Thr Asp Cys Val Ser Asn Lys Val Ser Ile Gln Pro Leu Asp Glu Thr
515 520 525
Ala Val Thr Asp Lys Glu Asn Asn Leu His Glu Ser Glu Tyr Gly Asp
530 535 540
Gln Glu Gly Lys Arg Leu Val Asp Thr Asp Val Ala Arg Asn Ser Ser
545 550 555 560
Asp Asp Ile Pro Asn Asn His Ile Pro Gly Asp His Ile Pro Asp Lys
565 570 575
Ala Thr Val Phe Thr Asp Glu Glu Ser Tyr Ser Phe Glu Ser Ser Lys
580 585 590
Phe Thr Arg Thr Ile Ser Pro Pro Thr Leu Gly Thr Leu Arg Ser Cys
595 600 605
Phe Ser Trp Ser Gly Gly Leu Gly Asp Phe Ser Arg Thr Pro Ser Pro
610 615 620
Ser Pro Ser Thr Ala Leu Gln Gln Phe Arg Arg Lys Ser Asp Ser Pro
625 630 635 640
Thr Ser Leu Pro Glu Asn Asn Met Ser Asp Val Ser Gln Leu Lys Ser
645 650 655
Glu Glu Ser Ser Asp Asp Glu Ser His Pro Leu Arg Glu Glu Ala Cys
660 665 670
Ser Ser Gln Ser Gln Glu Ser Gly Glu Phe Ser Leu Gln Ser Ser Asn
675 680 685
Ala Ser Lys Leu Ser Gln Cys Ser Ser Lys Asp Ser Asp Ser Glu Glu
690 695 700
Ser Asp Cys Asn Ile Lys Leu Leu Asp Ser Gln Ser Asp Gln Thr Ser
705 710 715 720
Lys Leu Arg Leu Ser His Phe Ser Lys Lys Asp Thr Pro Leu Arg Asn
725 730 735
Lys Val Pro Gly Leu Tyr Lys Ser Ser Ser Ala Asp Ser Leu Ser Thr
740 745 750
Thr Lys Ile Lys Pro Leu Gly Pro Ala Arg Ala Ser Gly Leu Ser Lys
755 760 765
Lys Pro Ala Ser Ile Gln Lys Arg Lys His His Asn Ala Glu Asn Lys
770 775 780
Pro Gly Leu Gln Ile Lys Leu Asn Glu Leu Trp Lys Asn Phe Gly Phe
785 790 795 800
Lys Lys Phe
<210> 78
<211> 3183
<212> DNA
<213> 智人(Homo sapiens)
<400> 78
atggagcagc tgaacgaact ggagctgctg atggagaaga gtttttggga ggaggcggag 60
ctgccggcgg agctatttca gaagaaagtg gtagcttcct ttccaagaac agttctgagc 120
acaggaatgg ataaccggta cctggtgttg gcagtcaata ctgtacagaa caaagaggga 180
aactgtgaaa agcgcctggt catcactgct tcacagtcac tagaaaataa agaactatgc 240
atccttagga atgactggtg ttctgttcca gtagagccag gagatatcat tcatttggag 300
ggagactgca catctgacac ttggataata gataaagatt ttggatattt gattctgtat 360
ccagacatgc tgatttctgg caccagcata gccagtagta ttcgatgtat gagaagagct 420
gtcctgagtg aaacttttag gagctctgat ccagccacac gccaaatgct aattggtacg 480
gttctccatg aggtgtttca aaaagccata aataatagct ttgccccaga aaagctacaa 540
gaacttgctt ttcaaacaat tcaagaaata agacatttga aggaaatgta ccgcttaaat 600
ctaagtcaag atgaaataaa acaagaagta gaggactatc ttccttcgtt ttgtaaatgg 660
gcaggagatt tcatgcataa aaacacttcg actgacttcc ctcagatgca gctctctctg 720
ccaagtgata atagtaagga taattcaaca tgtaacattg aagtcgtgaa accaatggat 780
attgaagaaa gcatttggtc ccctaggttt ggattgaaag gcaaaataga tgttacagtt 840
ggtgtgaaaa tacatcgagg gtataaaaca aaatacaaga taatgccgct ggaacttaaa 900
actggcaaag aatcaaattc tattgaacac cgtagtcagg ttgttctgta cactctacta 960
agccaagaga gaagagctga tccagaggct ggcttgcttc tctacctcaa gactggtcag 1020
atgtaccctg tgcctgccaa ccatctagat aaaagagaat tattaaagct aagaaaccag 1080
atggcattct cattgtttca ccgtattagc aaatctgcta ctagacagaa gacacagctt 1140
gcttctttgc cacaaataat tgaggaagag aaaacttgta aatattgttc acaaattggc 1200
aattgtgctc tttatagcag agcagttgaa caacagatgg attgtagttc agtcccaatt 1260
gtgatgctgc ccaaaataga agaagaaacc cagcatctga agcaaacaca cttagaatat 1320
ttcagccttt ggtgtctaat gttaaccctg gagtcacaat cgaaggataa taaaaagaat 1380
caccaaaata tctggctaat gcctgcttcg gaaatggaga agagtggcag ttgcattgga 1440
aacctgatta gaatggaaca tgtaaagata gtttgtgatg ggcaatattt acataatttc 1500
caatgtaaac atggtgccat acctgtcaca aatctaatgg caggtgacag agttattgta 1560
agtggagaag aaaggtcact gtttgctttg tctagaggat atgtgaagga gattaacatg 1620
acaacagtaa cttgtttatt agacagaaac ttgtcggtcc ttccagaatc aactttgttc 1680
agattagacc aagaagaaaa aaattgtgat atagataccc cattaggaaa tctttccaaa 1740
ttgatggaaa acacgtttgt cagcaaaaaa cttcgagatt taattattga ctttcgtgaa 1800
cctcagttta tatcctacct tagttctgtt cttccacatg atgcaaagga tacagttgcc 1860
tgcattctaa agggtttgaa taagcctcag aggcaagcga tgaaaaaggt acttctttca 1920
aaagactaca cactcatcgt gggtatgcct gggacaggaa aaacaactac gatatgtact 1980
ctcgtaagaa ttctctacgc ctgtggtttt agcgttttgt tgaccagcta tacacactct 2040
gctgttgaca atattctttt gaagttagcc aagtttaaaa taggattttt gcgtttgggt 2100
cagattcaga aggttcatcc agctatccag caatttacag agcaagaaat ttgcagatca 2160
aagtccatta aatccttagc tcttctagaa gaactctaca atagtcaact tatagttgca 2220
acaacatgta tgggaataaa ccatccaata ttttcccgta aaatttttga tttttgtatt 2280
gtggatgaag cctctcaaat tagccaacca atttgtctgg gccccctttt tttttcacgg 2340
agatttgtgt tagtggggga ccatcagcag cttcctcccc tggtgctaaa ccgtgaagca 2400
agagctcttg gcatgagtga aagcttattc aagaggctgg agcagaataa gagtgctgtt 2460
gtacagttaa ccgtgcagta cagaatgaac agtaaaatta tgtccttaag taataagctg 2520
acctatgagg gcaagctgga gtgtggatca gacaaagtgg ccaatgcagt gataaaccta 2580
cgtcacttta aagatgtgaa gctggaactg gaattttatg ctgactattc tgataatcct 2640
tggttgatgg gagtatttga acccaacaat cctgtttgtt tccttaatac agacaaggtt 2700
ccagcgccag aacaagttga aaaaggtggt gtgagcaatg taacagaagc caaactcata 2760
gttttcctaa cctccatttt tgttaaggct ggatgcagtc cctctgatat tggtattatt 2820
gcaccgtaca ggcagcaatt aaagatcatc aatgatttat tggcacgttc tattgggatg 2880
gtcgaagtta atacagtaga caaataccaa ggaagggaca aaagtattgt cctagtatct 2940
tttgttagaa gtaataagga tggaactgtt ggtgaactct tgaaagattg gcgacgtctt 3000
aatgttgcta taaccagagc caaacataaa ctgattcttc tggggtgtgt gccctcacta 3060
aattgctatc ctcctttgga gaagctgctt aatcatttaa actcagaaaa attaatcatt 3120
gatcttccat caagagaaca tgaaagtctt tgccacatat tgggtgactt tcaaagagaa 3180
taa 3183
<210> 79
<211> 1060
<212> PRT
<213> 智人(Homo sapiens)
<400> 79
Met Glu Gln Leu Asn Glu Leu Glu Leu Leu Met Glu Lys Ser Phe Trp
1 5 10 15
Glu Glu Ala Glu Leu Pro Ala Glu Leu Phe Gln Lys Lys Val Val Ala
20 25 30
Ser Phe Pro Arg Thr Val Leu Ser Thr Gly Met Asp Asn Arg Tyr Leu
35 40 45
Val Leu Ala Val Asn Thr Val Gln Asn Lys Glu Gly Asn Cys Glu Lys
50 55 60
Arg Leu Val Ile Thr Ala Ser Gln Ser Leu Glu Asn Lys Glu Leu Cys
65 70 75 80
Ile Leu Arg Asn Asp Trp Cys Ser Val Pro Val Glu Pro Gly Asp Ile
85 90 95
Ile His Leu Glu Gly Asp Cys Thr Ser Asp Thr Trp Ile Ile Asp Lys
100 105 110
Asp Phe Gly Tyr Leu Ile Leu Tyr Pro Asp Met Leu Ile Ser Gly Thr
115 120 125
Ser Ile Ala Ser Ser Ile Arg Cys Met Arg Arg Ala Val Leu Ser Glu
130 135 140
Thr Phe Arg Ser Ser Asp Pro Ala Thr Arg Gln Met Leu Ile Gly Thr
145 150 155 160
Val Leu His Glu Val Phe Gln Lys Ala Ile Asn Asn Ser Phe Ala Pro
165 170 175
Glu Lys Leu Gln Glu Leu Ala Phe Gln Thr Ile Gln Glu Ile Arg His
180 185 190
Leu Lys Glu Met Tyr Arg Leu Asn Leu Ser Gln Asp Glu Ile Lys Gln
195 200 205
Glu Val Glu Asp Tyr Leu Pro Ser Phe Cys Lys Trp Ala Gly Asp Phe
210 215 220
Met His Lys Asn Thr Ser Thr Asp Phe Pro Gln Met Gln Leu Ser Leu
225 230 235 240
Pro Ser Asp Asn Ser Lys Asp Asn Ser Thr Cys Asn Ile Glu Val Val
245 250 255
Lys Pro Met Asp Ile Glu Glu Ser Ile Trp Ser Pro Arg Phe Gly Leu
260 265 270
Lys Gly Lys Ile Asp Val Thr Val Gly Val Lys Ile His Arg Gly Tyr
275 280 285
Lys Thr Lys Tyr Lys Ile Met Pro Leu Glu Leu Lys Thr Gly Lys Glu
290 295 300
Ser Asn Ser Ile Glu His Arg Ser Gln Val Val Leu Tyr Thr Leu Leu
305 310 315 320
Ser Gln Glu Arg Arg Ala Asp Pro Glu Ala Gly Leu Leu Leu Tyr Leu
325 330 335
Lys Thr Gly Gln Met Tyr Pro Val Pro Ala Asn His Leu Asp Lys Arg
340 345 350
Glu Leu Leu Lys Leu Arg Asn Gln Met Ala Phe Ser Leu Phe His Arg
355 360 365
Ile Ser Lys Ser Ala Thr Arg Gln Lys Thr Gln Leu Ala Ser Leu Pro
370 375 380
Gln Ile Ile Glu Glu Glu Lys Thr Cys Lys Tyr Cys Ser Gln Ile Gly
385 390 395 400
Asn Cys Ala Leu Tyr Ser Arg Ala Val Glu Gln Gln Met Asp Cys Ser
405 410 415
Ser Val Pro Ile Val Met Leu Pro Lys Ile Glu Glu Glu Thr Gln His
420 425 430
Leu Lys Gln Thr His Leu Glu Tyr Phe Ser Leu Trp Cys Leu Met Leu
435 440 445
Thr Leu Glu Ser Gln Ser Lys Asp Asn Lys Lys Asn His Gln Asn Ile
450 455 460
Trp Leu Met Pro Ala Ser Glu Met Glu Lys Ser Gly Ser Cys Ile Gly
465 470 475 480
Asn Leu Ile Arg Met Glu His Val Lys Ile Val Cys Asp Gly Gln Tyr
485 490 495
Leu His Asn Phe Gln Cys Lys His Gly Ala Ile Pro Val Thr Asn Leu
500 505 510
Met Ala Gly Asp Arg Val Ile Val Ser Gly Glu Glu Arg Ser Leu Phe
515 520 525
Ala Leu Ser Arg Gly Tyr Val Lys Glu Ile Asn Met Thr Thr Val Thr
530 535 540
Cys Leu Leu Asp Arg Asn Leu Ser Val Leu Pro Glu Ser Thr Leu Phe
545 550 555 560
Arg Leu Asp Gln Glu Glu Lys Asn Cys Asp Ile Asp Thr Pro Leu Gly
565 570 575
Asn Leu Ser Lys Leu Met Glu Asn Thr Phe Val Ser Lys Lys Leu Arg
580 585 590
Asp Leu Ile Ile Asp Phe Arg Glu Pro Gln Phe Ile Ser Tyr Leu Ser
595 600 605
Ser Val Leu Pro His Asp Ala Lys Asp Thr Val Ala Cys Ile Leu Lys
610 615 620
Gly Leu Asn Lys Pro Gln Arg Gln Ala Met Lys Lys Val Leu Leu Ser
625 630 635 640
Lys Asp Tyr Thr Leu Ile Val Gly Met Pro Gly Thr Gly Lys Thr Thr
645 650 655
Thr Ile Cys Thr Leu Val Arg Ile Leu Tyr Ala Cys Gly Phe Ser Val
660 665 670
Leu Leu Thr Ser Tyr Thr His Ser Ala Val Asp Asn Ile Leu Leu Lys
675 680 685
Leu Ala Lys Phe Lys Ile Gly Phe Leu Arg Leu Gly Gln Ile Gln Lys
690 695 700
Val His Pro Ala Ile Gln Gln Phe Thr Glu Gln Glu Ile Cys Arg Ser
705 710 715 720
Lys Ser Ile Lys Ser Leu Ala Leu Leu Glu Glu Leu Tyr Asn Ser Gln
725 730 735
Leu Ile Val Ala Thr Thr Cys Met Gly Ile Asn His Pro Ile Phe Ser
740 745 750
Arg Lys Ile Phe Asp Phe Cys Ile Val Asp Glu Ala Ser Gln Ile Ser
755 760 765
Gln Pro Ile Cys Leu Gly Pro Leu Phe Phe Ser Arg Arg Phe Val Leu
770 775 780
Val Gly Asp His Gln Gln Leu Pro Pro Leu Val Leu Asn Arg Glu Ala
785 790 795 800
Arg Ala Leu Gly Met Ser Glu Ser Leu Phe Lys Arg Leu Glu Gln Asn
805 810 815
Lys Ser Ala Val Val Gln Leu Thr Val Gln Tyr Arg Met Asn Ser Lys
820 825 830
Ile Met Ser Leu Ser Asn Lys Leu Thr Tyr Glu Gly Lys Leu Glu Cys
835 840 845
Gly Ser Asp Lys Val Ala Asn Ala Val Ile Asn Leu Arg His Phe Lys
850 855 860
Asp Val Lys Leu Glu Leu Glu Phe Tyr Ala Asp Tyr Ser Asp Asn Pro
865 870 875 880
Trp Leu Met Gly Val Phe Glu Pro Asn Asn Pro Val Cys Phe Leu Asn
885 890 895
Thr Asp Lys Val Pro Ala Pro Glu Gln Val Glu Lys Gly Gly Val Ser
900 905 910
Asn Val Thr Glu Ala Lys Leu Ile Val Phe Leu Thr Ser Ile Phe Val
915 920 925
Lys Ala Gly Cys Ser Pro Ser Asp Ile Gly Ile Ile Ala Pro Tyr Arg
930 935 940
Gln Gln Leu Lys Ile Ile Asn Asp Leu Leu Ala Arg Ser Ile Gly Met
945 950 955 960
Val Glu Val Asn Thr Val Asp Lys Tyr Gln Gly Arg Asp Lys Ser Ile
965 970 975
Val Leu Val Ser Phe Val Arg Ser Asn Lys Asp Gly Thr Val Gly Glu
980 985 990
Leu Leu Lys Asp Trp Arg Arg Leu Asn Val Ala Ile Thr Arg Ala Lys
995 1000 1005
His Lys Leu Ile Leu Leu Gly Cys Val Pro Ser Leu Asn Cys Tyr
1010 1015 1020
Pro Pro Leu Glu Lys Leu Leu Asn His Leu Asn Ser Glu Lys Leu
1025 1030 1035
Ile Ile Asp Leu Pro Ser Arg Glu His Glu Ser Leu Cys His Ile
1040 1045 1050
Leu Gly Asp Phe Gln Arg Glu
1055 1060
<210> 80
<211> 2694
<212> DNA
<213> 智人(Homo sapiens)
<400> 80
atgaacatct cgggaagcag ctgtggaagc cctaactctg cagatacatc tagtgacttt 60
aaggaccttt ggacaaaact aaaagaatgt catgatagag aagtacaagg tttacaagta 120
aaagtaacca agctaaaaca ggaacgaatc ttagatgcac aaagactaga agaattcttc 180
accaaaaatc aacagctgag ggaacagcag aaagtccttc atgaaaccat taaagtttta 240
gaagatcggt taagagcagg cttatgtgat cgctgtgcag taactgaaga acatatgcgg 300
aaaaaacagc aagagtttga aaatatccgg cagcagaatc ttaaacttat tacagaactt 360
atgaatgaaa ggaatactct acaggaagaa aataaaaagc tttctgaaca actccagcag 420
aaaattgaga atgatcaaca gcatcaagca gctgagcttg aatgtgagga agacgttatt 480
ccagattcac cgataacagc cttctcattt tctggcgtta accggctacg aagaaaggag 540
aacccccatg tccgatacat agaacaaaca catactaaat tggagcactc tgtgtgtgca 600
aatgaaatga gaaaagtttc caagtcttca actcatccac aacataatcc taatgaaaat 660
gaaattctag tagctgacac ttatgaccaa agtcaatctc caatggccaa agcacatgga 720
acaagcagct atacccctga taagtcatct tttaatttag ctacagttgt tgctgaaaca 780
cttggacttg gtgttcaaga agaatctgaa actcaaggtc ccatgagccc ccttggtgat 840
gagctctacc actgtctgga aggaaatcac aagaaacagc cttttgagga atctacaaga 900
aatactgaag atagtttaag attttcagat tctacttcaa agactcctcc tcaagaagaa 960
ttacctactc gagtgtcatc tcctgtattt ggagctacct ctagtatcaa aagtggttta 1020
gatttgaata caagtttgtc cccttctctt ttacagcctg ggaaaaaaaa acatctgaaa 1080
acactccctt ttagcaacac ttgtatatct agattagaaa aaactagatc aaaatctgaa 1140
gatagtgccc ttttcacaca tcacagtctt gggtctgaag tgaacaagat cattatccag 1200
tcatctaata aacagatact tataaataaa aatataagtg aatccctagg tgaacagaat 1260
aggactgagt acggtaaaga ttctaacact gataaacatt tggagcccct gaaatcattg 1320
ggaggccgaa catccaaaag gaagaaaact gaggaagaaa gtgaacatga agtaagctgc 1380
ccccaagctt cttttgataa agaaaatgct ttcccttttc caatggataa tcagttttcc 1440
atgaatggag actgtgtgat ggataaacct ctggatctgt ctgatcgatt ttcagctatt 1500
cagcgtcaag agaaaagcca aggaagtgag acttctaaaa acaaatttag gcaagtgact 1560
ctttatgagg ctttgaagac cattccaaag ggcttttcct caagccgtaa ggcctcagat 1620
ggcaactgca cgttgcccaa agattcccca ggggagccct gttcacagga atgcatcatc 1680
cttcagccct tgaataaatg ctctccagac aataaaccat cattacaaat aaaagaagaa 1740
aatgctgtct ttaaaattcc tctacgtcca cgtgaaagtt tggagactga gaatgtttta 1800
gatgacataa agagtgctgg ttctcatgag ccaataaaaa tacaaaccag gtcagaccat 1860
ggaggatgtg aacttgcatc agttcttcag ttaaatccat gtagaactgg taaaataaag 1920
tctctacaaa acaaccaaga tgtatccttt gaaaatatcc agtggagtat agatccggga 1980
gcagaccttt ctcagtataa aatggatgtt actgtaatag atacaaagga tggcagtcag 2040
tcaaaattag gaggagagac agtggacatg gactgtacat tggttagtga aaccgttctc 2100
ttaaaaatga agaagcaaga gcagaaggga gaaaaaagtt caaatgaaga aagaaaaatg 2160
aatgatagct tggaagatat gtttgatcgg acaacacatg aagagtatga atcctgtttg 2220
gcagacagtt tctcccaagc agcagatgaa gaggaggaat tgtctactgc cacaaagaaa 2280
ctacacactc atggtgataa acaagacaaa gtcaagcaga aagcgtttgt ggagccgtat 2340
tttaaaggtg atgaaagaga gactagcttg caaaattttc ctcatattga ggtggttcgg 2400
aaaaaagagg agagaagaaa actgcttggg cacacgtgta aggaatgtga aatttattat 2460
gcagatatgc cagcagaaga aagagaaaag aaattggctt cctgctcaag acaccgattc 2520
cgctacattc cacccaacac accagagaat ttttgggaag ttggttttcc ttccactcag 2580
acttgtatgg aaagaggtta tattaaggaa gatcttgatc cttgtcctcg tccaaaaaga 2640
cgtcagcctt acaacgcaat attttctcca aaaggcaagg agcagaagac atag 2694
<210> 81
<211> 897
<212> PRT
<213> 智人(Homo sapiens)
<400> 81
Met Asn Ile Ser Gly Ser Ser Cys Gly Ser Pro Asn Ser Ala Asp Thr
1 5 10 15
Ser Ser Asp Phe Lys Asp Leu Trp Thr Lys Leu Lys Glu Cys His Asp
20 25 30
Arg Glu Val Gln Gly Leu Gln Val Lys Val Thr Lys Leu Lys Gln Glu
35 40 45
Arg Ile Leu Asp Ala Gln Arg Leu Glu Glu Phe Phe Thr Lys Asn Gln
50 55 60
Gln Leu Arg Glu Gln Gln Lys Val Leu His Glu Thr Ile Lys Val Leu
65 70 75 80
Glu Asp Arg Leu Arg Ala Gly Leu Cys Asp Arg Cys Ala Val Thr Glu
85 90 95
Glu His Met Arg Lys Lys Gln Gln Glu Phe Glu Asn Ile Arg Gln Gln
100 105 110
Asn Leu Lys Leu Ile Thr Glu Leu Met Asn Glu Arg Asn Thr Leu Gln
115 120 125
Glu Glu Asn Lys Lys Leu Ser Glu Gln Leu Gln Gln Lys Ile Glu Asn
130 135 140
Asp Gln Gln His Gln Ala Ala Glu Leu Glu Cys Glu Glu Asp Val Ile
145 150 155 160
Pro Asp Ser Pro Ile Thr Ala Phe Ser Phe Ser Gly Val Asn Arg Leu
165 170 175
Arg Arg Lys Glu Asn Pro His Val Arg Tyr Ile Glu Gln Thr His Thr
180 185 190
Lys Leu Glu His Ser Val Cys Ala Asn Glu Met Arg Lys Val Ser Lys
195 200 205
Ser Ser Thr His Pro Gln His Asn Pro Asn Glu Asn Glu Ile Leu Val
210 215 220
Ala Asp Thr Tyr Asp Gln Ser Gln Ser Pro Met Ala Lys Ala His Gly
225 230 235 240
Thr Ser Ser Tyr Thr Pro Asp Lys Ser Ser Phe Asn Leu Ala Thr Val
245 250 255
Val Ala Glu Thr Leu Gly Leu Gly Val Gln Glu Glu Ser Glu Thr Gln
260 265 270
Gly Pro Met Ser Pro Leu Gly Asp Glu Leu Tyr His Cys Leu Glu Gly
275 280 285
Asn His Lys Lys Gln Pro Phe Glu Glu Ser Thr Arg Asn Thr Glu Asp
290 295 300
Ser Leu Arg Phe Ser Asp Ser Thr Ser Lys Thr Pro Pro Gln Glu Glu
305 310 315 320
Leu Pro Thr Arg Val Ser Ser Pro Val Phe Gly Ala Thr Ser Ser Ile
325 330 335
Lys Ser Gly Leu Asp Leu Asn Thr Ser Leu Ser Pro Ser Leu Leu Gln
340 345 350
Pro Gly Lys Lys Lys His Leu Lys Thr Leu Pro Phe Ser Asn Thr Cys
355 360 365
Ile Ser Arg Leu Glu Lys Thr Arg Ser Lys Ser Glu Asp Ser Ala Leu
370 375 380
Phe Thr His His Ser Leu Gly Ser Glu Val Asn Lys Ile Ile Ile Gln
385 390 395 400
Ser Ser Asn Lys Gln Ile Leu Ile Asn Lys Asn Ile Ser Glu Ser Leu
405 410 415
Gly Glu Gln Asn Arg Thr Glu Tyr Gly Lys Asp Ser Asn Thr Asp Lys
420 425 430
His Leu Glu Pro Leu Lys Ser Leu Gly Gly Arg Thr Ser Lys Arg Lys
435 440 445
Lys Thr Glu Glu Glu Ser Glu His Glu Val Ser Cys Pro Gln Ala Ser
450 455 460
Phe Asp Lys Glu Asn Ala Phe Pro Phe Pro Met Asp Asn Gln Phe Ser
465 470 475 480
Met Asn Gly Asp Cys Val Met Asp Lys Pro Leu Asp Leu Ser Asp Arg
485 490 495
Phe Ser Ala Ile Gln Arg Gln Glu Lys Ser Gln Gly Ser Glu Thr Ser
500 505 510
Lys Asn Lys Phe Arg Gln Val Thr Leu Tyr Glu Ala Leu Lys Thr Ile
515 520 525
Pro Lys Gly Phe Ser Ser Ser Arg Lys Ala Ser Asp Gly Asn Cys Thr
530 535 540
Leu Pro Lys Asp Ser Pro Gly Glu Pro Cys Ser Gln Glu Cys Ile Ile
545 550 555 560
Leu Gln Pro Leu Asn Lys Cys Ser Pro Asp Asn Lys Pro Ser Leu Gln
565 570 575
Ile Lys Glu Glu Asn Ala Val Phe Lys Ile Pro Leu Arg Pro Arg Glu
580 585 590
Ser Leu Glu Thr Glu Asn Val Leu Asp Asp Ile Lys Ser Ala Gly Ser
595 600 605
His Glu Pro Ile Lys Ile Gln Thr Arg Ser Asp His Gly Gly Cys Glu
610 615 620
Leu Ala Ser Val Leu Gln Leu Asn Pro Cys Arg Thr Gly Lys Ile Lys
625 630 635 640
Ser Leu Gln Asn Asn Gln Asp Val Ser Phe Glu Asn Ile Gln Trp Ser
645 650 655
Ile Asp Pro Gly Ala Asp Leu Ser Gln Tyr Lys Met Asp Val Thr Val
660 665 670
Ile Asp Thr Lys Asp Gly Ser Gln Ser Lys Leu Gly Gly Glu Thr Val
675 680 685
Asp Met Asp Cys Thr Leu Val Ser Glu Thr Val Leu Leu Lys Met Lys
690 695 700
Lys Gln Glu Gln Lys Gly Glu Lys Ser Ser Asn Glu Glu Arg Lys Met
705 710 715 720
Asn Asp Ser Leu Glu Asp Met Phe Asp Arg Thr Thr His Glu Glu Tyr
725 730 735
Glu Ser Cys Leu Ala Asp Ser Phe Ser Gln Ala Ala Asp Glu Glu Glu
740 745 750
Glu Leu Ser Thr Ala Thr Lys Lys Leu His Thr His Gly Asp Lys Gln
755 760 765
Asp Lys Val Lys Gln Lys Ala Phe Val Glu Pro Tyr Phe Lys Gly Asp
770 775 780
Glu Arg Glu Thr Ser Leu Gln Asn Phe Pro His Ile Glu Val Val Arg
785 790 795 800
Lys Lys Glu Glu Arg Arg Lys Leu Leu Gly His Thr Cys Lys Glu Cys
805 810 815
Glu Ile Tyr Tyr Ala Asp Met Pro Ala Glu Glu Arg Glu Lys Lys Leu
820 825 830
Ala Ser Cys Ser Arg His Arg Phe Arg Tyr Ile Pro Pro Asn Thr Pro
835 840 845
Glu Asn Phe Trp Glu Val Gly Phe Pro Ser Thr Gln Thr Cys Met Glu
850 855 860
Arg Gly Tyr Ile Lys Glu Asp Leu Asp Pro Cys Pro Arg Pro Lys Arg
865 870 875 880
Arg Gln Pro Tyr Asn Ala Ile Phe Ser Pro Lys Gly Lys Glu Gln Lys
885 890 895
Thr
<210> 82
<211> 2604
<212> DNA
<213> 智人(Homo sapiens)
<400> 82
atgaacatct cgggaagcag ctgtggaagc cctaactctg cagatacatc tagtgacttt 60
aaggaccttt ggacaaaact aaaagaatgt catgatagag aagtacaagg tttacaagta 120
aaagtaacca agctaaaaca ggaacgaatc ttagatgcac aaagactaga agaattcttc 180
accaaaaatc aacagctgag ggaacagcag aaagtccttc atgaaaccat taaagtttta 240
gaagatcggt taagagcagg cttatgtgat cgctgtgcag taactgaaga acatatgcgg 300
aaaaaacagc aagagtttga aaatatccgg cagcagaatc ttaaacttat tacagaactt 360
atgaatgaaa ggaatactct acaggaagaa aataaaaagc tttctgaaca actccagcag 420
aaaattgaga atgatcaaca gcatcaagca gctgagcttg aatgtgagga agacgttatt 480
ccagattcac cgataacagc cttctcattt tctggcgtta accggctacg aagaaaggag 540
aacccccatg tccgatacat agaacaaaca catactaaat tggagcactc tgtgtgtgca 600
aatgaaatga gaaaagtttc caagtcttca actcatccac aacataatcc taatgaaaat 660
gaaattctag tagctgacac ttatgaccaa agtcaatctc caatggccaa agcacatgga 720
acaagcagct atacccctga taagtcatct tttaatttag ctacagttgt tgctgaaaca 780
cttggacttg gtgttcaaga agaatctgaa actcaaggtc ccatgagccc ccttggtgat 840
gagctctacc actgtctgga aggaaatcac aagaaacagc cttttgagga atctacaaga 900
aatactgaag atagtttaag attttcagat tctacttcaa agactcctcc tcaagaagaa 960
ttacctactc gagtgtcatc tcctgtattt ggagctacct ctagtatcaa aagtggttta 1020
gatttgaata caagtttgtc cccttctctt ttacagcctg ggaaaaaaaa acatctgaaa 1080
acactccctt ttagcaacac ttgtatatct agattagaaa aaactagatc aaaatctgaa 1140
gatagtgccc ttttcacaca tcacagtctt gggtctgaag tgaacaagat cattatccag 1200
tcatctaata aacagatact tataaataaa aatataagtg aatccctagg tgaacagaat 1260
aggactgagt acggtaaaga ttctaacact gataaacatt tggagcccct gaaatcattg 1320
ggaggccgaa catccaaaag gaagaaaact gaggaagaaa gtgaacatga agtaagctgc 1380
ccccaagctt cttttgataa agaaaatgct ttcccttttc caatggataa tcagttttcc 1440
atgaatggag actgtgtgat ggataaacct ctggatctgt ctgatcgatt ttcagctatt 1500
cagcgtcaag agaaaagcca aggaagtgag acttctaaaa acaaatttag gcaagtgact 1560
ctttatgagg ctttgaagac cattccaaag ggcttttcct caagccgtaa ggcctcagat 1620
ggcaactgca cgttgcccaa agattcccca ggggagccct gttcacagga atgcatcatc 1680
cttcagccct tgaataaatg ctctccagac aataaaccat cattacaaat aaaagaagaa 1740
aatgctgtct ttaaaattcc tctacgtcca cgtgaaagtt tggagactga gaatgtttta 1800
gatgacataa agagtgctgg ttctcatgag ccaataaaaa tacaaaccag gtcagaccat 1860
ggaggatgtg aacttgcatc agttcttcag ttaaatccat gtagaactgg taaaataaag 1920
tctctacaaa acaaccaaga tgtatccttt gaaaatatcc agtggagtat agatccggga 1980
gcagaccttt ctcagtataa aatggatgtt actgtaatag atacaaagga tggcagtcag 2040
tcaaaattag gaggagagac agtggacatg gactgtacat tggttagtga aaccgttctc 2100
ttaaaaatga agaagcaaga gcagaaggga gaaaaaagtt caaatgaaga aagaaaaatg 2160
aatgatagct tggaagatat gtttgatcgg acaacacatg aagagtatga atcctgtttg 2220
gcagacagtt tctcccaagc agcagatgaa gaggaggaat tgtctactgc cacaaagaaa 2280
ctacacactc atggtgataa acaagacaaa gtcaagcaga aagcgtttgt ggagccgtat 2340
tttaaaggtg atgaaagtat tatgcagata tgccagcaga agaaagagaa aagaaattgg 2400
cttcctgctc aagacaccga ttccgctaca ttccacccaa cacaccagag aatttttggg 2460
aagttggttt tccttccact cagacttgta tggaaagagg ttatattaag gaagatcttg 2520
atccttgtcc tcgtccaaaa agacgtcagc cttacaacgc aatattttct ccaaaaggca 2580
aggagcagaa gacatagacg ttga 2604
<210> 83
<211> 867
<212> PRT
<213> 智人(Homo sapiens)
<400> 83
Met Asn Ile Ser Gly Ser Ser Cys Gly Ser Pro Asn Ser Ala Asp Thr
1 5 10 15
Ser Ser Asp Phe Lys Asp Leu Trp Thr Lys Leu Lys Glu Cys His Asp
20 25 30
Arg Glu Val Gln Gly Leu Gln Val Lys Val Thr Lys Leu Lys Gln Glu
35 40 45
Arg Ile Leu Asp Ala Gln Arg Leu Glu Glu Phe Phe Thr Lys Asn Gln
50 55 60
Gln Leu Arg Glu Gln Gln Lys Val Leu His Glu Thr Ile Lys Val Leu
65 70 75 80
Glu Asp Arg Leu Arg Ala Gly Leu Cys Asp Arg Cys Ala Val Thr Glu
85 90 95
Glu His Met Arg Lys Lys Gln Gln Glu Phe Glu Asn Ile Arg Gln Gln
100 105 110
Asn Leu Lys Leu Ile Thr Glu Leu Met Asn Glu Arg Asn Thr Leu Gln
115 120 125
Glu Glu Asn Lys Lys Leu Ser Glu Gln Leu Gln Gln Lys Ile Glu Asn
130 135 140
Asp Gln Gln His Gln Ala Ala Glu Leu Glu Cys Glu Glu Asp Val Ile
145 150 155 160
Pro Asp Ser Pro Ile Thr Ala Phe Ser Phe Ser Gly Val Asn Arg Leu
165 170 175
Arg Arg Lys Glu Asn Pro His Val Arg Tyr Ile Glu Gln Thr His Thr
180 185 190
Lys Leu Glu His Ser Val Cys Ala Asn Glu Met Arg Lys Val Ser Lys
195 200 205
Ser Ser Thr His Pro Gln His Asn Pro Asn Glu Asn Glu Ile Leu Val
210 215 220
Ala Asp Thr Tyr Asp Gln Ser Gln Ser Pro Met Ala Lys Ala His Gly
225 230 235 240
Thr Ser Ser Tyr Thr Pro Asp Lys Ser Ser Phe Asn Leu Ala Thr Val
245 250 255
Val Ala Glu Thr Leu Gly Leu Gly Val Gln Glu Glu Ser Glu Thr Gln
260 265 270
Gly Pro Met Ser Pro Leu Gly Asp Glu Leu Tyr His Cys Leu Glu Gly
275 280 285
Asn His Lys Lys Gln Pro Phe Glu Glu Ser Thr Arg Asn Thr Glu Asp
290 295 300
Ser Leu Arg Phe Ser Asp Ser Thr Ser Lys Thr Pro Pro Gln Glu Glu
305 310 315 320
Leu Pro Thr Arg Val Ser Ser Pro Val Phe Gly Ala Thr Ser Ser Ile
325 330 335
Lys Ser Gly Leu Asp Leu Asn Thr Ser Leu Ser Pro Ser Leu Leu Gln
340 345 350
Pro Gly Lys Lys Lys His Leu Lys Thr Leu Pro Phe Ser Asn Thr Cys
355 360 365
Ile Ser Arg Leu Glu Lys Thr Arg Ser Lys Ser Glu Asp Ser Ala Leu
370 375 380
Phe Thr His His Ser Leu Gly Ser Glu Val Asn Lys Ile Ile Ile Gln
385 390 395 400
Ser Ser Asn Lys Gln Ile Leu Ile Asn Lys Asn Ile Ser Glu Ser Leu
405 410 415
Gly Glu Gln Asn Arg Thr Glu Tyr Gly Lys Asp Ser Asn Thr Asp Lys
420 425 430
His Leu Glu Pro Leu Lys Ser Leu Gly Gly Arg Thr Ser Lys Arg Lys
435 440 445
Lys Thr Glu Glu Glu Ser Glu His Glu Val Ser Cys Pro Gln Ala Ser
450 455 460
Phe Asp Lys Glu Asn Ala Phe Pro Phe Pro Met Asp Asn Gln Phe Ser
465 470 475 480
Met Asn Gly Asp Cys Val Met Asp Lys Pro Leu Asp Leu Ser Asp Arg
485 490 495
Phe Ser Ala Ile Gln Arg Gln Glu Lys Ser Gln Gly Ser Glu Thr Ser
500 505 510
Lys Asn Lys Phe Arg Gln Val Thr Leu Tyr Glu Ala Leu Lys Thr Ile
515 520 525
Pro Lys Gly Phe Ser Ser Ser Arg Lys Ala Ser Asp Gly Asn Cys Thr
530 535 540
Leu Pro Lys Asp Ser Pro Gly Glu Pro Cys Ser Gln Glu Cys Ile Ile
545 550 555 560
Leu Gln Pro Leu Asn Lys Cys Ser Pro Asp Asn Lys Pro Ser Leu Gln
565 570 575
Ile Lys Glu Glu Asn Ala Val Phe Lys Ile Pro Leu Arg Pro Arg Glu
580 585 590
Ser Leu Glu Thr Glu Asn Val Leu Asp Asp Ile Lys Ser Ala Gly Ser
595 600 605
His Glu Pro Ile Lys Ile Gln Thr Arg Ser Asp His Gly Gly Cys Glu
610 615 620
Leu Ala Ser Val Leu Gln Leu Asn Pro Cys Arg Thr Gly Lys Ile Lys
625 630 635 640
Ser Leu Gln Asn Asn Gln Asp Val Ser Phe Glu Asn Ile Gln Trp Ser
645 650 655
Ile Asp Pro Gly Ala Asp Leu Ser Gln Tyr Lys Met Asp Val Thr Val
660 665 670
Ile Asp Thr Lys Asp Gly Ser Gln Ser Lys Leu Gly Gly Glu Thr Val
675 680 685
Asp Met Asp Cys Thr Leu Val Ser Glu Thr Val Leu Leu Lys Met Lys
690 695 700
Lys Gln Glu Gln Lys Gly Glu Lys Ser Ser Asn Glu Glu Arg Lys Met
705 710 715 720
Asn Asp Ser Leu Glu Asp Met Phe Asp Arg Thr Thr His Glu Glu Tyr
725 730 735
Glu Ser Cys Leu Ala Asp Ser Phe Ser Gln Ala Ala Asp Glu Glu Glu
740 745 750
Glu Leu Ser Thr Ala Thr Lys Lys Leu His Thr His Gly Asp Lys Gln
755 760 765
Asp Lys Val Lys Gln Lys Ala Phe Val Glu Pro Tyr Phe Lys Gly Asp
770 775 780
Glu Ser Ile Met Gln Ile Cys Gln Gln Lys Lys Glu Lys Arg Asn Trp
785 790 795 800
Leu Pro Ala Gln Asp Thr Asp Ser Ala Thr Phe His Pro Thr His Gln
805 810 815
Arg Ile Phe Gly Lys Leu Val Phe Leu Pro Leu Arg Leu Val Trp Lys
820 825 830
Glu Val Ile Leu Arg Lys Ile Leu Ile Leu Val Leu Val Gln Lys Asp
835 840 845
Val Ser Leu Thr Thr Gln Tyr Phe Leu Gln Lys Ala Arg Ser Arg Arg
850 855 860
His Arg Arg
865
<210> 84
<211> 2127
<212> DNA
<213> 智人(Homo sapiens)
<400> 84
atgagtactg cagatgcact tgatgatgaa aacacattta aaatattagt tgcaacagat 60
attcatcttg gatttatgga gaaagatgca gtcagaggaa atgatacgtt tgtaacactc 120
gatgaaattt taagacttgc ccaggaaaat gaagtggatt ttattttgtt aggtggtgat 180
ctttttcatg aaaataagcc ctcaaggaaa acattacata cctgcctcga gttattaaga 240
aaatattgta tgggtgatcg gcctgtccag tttgaaattc tcagtgatca gtcagtcaac 300
tttggtttta gtaagtttcc atgggtgaac tatcaagatg gcaacctcaa catttcaatt 360
ccagtgttta gtattcatgg caatcatgac gatcccacag gggcagatgc actttgtgcc 420
ttggacattt taagttgtgc tggatttgta aatcactttg gacgttcaat gtctgtggag 480
aagatagaca ttagtccggt tttgcttcaa aaaggaagca caaagattgc gctatatggt 540
ttaggatcca ttccagatga aaggctctat cgaatgtttg tcaataaaaa agtaacaatg 600
ttgagaccaa aggaagatga gaactcttgg tttaacttat ttgtgattca tcagaacagg 660
agtaaacatg gaagtactaa cttcattcca gaacaatttt tggatgactt cattgatctt 720
gttatctggg gccatgaaca tgagtgtaaa atagctccaa ccaaaaatga acaacagctg 780
ttttatatct cacaacctgg aagctcagtg gttacttctc tttccccagg agaagctgta 840
aagaaacatg ttggtttgct gcgtattaaa gggaggaaga tgaatatgca taaaattcct 900
cttcacacag tgcggcagtt tttcatggag gatattgttc tagctaatca tccagacatt 960
tttaacccag ataatcctaa agtaacccaa gccatacaaa gcttctgttt ggagaagatt 1020
gaagaaatgc ttgaaaatgc tgaacgggaa cgtctgggta attctcacca gccagagaag 1080
cctcttgtac gactgcgagt ggactatagt ggaggttttg aacctttcag tgttcttcgc 1140
tttagccaga aatttgtgga tcgggtagct aatccaaaag acattatcca ttttttcagg 1200
catagagaac aaaaggaaaa aacaggagaa gagatcaact ttgggaaact tatcacaaag 1260
ccttcagaag gaacaacttt aagggtagaa gatcttgtaa aacagtactt tcaaaccgca 1320
gagaagaatg tgcagctctc actgctaaca gaaagaggga tgggtgaagc agtacaagaa 1380
tttgtggaca aggaggagaa agatgccatt gaggaattag tgaaatacca gttggaaaaa 1440
acacagcgat ttcttaaaga acgtcatatt gatgccctcg aagacaaaat cgatgaggag 1500
gtacgtcgtt tcagagaaac cagacaaaaa aatactaatg aagaagatga tgaagtccgt 1560
gaggctatga ccagggccag agcactcaga tctcagtcag aggagtctgc ttctgccttt 1620
agtgctgatg accttatgag tatagattta gcagaacaga tggctaatga ctctgatgat 1680
agcatctcag cagcaaccaa caaaggaaga ggccgaggaa gaggtcgaag aggtggaaga 1740
gggcagaatt cagcatcgag aggagggtct caaagaggaa gagcagacac tggtctggag 1800
acttctaccc gtagcaggaa ctcaaagact gctgtgtcag catctagaaa tatgtctatt 1860
atagatgcct ttaaatctac aagacagcag ccttcccgaa atgtcactac taagaattat 1920
tcagaggtga ttgaggtaga tgaatcagat gtggaagaag acatttttcc taccacttca 1980
aagacagatc aaaggtggtc cagcacatca tccagcaaaa tcatgtccca gagtcaagta 2040
tcgaaagggg ttgattttga atcaagtgag gatgatgatg atgatccttt tatgaacact 2100
agttctttaa gaagaaatag aagataa 2127
<210> 85
<211> 708
<212> PRT
<213> 智人(Homo sapiens)
<400> 85
Met Ser Thr Ala Asp Ala Leu Asp Asp Glu Asn Thr Phe Lys Ile Leu
1 5 10 15
Val Ala Thr Asp Ile His Leu Gly Phe Met Glu Lys Asp Ala Val Arg
20 25 30
Gly Asn Asp Thr Phe Val Thr Leu Asp Glu Ile Leu Arg Leu Ala Gln
35 40 45
Glu Asn Glu Val Asp Phe Ile Leu Leu Gly Gly Asp Leu Phe His Glu
50 55 60
Asn Lys Pro Ser Arg Lys Thr Leu His Thr Cys Leu Glu Leu Leu Arg
65 70 75 80
Lys Tyr Cys Met Gly Asp Arg Pro Val Gln Phe Glu Ile Leu Ser Asp
85 90 95
Gln Ser Val Asn Phe Gly Phe Ser Lys Phe Pro Trp Val Asn Tyr Gln
100 105 110
Asp Gly Asn Leu Asn Ile Ser Ile Pro Val Phe Ser Ile His Gly Asn
115 120 125
His Asp Asp Pro Thr Gly Ala Asp Ala Leu Cys Ala Leu Asp Ile Leu
130 135 140
Ser Cys Ala Gly Phe Val Asn His Phe Gly Arg Ser Met Ser Val Glu
145 150 155 160
Lys Ile Asp Ile Ser Pro Val Leu Leu Gln Lys Gly Ser Thr Lys Ile
165 170 175
Ala Leu Tyr Gly Leu Gly Ser Ile Pro Asp Glu Arg Leu Tyr Arg Met
180 185 190
Phe Val Asn Lys Lys Val Thr Met Leu Arg Pro Lys Glu Asp Glu Asn
195 200 205
Ser Trp Phe Asn Leu Phe Val Ile His Gln Asn Arg Ser Lys His Gly
210 215 220
Ser Thr Asn Phe Ile Pro Glu Gln Phe Leu Asp Asp Phe Ile Asp Leu
225 230 235 240
Val Ile Trp Gly His Glu His Glu Cys Lys Ile Ala Pro Thr Lys Asn
245 250 255
Glu Gln Gln Leu Phe Tyr Ile Ser Gln Pro Gly Ser Ser Val Val Thr
260 265 270
Ser Leu Ser Pro Gly Glu Ala Val Lys Lys His Val Gly Leu Leu Arg
275 280 285
Ile Lys Gly Arg Lys Met Asn Met His Lys Ile Pro Leu His Thr Val
290 295 300
Arg Gln Phe Phe Met Glu Asp Ile Val Leu Ala Asn His Pro Asp Ile
305 310 315 320
Phe Asn Pro Asp Asn Pro Lys Val Thr Gln Ala Ile Gln Ser Phe Cys
325 330 335
Leu Glu Lys Ile Glu Glu Met Leu Glu Asn Ala Glu Arg Glu Arg Leu
340 345 350
Gly Asn Ser His Gln Pro Glu Lys Pro Leu Val Arg Leu Arg Val Asp
355 360 365
Tyr Ser Gly Gly Phe Glu Pro Phe Ser Val Leu Arg Phe Ser Gln Lys
370 375 380
Phe Val Asp Arg Val Ala Asn Pro Lys Asp Ile Ile His Phe Phe Arg
385 390 395 400
His Arg Glu Gln Lys Glu Lys Thr Gly Glu Glu Ile Asn Phe Gly Lys
405 410 415
Leu Ile Thr Lys Pro Ser Glu Gly Thr Thr Leu Arg Val Glu Asp Leu
420 425 430
Val Lys Gln Tyr Phe Gln Thr Ala Glu Lys Asn Val Gln Leu Ser Leu
435 440 445
Leu Thr Glu Arg Gly Met Gly Glu Ala Val Gln Glu Phe Val Asp Lys
450 455 460
Glu Glu Lys Asp Ala Ile Glu Glu Leu Val Lys Tyr Gln Leu Glu Lys
465 470 475 480
Thr Gln Arg Phe Leu Lys Glu Arg His Ile Asp Ala Leu Glu Asp Lys
485 490 495
Ile Asp Glu Glu Val Arg Arg Phe Arg Glu Thr Arg Gln Lys Asn Thr
500 505 510
Asn Glu Glu Asp Asp Glu Val Arg Glu Ala Met Thr Arg Ala Arg Ala
515 520 525
Leu Arg Ser Gln Ser Glu Glu Ser Ala Ser Ala Phe Ser Ala Asp Asp
530 535 540
Leu Met Ser Ile Asp Leu Ala Glu Gln Met Ala Asn Asp Ser Asp Asp
545 550 555 560
Ser Ile Ser Ala Ala Thr Asn Lys Gly Arg Gly Arg Gly Arg Gly Arg
565 570 575
Arg Gly Gly Arg Gly Gln Asn Ser Ala Ser Arg Gly Gly Ser Gln Arg
580 585 590
Gly Arg Ala Asp Thr Gly Leu Glu Thr Ser Thr Arg Ser Arg Asn Ser
595 600 605
Lys Thr Ala Val Ser Ala Ser Arg Asn Met Ser Ile Ile Asp Ala Phe
610 615 620
Lys Ser Thr Arg Gln Gln Pro Ser Arg Asn Val Thr Thr Lys Asn Tyr
625 630 635 640
Ser Glu Val Ile Glu Val Asp Glu Ser Asp Val Glu Glu Asp Ile Phe
645 650 655
Pro Thr Thr Ser Lys Thr Asp Gln Arg Trp Ser Ser Thr Ser Ser Ser
660 665 670
Lys Ile Met Ser Gln Ser Gln Val Ser Lys Gly Val Asp Phe Glu Ser
675 680 685
Ser Glu Asp Asp Asp Asp Asp Pro Phe Met Asn Thr Ser Ser Leu Arg
690 695 700
Arg Asn Arg Arg
705
<210> 86
<211> 2043
<212> DNA
<213> 智人(Homo sapiens)
<400> 86
atgagtactg cagatgcact tgatgatgaa aacacattta aaatattagt tgcaacagat 60
attcatcttg gatttatgga gaaagatgca gtcagaggaa atgatacgtt tgtaacactc 120
gatgaaattt taagacttgc ccaggaaaat gaagtggatt ttattttgtt aggtggtgat 180
ctttttcatg aaaataagcc ctcaaggaaa acattacata cctgcctcga gttattaaga 240
aaatattgta tgggtgatcg gcctgtccag tttgaaattc tcagtgatca gtcagtcaac 300
tttggtttta gtaagtttcc atgggtgaac tatcaagatg gcaacctcaa catttcaatt 360
ccagtgttta gtattcatgg caatcatgac gatcccacag gggcagatgc actttgtgcc 420
ttggacattt taagttgtgc tggatttgta aatcactttg gacgttcaat gtctgtggag 480
aagatagaca ttagtccggt tttgcttcaa aaaggaagca caaagattgc gctatatggt 540
ttaggatcca ttccagatga aaggctctat cgaatgtttg tcaataaaaa agtaacaatg 600
ttgagaccaa aggaagatga gaactcttgg tttaacttat ttgtgattca tcagaacagg 660
agtaaacatg gaagtactaa cttcattcca gaacaatttt tggatgactt cattgatctt 720
gttatctggg gccatgaaca tgagtgtaaa atagctccaa ccaaaaatga acaacagctg 780
ttttatatct cacaacctgg aagctcagtg gttacttctc tttccccagg agaagctgta 840
aagaaacatg ttggtttgct gcgtattaaa gggaggaaga tgaatatgca taaaattcct 900
cttcacacag tgcggcagtt tttcatggag gatattgttc tagctaatca tccagacatt 960
tttaacccag ataatcctaa agtaacccaa gccatacaaa gcttctgttt ggagaagatt 1020
gaagaaatgc ttgaaaatgc tgaacgggaa cgtctgggta attctcacca gccagagaag 1080
cctcttgtac gactgcgagt ggactatagt ggaggttttg aacctttcag tgttcttcgc 1140
tttagccaga aatttgtgga tcgggtagct aatccaaaag acattatcca ttttttcagg 1200
catagagaac aaaaggaaaa aacaggagaa gagatcaact ttgggaaact tatcacaaag 1260
ccttcagaag gaacaacttt aagggtagaa gatcttgtaa aacagtactt tcaaaccgca 1320
gagaagaatg tgcagctctc actgctaaca gaaagaggga tgggtgaagc agtacaagaa 1380
tttgtggaca aggaggagaa agatgccatt gaggaattag tgaaatacca gttggaaaaa 1440
acacagcgat ttcttaaaga acgtcatatt gatgccctcg aagacaaaat cgatgaggag 1500
gtacgtcgtt tcagagaaac cagacaaaaa aatactaatg aagaagatga tgaagtccgt 1560
gaggctatga ccagggccag agcactcaga tctcagtcag aggagtctgc ttctgccttt 1620
agtgctgatg accttatgag tatagattta gcagaacaga tggctaatga ctctgatgat 1680
agcatctcag cagcaaccaa caaaggaaga ggccgaggaa gaggtcgaag aggtggaaga 1740
gggcagaatt cagcatcgag aggagggtct caaagaggaa gagcctttaa atctacaaga 1800
cagcagcctt cccgaaatgt cactactaag aattattcag aggtgattga ggtagatgaa 1860
tcagatgtgg aagaagacat ttttcctacc acttcaaaga cagatcaaag gtggtccagc 1920
acatcatcca gcaaaatcat gtcccagagt caagtatcga aaggggttga ttttgaatca 1980
agtgaggatg atgatgatga tccttttatg aacactagtt ctttaagaag aaatagaaga 2040
taa 2043
<210> 87
<211> 680
<212> PRT
<213> 智人(Homo sapiens)
<400> 87
Met Ser Thr Ala Asp Ala Leu Asp Asp Glu Asn Thr Phe Lys Ile Leu
1 5 10 15
Val Ala Thr Asp Ile His Leu Gly Phe Met Glu Lys Asp Ala Val Arg
20 25 30
Gly Asn Asp Thr Phe Val Thr Leu Asp Glu Ile Leu Arg Leu Ala Gln
35 40 45
Glu Asn Glu Val Asp Phe Ile Leu Leu Gly Gly Asp Leu Phe His Glu
50 55 60
Asn Lys Pro Ser Arg Lys Thr Leu His Thr Cys Leu Glu Leu Leu Arg
65 70 75 80
Lys Tyr Cys Met Gly Asp Arg Pro Val Gln Phe Glu Ile Leu Ser Asp
85 90 95
Gln Ser Val Asn Phe Gly Phe Ser Lys Phe Pro Trp Val Asn Tyr Gln
100 105 110
Asp Gly Asn Leu Asn Ile Ser Ile Pro Val Phe Ser Ile His Gly Asn
115 120 125
His Asp Asp Pro Thr Gly Ala Asp Ala Leu Cys Ala Leu Asp Ile Leu
130 135 140
Ser Cys Ala Gly Phe Val Asn His Phe Gly Arg Ser Met Ser Val Glu
145 150 155 160
Lys Ile Asp Ile Ser Pro Val Leu Leu Gln Lys Gly Ser Thr Lys Ile
165 170 175
Ala Leu Tyr Gly Leu Gly Ser Ile Pro Asp Glu Arg Leu Tyr Arg Met
180 185 190
Phe Val Asn Lys Lys Val Thr Met Leu Arg Pro Lys Glu Asp Glu Asn
195 200 205
Ser Trp Phe Asn Leu Phe Val Ile His Gln Asn Arg Ser Lys His Gly
210 215 220
Ser Thr Asn Phe Ile Pro Glu Gln Phe Leu Asp Asp Phe Ile Asp Leu
225 230 235 240
Val Ile Trp Gly His Glu His Glu Cys Lys Ile Ala Pro Thr Lys Asn
245 250 255
Glu Gln Gln Leu Phe Tyr Ile Ser Gln Pro Gly Ser Ser Val Val Thr
260 265 270
Ser Leu Ser Pro Gly Glu Ala Val Lys Lys His Val Gly Leu Leu Arg
275 280 285
Ile Lys Gly Arg Lys Met Asn Met His Lys Ile Pro Leu His Thr Val
290 295 300
Arg Gln Phe Phe Met Glu Asp Ile Val Leu Ala Asn His Pro Asp Ile
305 310 315 320
Phe Asn Pro Asp Asn Pro Lys Val Thr Gln Ala Ile Gln Ser Phe Cys
325 330 335
Leu Glu Lys Ile Glu Glu Met Leu Glu Asn Ala Glu Arg Glu Arg Leu
340 345 350
Gly Asn Ser His Gln Pro Glu Lys Pro Leu Val Arg Leu Arg Val Asp
355 360 365
Tyr Ser Gly Gly Phe Glu Pro Phe Ser Val Leu Arg Phe Ser Gln Lys
370 375 380
Phe Val Asp Arg Val Ala Asn Pro Lys Asp Ile Ile His Phe Phe Arg
385 390 395 400
His Arg Glu Gln Lys Glu Lys Thr Gly Glu Glu Ile Asn Phe Gly Lys
405 410 415
Leu Ile Thr Lys Pro Ser Glu Gly Thr Thr Leu Arg Val Glu Asp Leu
420 425 430
Val Lys Gln Tyr Phe Gln Thr Ala Glu Lys Asn Val Gln Leu Ser Leu
435 440 445
Leu Thr Glu Arg Gly Met Gly Glu Ala Val Gln Glu Phe Val Asp Lys
450 455 460
Glu Glu Lys Asp Ala Ile Glu Glu Leu Val Lys Tyr Gln Leu Glu Lys
465 470 475 480
Thr Gln Arg Phe Leu Lys Glu Arg His Ile Asp Ala Leu Glu Asp Lys
485 490 495
Ile Asp Glu Glu Val Arg Arg Phe Arg Glu Thr Arg Gln Lys Asn Thr
500 505 510
Asn Glu Glu Asp Asp Glu Val Arg Glu Ala Met Thr Arg Ala Arg Ala
515 520 525
Leu Arg Ser Gln Ser Glu Glu Ser Ala Ser Ala Phe Ser Ala Asp Asp
530 535 540
Leu Met Ser Ile Asp Leu Ala Glu Gln Met Ala Asn Asp Ser Asp Asp
545 550 555 560
Ser Ile Ser Ala Ala Thr Asn Lys Gly Arg Gly Arg Gly Arg Gly Arg
565 570 575
Arg Gly Gly Arg Gly Gln Asn Ser Ala Ser Arg Gly Gly Ser Gln Arg
580 585 590
Gly Arg Ala Phe Lys Ser Thr Arg Gln Gln Pro Ser Arg Asn Val Thr
595 600 605
Thr Lys Asn Tyr Ser Glu Val Ile Glu Val Asp Glu Ser Asp Val Glu
610 615 620
Glu Asp Ile Phe Pro Thr Thr Ser Lys Thr Asp Gln Arg Trp Ser Ser
625 630 635 640
Thr Ser Ser Ser Lys Ile Met Ser Gln Ser Gln Val Ser Lys Gly Val
645 650 655
Asp Phe Glu Ser Ser Glu Asp Asp Asp Asp Asp Pro Phe Met Asn Thr
660 665 670
Ser Ser Leu Arg Arg Asn Arg Arg
675 680
<210> 88
<211> 2124
<212> DNA
<213> 智人(Homo sapiens)
<400> 88
atgagtactg cagatgcact tgatgatgaa aacacattta aaatattagt tgcaacagat 60
attcatcttg gatttatgga gaaagatgca gtcagaggaa atgatacgtt tgtaacactc 120
gatgaaattt taagacttgc ccaggaaaat gaagtggatt ttattttgtt aggtggtgat 180
ctttttcatg aaaataagcc ctcaaggaaa acattacata cctgcctcga gttattaaga 240
aaatattgta tgggtgatcg gcctgtccag tttgaaattc tcagtgatca gtcagtcaac 300
tttggtttta gtaagtttcc atgggtgaac tatcaagatg gcaacctcaa catttcaatt 360
ccagtgttta gtattcatgg caatcatgac gatcccacag gggcagatgc actttgtgcc 420
ttggacattt taagttgtgc tggatttgta aatcactttg gacgttcaat gtctgtggag 480
aagatagaca ttagtccggt tttgcttcaa aaaggaagca caaagattgc gctatatggt 540
ttaggatcca ttccagatga aaggctctat cgaatgtttg tcaataaaaa agtaacaatg 600
ttgagaccaa aggaagatga gaactcttgg tttaacttat ttgtgattca tcagaacagg 660
agtaaacatg gaagtactaa cttcattcca gaacaatttt tggatgactt cattgatctt 720
gttatctggg gccatgaaca tgagtgtaaa atagctccaa ccaaaaatga acaacagctg 780
ttttatatct cacaacctgg aagctcagtg gttacttctc tttccccagg agaagctgta 840
aagaaacatg ttggtttgct gcgtattaaa gggaggaaga tgaatatgca taaaattcct 900
cttcacacag tgcggcagtt tttcatggag gatattgttc tagctaatca tccagacatt 960
tttaacccag ataatcctaa agtaacccaa gccatacaaa gcttctgttt ggagaagatt 1020
gaagaaatgc ttgaaaatgc tgaacgggaa cgtctgggta attctcacca gccagagaag 1080
cctcttgtac gactgcgagt ggactatagt ggaggttttg aacctttcag tgttcttcgc 1140
tttagccaga aatttgtgga tcgggtagct aatccaaaag acattatcca ttttttcagg 1200
catagagaac aaaaggaaaa aacaggagaa gagatcaact ttgggaaact tatcacaaag 1260
ccttcagaag gaacaacttt aagggtagaa gatcttgtaa aacagtactt tcaaaccgca 1320
gagaagaatg tgcagctctc actgctaaca gaaagaggga tgggtgaagc agtacaagaa 1380
tttgtggaca aggaggagaa agatgccatt gaggaattag tgaaatacca gttggaaaaa 1440
acacagcgat ttcttaaaga acgtcatatt gatgccctcg aagacaaaat cgatgaggag 1500
gtacgtcgtt tcagagaaac cagacaaaaa aatactaatg aagaagatga tgaagtccgt 1560
gaggctatga ccagggccag agcactcaga tctcagtcag aggagtctgc ttctgccttt 1620
agtgctgatg accttatgag tatagattta gcagaacaga tggctaatga ctctgatgat 1680
agcatctcag cagcaaccaa caaaggaaga ggccgaggaa gaggtcgaag aggtggaaga 1740
gggcagaatt cagcatcgag aggagggtct caaagaggaa gagacactgg tctggagact 1800
tctacccgta gcaggaactc aaagactgct gtgtcagcat ctagaaatat gtctattata 1860
gatgccttta aatctacaag acagcagcct tcccgaaatg tcactactaa gaattattca 1920
gaggtgattg aggtagatga atcagatgtg gaagaagaca tttttcctac cacttcaaag 1980
acagatcaaa ggtggtccag cacatcatcc agcaaaatca tgtcccagag tcaagtatcg 2040
aaaggggttg attttgaatc aagtgaggat gatgatgatg atccttttat gaacactagt 2100
tctttaagaa gaaatagaag ataa 2124
<210> 89
<211> 707
<212> PRT
<213> 智人(Homo sapiens)
<400> 89
Met Ser Thr Ala Asp Ala Leu Asp Asp Glu Asn Thr Phe Lys Ile Leu
1 5 10 15
Val Ala Thr Asp Ile His Leu Gly Phe Met Glu Lys Asp Ala Val Arg
20 25 30
Gly Asn Asp Thr Phe Val Thr Leu Asp Glu Ile Leu Arg Leu Ala Gln
35 40 45
Glu Asn Glu Val Asp Phe Ile Leu Leu Gly Gly Asp Leu Phe His Glu
50 55 60
Asn Lys Pro Ser Arg Lys Thr Leu His Thr Cys Leu Glu Leu Leu Arg
65 70 75 80
Lys Tyr Cys Met Gly Asp Arg Pro Val Gln Phe Glu Ile Leu Ser Asp
85 90 95
Gln Ser Val Asn Phe Gly Phe Ser Lys Phe Pro Trp Val Asn Tyr Gln
100 105 110
Asp Gly Asn Leu Asn Ile Ser Ile Pro Val Phe Ser Ile His Gly Asn
115 120 125
His Asp Asp Pro Thr Gly Ala Asp Ala Leu Cys Ala Leu Asp Ile Leu
130 135 140
Ser Cys Ala Gly Phe Val Asn His Phe Gly Arg Ser Met Ser Val Glu
145 150 155 160
Lys Ile Asp Ile Ser Pro Val Leu Leu Gln Lys Gly Ser Thr Lys Ile
165 170 175
Ala Leu Tyr Gly Leu Gly Ser Ile Pro Asp Glu Arg Leu Tyr Arg Met
180 185 190
Phe Val Asn Lys Lys Val Thr Met Leu Arg Pro Lys Glu Asp Glu Asn
195 200 205
Ser Trp Phe Asn Leu Phe Val Ile His Gln Asn Arg Ser Lys His Gly
210 215 220
Ser Thr Asn Phe Ile Pro Glu Gln Phe Leu Asp Asp Phe Ile Asp Leu
225 230 235 240
Val Ile Trp Gly His Glu His Glu Cys Lys Ile Ala Pro Thr Lys Asn
245 250 255
Glu Gln Gln Leu Phe Tyr Ile Ser Gln Pro Gly Ser Ser Val Val Thr
260 265 270
Ser Leu Ser Pro Gly Glu Ala Val Lys Lys His Val Gly Leu Leu Arg
275 280 285
Ile Lys Gly Arg Lys Met Asn Met His Lys Ile Pro Leu His Thr Val
290 295 300
Arg Gln Phe Phe Met Glu Asp Ile Val Leu Ala Asn His Pro Asp Ile
305 310 315 320
Phe Asn Pro Asp Asn Pro Lys Val Thr Gln Ala Ile Gln Ser Phe Cys
325 330 335
Leu Glu Lys Ile Glu Glu Met Leu Glu Asn Ala Glu Arg Glu Arg Leu
340 345 350
Gly Asn Ser His Gln Pro Glu Lys Pro Leu Val Arg Leu Arg Val Asp
355 360 365
Tyr Ser Gly Gly Phe Glu Pro Phe Ser Val Leu Arg Phe Ser Gln Lys
370 375 380
Phe Val Asp Arg Val Ala Asn Pro Lys Asp Ile Ile His Phe Phe Arg
385 390 395 400
His Arg Glu Gln Lys Glu Lys Thr Gly Glu Glu Ile Asn Phe Gly Lys
405 410 415
Leu Ile Thr Lys Pro Ser Glu Gly Thr Thr Leu Arg Val Glu Asp Leu
420 425 430
Val Lys Gln Tyr Phe Gln Thr Ala Glu Lys Asn Val Gln Leu Ser Leu
435 440 445
Leu Thr Glu Arg Gly Met Gly Glu Ala Val Gln Glu Phe Val Asp Lys
450 455 460
Glu Glu Lys Asp Ala Ile Glu Glu Leu Val Lys Tyr Gln Leu Glu Lys
465 470 475 480
Thr Gln Arg Phe Leu Lys Glu Arg His Ile Asp Ala Leu Glu Asp Lys
485 490 495
Ile Asp Glu Glu Val Arg Arg Phe Arg Glu Thr Arg Gln Lys Asn Thr
500 505 510
Asn Glu Glu Asp Asp Glu Val Arg Glu Ala Met Thr Arg Ala Arg Ala
515 520 525
Leu Arg Ser Gln Ser Glu Glu Ser Ala Ser Ala Phe Ser Ala Asp Asp
530 535 540
Leu Met Ser Ile Asp Leu Ala Glu Gln Met Ala Asn Asp Ser Asp Asp
545 550 555 560
Ser Ile Ser Ala Ala Thr Asn Lys Gly Arg Gly Arg Gly Arg Gly Arg
565 570 575
Arg Gly Gly Arg Gly Gln Asn Ser Ala Ser Arg Gly Gly Ser Gln Arg
580 585 590
Gly Arg Asp Thr Gly Leu Glu Thr Ser Thr Arg Ser Arg Asn Ser Lys
595 600 605
Thr Ala Val Ser Ala Ser Arg Asn Met Ser Ile Ile Asp Ala Phe Lys
610 615 620
Ser Thr Arg Gln Gln Pro Ser Arg Asn Val Thr Thr Lys Asn Tyr Ser
625 630 635 640
Glu Val Ile Glu Val Asp Glu Ser Asp Val Glu Glu Asp Ile Phe Pro
645 650 655
Thr Thr Ser Lys Thr Asp Gln Arg Trp Ser Ser Thr Ser Ser Ser Lys
660 665 670
Ile Met Ser Gln Ser Gln Val Ser Lys Gly Val Asp Phe Glu Ser Ser
675 680 685
Glu Asp Asp Asp Asp Asp Pro Phe Met Asn Thr Ser Ser Leu Arg Arg
690 695 700
Asn Arg Arg
705
<210> 90
<211> 3056
<212> PRT
<213> 智人(Homo sapiens)
<400> 90
Met Ser Leu Val Leu Asn Asp Leu Leu Ile Cys Cys Arg Gln Leu Glu
1 5 10 15
His Asp Arg Ala Thr Glu Arg Lys Lys Glu Val Glu Lys Phe Lys Arg
20 25 30
Leu Ile Arg Asp Pro Glu Thr Ile Lys His Leu Asp Arg His Ser Asp
35 40 45
Ser Lys Gln Gly Lys Tyr Leu Asn Trp Asp Ala Val Phe Arg Phe Leu
50 55 60
Gln Lys Tyr Ile Gln Lys Glu Thr Glu Cys Leu Arg Ile Ala Lys Pro
65 70 75 80
Asn Val Ser Ala Ser Thr Gln Ala Ser Arg Gln Lys Lys Met Gln Glu
85 90 95
Ile Ser Ser Leu Val Lys Tyr Phe Ile Lys Cys Ala Asn Arg Arg Ala
100 105 110
Pro Arg Leu Lys Cys Gln Glu Leu Leu Asn Tyr Ile Met Asp Thr Val
115 120 125
Lys Asp Ser Ser Asn Gly Ala Ile Tyr Gly Ala Asp Cys Ser Asn Ile
130 135 140
Leu Leu Lys Asp Ile Leu Ser Val Arg Lys Tyr Trp Cys Glu Ile Ser
145 150 155 160
Gln Gln Gln Trp Leu Glu Leu Phe Ser Val Tyr Phe Arg Leu Tyr Leu
165 170 175
Lys Pro Ser Gln Asp Val His Arg Val Leu Val Ala Arg Ile Ile His
180 185 190
Ala Val Thr Lys Gly Cys Cys Ser Gln Thr Asp Gly Leu Asn Ser Lys
195 200 205
Phe Leu Asp Phe Phe Ser Lys Ala Ile Gln Cys Ala Arg Gln Glu Lys
210 215 220
Ser Ser Ser Gly Leu Asn His Ile Leu Ala Ala Leu Thr Ile Phe Leu
225 230 235 240
Lys Thr Leu Ala Val Asn Phe Arg Ile Arg Val Cys Glu Leu Gly Asp
245 250 255
Glu Ile Leu Pro Thr Leu Leu Tyr Ile Trp Thr Gln His Arg Leu Asn
260 265 270
Asp Ser Leu Lys Glu Val Ile Ile Glu Leu Phe Gln Leu Gln Ile Tyr
275 280 285
Ile His His Pro Lys Gly Ala Lys Thr Gln Glu Lys Gly Ala Tyr Glu
290 295 300
Ser Thr Lys Trp Arg Ser Ile Leu Tyr Asn Leu Tyr Asp Leu Leu Val
305 310 315 320
Asn Glu Ile Ser His Ile Gly Ser Arg Gly Lys Tyr Ser Ser Gly Phe
325 330 335
Arg Asn Ile Ala Val Lys Glu Asn Leu Ile Glu Leu Met Ala Asp Ile
340 345 350
Cys His Gln Val Phe Asn Glu Asp Thr Arg Ser Leu Glu Ile Ser Gln
355 360 365
Ser Tyr Thr Thr Thr Gln Arg Glu Ser Ser Asp Tyr Ser Val Pro Cys
370 375 380
Lys Arg Lys Lys Ile Glu Leu Gly Trp Glu Val Ile Lys Asp His Leu
385 390 395 400
Gln Lys Ser Gln Asn Asp Phe Asp Leu Val Pro Trp Leu Gln Ile Ala
405 410 415
Thr Gln Leu Ile Ser Lys Tyr Pro Ala Ser Leu Pro Asn Cys Glu Leu
420 425 430
Ser Pro Leu Leu Met Ile Leu Ser Gln Leu Leu Pro Gln Gln Arg His
435 440 445
Gly Glu Arg Thr Pro Tyr Val Leu Arg Cys Leu Thr Glu Val Ala Leu
450 455 460
Cys Gln Asp Lys Arg Ser Asn Leu Glu Ser Ser Gln Lys Ser Asp Leu
465 470 475 480
Leu Lys Leu Trp Asn Lys Ile Trp Cys Ile Thr Phe Arg Gly Ile Ser
485 490 495
Ser Glu Gln Ile Gln Ala Glu Asn Phe Gly Leu Leu Gly Ala Ile Ile
500 505 510
Gln Gly Ser Leu Val Glu Val Asp Arg Glu Phe Trp Lys Leu Phe Thr
515 520 525
Gly Ser Ala Cys Arg Pro Ser Cys Pro Ala Val Cys Cys Leu Thr Leu
530 535 540
Ala Leu Thr Thr Ser Ile Val Pro Gly Thr Val Lys Met Gly Ile Glu
545 550 555 560
Gln Asn Met Cys Glu Val Asn Arg Ser Phe Ser Leu Lys Glu Ser Ile
565 570 575
Met Lys Trp Leu Leu Phe Tyr Gln Leu Glu Gly Asp Leu Glu Asn Ser
580 585 590
Thr Glu Val Pro Pro Ile Leu His Ser Asn Phe Pro His Leu Val Leu
595 600 605
Glu Lys Ile Leu Val Ser Leu Thr Met Lys Asn Cys Lys Ala Ala Met
610 615 620
Asn Phe Phe Gln Ser Val Pro Glu Cys Glu His His Gln Lys Asp Lys
625 630 635 640
Glu Glu Leu Ser Phe Ser Glu Val Glu Glu Leu Phe Leu Gln Thr Thr
645 650 655
Phe Asp Lys Met Asp Phe Leu Thr Ile Val Arg Glu Cys Gly Ile Glu
660 665 670
Lys His Gln Ser Ser Ile Gly Phe Ser Val His Gln Asn Leu Lys Glu
675 680 685
Ser Leu Asp Arg Cys Leu Leu Gly Leu Ser Glu Gln Leu Leu Asn Asn
690 695 700
Tyr Ser Ser Glu Ile Thr Asn Ser Glu Thr Leu Val Arg Cys Ser Arg
705 710 715 720
Leu Leu Val Gly Val Leu Gly Cys Tyr Cys Tyr Met Gly Val Ile Ala
725 730 735
Glu Glu Glu Ala Tyr Lys Ser Glu Leu Phe Gln Lys Ala Lys Ser Leu
740 745 750
Met Gln Cys Ala Gly Glu Ser Ile Thr Leu Phe Lys Asn Lys Thr Asn
755 760 765
Glu Glu Phe Arg Ile Gly Ser Leu Arg Asn Met Met Gln Leu Cys Thr
770 775 780
Arg Cys Leu Ser Asn Cys Thr Lys Lys Ser Pro Asn Lys Ile Ala Ser
785 790 795 800
Gly Phe Phe Leu Arg Leu Leu Thr Ser Lys Leu Met Asn Asp Ile Ala
805 810 815
Asp Ile Cys Lys Ser Leu Ala Ser Phe Ile Lys Lys Pro Phe Asp Arg
820 825 830
Gly Glu Val Glu Ser Met Glu Asp Asp Thr Asn Gly Asn Leu Met Glu
835 840 845
Val Glu Asp Gln Ser Ser Met Asn Leu Phe Asn Asp Tyr Pro Asp Ser
850 855 860
Ser Val Ser Asp Ala Asn Glu Pro Gly Glu Ser Gln Ser Thr Ile Gly
865 870 875 880
Ala Ile Asn Pro Leu Ala Glu Glu Tyr Leu Ser Lys Gln Asp Leu Leu
885 890 895
Phe Leu Asp Met Leu Lys Phe Leu Cys Leu Cys Val Thr Thr Ala Gln
900 905 910
Thr Asn Thr Val Ser Phe Arg Ala Ala Asp Ile Arg Arg Lys Leu Leu
915 920 925
Met Leu Ile Asp Ser Ser Thr Leu Glu Pro Thr Lys Ser Leu His Leu
930 935 940
His Met Tyr Leu Met Leu Leu Lys Glu Leu Pro Gly Glu Glu Tyr Pro
945 950 955 960
Leu Pro Met Glu Asp Val Leu Glu Leu Leu Lys Pro Leu Ser Asn Val
965 970 975
Cys Ser Leu Tyr Arg Arg Asp Gln Asp Val Cys Lys Thr Ile Leu Asn
980 985 990
His Val Leu His Val Val Lys Asn Leu Gly Gln Ser Asn Met Asp Ser
995 1000 1005
Glu Asn Thr Arg Asp Ala Gln Gly Gln Phe Leu Thr Val Ile Gly
1010 1015 1020
Ala Phe Trp His Leu Thr Lys Glu Arg Lys Tyr Ile Phe Ser Val
1025 1030 1035
Arg Met Ala Leu Val Asn Cys Leu Lys Thr Leu Leu Glu Ala Asp
1040 1045 1050
Pro Tyr Ser Lys Trp Ala Ile Leu Asn Val Met Gly Lys Asp Phe
1055 1060 1065
Pro Val Asn Glu Val Phe Thr Gln Phe Leu Ala Asp Asn His His
1070 1075 1080
Gln Val Arg Met Leu Ala Ala Glu Ser Ile Asn Arg Leu Phe Gln
1085 1090 1095
Asp Thr Lys Gly Asp Ser Ser Arg Leu Leu Lys Ala Leu Pro Leu
1100 1105 1110
Lys Leu Gln Gln Thr Ala Phe Glu Asn Ala Tyr Leu Lys Ala Gln
1115 1120 1125
Glu Gly Met Arg Glu Met Ser His Ser Ala Glu Asn Pro Glu Thr
1130 1135 1140
Leu Asp Glu Ile Tyr Asn Arg Lys Ser Val Leu Leu Thr Leu Ile
1145 1150 1155
Ala Val Val Leu Ser Cys Ser Pro Ile Cys Glu Lys Gln Ala Leu
1160 1165 1170
Phe Ala Leu Cys Lys Ser Val Lys Glu Asn Gly Leu Glu Pro His
1175 1180 1185
Leu Val Lys Lys Val Leu Glu Lys Val Ser Glu Thr Phe Gly Tyr
1190 1195 1200
Arg Arg Leu Glu Asp Phe Met Ala Ser His Leu Asp Tyr Leu Val
1205 1210 1215
Leu Glu Trp Leu Asn Leu Gln Asp Thr Glu Tyr Asn Leu Ser Ser
1220 1225 1230
Phe Pro Phe Ile Leu Leu Asn Tyr Thr Asn Ile Glu Asp Phe Tyr
1235 1240 1245
Arg Ser Cys Tyr Lys Val Leu Ile Pro His Leu Val Ile Arg Ser
1250 1255 1260
His Phe Asp Glu Val Lys Ser Ile Ala Asn Gln Ile Gln Glu Asp
1265 1270 1275
Trp Lys Ser Leu Leu Thr Asp Cys Phe Pro Lys Ile Leu Val Asn
1280 1285 1290
Ile Leu Pro Tyr Phe Ala Tyr Glu Gly Thr Arg Asp Ser Gly Met
1295 1300 1305
Ala Gln Gln Arg Glu Thr Ala Thr Lys Val Tyr Asp Met Leu Lys
1310 1315 1320
Ser Glu Asn Leu Leu Gly Lys Gln Ile Asp His Leu Phe Ile Ser
1325 1330 1335
Asn Leu Pro Glu Ile Val Val Glu Leu Leu Met Thr Leu His Glu
1340 1345 1350
Pro Ala Asn Ser Ser Ala Ser Gln Ser Thr Asp Leu Cys Asp Phe
1355 1360 1365
Ser Gly Asp Leu Asp Pro Ala Pro Asn Pro Pro His Phe Pro Ser
1370 1375 1380
His Val Ile Lys Ala Thr Phe Ala Tyr Ile Ser Asn Cys His Lys
1385 1390 1395
Thr Lys Leu Lys Ser Ile Leu Glu Ile Leu Ser Lys Ser Pro Asp
1400 1405 1410
Ser Tyr Gln Lys Ile Leu Leu Ala Ile Cys Glu Gln Ala Ala Glu
1415 1420 1425
Thr Asn Asn Val Tyr Lys Lys His Arg Ile Leu Lys Ile Tyr His
1430 1435 1440
Leu Phe Val Ser Leu Leu Leu Lys Asp Ile Lys Ser Gly Leu Gly
1445 1450 1455
Gly Ala Trp Ala Phe Val Leu Arg Asp Val Ile Tyr Thr Leu Ile
1460 1465 1470
His Tyr Ile Asn Gln Arg Pro Ser Cys Ile Met Asp Val Ser Leu
1475 1480 1485
Arg Ser Phe Ser Leu Cys Cys Asp Leu Leu Ser Gln Val Cys Gln
1490 1495 1500
Thr Ala Val Thr Tyr Cys Lys Asp Ala Leu Glu Asn His Leu His
1505 1510 1515
Val Ile Val Gly Thr Leu Ile Pro Leu Val Tyr Glu Gln Val Glu
1520 1525 1530
Val Gln Lys Gln Val Leu Asp Leu Leu Lys Tyr Leu Val Ile Asp
1535 1540 1545
Asn Lys Asp Asn Glu Asn Leu Tyr Ile Thr Ile Lys Leu Leu Asp
1550 1555 1560
Pro Phe Pro Asp His Val Val Phe Lys Asp Leu Arg Ile Thr Gln
1565 1570 1575
Gln Lys Ile Lys Tyr Ser Arg Gly Pro Phe Ser Leu Leu Glu Glu
1580 1585 1590
Ile Asn His Phe Leu Ser Val Ser Val Tyr Asp Ala Leu Pro Leu
1595 1600 1605
Thr Arg Leu Glu Gly Leu Lys Asp Leu Arg Arg Gln Leu Glu Leu
1610 1615 1620
His Lys Asp Gln Met Val Asp Ile Met Arg Ala Ser Gln Asp Asn
1625 1630 1635
Pro Gln Asp Gly Ile Met Val Lys Leu Val Val Asn Leu Leu Gln
1640 1645 1650
Leu Ser Lys Met Ala Ile Asn His Thr Gly Glu Lys Glu Val Leu
1655 1660 1665
Glu Ala Val Gly Ser Cys Leu Gly Glu Val Gly Pro Ile Asp Phe
1670 1675 1680
Ser Thr Ile Ala Ile Gln His Ser Lys Asp Ala Ser Tyr Thr Lys
1685 1690 1695
Ala Leu Lys Leu Phe Glu Asp Lys Glu Leu Gln Trp Thr Phe Ile
1700 1705 1710
Met Leu Thr Tyr Leu Asn Asn Thr Leu Val Glu Asp Cys Val Lys
1715 1720 1725
Val Arg Ser Ala Ala Val Thr Cys Leu Lys Asn Ile Leu Ala Thr
1730 1735 1740
Lys Thr Gly His Ser Phe Trp Glu Ile Tyr Lys Met Thr Thr Asp
1745 1750 1755
Pro Met Leu Ala Tyr Leu Gln Pro Phe Arg Thr Ser Arg Lys Lys
1760 1765 1770
Phe Leu Glu Val Pro Arg Phe Asp Lys Glu Asn Pro Phe Glu Gly
1775 1780 1785
Leu Asp Asp Ile Asn Leu Trp Ile Pro Leu Ser Glu Asn His Asp
1790 1795 1800
Ile Trp Ile Lys Thr Leu Thr Cys Ala Phe Leu Asp Ser Gly Gly
1805 1810 1815
Thr Lys Cys Glu Ile Leu Gln Leu Leu Lys Pro Met Cys Glu Val
1820 1825 1830
Lys Thr Asp Phe Cys Gln Thr Val Leu Pro Tyr Leu Ile His Asp
1835 1840 1845
Ile Leu Leu Gln Asp Thr Asn Glu Ser Trp Arg Asn Leu Leu Ser
1850 1855 1860
Thr His Val Gln Gly Phe Phe Thr Ser Cys Leu Arg His Phe Ser
1865 1870 1875
Gln Thr Ser Arg Ser Thr Thr Pro Ala Asn Leu Asp Ser Glu Ser
1880 1885 1890
Glu His Phe Phe Arg Cys Cys Leu Asp Lys Lys Ser Gln Arg Thr
1895 1900 1905
Met Leu Ala Val Val Asp Tyr Met Arg Arg Gln Lys Arg Pro Ser
1910 1915 1920
Ser Gly Thr Ile Phe Asn Asp Ala Phe Trp Leu Asp Leu Asn Tyr
1925 1930 1935
Leu Glu Val Ala Lys Val Ala Gln Ser Cys Ala Ala His Phe Thr
1940 1945 1950
Ala Leu Leu Tyr Ala Glu Ile Tyr Ala Asp Lys Lys Ser Met Asp
1955 1960 1965
Asp Gln Glu Lys Arg Ser Leu Ala Phe Glu Glu Gly Ser Gln Ser
1970 1975 1980
Thr Thr Ile Ser Ser Leu Ser Glu Lys Ser Lys Glu Glu Thr Gly
1985 1990 1995
Ile Ser Leu Gln Asp Leu Leu Leu Glu Ile Tyr Arg Ser Ile Gly
2000 2005 2010
Glu Pro Asp Ser Leu Tyr Gly Cys Gly Gly Gly Lys Met Leu Gln
2015 2020 2025
Pro Ile Thr Arg Leu Arg Thr Tyr Glu His Glu Ala Met Trp Gly
2030 2035 2040
Lys Ala Leu Val Thr Tyr Asp Leu Glu Thr Ala Ile Pro Ser Ser
2045 2050 2055
Thr Arg Gln Ala Gly Ile Ile Gln Ala Leu Gln Asn Leu Gly Leu
2060 2065 2070
Cys His Ile Leu Ser Val Tyr Leu Lys Gly Leu Asp Tyr Glu Asn
2075 2080 2085
Lys Asp Trp Cys Pro Glu Leu Glu Glu Leu His Tyr Gln Ala Ala
2090 2095 2100
Trp Arg Asn Met Gln Trp Asp His Cys Thr Ser Val Ser Lys Glu
2105 2110 2115
Val Glu Gly Thr Ser Tyr His Glu Ser Leu Tyr Asn Ala Leu Gln
2120 2125 2130
Ser Leu Arg Asp Arg Glu Phe Ser Thr Phe Tyr Glu Ser Leu Lys
2135 2140 2145
Tyr Ala Arg Val Lys Glu Val Glu Glu Met Cys Lys Arg Ser Leu
2150 2155 2160
Glu Ser Val Tyr Ser Leu Tyr Pro Thr Leu Ser Arg Leu Gln Ala
2165 2170 2175
Ile Gly Glu Leu Glu Ser Ile Gly Glu Leu Phe Ser Arg Ser Val
2180 2185 2190
Thr His Arg Gln Leu Ser Glu Val Tyr Ile Lys Trp Gln Lys His
2195 2200 2205
Ser Gln Leu Leu Lys Asp Ser Asp Phe Ser Phe Gln Glu Pro Ile
2210 2215 2220
Met Ala Leu Arg Thr Val Ile Leu Glu Ile Leu Met Glu Lys Glu
2225 2230 2235
Met Asp Asn Ser Gln Arg Glu Cys Ile Lys Asp Ile Leu Thr Lys
2240 2245 2250
His Leu Val Glu Leu Ser Ile Leu Ala Arg Thr Phe Lys Asn Thr
2255 2260 2265
Gln Leu Pro Glu Arg Ala Ile Phe Gln Ile Lys Gln Tyr Asn Ser
2270 2275 2280
Val Ser Cys Gly Val Ser Glu Trp Gln Leu Glu Glu Ala Gln Val
2285 2290 2295
Phe Trp Ala Lys Lys Glu Gln Ser Leu Ala Leu Ser Ile Leu Lys
2300 2305 2310
Gln Met Ile Lys Lys Leu Asp Ala Ser Cys Ala Ala Asn Asn Pro
2315 2320 2325
Ser Leu Lys Leu Thr Tyr Thr Glu Cys Leu Arg Val Cys Gly Asn
2330 2335 2340
Trp Leu Ala Glu Thr Cys Leu Glu Asn Pro Ala Val Ile Met Gln
2345 2350 2355
Thr Tyr Leu Glu Lys Ala Val Glu Val Ala Gly Asn Tyr Asp Gly
2360 2365 2370
Glu Ser Ser Asp Glu Leu Arg Asn Gly Lys Met Lys Ala Phe Leu
2375 2380 2385
Ser Leu Ala Arg Phe Ser Asp Thr Gln Tyr Gln Arg Ile Glu Asn
2390 2395 2400
Tyr Met Lys Ser Ser Glu Phe Glu Asn Lys Gln Ala Leu Leu Lys
2405 2410 2415
Arg Ala Lys Glu Glu Val Gly Leu Leu Arg Glu His Lys Ile Gln
2420 2425 2430
Thr Asn Arg Tyr Thr Val Lys Val Gln Arg Glu Leu Glu Leu Asp
2435 2440 2445
Glu Leu Ala Leu Arg Ala Leu Lys Glu Asp Arg Lys Arg Phe Leu
2450 2455 2460
Cys Lys Ala Val Glu Asn Tyr Ile Asn Cys Leu Leu Ser Gly Glu
2465 2470 2475
Glu His Asp Met Trp Val Phe Arg Leu Cys Ser Leu Trp Leu Glu
2480 2485 2490
Asn Ser Gly Val Ser Glu Val Asn Gly Met Met Lys Arg Asp Gly
2495 2500 2505
Met Lys Ile Pro Thr Tyr Lys Phe Leu Pro Leu Met Tyr Gln Leu
2510 2515 2520
Ala Ala Arg Met Gly Thr Lys Met Met Gly Gly Leu Gly Phe His
2525 2530 2535
Glu Val Leu Asn Asn Leu Ile Ser Arg Ile Ser Met Asp His Pro
2540 2545 2550
His His Thr Leu Phe Ile Ile Leu Ala Leu Ala Asn Ala Asn Arg
2555 2560 2565
Asp Glu Phe Leu Thr Lys Pro Glu Val Ala Arg Arg Ser Arg Ile
2570 2575 2580
Thr Lys Asn Val Pro Lys Gln Ser Ser Gln Leu Asp Glu Asp Arg
2585 2590 2595
Thr Glu Ala Ala Asn Arg Ile Ile Cys Thr Ile Arg Ser Arg Arg
2600 2605 2610
Pro Gln Met Val Arg Ser Val Glu Ala Leu Cys Asp Ala Tyr Ile
2615 2620 2625
Ile Leu Ala Asn Leu Asp Ala Thr Gln Trp Lys Thr Gln Arg Lys
2630 2635 2640
Gly Ile Asn Ile Pro Ala Asp Gln Pro Ile Thr Lys Leu Lys Asn
2645 2650 2655
Leu Glu Asp Val Val Val Pro Thr Met Glu Ile Lys Val Asp His
2660 2665 2670
Thr Gly Glu Tyr Gly Asn Leu Val Thr Ile Gln Ser Phe Lys Ala
2675 2680 2685
Glu Phe Arg Leu Ala Gly Gly Val Asn Leu Pro Lys Ile Ile Asp
2690 2695 2700
Cys Val Gly Ser Asp Gly Lys Glu Arg Arg Gln Leu Val Lys Gly
2705 2710 2715
Arg Asp Asp Leu Arg Gln Asp Ala Val Met Gln Gln Val Phe Gln
2720 2725 2730
Met Cys Asn Thr Leu Leu Gln Arg Asn Thr Glu Thr Arg Lys Arg
2735 2740 2745
Lys Leu Thr Ile Cys Thr Tyr Lys Val Val Pro Leu Ser Gln Arg
2750 2755 2760
Ser Gly Val Leu Glu Trp Cys Thr Gly Thr Val Pro Ile Gly Glu
2765 2770 2775
Phe Leu Val Asn Asn Glu Asp Gly Ala His Lys Arg Tyr Arg Pro
2780 2785 2790
Asn Asp Phe Ser Ala Phe Gln Cys Gln Lys Lys Met Met Glu Val
2795 2800 2805
Gln Lys Lys Ser Phe Glu Glu Lys Tyr Glu Val Phe Met Asp Val
2810 2815 2820
Cys Gln Asn Phe Gln Pro Val Phe Arg Tyr Phe Cys Met Glu Lys
2825 2830 2835
Phe Leu Asp Pro Ala Ile Trp Phe Glu Lys Arg Leu Ala Tyr Thr
2840 2845 2850
Arg Ser Val Ala Thr Ser Ser Ile Val Gly Tyr Ile Leu Gly Leu
2855 2860 2865
Gly Asp Arg His Val Gln Asn Ile Leu Ile Asn Glu Gln Ser Ala
2870 2875 2880
Glu Leu Val His Ile Asp Leu Gly Val Ala Phe Glu Gln Gly Lys
2885 2890 2895
Ile Leu Pro Thr Pro Glu Thr Val Pro Phe Arg Leu Thr Arg Asp
2900 2905 2910
Ile Val Asp Gly Met Gly Ile Thr Gly Val Glu Gly Val Phe Arg
2915 2920 2925
Arg Cys Cys Glu Lys Thr Met Glu Val Met Arg Asn Ser Gln Glu
2930 2935 2940
Thr Leu Leu Thr Ile Val Glu Val Leu Leu Tyr Asp Pro Leu Phe
2945 2950 2955
Asp Trp Thr Met Asn Pro Leu Lys Ala Leu Tyr Leu Gln Gln Arg
2960 2965 2970
Pro Glu Asp Glu Thr Glu Leu His Pro Thr Leu Asn Ala Asp Asp
2975 2980 2985
Gln Glu Cys Lys Arg Asn Leu Ser Asp Ile Asp Gln Ser Phe Asn
2990 2995 3000
Lys Val Ala Glu Arg Val Leu Met Arg Leu Gln Glu Lys Leu Lys
3005 3010 3015
Gly Val Glu Glu Gly Thr Val Leu Ser Val Gly Gly Gln Val Asn
3020 3025 3030
Leu Leu Ile Gln Gln Ala Ile Asp Pro Lys Asn Leu Ser Arg Leu
3035 3040 3045
Phe Pro Gly Trp Lys Ala Trp Val
3050 3055
<210> 91
<211> 12915
<212> DNA
<213> 智人(Homo sapiens)
<400> 91
aggtagctgc gtggctaacg gagaaaagaa gccgtggccg cgggaggagg cgagaggagt 60
cgggatctgc gctgcagcca ccgccgcggt tgatactact ttgaccttcc gagtgcagtg 120
acagtgatgt gtgttctgaa attgtgaacc atgagtctag tacttaatga tctgcttatc 180
tgctgccgtc aactagaaca tgatagagct acagaacgaa agaaagaagt tgagaaattt 240
aagcgcctga ttcgagatcc tgaaacaatt aaacatctag atcggcattc agattccaaa 300
caaggaaaat atttgaattg ggatgctgtt tttagatttt tacagaaata tattcagaaa 360
gaaacagaat gtctgagaat agcaaaacca aatgtatcag cctcaacaca agcctccagg 420
cagaaaaaga tgcaggaaat cagtagtttg gtcaaatact tcatcaaatg tgcaaacaga 480
agagcaccta ggctaaaatg tcaagaactc ttaaattata tcatggatac agtgaaagat 540
tcatctaatg gtgctattta cggagctgat tgtagcaaca tactactcaa agacattctt 600
tctgtgagaa aatactggtg tgaaatatct cagcaacagt ggttagaatt gttctctgtg 660
tacttcaggc tctatctgaa accttcacaa gatgttcata gagttttagt ggctagaata 720
attcatgctg ttaccaaagg atgctgttct cagactgacg gattaaattc caaatttttg 780
gacttttttt ccaaggctat tcagtgtgcg agacaagaaa agagctcttc aggtctaaat 840
catatcttag cagctcttac tatcttcctc aagactttgg ctgtcaactt tcgaattcga 900
gtgtgtgaat taggagatga aattcttccc actttgcttt atatttggac tcaacatagg 960
cttaatgatt ctttaaaaga agtcattatt gaattatttc aactgcaaat ttatatccat 1020
catccgaaag gagccaaaac ccaagaaaaa ggtgcttatg aatcaacaaa atggagaagt 1080
attttataca acttatatga tctgctagtg aatgagataa gtcatatagg aagtagagga 1140
aagtattctt caggatttcg taatattgcc gtcaaagaaa atttgattga attgatggca 1200
gatatctgtc accaggtttt taatgaagat accagatcct tggagatttc tcaatcttac 1260
actactacac aaagagaatc tagtgattac agtgtccctt gcaaaaggaa gaaaatagaa 1320
ctaggctggg aagtaataaa agatcacctt cagaagtcac agaatgattt tgatcttgtg 1380
ccttggctac agattgcaac ccaattaata tcaaagtatc ctgcaagttt acctaactgt 1440
gagctgtctc cattactgat gatactatct cagcttctac cccaacagcg acatggggaa 1500
cgtacaccat atgtgttacg atgccttacg gaagttgcat tgtgtcaaga caagaggtca 1560
aacctagaaa gctcacaaaa gtcagattta ttaaaactct ggaataaaat ttggtgtatt 1620
acctttcgtg gtataagttc tgagcaaata caagctgaaa actttggctt acttggagcc 1680
ataattcagg gtagtttagt tgaggttgac agagaattct ggaagttatt tactgggtca 1740
gcctgcagac cttcatgtcc tgcagtatgc tgtttgactt tggcactgac caccagtata 1800
gttccaggaa cggtaaaaat gggaatagag caaaatatgt gtgaagtaaa tagaagcttt 1860
tctttaaagg aatcaataat gaaatggctc ttattctatc agttagaggg tgacttagaa 1920
aatagcacag aagtgcctcc aattcttcac agtaattttc ctcatcttgt actggagaaa 1980
attcttgtga gtctcactat gaaaaactgt aaagctgcaa tgaatttttt ccaaagcgtg 2040
ccagaatgtg aacaccacca aaaagataaa gaagaacttt cattctcaga agtagaagaa 2100
ctatttcttc agacaacttt tgacaagatg gactttttaa ccattgtgag agaatgtggt 2160
atagaaaagc accagtccag tattggcttc tctgtccacc agaatctcaa ggaatcactg 2220
gatcgctgtc ttctgggatt atcagaacag cttctgaata attactcatc tgagattaca 2280
aattcagaaa ctcttgtccg gtgttcacgt cttttggtgg gtgtccttgg ctgctactgt 2340
tacatgggtg taatagctga agaggaagca tataagtcag aattattcca gaaagccaag 2400
tctctaatgc aatgtgcagg agaaagtatc actctgttta aaaataagac aaatgaggaa 2460
ttcagaattg gttccttgag aaatatgatg cagctatgta cacgttgctt gagcaactgt 2520
accaagaaga gtccaaataa gattgcatct ggctttttcc tgcgattgtt aacatcaaag 2580
ctaatgaatg acattgcaga tatttgtaaa agtttagcat ccttcatcaa aaagccattt 2640
gaccgtggag aagtagaatc aatggaagat gatactaatg gaaatctaat ggaggtggag 2700
gatcagtcat ccatgaatct atttaacgat taccctgata gtagtgttag tgatgcaaac 2760
gaacctggag agagccaaag taccataggt gccattaatc ctttagctga agaatatctg 2820
tcaaagcaag atctactttt cttagacatg ctcaagttct tgtgtttgtg tgtaactact 2880
gctcagacca atactgtgtc ctttagggca gctgatattc ggaggaaatt gttaatgtta 2940
attgattcta gcacgctaga acctaccaaa tccctccacc tgcatatgta tctaatgctt 3000
ttaaaggagc ttcctggaga agagtacccc ttgccaatgg aagatgttct tgaacttctg 3060
aaaccactat ccaatgtgtg ttctttgtat cgtcgtgacc aagatgtttg taaaactatt 3120
ttaaaccatg tccttcatgt agtgaaaaac ctaggtcaaa gcaatatgga ctctgagaac 3180
acaagggatg ctcaaggaca gtttcttaca gtaattggag cattttggca tctaacaaag 3240
gagaggaaat atatattctc tgtaagaatg gccctagtaa attgccttaa aactttgctt 3300
gaggctgatc cttattcaaa atgggccatt cttaatgtaa tgggaaaaga ctttcctgta 3360
aatgaagtat ttacacaatt tcttgctgac aatcatcacc aagttcgcat gttggctgca 3420
gagtcaatca atagattgtt ccaggacacg aagggagatt cttccaggtt actgaaagca 3480
cttcctttga agcttcagca aacagctttt gaaaatgcat acttgaaagc tcaggaagga 3540
atgagagaaa tgtcccatag tgctgagaac cctgaaactt tggatgaaat ttataataga 3600
aaatctgttt tactgacgtt gatagctgtg gttttatcct gtagccctat ctgcgaaaaa 3660
caggctttgt ttgccctgtg taaatctgtg aaagagaatg gattagaacc tcaccttgtg 3720
aaaaaggttt tagagaaagt ttctgaaact tttggatata gacgtttaga agactttatg 3780
gcatctcatt tagattatct ggttttggaa tggctaaatc ttcaagatac tgaatacaac 3840
ttatcttctt ttccttttat tttattaaac tacacaaata ttgaggattt ctatagatct 3900
tgttataagg ttttgattcc acatctggtg attagaagtc attttgatga ggtgaagtcc 3960
attgctaatc agattcaaga ggactggaaa agtcttctaa cagactgctt tccaaagatt 4020
cttgtaaata ttcttcctta ttttgcctat gagggtacca gagacagtgg gatggcacag 4080
caaagagaga ctgctaccaa ggtctatgat atgcttaaaa gtgaaaactt attgggaaaa 4140
cagattgatc acttattcat tagtaattta ccagagattg tggtggagtt attgatgacg 4200
ttacatgagc cagcaaattc tagtgccagt cagagcactg acctctgtga cttttcaggg 4260
gatttggatc ctgctcctaa tccacctcat tttccatcgc atgtgattaa agcaacattt 4320
gcctatatca gcaattgtca taaaaccaag ttaaaaagca ttttagaaat tctttccaaa 4380
agccctgatt cctatcagaa aattcttctt gccatatgtg agcaagcagc tgaaacaaat 4440
aatgtttata agaagcacag aattcttaaa atatatcacc tgtttgttag tttattactg 4500
aaagatataa aaagtggctt aggaggagct tgggcctttg ttcttcgaga cgttatttat 4560
actttgattc actatatcaa ccaaaggcct tcttgtatca tggatgtgtc attacgtagc 4620
ttctcccttt gttgtgactt attaagtcag gtttgccaga cagccgtgac ttactgtaag 4680
gatgctctag aaaaccatct tcatgttatt gttggtacac ttatacccct tgtgtatgag 4740
caggtggagg ttcagaaaca ggtattggac ttgttgaaat acttagtgat agataacaag 4800
gataatgaaa acctctatat cacgattaag cttttagatc cttttcctga ccatgttgtt 4860
tttaaggatt tgcgtattac tcagcaaaaa atcaaataca gtagaggacc cttttcactc 4920
ttggaggaaa ttaaccattt tctctcagta agtgtttatg atgcacttcc attgacaaga 4980
cttgaaggac taaaggatct tcgaagacaa ctggaactac ataaagatca gatggtggac 5040
attatgagag cttctcagga taatccgcaa gatgggatta tggtgaaact agttgtcaat 5100
ttgttgcagt tatccaagat ggcaataaac cacactggtg aaaaagaagt tctagaggct 5160
gttggaagct gcttgggaga agtgggtcct atagatttct ctaccatagc tatacaacat 5220
agtaaagatg catcttatac caaggccctt aagttatttg aagataaaga acttcagtgg 5280
accttcataa tgctgaccta cctgaataac acactggtag aagattgtgt caaagttcga 5340
tcagcagctg ttacctgttt gaaaaacatt ttagccacaa agactggaca tagtttctgg 5400
gagatttata agatgacaac agatccaatg ctggcctatc tacagccttt tagaacatca 5460
agaaaaaagt ttttagaagt acccagattt gacaaagaaa acccttttga aggcctggat 5520
gatataaatc tgtggattcc tctaagtgaa aatcatgaca tttggataaa gacactgact 5580
tgtgcttttt tggacagtgg aggcacaaaa tgtgaaattc ttcaattatt aaagccaatg 5640
tgtgaagtga aaactgactt ttgtcagact gtacttccat acttgattca tgatatttta 5700
ctccaagata caaatgaatc atggagaaat ctgctttcta cacatgttca gggatttttc 5760
accagctgtc ttcgacactt ctcgcaaacg agccgatcca caacccctgc aaacttggat 5820
tcagagtcag agcacttttt ccgatgctgt ttggataaaa aatcacaaag aacaatgctt 5880
gctgttgtgg actacatgag aagacaaaag agaccttctt caggaacaat ttttaatgat 5940
gctttctggc tggatttaaa ttatctagaa gttgccaagg tagctcagtc ttgtgctgct 6000
cactttacag ctttactcta tgcagaaatc tatgcagata agaaaagtat ggatgatcaa 6060
gagaaaagaa gtcttgcatt tgaagaagga agccagagta caactatttc tagcttgagt 6120
gaaaaaagta aagaagaaac tggaataagt ttacaggatc ttctcttaga aatctacaga 6180
agtatagggg agccagatag tttgtatggc tgtggtggag ggaagatgtt acaacccatt 6240
actagactac gaacatatga acacgaagca atgtggggca aagccctagt aacatatgac 6300
ctcgaaacag caatcccctc atcaacacgc caggcaggaa tcattcaggc cttgcagaat 6360
ttgggactct gccatattct ttccgtctat ttaaaaggat tggattatga aaataaagac 6420
tggtgtcctg aactagaaga acttcattac caagcagcat ggaggaatat gcagtgggac 6480
cattgcactt ccgtcagcaa agaagtagaa ggaaccagtt accatgaatc attgtacaat 6540
gctctacaat ctctaagaga cagagaattc tctacatttt atgaaagtct caaatatgcc 6600
agagtaaaag aagtggaaga gatgtgtaag cgcagccttg agtctgtgta ttcgctctat 6660
cccacactta gcaggttgca ggccattgga gagctggaaa gcattgggga gcttttctca 6720
agatcagtca cacatagaca actctctgaa gtatatatta agtggcagaa acactcccag 6780
cttctcaagg acagtgattt tagttttcag gagcctatca tggctctacg cacagtcatt 6840
ttggagatcc tgatggaaaa ggaaatggac aactcacaaa gagaatgtat taaggacatt 6900
ctcaccaaac accttgtaga actctctata ctggccagaa ctttcaagaa cactcagctc 6960
cctgaaaggg caatatttca aattaaacag tacaattcag ttagctgtgg agtctctgag 7020
tggcagctgg aagaagcaca agtattctgg gcaaaaaagg agcagagtct tgccctgagt 7080
attctcaagc aaatgatcaa gaagttggat gccagctgtg cagcgaacaa tcccagccta 7140
aaacttacat acacagaatg tctgagggtt tgtggcaact ggttagcaga aacgtgctta 7200
gaaaatcctg cggtcatcat gcagacctat ctagaaaagg cagtagaagt tgctggaaat 7260
tatgatggag aaagtagtga tgagctaaga aatggaaaaa tgaaggcatt tctctcatta 7320
gcccggtttt cagatactca ataccaaaga attgaaaact acatgaaatc atcggaattt 7380
gaaaacaagc aagctctcct gaaaagagcc aaagaggaag taggtctcct tagggaacat 7440
aaaattcaga caaacagata cacagtaaag gttcagcgag agctggagtt ggatgaatta 7500
gccctgcgtg cactgaaaga ggatcgtaaa cgcttcttat gtaaagcagt tgaaaattat 7560
atcaactgct tattaagtgg agaagaacat gatatgtggg tattccgact ttgttccctc 7620
tggcttgaaa attctggagt ttctgaagtc aatggcatga tgaagagaga cggaatgaag 7680
attccaacat ataaattttt gcctcttatg taccaattgg ctgctagaat ggggaccaag 7740
atgatgggag gcctaggatt tcatgaagtc ctcaataatc taatctctag aatttcaatg 7800
gatcaccccc atcacacttt gtttattata ctggccttag caaatgcaaa cagagatgaa 7860
tttctgacta aaccagaggt agccagaaga agcagaataa ctaaaaatgt gcctaaacaa 7920
agctctcagc ttgatgagga tcgaacagag gctgcaaata gaataatatg tactatcaga 7980
agtaggagac ctcagatggt cagaagtgtt gaggcacttt gtgatgctta tattatatta 8040
gcaaacttag atgccactca gtggaagact cagagaaaag gcataaatat tccagcagac 8100
cagccaatta ctaaacttaa gaatttagaa gatgttgttg tccctactat ggaaattaag 8160
gtggaccaca caggagaata tggaaatctg gtgactatac agtcatttaa agcagaattt 8220
cgcttagcag gaggtgtaaa tttaccaaaa ataatagatt gtgtaggttc cgatggcaag 8280
gagaggagac agcttgttaa gggccgtgat gacctgagac aagatgctgt catgcaacag 8340
gtcttccaga tgtgtaatac attactgcag agaaacacgg aaactaggaa gaggaaatta 8400
actatctgta cttataaggt ggttcccctc tctcagcgaa gtggtgttct tgaatggtgc 8460
acaggaactg tccccattgg tgaatttctt gttaacaatg aagatggtgc tcataaaaga 8520
tacaggccaa atgatttcag tgcctttcag tgccaaaaga aaatgatgga ggtgcaaaaa 8580
aagtcttttg aagagaaata tgaagtcttc atggatgttt gccaaaattt tcaaccagtt 8640
ttccgttact tctgcatgga aaaattcttg gatccagcta tttggtttga gaagcgattg 8700
gcttatacgc gcagtgtagc tacttcttct attgttggtt acatacttgg acttggtgat 8760
agacatgtac agaatatctt gataaatgag cagtcagcag aacttgtaca tatagatcta 8820
ggtgttgctt ttgaacaggg caaaatcctt cctactcctg agacagttcc ttttagactc 8880
accagagata ttgtggatgg catgggcatt acgggtgttg aaggtgtctt cagaagatgc 8940
tgtgagaaaa ccatggaagt gatgagaaac tctcaggaaa ctctgttaac cattgtagag 9000
gtccttctat atgatccact ctttgactgg accatgaatc ctttgaaagc tttgtattta 9060
cagcagaggc cggaagatga aactgagctt caccctactc tgaatgcaga tgaccaagaa 9120
tgcaaacgaa atctcagtga tattgaccag agtttcaaca aagtagctga acgtgtctta 9180
atgagactac aagagaaact gaaaggagtg gaagaaggca ctgtgctcag tgttggtgga 9240
caagtgaatt tgctcataca gcaggccata gaccccaaaa atctcagccg acttttccca 9300
ggatggaaag cttgggtgtg atcttcagta tatgaattac cctttcattc agcctttaga 9360
aattatattt tagcctttat ttttaacctg ccaacatact ttaagtaggg attaatattt 9420
aagtgaacta ttgtgggttt ttttgaatgt tggttttaat acttgattta atcaccactc 9480
aaaaatgttt tgatggtctt aaggaacatc tctgctttca ctctttagaa ataatggtca 9540
ttcgggctgg gcgcagcggc tcacgcctgt aatcccagca ctttgggagg ccgaggtgag 9600
cggatcacaa ggtcaggagt tcgagaccag cctggccaag agaccagcct ggccagtatg 9660
gtgaaaccct gtctctacta aaaatacaaa aattagccga gcatggtggc gggcacctgt 9720
aatcccagct actcgagagg ctgaggcagg agaatctctt gaacctggga ggtgaaggtt 9780
gctgtgggcc aaaatcatgc cattgcactc cagcctgggt gacaagagcg aaactccatc 9840
tcaaaaaaaa aaaaaaaaaa acagaaacgt atttggattt ttcctagtaa gatcactcag 9900
tgttactaaa taatgaagtt gttatggaga acaaatttca aagacacagt tagtgtagtt 9960
actatttttt taagtgtgta ttaaaacttc tcattctatt ctctttatct tttaagccct 10020
tctgtactgt ccatgtatgt tatctttctg tgataacttc atagattgcc ttctagttca 10080
tgaattctct tgtcagatgt atataatctc ttttacccta tccattgggc ttcttctttc 10140
agaaattgtt tttcatttct aattatgcat catttttcag atctctgttt cttgatgtca 10200
tttttaatgt ttttttaatg ttttttatgt cactaattat tttaaatgtc tgtacttgat 10260
agacactgta atagttctat taaatttagt tcctgctgtt tatatctgtt gatttttgta 10320
tttgataggc tgttcatcca gttttgtctt tttgaaaagt gagtttattt tcagcaaggc 10380
tttatctatg ggaatcttga gtgtctgttt atgtcatatt cccagggctg ttgctgcaca 10440
caagcccatt cttattttaa tttcttggct ttagggtttc catacctgaa gtgtagcata 10500
aatactgata ggagatttcc caggccaagg caaacacact tcctcctcat ctccttgtgc 10560
tagtgggcag aatatttgat tgatgccttt ttcactgaga gtataagctt ccatgtgtcc 10620
cacctttatg gcaggggtgg aaggaggtac atttaattcc cactgcctgc ctttggcaag 10680
ccctgggttc tttgctcccc atatagatgt ctaagctaaa agccgtgggt taatgagact 10740
ggcaaattgt tccaggacag ctacagcatc agctcacata ttcacctctc tggtttttca 10800
ttcccctcat ttttttctga gacagagtct tgctctgtca cccaggctgg agtgcagtgg 10860
catgatctca gctcactgaa acctctgcct cctgggttca agcaattctc ctgcctcagc 10920
ctcccgagta gctgggacta caggcgtgtg ccaacacgcc cggctaattt tttgtatttt 10980
tattagagac ggagtttcac cgtgttagcc aggatggtct cgatcgcttg acctcgtgat 11040
ccaccctcct cggcctccca aagtgctggg attacaggtg tgagccaccg cgcccggcct 11100
cattcccctc atttttgacc gtaaggattt cccctttctt gtaagttctg ctatgtattt 11160
aaaagaatgt tttctacatt ttatccagca tttctctgtg ttctgttgga agggaagggc 11220
ttaggtatct agtttgatac ataggtagaa gtggaacatt tctctgtccc ccagctgtca 11280
tcatataaga taaacatcag ataaaaagcc acctgaaagt aaaactactg actcgtgtat 11340
tagtgagtat aatctcttct ccatccttag gaaaatgttc atcccagctg cggagattaa 11400
caaatgggtg attgagcttt ctcctcgtat ttggaccttg aaggttatat aaattttttt 11460
cttatgaaga gttggcattt ctttttattg ccaatggcag gcactcattc atatttgatc 11520
tcctcacctt cccctcccct aaaaccaatc tccagaactt tttggactat aaatttcttg 11580
gtttgacttc tggagaactg ttcagaatat tactttgcat ttcaaattac aaacttacct 11640
tggtgtatct ttttcttaca agctgcctaa atgaatattt ggtatatatt ggtagtttta 11700
ttactatagt aaatcaagga aatgcagtaa acttaaaatg tctttaagaa agccctgaaa 11760
tcttcatggg tgaaattaga aattatcaac tagataatag tatagataaa tgaatttgta 11820
gctaattctt gctagttgtt gcatccagag agctttgaat aacatcatta atctactctt 11880
tagccttgca tggtatgcta tgaggctcct gttctgttca agtattctaa tcaatggctt 11940
tgaaaagttt atcaaattta catacagatc acaagcctag gagaaataac taattcacag 12000
atgacagaat taagattata aaagattttt tttttgtaat tttagtagag acagggttgc 12060
cattgtattc cagccttggc gacagagcaa gactctgcct caaaaaaaaa aaaaaaaagg 12120
ttttggcaag ctggaactct ttctgcaaat gactaagata gaaaactgcc aaggacaaat 12180
gaggagtagt tagattttga aaatattaat catagaatag ttgttgtatg ctaagtcact 12240
gacccatatt atgtacagca tttctgatct ttactttgca agattagtga tactatccca 12300
atacactgct ggagaaatca gaatttggag aaataagttg tccaaggcaa gaagatagta 12360
aattataagt acaagtgtaa tatggacagt atctaacttg aaaagatttc aggcgaaaag 12420
aatctggggt ttgccagtca gttgctcaaa aggtcaatga aaaccaaata gtgaagctat 12480
cagagaagct aataaattat agactgcttg aacagttgtg tccagattaa gggagataat 12540
agctttccca ccctactttg tgcaggtcat acctccccaa agtgtttacc taatcagtag 12600
gttcacaaac tcttggtcat tatagtatat gcctaaaatg tatgcactta ggaatgctaa 12660
aaatttaaat atggtctaaa gcaaataaaa gcaaagagga aaaactttgg acagcgtaaa 12720
gactagaata gtcttttaaa aagaaagcca gtatattggt ttgaaatata gagatgtgtc 12780
ccaatttcaa gtattttaat tgcaccttaa tgaaattatc tattttctat agattttagt 12840
actattgaat gtattacttt actgttacct gaatttatta taaagtgttt ttgaataaat 12900
aattctaaaa gcata 12915

Claims (17)

1.一种治疗有需要的对象的方法,所述方法包括:
(a)鉴定对象,其在自所述对象获得的肿瘤样品中具有癌细胞,其具有与参考水平相比降低的ATM水平和/或活性;和
(b)给予经鉴定的对象治疗,所述治疗包括治疗有效量的STING拮抗剂或cGAS抑制剂或其药学上可接受的盐、溶剂化物,或共晶体。
2.一种治疗有需要的对象的方法,所述方法包括给予对象包括治疗有效量的STING拮抗剂或cGAS抑制剂或其药学上可接受的盐、溶剂化物或共晶体的治疗,所述对象被鉴定为在从对象获得的肿瘤样品中具有具有癌细胞,其具有与参考水平相比降低的ATM水平和/或活性。
3.一种为需要治疗的对象选择治疗的方法,所述方法包括:
(a)鉴定对象,其在自所述对象获得的肿瘤样品中具有癌细胞,其具有与参考水平相比降低的ATM水平和/或活性;和
(b)为经鉴定的对象选择治疗,所述治疗包括治疗有效量的STING拮抗剂或cGAS抑制剂或其药学上可接受的盐、溶剂化物,或共晶体。
4.一种为有需要的对象选择治疗的方法,所述方法包括为经鉴定的对象选择包括治疗有效量的STING拮抗剂或cGAS抑制剂或其药学上可接受的盐、溶剂化物或共晶体的治疗,所述对象被鉴定为在从所述对象获得的肿瘤样品中具有癌细胞,其具有与参考水平相比降低的ATM水平和/或活性。
5.一种选择治疗对象的方法,所述方法包括:
(a)鉴定对象,其在自所述对象获得的肿瘤样品中具有癌细胞,其具有与参考水平相比降低的ATM水平和/或活性;和
(b)选择经鉴定的对象用治疗有效量的STING拮抗剂或cGAS抑制剂或其药学上可接受的盐、溶剂化物,或共晶体进行治疗。
6.一种选择参加临床试验的对象的方法,所述方法包括:
(a)鉴定对象,其在自所述对象获得的肿瘤样品中具有癌细胞,其具有与参考水平相比降低的ATM水平和/或活性;和
(b)选择经鉴定的对象参与临床试验,所述临床试验包括给予治疗,所述治疗包括治疗有效量的STING拮抗剂或cGAS抑制剂或其药学上可接受的盐、溶剂化物,或共晶体。
7.一种选择参加临床试验的对象的方法,所述方法包括选择鉴定为在从所述对象获得的肿瘤样品中具有癌细胞,其具有与参考水平相比降低的ATM水平和/或活性的对象参加临床试验,所述临床试验包括给予包括治疗有效量的STING拮抗剂或cGAS抑制剂或其药学上可接受的盐、溶剂化物或共晶体的治疗。
8.一种预测对象对STING拮抗剂或cGAS抑制剂的反应性的方法,所述方法包括:
(a)确定对象在自所述对象获得的肿瘤样品中具有癌细胞,其具有与参考水平相比降低的ATM水平和/或活性;和
(b)将步骤(a)中确定自所述对象获得的肿瘤样品中具有与参考水平相比降低的ATM表达和/或活性的对象鉴定为对STING拮抗剂或cGAS抑制剂治疗有反应的可能性增加。
9.一种预测对象对STING拮抗剂或cGAS抑制剂反应性的方法,所述方法包括鉴定被确定在自所述对象获得的肿瘤样品中具有癌细胞,其具有与参考水平相比降低的ATM水平和/或活性的对象,所述对象被鉴定为对STING拮抗剂或cGAS抑制剂治疗有反应的可能性增加。
10.如权利要求1-9中任一项所述的方法,其中所述对象被鉴定为具有癌细胞,与参考水平相比,其同时具有(i)降低的ATM水平和/或活性和(ii)增加的cGAS/STING信号转导途径活性;和
任选地,其中所述对象经鉴定为从所述对象获得的血清或肿瘤样品中具有与参考水平相比升高的cGAMP水平。
11.如权利要求1-10中任一项所述的方法,其中所述ATM水平和/或活性降低是对象中ATM基因的一个或两个等位基因同时缺失的结果。
12.如权利要求1-10中任一项所述的方法,其中所述ATM水平和/或活性降低是对象中ATM基因的一个或两个等位基因同时突变的结果。
13.如权利要求3或4所述的方法,其进一步包括给予对象所选治疗。
14.如权利要求8或9所述的方法,其进一步包括向经鉴定为对使用STING拮抗剂或cGAS抑制剂的治疗反应的可能性增加的对象给予治疗有效量的STING拮抗剂或cGAS抑制剂。
15.如权利要求1-14中任一项所述的方法,其中所述对象已被诊断或鉴定为患有癌症,例如选自下组的癌症:肾透明细胞癌、肾乳头状细胞癌、嫌色肾细胞癌、葡萄膜黑色素瘤、舌鳞状细胞癌、乳腺癌、骨肉瘤和皮肤癌。
16.如权利要求1-15中任一项所述的方法,其中所述STING拮抗剂是具有式I-XXIV或式M1-M6的任一化合物,或其药学上可接受的盐、溶剂化物或共晶体。
17.如权利要求1-15中任一项所述的方法,其中所述STING拮抗剂或cGAS抑制剂选自表C1-C2中的化合物,或其药学上可接受的盐、溶剂化物或共晶体。
CN202180094288.1A 2020-12-22 2021-12-21 治疗癌症的方法 Pending CN117320708A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063129229P 2020-12-22 2020-12-22
US63/129,229 2020-12-22
PCT/US2021/064638 WO2022140403A1 (en) 2020-12-22 2021-12-21 Methods of treating cancer

Publications (1)

Publication Number Publication Date
CN117320708A true CN117320708A (zh) 2023-12-29

Family

ID=79831386

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202180094288.1A Pending CN117320708A (zh) 2020-12-22 2021-12-21 治疗癌症的方法

Country Status (5)

Country Link
US (1) US20240060982A1 (zh)
EP (1) EP4267127A1 (zh)
JP (1) JP2024500877A (zh)
CN (1) CN117320708A (zh)
WO (1) WO2022140403A1 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024064358A1 (en) 2022-09-23 2024-03-28 Ifm Due, Inc. Compounds and compositions for treating conditions associated with sting activity

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5116742A (en) 1986-12-03 1992-05-26 University Patents, Inc. RNA ribozyme restriction endoribonucleases and methods
US4987071A (en) 1986-12-03 1991-01-22 University Patents, Inc. RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
JP7116422B2 (ja) 2016-04-05 2022-08-10 イミューン センサー リミテッド ライアビリティ カンパニー cGASアンタゴニスト化合物
US11603568B2 (en) * 2016-09-19 2023-03-14 Institut Gustave Roussy NOX2 as a biomarker of radiotherapy efficiency in cancer patients
TW202014408A (zh) 2018-07-03 2020-04-16 美商Ifm Due有限公司 用於治療與sting活性相關之病症的化合物及組合物
WO2020010155A1 (en) 2018-07-03 2020-01-09 Ifm Due, Inc. Compounds and compositions for treating conditions associated with sting activity
US20230047905A1 (en) 2018-11-19 2023-02-16 Ifm Due, Inc. Compounds and compositions for treating conditions associated with sting activity
WO2020106741A1 (en) 2018-11-19 2020-05-28 Ifm Due, Inc. Compounds and compositions for treating conditions associated with sting activity
WO2020150439A1 (en) 2019-01-17 2020-07-23 Ifm Due, Inc. Compounds and compositions for treating conditions associated with sting activity
WO2020150417A2 (en) 2019-01-17 2020-07-23 Ifm Due, Inc. Compounds and compositions for treating conditions associated with sting activity
WO2020236586A1 (en) 2019-05-17 2020-11-26 Ifm Due, Inc. N-hetaryl-squaramide compounds for treating conditions associated with sting activity
JP2022535743A (ja) 2019-05-29 2022-08-10 アイエフエム デュー インコーポレイテッド Sting活性に関連する状態を治療するための化合物および組成物
EP3983383A1 (en) 2019-06-14 2022-04-20 IFM Due, Inc. Compounds and compositions for treating conditions associated with sting activity
US20230002373A1 (en) 2019-10-03 2023-01-05 Ifm Due, Inc. Compounds and compositions for treating conditions associated with sting activity
US20230021448A1 (en) 2019-10-03 2023-01-26 Ifm Due, Inc. Compounds and compositions for treating conditions associated with sting activity
US20230002320A1 (en) 2019-10-03 2023-01-05 Ifm Due, Inc. Compounds and compositions for treating conditions associated with sting activity
CN115279770A (zh) 2019-12-31 2022-11-01 艾福姆德尤股份有限公司 用于治疗与sting活性有关的疾病的化合物和组合物
WO2021138434A1 (en) 2019-12-31 2021-07-08 Ifm Due, Inc. Compounds and compositions for treating conditions associated with sting activity

Also Published As

Publication number Publication date
US20240060982A1 (en) 2024-02-22
WO2022140403A1 (en) 2022-06-30
EP4267127A1 (en) 2023-11-01
JP2024500877A (ja) 2024-01-10

Similar Documents

Publication Publication Date Title
CN114761804A (zh) 治疗癌症的方法
KR102565167B1 (ko) Nlrp 활성과 관련된 병태를 치료하기 위한 화합물 및 조성물
KR20210030947A (ko) Nlrp3 길항제를 사용한 tnf 억제제 저항성 대상체를 위한 치료 방법 또는 치료제의 선택 방법
US20200323772A1 (en) Treatment of inflammatory disease using ingestible device to release immune modulator
KR20210046031A (ko) 유방암 치료를 위한 진단 및 치료 방법들
US6262333B1 (en) Human genes and gene expression products
CN117412745A (zh) 治疗癌症的方法
CN108359668A (zh) 用于调节载脂蛋白(a)表达的方法和组合物
KR20190120204A (ko) 과다증식성 질환을 치료하는 방법에 사용하기 위한 atr 키나제의 억제제
TW202321213A (zh) Kif18a抑制劑化合物之鹽和固態形式
CN117320708A (zh) 治疗癌症的方法
CA2518101A1 (en) Compositions and methods for the treatment of systemic lupus erythematosis
CN117425475A (zh) 治疗癌症的方法
CN117597117A (zh) 治疗癌症的方法
US6262334B1 (en) Human genes and expression products: II
US20230009902A1 (en) Treatment of a disease or condition in a tissue orginating from the endoderm
KR20190126812A (ko) 질환 진단용 바이오마커
AU778868B2 (en) Schizophrenia associated genes, proteins and biallelic markers
US20220251651A1 (en) Methods of characterizing resistance to modulators of cereblon
US6020476A (en) DAZ: a gene family associated with azoospermia
US20210324478A1 (en) Compositions and methods for identification assessment, prevention, and treatment of ewing sarcoma using tp53 dependency biomarkers and modulators
US20050233341A1 (en) Methods for identifying risk of melanoma and treatments thereof
RU2786719C2 (ru) Соединения и композиции для лечения состояний, ассоциированных с активностью nlrp
WO2005017176A2 (en) Methods for identifying risk of melanoma and treatments thereof
KR20240006511A (ko) 포스포디에스테라제 3b (pde3b) 억제제를 이용한 간 질환 치료 방법

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination